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Accurate diagnosis and measurement of limb volume in people with lymphoedema is 
important in order to provide best information for treatment, management and self-
management. Current assessment methods lack detail and accuracy. Three-dimensional 
camera imaging (3DCI) holds the potential to be cheap, accurate, and provide additional 
material about limb shape not provided by current methods. However, there is a need to 
ensure that this assessment method is valid and reliable.  
Methodology 
This prospective, observational, longitudinal study utilised a diagnostic test study 
framework to determine the validity, reliability and accuracy of 3DCI compared to 
circumferential tape measurement (CTM) and perometry and to explore whether shape 
is a feasible alternative to measure upper limb lymphoedema. 
Twenty women with breast cancer-related lymphoedema were recruited.  Phase one 
assessed criterion validity, intra-rater reliability, and accuracy of 3DCI by measuring 
limb volume of each participant with CTM, perometry and 3DCI four times over six 
months.   
Phase two investigated the use of limb shape as a method of lymphoedema assessment 
using oedema maps and calculations of shape redundancy derived from the 3DCI images 
in phase one.  These data sets were matched against limb volume to determine criterion 
validity, intra-rater reliability and accuracy.  
Results 
3DCI had high intra-rater correlation (ICC=0.87; p<0.00).  Concurrent validity ranged 
from 0.82 to 0.86 against perometry and CTM, with good sensitivity (91.7% to 100%) 
and moderate specificity (50% to 66.7%).   
Limb shape calculation (shape redundancy) had moderate intra-rater correlation 
(ICC=0.71; p=0.01); but correlated poorly with limb volume (r=0.19 to 0.39).  Coloured 
oedema maps were sensitive to change over time with colours clearly identifying 
problem areas and fluctuations within the affected limb. 
Conclusion 
Our study shows that 3DCI is a reliable, valid and accurate method of limb volume 
measurement, and that it could provide supportive information in clinical assessment.  In 
addition, limb shape provides insight into localised areas of swelling, which other 
methods of lymphoedema measurement do not. However, shape redundancy requires 
further refinement.    
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Lymphoedema is a dysfunction of the lymphatic system leading to chronic, progressive 
swelling.  It is described as an excess accumulation of interstitial, protein-rich fluid in 
the subcutaneous periphery of the body that can also be a vital sign of ill health in clinical 
medicine (Mortimer & Levick, 2004; Maclellan & Greene, 2014).  Lymphoedema is a 
morbid condition that can lead to painful limbs with a predisposition to infection, 
cutaneous changes, ulceration and in rare cases, malignant transformation (Grada & 
Phillips, 2017).  There are numerous causes for lymphoedema, both congenital and 
acquired, that can affect any part of the body, but occurs more commonly in the 
extremities (Thomas, 2017).  Finnane, Janda, & Hayes (2015), and Gebruers et al. (2017) 
report that lymphoedema is amongst the most feared consequences of cancer treatment 
because of its chronicity, and that it can result in significant physical, emotional, and 
psychological distress (due to altered appearance of the limb).  Furthermore, there are 
social repercussions such as difficulty fitting into clothing, as well as loss of functional 




Figure 1: Photo of breast cancer-related lymphoedema 
 
The most common cause of lymphoedema worldwide is filariasis (a parasitic worm), 
which is endemic in developing countries (Hadamitzky, Pabst, Gordon, & Vogt, 2014).  
However, in developed countries, lymphoedema secondary to cancer treatment     
(Figure 1) is the more common cause of lymphoedema, with breast cancer-related 
lymphoedema (BCRL) making up the highest volume in lymphoedema clinic caseloads 
(Lu & Dixon, 2019).  The literature reports that 21% of people diagnosed with breast 
cancer develop lymphoedema due to their cancer treatment (DiSipio, Rye, Newman, & 
Hayes, 2013), usually within a year of surgery and radiotherapy.  Moffatt et al. (2003) 
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raised awareness of the breadth of the impact lymphoedema has on the quality of life of 
people with BCRL.  However Cornelissen et al. (2018) reported that BCRL was still 
considered to be one of the most distressing and underestimated side-effects of cancer 
treatment in their study cohort.  Although this thesis will focus on the assessment of 
BCRL, it is important to consider the background and epidemiology of lymphoedema. 
 
1.1 Background and Epidemiology of Lymphoedema 
Lymphoedema is a chronic swelling (oedema) that persists for more than three months 
due to an overload of tissue fluid and is often used interchangeably with the term chronic 
oedema in the literature (National Lymphoedema Partnership, 2015).  As such, chronic 
oedema can be classified as either: 
 Lymphoedema – Primary or Secondary.  Primary lymphoedema is caused by 
congenital disease or abnormality of the lymphatics; Secondary lymphoedema is 
due to damage of the lymphatic system through infection, trauma, cancer and its 
treatments including excision of lymph nodes and radiotherapy, and obstruction 
of the lymphatic system; 
 Lymphovenous oedema – is due to the failure of the venous system such as deep 
vein thrombosis, valvular incompetence and varicose veins; 
 Dependency oedema – loss of muscle pump causes poor venous return resulting 
in a build-up of tissue fluid;  
 Lipoedema – is a swelling of fat deposits resulting in limb distortion but is 
sparing of the feet and hands.   
(International Lymphoedema Framework, 2012; Maclellan & Greene, 2014)  
 
Obesity is both a cause and exacerbating factor of lymphoedema (Greene, Grant, Slavin, 
& Maclellan, 2015).  It can result in any of the first three types of chronic oedema, i.e. 
secondary lymphoedema due to obstruction as the fat cells compress the lymphatics; 
lymphovenous oedema due to increased pressure on the cardiovascular system resulting 
in venous disease; and dependency oedema due to reduced mobility and an inactive 
lifestyle.    
 
The prevalence of lymphoedema has increased from 1.33 per 1000 (Moffatt et al., 2003) 
to 3.93 per 1000, with the highest incidence for those aged 85 or above (28.75 per 1000) 
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(Moffatt, Keeley, Franks, Rich, & Pinnington, 2017).  Following the inception of 
lymphoedema services in each of the Health Boards across Wales (Welsh Assembly 
Government, 2009), collected data captures the number of patients on each service 
caseload, including the number of new referrals and number of discharges each month.  
Since 2013, there has been a demonstrable increase in prevalence and incidence in 
Wales, with the prevalence increasing from 4.12 per 1000 to 6.83 per 1000 by the end 
of March 2020, and incidence increasing from 1.56 to 2.58 per 1000 (Lymphoedema 
Network Wales [LNW], 2020a).  Cancer cases account for 30% of caseloads in Wales 
and of these, 85% are BCRL.  Thus, the estimated prevalence of BCRL in Wales is 1.74 
per 1000.  With rising prevalence and limited capability, services have to ensure that 
health care provided is both valuable to the patient and the National Health Service 
(NHS). 
 
Porter, Pabo, & Lee (2013) express that the overarching strategy for health care should 
be to improve value for patients.  They define value as patient outcomes achieved 
relative to the amount of money spent.  The Allied Health Professions Outcome 
Measures UK Working Group (2019) developed a checklist for selecting outcomes 
measures.  There is currently no standardised outcome measure for lymphoedema, and 
outcomes can vary from clinical decisions, such as volume reduction, a decrease in pain, 
reduced number of reported episodes of cellulitis, improved function and/or level of 
compression therapy required, to more practical outcomes for the patient such as impact 
on work, resuming hobbies, and wearing normal clothes.  Thus, determining an 
assessment measurement tool that offers results that the therapist can easily interpret, 
and that the patient understands, is vital towards implementing Value-Based Healthcare. 
 
1.2 Statement of the Diagnostic Problem 
Diagnosing lymphoedema can be challenging due to a lack of national and international 
protocols and guidance regarding thresholds for its clinical diagnosis and the different 
methods of lymphoedema measurement used in clinical practice.  Medical scanning and 
imaging of lymphoedema are costly and do not add value to the diagnosis or choice of 
conservative treatments.  They are thus not routinely performed.  Hence, clinicians need 
to rely on the person's history and symptom reports, physical assessment of the skin and 
soft tissues, and the measurement of the swollen limb (Maclellan & Greene, 2014).  
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Furthermore, observation of the limb shape comparing the affected to the unaffected 
side (see Figure 1) reveals areas of localised swelling of the affected arm that may 
require intensive intervention.   
 
Physical measurements, such as circumferential tape measurement (CTM), water 
displacement, and perometry are used to calculate volume differences between the 
affected and unaffected sides to determine the extent of lymphoedema (Hidding et al., 
2016).  Newer technological devices are now available to determine tissue fluid content 
of a limb, and more recently, three-dimensional camera imaging (3DCI) has been used 
to capture limb volumes and limb volume differences (Levenhagen, Davies, Perdomo, 
Ryans, & Gilchrist, 2017).  Studies indicate that 3DCI could be used to assess limb 
shape, which may aid in the diagnosis of lymphoedema (Karakashian, Shaban, Pike, & 
van Loon, 2018). 
 
By utilising data from Three-Dimensional (3D) images, shape potentially offers a 
supplementary or alternative method of measuring lymphoedema.  Using the images 
gained from 3DCI, areas of localised swelling can be objectively identified for the first 
time.  3DCI is non-invasive, fast to perform and relatively inexpensive compared to 
other technologies on the market.  It provides data about the shape of the affected limb, 
something that current methods of measurement do not.  However, what is not yet clear 
is whether this method is equivalent, or more accurate than current methods of volume 
measurement.   
  
Clinical practice within the NHS is driven by the evidence-base, but with conflicting 
outcomes for measuring methods in the literature, and limited resources available to 
services, CTM is used most extensively since it requires minimal equipment, and can be 
used in most locations.  However, no study to date has evaluated the economic value of 
each method of measurement; thus, no evidence exists to support that CTM may or may 
not be the most resource-effective method of assessing lymphoedema.   
 
Due to ambiguity in the current methods of assessing lymphoedema, this thesis will 
present the investigations into the possibility of a new way of measuring for 
lymphoedema as opposed to current methods of volume and tissue water content.  The 
overarching aims of this study were to determine the validity, reliability and accuracy 
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of upper limb volume results obtained from 3DCI compared to CTM and perometry, and 
to analyse whether the shape of the limb is a feasible alternative to measure 
lymphoedema.  Four objectives were identified to meet the aims of this study, which 
were to: 
 
1. Determine whether 3DCI volume outcomes are comparable to CTM and 
perometry as a measure of intra-rater reliability 
2. Assess the criterion validity of 3DCI against previously validated measures, i.e. 
CTM and perometry 
3. Establish whether 3DCI is an accurate method of measurement for upper limb 
lymphoedema 
4. Ascertain whether limb shape derived from 3DCI is a potential new method of 
lymphoedema measurement 
 
1.3 Organisation of the Thesis 
Figure 2 provides an overview of the layout of the thesis.  The thesis comprises six 
chapters, with this first chapter as an introduction to the study undertaken.  Chapter 2 
explains how lymphoedema is assessed and classified.  The systematic literature review, 
presented in Chapter 3, analyses the three measurements used in the study focussing on 
delivery, validity, reliability and the diagnostic thresholds.   
 
Chapter 4 describes the study design that was used to address the research questions 
identified.  The results of the study are presented in Chapter 5, with the discussion and 
conclusion of the findings conveyed in Chapter 6.  This final chapter also identifies the 






Figure 2: Graphic illustration of the organisation of the thesis chapters 
 
• Background and Epidemiology of Lymphoedema
• Elucidating the need for lymphoedema assessment
Chapter 1: 
Introduction
• Clarifies the assessment process to diagnose 
lymphoedema




• CTM, Perometer and 3DCI reviewed
• Analysis of the measurement procedure, reliability, 





• Study design described
• Phase One: analysis of limb volume derived from 
3DCI and compared to CTM and perometer
• Phase Two: investigates the use of limb shape as a 
method of lymphoedema assessment through the 









• Discussion of findings













2.1 Introduction  
Unlike the triple test for diagnosing breast cancer, there is no protocol to help define a 
clinical diagnosis of upper limb lymphoedema.  The lack of a clear protocol is 
compounded by the fact that there is no international consensus for the classification of 
lymphoedema, making a diagnosis even more challenging.  There is also a lack of 
agreement when measuring to determine the extent of lymphoedema.  Lu & Dixon 
(2019) report that the most common approach to measure lymphoedema of the limb is 
using volumetric measurements.  However, this method does not account for variations 
in muscle mass and adipose tissues, as the measurements include bone, fat, muscle and 
subcutaneous tissues and is unable to discern between these (Fu et al., 2013).   
 
Following the principle of Archimedes, water displacement is considered the gold 
standard in measuring limb volume (Levenhagen et al., 2017) as the water displaced by 
an object equals the volume of that object.  Clinically, the use of a tape measure to 
measure limb volume is the most popular method employed, while in research, 
perometry is highly valued due to its perceived accuracy in calculating the circumference 
of a limb through the use of infra-red and light-emitting diodes (LEDs) (Batista, 
Baiocchi, Campanholi, Bergmann, & Duprat, 2018).  However, measurement of actual 
tissue fluid would be more accurate than the volumetric value of a limb that includes 
bone, muscle, fat and skin.  Thus technologies, such as tissue dielectric constant (TDC) 
(see section 2.4.3.2) and bio-impedance spectroscopy (BIS) (see section 2.4.3.3), which 
measure tissue fluid content, have been investigated for several years, but are yet to be 
used with confidence in clinical settings (Levenhagen et al., 2017).   
 
3DCI has more recently been studied to determine limb volume; however, no research 
to date has evaluated the concept of determining the presence or extent of lymphoedema 
by objectively assessing the shape of the limb.  The advantage of measuring the shape 
of a limb is that it can identify the amount of distortion in shape from the unaffected 
side, which would indicate the presence of localised lymphoedema, something that a 
volume measurement cannot.  The importance of assessing for localised lymphoedema 
is that it informs the true severity of the lymphoedema and the need for specific 
compression therapy.  Additionally, it provides a deeper understanding to support the 
patient’s reported symptoms such as clothing not fitting.  For example, real value for a 
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patient is treatment that can enable them to button up a long sleeve shirt when their 
swelling is localised at the wrist. 
 
Value-Based Healthcare aims to reduce variations in services to maximise the value of 
person-centred care (Gray, 2017).  Research to establish what people desire in terms of 
monitoring their lymphoedema is lacking; thus, lymphoedema services are unable to 
evidence the value of their service to their stakeholders in these terms.  Understanding 
whether patients comprehend their limb volume difference expressed as a percentage 
(%) or volume as millilitres (ml) of the affected side's deviation from the unaffected is 
fundamental.  Alternatively, therapists should determine whether it is easier to express 
this difference using a graph, or whether a picture could express the archetypical one 
thousand words.  3DCI has the potential of presenting swelling in a visual format, but 
this has not been researched previously.  Thus, this thesis will present the research that 
proposes that limb shape, derived from 3DCI, could add a new way of assessing and 
monitoring upper limb lymphoedema.  As the incidence of BCRL is 21% (DiSipio et al., 
2013) and predisposes a high caseload of patients, this thesis will study 3DCI limb 
volume and shape of the upper limb. 
 
2.2 Diagnosing Lymphoedema 
Diagnosis of lymphoedema can be established in 90% of cases by appraising a person’s 
history, self-reported symptoms and undertaking a physical examination (Maclellan & 
Greene, 2014; Perdomo, Davies, Levenhagen, & Ryans, 2014).  Not all upper limb 
lymphoedema is due to BCRL, thus indicative contributors to lymphoedema such as 
other cancers (melanoma), familial history (i.e. potential genetic link), trauma, number 
of infections (including cellulitis), surgery (including orthopaedic), obesity, and travel 
to countries endemic with filariasis need to be determined.   
 
In the case of BCRL, a breast cancer diagnosis together with the type of surgery (wide 
local excision, mastectomy or primary reconstruction), the number of lymph nodes 
removed (sentinel lymph node biopsy and/or axillary node clearance), chemotherapy, 
radiotherapy, and/or hormone therapy will inform the risk and cause of the 
lymphoedema (Göker et al., 2013).  In some cases, trauma or infection to the ‘at risk’ 
arm may be the trigger of the person’s sudden onset of lymphoedema, as opposed to the 
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slow progressive deterioration of lymphatic drainage of the ‘at risk’ arm due to either of 
the cancer treatments.   
 
Patient self-reported symptoms may include swelling, heaviness, tightness, pain, 
discomfort, aching and numbness of the swollen area (Williams, Moffatt, & Franks, 
2004).  Exploration of these symptoms includes identifying the location of the swelling, 
ascertaining when the person first noticed the swelling and what the behaviour of the 
symptoms are, i.e. is the swelling getting better, worse, stays the same or fluctuates.  
Personal experience of the lymphoedema must be considered, and these could include 
exacerbating factors such as heat, repetitive activities and static postures.  Limitations in 
personal attire can also occur such as clothing too tight over a misshapen arm, rings no 
longer fitting on fingers; and functional difficulties like cooking, lifting pans or not being 
able to hang up washing due to the heaviness of the arm (Lam, Wallace, Burbidge, 
Franks, & Moffatt, 2006).  The level of treatment to be agreed takes into consideration 
the person’s social circumstances in terms of their support structure, childcare 
arrangements, the responsibility of caring for elderly relatives, type of employment, as 
well as their social habits including smoking and drinking.  Environmental factors such 
as the need to sleep in a chair (as this causes and exacerbates dependency 
lymphoedema), and mobility aids used, gives the therapist insight into the impact of 
lymphoedema and potential for improvement (Thomas & Morgan, 2017). 
 
Williams, Moffatt, & Franks (2004) report that the impact of lymphoedema on a person 
can be considerable.  Alcorso & Sherman (2015) are more specific in stating that BCRL 
may impair quality of life, cause disturbance of body image and result in psychological 
distress.  Their study indicates that an increase in lymphoedema symptoms is associated 
with psychological distress, including negatively affecting a person's self-identity and 
emotional disturbances such as fear, sadness and worry. Furthermore, Alcorso & 
Sherman (2015) demonstrate that perceived treatment effectiveness, and the inability to 
self-regulate lymphoedema is associated with distress and body image disturbance, 
which can lead to psychological distress requiring appropriately targeted counselling 
and support.   
 
Thomas & Hamilton's (2014) qualitative study revealed that individuals who have 
BCRL report a loss of expression as they are unable to wear preferred clothing or 
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jewellery due to the size of their affected arm.  Their leisure activities are affected as 
they are no longer able to partake in previously enjoyed hobbies as their lymphoedema 
arm is too heavy.  Consequently, this results in changes to self-perception and social 
isolation.  They also opine a loss of independence in activities of daily living and self-
care.  It is thus essential to identify psychosocial obstructions as part of the holistic 
lymphoedema assessment. 
 
One of the most debilitating and frightening experiences as a direct complication of 
lymphoedema is cellulitis (skin infection / acute inflammatory episode) (Lam et al., 
2006).  Al-Niaimi & Cox (2009) report that up to 25% of patients with lymphoedema, 
regardless of cause, may develop cellulitis.  It can develop in the space of an hour with 
the person presenting with a red, swollen and hot to touch upper limb, and they feel 
generally unwell as if they have the flu.  In some cases, cellulitis may grumble for weeks 
before a diagnosis is made. In more severe instances the person may have a fever and/or 
rigors, and in extreme situations, they may require hospitalisation as it could develop 
into sepsis (Al-Niaimi & Cox, 2009; Cannon, Dyer, Carapetis, & Manning, 2018; 
Moffatt, Doherty, Franks, & Mortimer, 2018).  Cellulitis damages the lymphatics, 
potentially further exacerbating lymphoedema.  It is therefore vital to understand on 
assessment how many infections the person may have had in the previous 12 months as 
they may require prophylactic antibiotic management for at least a year in an attempt to 
prevent further damage to the lymphatics (Mason et al., 2014; BLS & LSN, 2016).  
Enquiring whether they were hospitalised for cellulitis will give the therapist an 
indication of the level of damage to their lymphatic system.  It is noteworthy that 
cellulitis can recur if not appropriately managed, or if lymphoedema is poorly controlled 
(Al-Niaimi & Cox, 2009). 
 
Once a lymphoedema diagnosis is suspected, further subjective and objective 
assessments need to be performed to confirm the type and severity of the lymphoedema, 
before a treatment plan is formulated.  The next section explains how the presenting 
lymphoedema may be classified using a system of staging to identify the level of severity 




2.3 Staging of the Severity of Lymphoedema 
Defining and staging lymphoedema remains a subject of international debate.  As such, 
there is no one system to aid clinicians in classifying lymphoedema, thus making it 
challenging to compare lymphoedema outcomes.  Even though limb shape distortion is 
a recognised indicator of lymphoedema, currently no classification of lymphoedema 
includes limb shape distortion as a factor in the diagnosis, severity and staging of 
lymphoedema.  Clinically, the greater the shape deviation from the normal, the more 
challenging and intensive the treatment will be (International Lymphoedema 
Framework, 2012).  It is also unlikely for large limb shape deviations to have a positive 
outcome similar to that of a normal shaped limb following lymphoedema treatment.  
Thus, a value needs to be attributed to the amount of deviation of the limb from the 
normal shape to assist with the staging of the lymphoedema.  Current staging focuses on 
limb volume and soft tissue changes in an attempt to capture the severity of the 
lymphoedema. 
 
The International Society of Lymphology (ISL) has developed a lymphoedema staging 
(Appendix 1) based on the physical condition of the extremities (ISL, 2013).  They 
acknowledge that this staging fails to capture the pathological and possible genetic 
defects of the condition.  Thus, the ISL staging can be considered a crude descriptor of 
the presentation of lymphoedema.  It is not sensitive to the different types of 
lymphoedema from the numerous causes (primary and secondary), nor does it allow for 
different presentations in one limb, for example, the hand may be soft and pitting (stage 
II), but the forearm may be firm with thickened skin (stage III).   
 
The British Lymphology Society (BLS) have developed a classification and staging of 
lymphoedema based on the ISL staging of 2009 (British Lymphology Society, 2016).  
Although they appear similar, they do not directly correlate (Appendix 1).  The BLS 
staging is also inclusive of the functional capabilities of the patient, making it more 
sensitive in terms of capturing the impact of the lymphoedema on the patient.  The BLS 
also acknowledges that for people with advanced cancer, or for those who are at the end 




In Wales, clinicians assign a ‘Treatment Outcome’ (Table 1) following each 
appointment to identify the severity of the lymphoedema and to determine the caseload 
within each clinic (LNW, 2020b).  As a ‘treatment outcome’, it is not considered a 
classification, especially as it is not a recognised, nor validated tool.  This is the only 
categorisation of lymphoedema severity in the world that refers to the shape of the limb 
as being 'normal' or 'distorted' (Figure 3) and relies on the ratio between the proximal 
(upper arm) to distal (forearm) segment of the limb being calculated using a programme 
called Lymcalc used for CTM.   
 
Table 1: Lymphoedema Treatment Outcomes (LNW, 2020b) 
# Description of Treatment Outcome 
1 
At Risk (no swelling) 
No evidence of lymphoedema; has known risk factors   
Limb shape normal: Proximal to Distal ratio of 0.0/ 0.1 
2 
Mild (minimal swelling) 
5 - 10% volume difference between limbs 
Limb shape is normal: Proximal to Distal ratio of 0.0/ 0.1  
3 
Moderate (moderate swelling) 
Overall volume difference 11- 20% between limbs.   
Limb shape distortion: Proximal to Distal ratio 0.2  
4 
Severe (severe swelling) 
21%- 49% total volume difference between limbs.   
Limb shape distortion: Proximal to Distal ratio 0.3  
5 
Complex 
50% or more total volume difference between limbs. 
Skin changes including Fibrosis, Peau d‘orange, papillomatosis, hyperkeratosis, skin folds and cellulitis  
Limb shape distortion: Proximal to Distal ratio 0.4 or above 
5W 
Complex with wound/leaking lymphorrhoea 
Patient has lymphoedema and a wound/or ‘wet legs’ with leaking lymphorrhoea. The open wound can be 
superficial or complex but requires dressings and compression. 
 
With the introduction of fluorescent lymphography, Yamamoto et al. (2011a) have 
devised new classifications for lymphoedema, whereby the rate of 'arm dermal backflow' 
is staged (Appendix 1).  They went on to devise a similar backflow staging for the lower 
limb, but Mihara et al. (2014) later advanced this staging based on the pumping function 
of the lymphatics to identify early-stage lymphedema and to evaluate the pathologic 
condition over a wider area, as opposed to being limited to the affected lower limb 
(Appendix 1).  The limitations of fluorescent staging are that very few clinics have 
access to this equipment as the cost is prohibitive and staff training would have to be at 




        
 
    
Figure 3: Treatment outcome using limb shape to aid categorisation of lymphoedema 
severity (photos with permission from LNW): 
A= right affected, Code 1 (At Risk) with normal shape  
B= right affected, Code 2 (Mild) with normal shape  
C= left affected, Code 3 (Moderate) with a distorted shape of the forearm  
D= left affected, Code 4 (Severe) with shape distortion and large excess volume  
E= right affected, Code 5 (Complex) with shape distortion and significant excess volume  
 
2.4 Assessment of Lymphoedema 
Understanding the development and behaviour of lymphoedema symptoms should 
facilitate confirmation of the diagnosis (Levenhagen et al., 2017) and commencement 
of treatment.  Where the cause or phenotype of lymphoedema is unknown, a person may 
be referred for genetic testing, especially in cases of primary lymphoedema 
(Lymphoedema Framework, 2006; Lee et al., 2013).   
 
The assessment process needs to capture both the patient's experience of their 
lymphoedema, together with the therapist's findings to ensure an accurate diagnosis and 
classification of the lymphoedema.  The application of a simple visual analogue scale 
can capture the patient's experience of pain and heaviness related to their lymphoedema 
(section 2.4.1).  Using validated quality of life questionnaires can also help the therapist 
understand the impact lymphoedema has on the patient and can be used to assess 
treatment outcomes (section 2.4.2).  The clinical examination that follows needs to 
incorporate elements of skin and tissue observation and palpation, physical 




measurements of limb volume or tissue fluid (section 2.4.3), and the use of medical 
imaging such as lymphoscintigraphy (section 2.4.4). 
 
2.4.1 Visual Analogue Scale 
A Visual Analogue Scale (Figure 4) is a self-report measure that can be modified for 
swelling, heaviness or pain.  It is a 10 centimetre (cm) horizontal line with ‘no (pain)’ 
anchoring at the 0 cm end, and ‘worst (pain)’ at the 10 cm anchor.  The distance of a 
mark made by the patient from 0 cm is measured with a ruler and can be recorded as 
‘how much pain, swelling, or heaviness’ is present.  The Visual Analogue Scale is a 
validated tool in the acute, chronic and oncology populations and has been used 
extensively in BCRL (Harrington, Gilchrist, & Sander, 2014; Levenhagen et al., 2017). 
 
 
0        10 
No pain             Worst pain 
 
Figure 4: Visual Analogue Scale 
 
Levenhagen, Davies, Perdomo, Ryans, & Gilchrist’s (2017) literature review found that 
self-report of swelling using a visual analogue scale demonstrated good inter-rater 
reliability (interclass correlation coefficient [ICC] = 0.70).  Czerniec et al. (2010) used 
the Visual Analogue Scale in their study to assess how swollen the participant felt their 
arm was, with the 0 cm anchor indicating “not at all” and, the 10 cm anchor indicating 
“extremely so”.  They found the correlation between Visual Analogue Scale and upper 
limb volumes by CTM and perometry to be moderate (r=0.66 and 0.65 respectively). 
   
The main factors influencing the Visual Analogue Scale is subjectivity as it measures a 
person’s experience of their lymphoedema, which is then compared to objective 
measurements.  Subjective indicators can be influenced by emotions, perceptions and 
previous experiences, all of which may distort the person’s account for their score. 
 
2.4.2 Quality of Life 
Lymphoedema of the arm secondary to breast cancer treatment is considered by some 
to be one of the most distressing and underestimated side effects (Cornelissen et al., 
2018).  Moffatt et al. (2003) highlighted the breadth of impact lymphoedema has on a 
17 
 
person's Quality of Life (QoL), including physical, emotional, social functioning and 
physical functioning.  They also found that there was a significant impact of cellulitis 
secondary to lymphoedema on people's lives; as well as restrictions in QoL in people’s 
ability to function physically and socially, plus the potentially devastating emotional 
consequences.   
 
Several tools exist to capture the impact that lymphoedema has on a person's life.  Pusic 
et al. (2013) and Cornelissen et al. (2018) did systematic reviews of the literature to 
identify the optimal methods of assessing QoL for those people with Breast Cancer-
Related Lymphoedema (BCRL).  They acknowledge that choosing the tool that would 
best inform treatment outcomes is often a challenge to clinicians who do not want to 
burden their patients with excessive paperwork, especially as many that have BCRL are 
often involved in clinical trials already requiring extensive questionnaires to be 
completed (Cornelissen et al., 2018).   
 
Pusic et al.’s (2013) systematic review identified 39 studies with high-quality data on 
health-related QoL outcomes with 17 instruments used, with two specific to BCRL.  
They recommend the use of the Upper Limb Lymphoedema 27 (ULL-27) by Launois, 
Mègnigbêto, Pocquet, & Alliot (2002) due to its strong psychometric properties. 
Cornelissen et al. (2018) also undertook a systematic review of which 49 studies met 
their inclusion criteria for QoL in BCRL, with 15 different questionnaires extracted.  
They concluded that the Lymphoedema Functioning, Disability, and Health (Lymph-
ICF) questionnaire by Devoogdt, Van Kampen, Geraerts, Coremans, & Christiaens, 
(2011), and the Lymphoedema Quality of Life Inventory (LyQLI) questionnaire by 
Klernäs, Johnsson, Horstmann, Kristjanson, & Johansson (2015) were the most 
complete and accurate questionnaires to assess QoL in patients with BCRL as these 
assess the largest number of QoL domains and specific arm symptoms.  A key difference 
between these two measures is that the Lymph-ICF uses a Visual Analogue Scale, 
whereas the LyQLI uses categorical answers.  Interestingly, even though the ULL-27 
measure was included in Cornelissen et al.’s (2018) study, it was not critiqued against 
the other measures, possibly due to not fully meeting the criteria to assess global QoL 
and the different QoL domains, together with assessing all specific arm symptoms as 




QoL measures in clinical practice can inform treatment and ensures that the assessment 
of lymphoedema focuses on the person rather than the condition.  In research, the use of 
QoL measures is dependent on the research questions being asked, and the sensitivity 
required of the test.  Thus, with the availability of several QoL tools ranging from the 
more generic and crude tools such as the EQ-5D-5L questionnaire (EuroQol, 2017) 
looking at function and well-being, to very subject-specific tools such as the Upper Limb 
Lymphoedema 27 (ULL-27) (Launois, Mègnigbêto, Pocquet, & Alliot, 2002) and 
'Quality of Life Measure for Limb Lymphoedema' (LYMQOL) (Keeley et al., 2010), 
clinicians and researchers need to understand the function of the tool before use. 
 
Following on from the subjective information, an examination of the person's symptoms 
follows.  Good clinical reasoning skills will pull all the subjective and objective data 
together to devise a treatment plan with the person to ensure they have ownership of the 
management of their lymphoedema. 
 
2.4.3 Clinical Examination 
The physical examination should include palpation of the soft tissues for fibrosis, pitting 
oedema, Stemmer’s Sign test (Figure 5), and overall tissue quality (Levenhagen et al., 
2017).  This will include identification of skin changes such as dermal fibrosis, 
hyperkeratosis, papillomatosis, fungal infections, wounds (including ulcers), 
lymphangiectasia, lymphorrhoea, folliculitis, dermatitis and cellulitis (Fife et al., 2017).  
Observation and documentation of soft tissue changes, for example, skin folds, as well 
as skin colour and temperature, are essential in providing the therapist with evidence as 
to the severity of the person's symptoms.  Limb shape distortion provides further 
evidence for the presence of lymphoedema.  This is established by visually comparing 
the affected to the unaffected side to see if there is any deviation from the unaffected 
side.  This deviation may be localised to the forearm, or there may be a noticeable 
difference in the size of the upper arm to the forearm.  Currently, no measurement exists 
to capture limb shape distortion, although, as discussed in section 2.3, a proximal to 
distal ratio can be calculated from CTM (LNW, 2017). 
 
Additional clinical signs may include reduced visibility on the affected side of the 
subcutaneous veins of the anterior forearm and posterior hand.  Furthermore, rounding 
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or fullness of the elbow and distal upper arm regions are also clear signs of the presence 










Figure 5: Positive Pitting Test (right) and Positive Stemmer's Sign (left) 
 
A vascular examination is required to ensure the safety of the application of compression 
and to determine contributing factors to lymphoedema.  This includes a visual and 
physical assessment of the arm to determine the presence of arterial insufficiency 
including hair loss, the colour of the nailbed, pain at night or rest, blanching on elevation 
and a capillary refill test (normal < 3 seconds).  Should there be any concern following 
this examination, it is advised that a referral to a vascular clinic be made. 
 
Assessment of upper limb functional movement is undertaken to determine restrictions 
in range of movement or muscle weakness as these may exacerbate lymphoedema.  It is 
worth determining at this stage whether referral to a physiotherapist and/or occupational 
therapist is required as part of their rehabilitation package and lymphoedema 
management. 
 
Measuring the arms by CTM, perometry, or water displacement determines volume 
differences between limbs that can help determine the severity of the lymphoedema 
(Levenhagen et al., 2017).  Both arms are measured as the unaffected limb can be used 
as a reference or control when calculating excess volume in the presence of unilateral 
lymphoedema (Casley-Smith, 1994).  Arm dominance must be known as it generally 
measures 1.6% to 4.7% bigger than the non-dominant limb (Smoot, Wong, & Dodd, 
2011).  Mayrovitz, Macdonald, Davey, Olson, & Washington (2007) state that assessing 
limb volume difference at each point of contact will determine effective treatment 
outcomes.  Casual variation in a person's general body mass index (BMI) over time is 
negated by measuring both arms at each point of contact (Perdomo et al., 2014) as the 
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volume of a limb includes bone, muscle, fat, interstitial fluid and the dermis (Fu et al., 
2013).   
 
Volume decrease or increase may be due to muscle atrophy or hypertrophy, and not 
necessarily an increase in the extracellular fluid (interstitial fluid) related to 
lymphoedema.  It is therefore prudent that a therapist determines whether a person's 
activity may account for unilateral limb hypertrophy due to overuse, such as a change in 
profession requiring more muscle activity, or limb atrophy as a consequence of 
avoidance behaviour, for example, due to pain or fear of movement.  A noticeable 
change in limb volume often follows a broken arm, when the muscles will be atrophied 
following immobilisation in a plaster cast.  Measurement of the arm will not mean an 
improvement in the lymphoedema, as the muscle volume will be significantly reduced.  
The reduction can be disproportional due to changes in the shape of the arm as a result 
of the loss of muscle mass, and dependent on the location of the break.   
 
 
Figure 6: Shape distortion due to BCRL 
 
Figure 6 portrays left arm lymphoedema secondary to breast cancer.  The limb shape 
disproportion is evident when compared to the right arm.  With mild to moderate 
lymphoedema, the calculated limb volumes may be much the same over time; however, 
the progression of the condition should also be monitored by assessing the shape of the 
limb and patient feedback.  Often the patient will report that their clothes are tighter over 
their forearm, or their rings no longer fit their fingers, which are indicative of a change 
in shape, and not necessarily a volume change.  This could be due to the presence of 
fibrosis, where the skin and tissues become thicker, distorting those tissues, without 
necessarily changing limb volume as such.  Both shape and limb volume are important, 
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but often clinicians only take limb volume into account in the treatment plan of mild to 
moderate lymphoedema, when a change in shape can indicate a change in the 
lymphoedema behaviour that may require more intensive treatment to stop the 
progression of the condition. 
 
Measuring for lymphoedema is a challenging issue as a consensus for defining 
lymphoedema based on limb volume is non-existent  (Tewari, Gill, Bochner, & Kollias, 
2008; Blaney et al., 2015).  Various thresholds exist for diagnosing lymphoedema.  The 
threshold measures compare the affected to the unaffected arm.  The types of thresholds 
described in the literature include >2cm circumference difference at any point; >5% 
increase in circumference at any site; >10% increase in circumference at any point; 5% 
difference in the sum of arm circumferences; >10% difference in total limb volume; and 
>200ml volume difference between limbs, or a combination of these (Asim et al., 2012; 
Levenhagen et al., 2017).  The threshold of a 10% increase in inter-limb differences is 
frequently used; however, although it has good specificity (the test identifies the absence 
of a condition), it has poor sensitivity (the test identifies the presence of a condition) for 
detecting mild lymphoedema (Wang et al., 2017).   
 
Some studies support limb measurements before breast cancer surgery as it helps take 
into consideration pre-existing asymmetry, is a baseline against which a diagnosis of 
early or mild lymphoedema can be determined within a screening programme, and are 
strongly encouraged (Blaney et al., 2015; Levenhagen et al., 2017; Bundred et al., 2020).  
Smoot et al. (2014) encourage pre-operative measurements to capture normal variability 
associated with limb dominance.  Blaney et al. (2015) opine that patients are interested 
in, and value BCRL screening programmes based on the high recruitment (85.7%) and 
retention rates (83.8%) within their BCRL screening study.  However, clinically, 
resources in terms of funding, staffing and time remain a challenge within the National 
Health Service (NHS).  Thus screening programmes are not standardised, i.e. some 
services measure limbs pre-operatively as part of a one-year screening programme, 
while other services may not offer any form of screening for lymphoedema following 
breast cancer surgery (Bundred et al., 2020).  For some patients awaiting surgery, pre-
operative measurements can be an inconvenience as it may be another appointment for 
them to attend, or it may interfere with their surgical preparation (Bundred et al., 2020).  
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In some instances, it can lead to distress if people feel that their potential risk of 
lymphoedema is high due to their pending cancer surgery. 
 
Technologies that can measure lymphoedema include perometry (Stanton, Northfield, 
Holroyd, Mortimer, & Levick, 1997), bio-impedance spectroscopy (Cornish, Ward, 
Thomas, & Bunce, 1998; Levenhagen et al., 2017), and dielectric constant devices 
(Nuutinen, Ikäheimo, & Lahtinen, 2004; Levenhagen et al., 2017).  Three-dimensional 
camera imaging (3DCI) has explored limb volume; however, this technology is 
underutilised, and prognostication of the image data is yet to be fully realised (Öhberg, 
Zachrisson, & Holmner-Rocklöv, 2014).  3DCI has the potential to measure geometric 
parameters enabling an alternative method of measurement using limb shape (Cau et al., 
2016).  Karakashian, Shaban, Pike, & van Loon (2018) developed swelling maps where 
colour is used to visualise areas of deviance from the non-lymphoedema arm.  This could 
make diagnosing lymphoedema easier for a clinician, and it may enable a person with 
lymphoedema to understand the severity of their condition better by visualising the 
colours that show the areas and size of localised swelling. 
 
The systematic literature review in Chapter 3 will critique three methods of 
measurement, namely CTM, as it is the most commonly used method of measurement 
in the clinical setting, Perometry, as it is widely used in lymphoedema research and 
3DCI, the new method of lympheodema measurement.  The systematic literature review 
will highlight the need for further research into the use of 3D technology, including the 
use of shape as a means of determining the severity of lymphoedema and the 
effectiveness of treatment outcomes.   
 
The other methods of measurements used in clinical practice include water 
displacement, tissue dielectric constant (TDC) and bio-impedance spectroscopy (BIS).  
These are discussed next: 
 
2.4.3.1  Water Displacement  
Within lymphoedema research, water displacement is still considered the gold standard, 
or reference standard, of volume measurement (Devoogdt et al., 2010; Lee, Boland, 
Czerniec, & Kilbreath, 2011; Adriaenssens, Buyl, Lievens, Fontaine, & Lamote, 2013; 
Öhberg et al., 2014; Buffa et al., 2015; Mori, Lustman, & Katz-Leurer, 2015; Hidding 
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et al., 2016; Levenhagen et al., 2017), however, there is growing disagreement to this 
statement (Adriaenssens et al., 2013; Lu, Han, DeSouza, Armer, & Shyu, 2014).  Water 
displacement is easy to perform, painless, able to measure objects with an irregular shape 
and is highly sensitive, thus able to detect small volume changes (Chen, Tsai, Hung, & 
Tsauo, 2008; Tewari et al., 2008; Perdomo et al., 2014).  Water displacement (Figure 7) 
measures limb volumes most accurately and is based on Archimedes’ Principle physical 
law of buoyancy (Öhberg et al., 2014).  It states that the volume of an object immersed 
in a fluid is equal to the volume of the displaced fluid (Brorson & Hoijer, 2012; Erends, 
van der Aa, van der Hulst, & de Grzymala, 2014; Lu et al., 2014; Öhberg et al., 2014).   
 
 
Figure 7: Measuring upper extremity limb volume by water displacement (Hameeteman, 
Verhulst, Vreeken, Maal, & Ulrich, 2016)1 
 
Consideration for the type of volumeter, methodology, water temperature, patient 
positioning and method of water displacement is essential for research and clinical use 
(Lee et al., 2011; Erends et al., 2014; Perdomo et al., 2014; Levenhagen et al., 2017) to 
ensure repeatability and standardisation of the technique.  Water displacement has 
excellent reliability (inter- and intra-rater) and validity with ICC between 0.97 and 0.99 
(Chen et al., 2008; Öhberg et al., 2014; Perdomo et al., 2014; Hidding et al., 2016; 
Levenhagen et al., 2017).  Water displacement is reportedly reproducible with an error 
rate of <1% (Barrio, Eaton, & Frazier, 2015; Lee et al., 2011) and has proven concurrent 
and construct validity compared to computed tomography (CT scan) and magnetic 
resonance imaging (MRI) in the presence of lymphoedema (Sagen, Kårensen, Skaane, 
& Risberg, 2009).  There are however difficulties in defining and implementing the 
                                                 
1 Reprinted from Journal of Plastic, Reconstructive and Aesthetic Surgery, volume 69, issue 2, 
Hameeteman et al., 3D stereophotogrammetry in upper-extremity lymphedema: An accurate diagnostic 
method, pages 241-247., Copyright (2016), with permission from Elsevier 
24 
 
upper level for immersion of limbs due to an inability to submerge the entire limb, thus 
there exist variations in limb lengths when measuring using water displacement (Tewari 
et al., 2008; Erends et al., 2014; Öhberg et al., 2014). 
 
There is an ongoing discussion within the literature about how volume thresholds should 
define the presence of lymphoedema, i.e., the volume difference between the affected 
and unaffected arms that confirms the presence of lymphoedema.  Seminal research 
performed by Stanton, Badger, & Sitzia (2000), concluded that a total volume difference 
between arms of >200ml as measured by water displacement is a sensitive indicator of 
lymphoedema.  However, Taylor, Jayasinghe, Koelmeyer, Ung, & Boyages (2006) 
report that a change of >150ml is unlikely to be attributable to a chance variation or 
measurement error, thus this lower volume should be considered as a measure of the 
presence of lymphoedema in the upper limb.  Sagen, Kårensen, Skaane, & Risberg 
(2009) report that an increase of 10% volume between the affected and unaffected arm 
should be the threshold value for the diagnosis of lymphoedema.  To date, there is no 
consensus as to which of these three thresholds should be used in clinical practice for 
the diagnosis of lymphoedema, and a study comparing these three thresholds to decide 
on the ideal value would benefit research and clinical practice. 
 
Water displacement records volume as a single value, making it challenging to identify 
the areas of change in limb size (Rincon, Shah, Ramella-Roman, & Bhansali, 2016);   
unlike CTM or perometry which are taken at fixed points making it easier to see where 
changes in limb size occur, thus informing the clinician about the impact of treatment 
(Belgrado et al., 2010).  There is a close correlation between the methods of measuring 
volume in that all are reliable and provide similar estimates.  However, due to limb 
length differences and variances in techniques, some studies report CTM 
underestimating limb volume compared to water displacement (Devoogdt et al., 2010; 
Brorson & Hoijer, 2012; Erends et al., 2014; Öhberg et al., 2014), while others report 
CTM  to overestimate volume (Tewari et al., 2008; Adriaenssens et al., 2013).  
Perometry was found to overestimate limb volume compared to water displacement in 
two studies (Lee et al., 2011; Adriaenssens et al., 2013); thus, the volumetric methods 
cannot be interchangeable due to the differences in outcomes (Devoogdt et al., 2010; 
Lee et al., 2011; Brorson & Hoijer, 2012; Adriaenssens et al., 2013; Öhberg et al., 2014; 
Landau, Kim, Gould, & Patel, 2018). 
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The disadvantages of water displacement as a method are that it is inconvenient for 
routine clinical use as it is time-consuming, costly, cumbersome, impractical as a 
portable test, and can be unsanitary (Tewari et al., 2008; Devoogdt et al., 2010; Lee et 
al., 2011; Brorson & Hoijer, 2012; Öhberg et al., 2014; Buffa et al., 2015; Hameeteman, 
Verhulst, Vreeken, Maal, & Ulrich, 2016; Landau et al., 2018).  Adriaenssens, Buyl, 
Lievens, Fontaine, & Lamote (2013) state that water displacement is challenging to use 
in a clinical setting due to water spillage; and it is negated for certain medical conditions 
such as ulcers, open wounds, abrasions, and some skin conditions (Tewari et al., 2008; 
Lee et al., 2011; Erends et al., 2014; Buffa et al., 2015; Landau et al., 2018).  
Furthermore, water displacement is unable to provide information on the shape of the 
limb.  
 
2.4.3.2  Tissue Dielectric Constant (TDC) 
Tissue Dielectric Constant (TDC) measurements evaluate local tissue water in the skin 
and subcutaneous tissues via a non-invasive device (Mayrovitz, Carson, & Luis, 2010; 
Mayrovitz, Corbitt, Grammenos, Abello, & Mammino, 2017a; Mayrovitz, Fasen, 
Spagna, & Wong, 2018a) and are performed at 300-megahertz (MHz) frequency using 
a concentric transmission line measurement technique. This, in turn, reflects 
electromagnetic energy dependant on the dielectric constant of the tissue, which is 
dependent on the amount of free and bound water in the tissue volume.  As fat has lower 
water content, TDC values decrease with an increase in depth testing (Mayrovitz, 2010; 
Mayrovitz et al., 2010; Mayrovitz, Weingrad, & Lopez, 2015; Mayrovitz, Grammenos, 
Corbitt, & Bartos, 2017b). 
 
There are two devices available to determine Local Tissue Water in the measurement of 
lymphoedema namely the 'MoistureMeterD' and the 'MoistureMeterD Compact'    
(Figure 8), manufactured by Delfin Technologies Ltd, Kuopio, Finland.  The main 
differences are that the former unit is a multi-probe system consisting of various sized 
probes that allow measurement of TDC at different depths.  In contrast, the latter device 
is a single depth, portable model of the MoistureMeterD with an effective measurement 
depth between 1.5 and 2.5mm (Mayrovitz, Weingrad, & Lopez, 2016; Mayrovitz et al., 
2017a; Bakar, Tuğral, & Űyetűrk, 2018; Mayrovitz, Arzanova, Somarriba, & Eisa, 





Figure 8: MoistureMeterD Compact (Delfin Technologies, 2017) 
 
The MoistureMeterD Compact has a built-in pressure sensor to enhance repeatability 
and user independence and is programmed to convert the TDC into water percentage on 
a scale of 0 to 100%.  The water percentage value is calculated using the formulae:   
 
Water% = [(ɛ-1)/(ɛw-1)]*100%, 
 
where ɛ is the measured dielectric constant, and ɛw is the dielectric constant of water 
(Delfin Technologies Ltd, 2014). 
 
TDC is a quick measurement and takes about 10 seconds for a reading, which is taken 
at multiple sites, measuring locally, thus making it a clinically efficient technique 
(Mayrovitz, Davey, & Shapiro, 2008; Mayrovitz, Davey, & Shapiro, 2009a; Mayrovitz, 
2010; Mayrovitz et al., 2010; Czerniec, Ward, & Kilbreath, 2015; Lahtinen, Seppala, 
Viren, & Johansson, 2015; Mayrovitz et al., 2015; Mayrovitz et al., 2017b; Mayrovitz 
et al., 2018a; De Vrieze et al., 2020).  Single measurements are as effective as triplicate 
measurements on the forearm and upper arm, thus less time consuming to measure 
within a clinical setting (Mayrovitz et al., 2009a; Mayrovitz et al., 2016; De Vrieze et 
al., 2020).  TDC values are converted to a ratio to determine the presence of 
lymphoedema, thus both sides must be measured at congruent points (Mayrovitz et al., 
2018b).  Mayrovitz, Weingrad, & Davey (2009b) concluded that a TDC ratio exceeding 
1.26 was indicative of early lymphoedema in the 'at-risk' person.  Application of the 
device needs to ensure repeatability, and thus pre-determined landmarks are required.  
All published research agrees that the midline of the anterior aspect of the arm should 
be used.   
 
Original work by Nuutinen, Ikäheimo, & Lahtinen (2004) validated the dielectric device 
as they found a statistically highly significant correlation between TDC and CTM of the 
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arm (r= 0.97, p<0.05).  Levenhagen et al.’s (2017) literature review confirmed moderate 
to good correlations between arm TDC ratios and arm volume (r=0.69), as well as 
segmental volume measures (r=0.77).  According to Bakar, Tuğral, & Űyetűrk (2018), 
TDC sensitivity and specificity was 65% and 94% respectively.  
 
Levenhagen et al. (2017) recommend against the use of TDC as a diagnostic tool for 
lymphoedema due to its limited clinical utility and lack of diagnostic evidence in the 
literature.  It does not, however, mean that it should not be used as an additional 
measurement tool for the assessment of lymphoedema, as it can contribute to the other 
examinations to decide on a lymphoedema diagnosis. 
 
2.4.3.3  Bio-Impedance Spectroscopy (BIS) 
Bio-Impedance Spectroscopy (BIS) is a non-invasive procedure whereby an alternating 
current (200-800 mA) is applied to a body segment via a set of cutaneous electrodes 
(Barrio et al., 2015; Svensson, Ward, Dylke, & Kilbreath, 2017).  In 1969, Bioelectrical 
Impedance Analysis (BIA) was used to measure total body water (Ward et al., 1992).  
The seminal paper by Ward et al. (1992) was able to demonstrate segmental analysis of 
extracellular fluid volume being accurately and reliably predicted by BIA over a range 
of frequencies (4 kHz to 1 MHz).   
 
In general, lower frequency currents pass through the extracellular fluid, whereas higher 
frequency currents cross both extracellular and intracellular fluid spaces as the reactance 
of the cell membranes decrease (York et al., 2009; Kim, Jeon, Sung, Jeong, & Do, 2011; 
Fu et al., 2013; Rincon et al., 2016; Bundred et al., 2020).  Impedance to current flow is 
inversely proportional to fluid accumulation, thus reduced impedance values in a 
measured extremity is considered indicative of the presence of lymphoedema (Ward, 
2009; Ward, Czerniec, & Kilbreath, 2009a; Czerniec et al., 2010; Jain, Danoff, & Paul, 
2010; Ward, Dylke, Czerniec, Isenring, & Kilbreath, 2011; Svensson et al., 2017; Jung 
et al., 2018).  BIS is ultimately the measure of resistance, or impedance, the current 
experiences while travelling through the cutaneous and subcutaneous matrixes.  It is 
recognised as one of the few techniques that attempts to directly measure lymph fluid 
volume in unilateral lymphoedema (Bilir, DeKoven, & Munakata, 2012; Dylke et al., 




Lymph fluid in lymphoedema is additional to the normal extracellular fluid 
compartment, thus results from BIS are considered as accurate measures of both lymph 
fluid impedance and total fluid impedance (Buendia et al., 2018).  Extrapolation of 
properties unique to lymphatic fluid in measuring the flow of current is based on the 
principle that tissues such as fat and bone act as insulators, while electrolytic fluids 
conduct electricity (Seward et al., 2016).  Buendia et al. (2018) later confirmed that BIS 
is not only useful for detecting lymph accumulation but is also able to estimate an 
increase in adipose tissue in BCRL.   
 
There are two manufacturers providing devices for determining BIS for lymphoedema 
in the UK.  The Bodystat Quadscan 4000 (Figure 9) from Bodystat Ltd, Cronkbourne, 
Isle of Man (Bodystat, 2017), provides accurate and immediate results of body 
composition, hydration status and fluid shifts in the extracellular and intracellular 
spaces.  The L-Dex® U400 BIS (Figure 9) from ImpediMed Ltd, Brisbane, Australia 
(ImpediMed Ltd, 2017), is a multi-frequency BIA device (Levenhagen et al., 2017) that 
quantifies changes in the extracellular fluid by the allocation of an L-Dex score, to 
enable clinicians to easily monitor fluid content in people with, or at risk of, 
lymphoedema. An advantage of using the Bodystat Quadscan 4000 is that measurements 





Figure 9: BodyStat Quadscan 4000 (left) and L-Dex® U400 (right) 
 
Calculation of the BIS ratio involves normalising the affected side to that of the 
unaffected side and then comparing it to normative values (Ward et al., 2011; Bundred 
et al., 2020).  BIS values differ between dominant and non-dominant sides due to the 
dominant limb containing more muscle and water as a result of common use in daily life 
29 
 
(Dylke, Yee, Ward, Foroughi, & Kilbreath, 2012; Smoot et al., 2014; Arinaga, Piller, & 
Sato, 2016).  Normative L-Dex scores lie between -10 and +10, which is the equivalent 
of an impedance range of 0.935 to 1.139 for at-risk dominant arms, and 0.862 to 1.006 
for at-risk non-dominant arms (Jain et al., 2010; Czerniec et al., 2011; Smoot et al., 2011; 
Fu et al., 2013; Blaney et al., 2015; Iyigun et al., 2015; Bundred et al., 2020).  With an 
increase in extracellular fluid, the L-Dex value will increase, and early signs of 
lymphoedema are suggested at a reading above the normal range, or an increase of 10 
L-Dex units from the baseline (Shah, Vicini, & Arthur, 2016; National Institute for 
Clinical Excellence (NICE), 2017). 
 
The normative population mean limb index ratio for BIS is 1.037 for the dominant side, 
and 0.964 for the non-dominant side (Ridner, Dietrich, Deng, Bonner, & Kidd, 2009).  
Based on the standard deviation (SD) of 0.034, thresholds have been set at three standard 
deviations (3SDs) above the normative mean at a ratio of 1.139 for the dominant side, 
or 1.066 for the non-dominant side (Dylke et al., 2016; Seward et al., 2016; Shah et al., 
2016; Svensson et al., 2017).   
 
The devices are small and portable, with built-in display screens; it utilises standardised 
anatomical landmarks and requires minimal training (Ridner et al., 2009; Ward, 
Czerniec, & Kilbreath, 2009b; Ridner et al., 2014; NICE, 2017).  It can be used on bed-
bound patients (Jain et al., 2010) and in private homes and offices (Ridner et al., 2009).  
BIS is quick and easy to perform (Ward et al., 2009a; Jung et al., 2018), taking less than 
one minute (min) (Ridner et al., 2009) but up to 5 min (Vicini, Shah, Lyden, & 
Whitworth, 2012) on average.  It is non-invasive (Ward et al., 2009a; Ward et al., 2009b; 
Berlit et al., 2012; Berlit et al., 2013; Barrio et al., 2015; Czerniec et al., 2015; Svensson, 
Dylke, Ward, & Kilbreath, 2015; Jung et al., 2018) and relatively inexpensive compared 
to perometry (Ridner et al., 2009; Ward et al., 2009a; Buendia et al., 2018).  A further 
advantage of BIS is that it can be used to measure bilateral upper limb lymphoedema by 
comparing it to a non-lymphoedematous leg (Ward, 2009; Ng & Munnoch, 2010). 
 
Disadvantages of BIS are the recurring cost of electrodes and the cost of the device itself 
(Perdomo et al., 2014; Hidding et al., 2016; Levenhagen et al., 2017; NICE, 2017).  
People with electrical devices such as pacemakers and metal implants should be 
excluded due to electrical interference (Ridner et al., 2009; Vicini et al., 2012; Hidding 
30 
 
et al., 2016).  BIS is limited to measuring the arm from the ulnar styloid process, thus 
excludes the hand in its results (Perdomo et al., 2014; Svensson et al., 2015).  BIS is 
unable to capture tissue changes such as fibrosis or adipose infiltration; thus, it is 
unsuitable for later-stage lymphoedema assessment (Levenhagen et al., 2017).  Some 
clinicians find it challenging to work with an index or ratio as opposed to the normative 
percentage volume differences, and it is not advised to convert either measure due to the 
questionable validity of calculations, especially as methods are not interchangeable 
(Ward et al., 2009a; Ward et al., 2009b).  Clinical decisions need to be made with caution 
due to differences in conditions (environmental and physiological) affecting results 
(Timmer, Bosman, Geertzen, & Dijkstra, 2020).  As BIS captures full arm values and 
compares one side to the other, it cannot detect limb shape distortion utilising a distal to 
proximal ratio like CTM. 
 
Tonometry is another means of assessing lymphoedema; however, the literature is weak 
and is not discussed as a valid measure of lymphoedema within this thesis. 
 
In most instances, the subjective information and objective measures are sufficient to 
commence a programme of care and self-management for a person with lymphoedema.  
However, in cases where there is a lack of clarity as to the cause of the lymphoedema, 
medical imaging techniques can further assist the diagnosis, staging and treatment 
options available (Pappalardo & Cheng, 2020).   
 
2.4.4 Medical Imaging 
A range of imaging techniques is available to aid in the diagnosis and understanding of 
lymphoedema.  Direct imaging includes lymphography and lymphangiography.  Indirect 
imaging, such as lymphoscintigraphy and fluorescent lymphography, is more commonly 
practised, and a variety of techniques exist to look at different aspects of the lymphatic 
system, and the impact lymphoedema has on the cutaneous and subcutaneous structures.  
The value of performing medical imaging is to gain a better insight as to what part of 
the lymphatic system is at fault, how the fluid flows and then backflows, and what 
lymphatic pathways exist that could be manipulated through intensive treatments to get 
a better reduction in volume and normalisation of the limb shape.  Imaging can also 
inform the type of surgical intervention that could be offered to a patient with 
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lymphoedema.  Appendix 2 provides more detail into the type of medical imaging 
available to lymphoedema clinicians and patients. 
 
2.5 Conclusion 
Self-reported symptoms, psychosocial and quality of life factors form the subjective 
information required to understand the complexities of a person's experience of their 
lymphoedema.  A physical examination, including measurement of the lymphoedema, 
together with the subjective assessment, is required to make a diagnosis of 
lymphoedema.  Chapter 3 reports on a systematic literature review to provide an in-
depth analysis of three assessment methods used in this study, i.e. CTM, perometry and 
3DCI.  Medical imaging is used in limited cases to help with the diagnosis of 
lymphoedema, or as a means to determine surgical suitability. 
 
Current classifications or staging of lymphoedema are limited in their description of the 
presenting swelling.  The shape of the limb needs to be considered as a small volume 
difference between two arms may be low in terms of percentage, but if the forearm is 
disproportionately bigger than the upper arm or the opposite arm, then the staging would 
be inaccurate.  However, the oversight of limb shape could be in part that there is no 
clinical measurement in use that can measure both limb volume and shape.  Thus, a 
measurement technique that offers not only volume as a measurement outcome, but 
shape as an additional outcome, need to be considered as it would make diagnosing of 
lymphoedema easier for a clinician, treatment more specific and targeted, and it would 



















Methods of lymphoedema measurement differ substantially in terms of application and 
thresholds used for diagnosing or categorising lymphoedema severity.  This chapter will 
explore the empirical evidence available in the literature about the performance, validity 
and reliability of three methods of lymphoedema measurement, namely CTM, 
perometry and 3DCI.   
 
This systematic literature review will also appraise how each method correlates to the 
other, to appreciate the relationships they may have in terms of measuring upper limb 
volume.  The recommended thresholds for diagnosing lymphoedema for each method 
will also be reviewed to determine any commonality between these methods.  
Exploration of additional outcomes from 3DCI data will be investigated to determine 
the potential benefits of using limb shape as a means of assessing lymphoedema.    
 
Thus, the research question for this systematic literature review is ‘how effective is 3DCI 
compared to CTM and perometry?’  Sub-objectives for this review include: 
 explore the thresholds for diagnosing lymphoedema for each method of 
measurement  
 analyse whether 3DCI is a valid measure of upper limb volume compared to CTM 
and perometry 
 determining whether 3DCI is as reliable as CTM and perometry, and 
 investigate whether 3DCI is capable of measuring limb shape. 
 
3.2. Methodology 
3.2.1 Identifying the Evidence 
Consultation with a university hospital librarian ensured correct and comprehensive 
Medical Subject Heading (MeSH) terms to identify the various assessment methods used 
in diagnosing and assessing lymphoedema.  The literature search was conducted from 
January 1, 2008, through to December 31, 2018; and a repeat search was conducted July 
1, 2020, to check for missed articles collected from monthly alerts received from the 




Ovid Medline and Embase are considered comprehensive databases for medical and 
health care research papers as they contain the listings of more than 4,600 journals 
reporting on biomedical research, and together they contain a considerable number of 
search terms, subheadings and synonyms.  An initial search strategy of Ovid Medline 
and Embase (Table 2) was performed, with search terms including 'lymphoedema' or 
'lymphedema'; 'breast cancer' or 'breast neoplasm'; 'circumferen' (for circumferential 
measurements), 'limb volume'; 'anthropometry'; 'imaging, three-dimensional'; 
'perometry' or 'perometer'; and a further limit of  'English language' was included.  Due 
to research in lymphoedema measurement having advanced in the last ten years from 
the initial literature search in 2018, a 10-year limit was placed; thus abstracts published 
from '2008 to current' were included.  However, earlier studies were retrieved if they 
were pertinent to this systematic literature review.  This reduced the number of abstracts 
from 941 to 754 prior to deduplication, which then resulted in 537 abstracts for review.   
 
Table 2: Search strategies for Embase and Ovid Medline databases 2018  
 
 
The above search was repeated in 2020 and produced an additional 146 abstracts for 
review (Table 3). 
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Table 3: Search strategies for Embase and Ovid Medline databases 2020 
 
 
It was noted that few papers from the initial search identified 3DCI as a method of 
lymphoedema measurement method; thus a second, more specific search strategy of 
Ovid Medline and Embase was performed (Table 4) with search terms including 
'lymphoedema' or 'lymphedema'; 'anthropometry'; '3d imaging' or '3d camera'; and 
'English language' limitation was added.  The same time scale was introduced (2008 to 
current), reducing the number of abstracts from 149 to 71, prior to deduplication which 
further reduced the abstracts to 54 for review.  This search was repeated in 2020 and 
produced an additional 19 abstracts for appraisal (Table 5). 
 










To ensure the maximum number of papers were included within this systematic literature 
review, further databases were searched including Pubmed, ProQuest Dialog, Cochrane, 
and Google Scholar; and journal alerts were reviewed (see Table 6).  The search term 
"upper limb" was used when searching PubMed and Google Scholar as the breast cancer 
terms produced too large a volume of irrelevant abstracts.  Following deduplication, ten 
abstracts were identified for inclusion for review.  Wiley Online Library, BMJ, Oxford 
Academic and Springer search engines were also utilised but produced no new abstracts 
for review.  Monthly alerts were also created with the library for the above MeSH-terms, 
and intermittent literature searches were performed to ensure no relevant papers were 
omitted.  Grey literature, including tweets and conference abstracts, were considered and 
followed up through contacting the authors to find out whether their research or clinical 
findings had been published.  Citation tracking was also performed to determine the 
impact the articles may have had on other research. 
 
As described, a comprehensive search of the various databases was performed.  Articles 
were cross-referenced using their reference lists to ensure quality and validity and to 








Table 6: Additional search engines utilised 
Search 
Engine 









Lymphoedema/Lymphedema + 3D 
Camera  
3 3 0 
Lymphoedema/Lymphedema + 3D 
Imaging + Upper Limb 
23 10 2 
Lymphoedema/Lymphedema + 
Perometer + Upper Limb 
28 11 1 
Lymphoedema/Lymphedema + 
Assessment + Upper Limb 
178 9 2 




Lymphoedema/Lymphedema + Breast 
Cancer/Breast Neoplasm + 
circumference + limb  volume 
28 5 2 
Lymphoedema/Lymphedema + Breast 
Cancer/Breast Neoplasm + 
anthropometric + perometer/perometry  
847   
Lymphoedema/Lymphedema + Breast 
Cancer/Breast Neoplasm + 
perometer/perometry  
872   
Lymphoedema/Lymphedema + Breast 
Cancer/Breast Neoplasm + limb  
volume + perometer/perometry  
913   
Lymphoedema/Lymphedema + Breast 
Cancer/Breast Neoplasm + limb  
volume + perometer/perometry + 
circumference 
29 5 0 
Lymphoedema/Lymphedema + Breast 
Cancer/Breast Neoplasm + limb  
volume + 3D imaging 
913   
Lymphoedema/Lymphedema + Breast 
Cancer/Breast Neoplasm + limb  
volume + perometer/perometry + 
circumference + 3D imaging 
29 5 0 
 Total 3631 15 2 
Cochrane Lymphoedema/Lymphedema 19 0  
 Total 19 0 0 
Google 
Scholar 
Lymphoedema + Breast Cancer + limb 
volume + circumference + 
anthropometry after 2008 
226 14 0 
 Total 226 14 0 
Journal 
Alerts 
Lymphoedema/Lymphedema + Breast 
Cancer/Breast Neoplasm + limb 
volume + perometer/perometry + 
circumference + 3D imaging 
10 6 3 
 Total 10 6 3 







3.2.2 Inclusion and Exclusion Criteria 
There is more evidence in the literature for upper limb lymphoedema secondary to breast 
cancer compared to any other type or region of lymphoedema.  It was therefore decided 
to focus on this group exclusively.  Table 7 summarises the final inclusion and exclusion 
criteria for the systematic literature review based on the key words used.  No filters were 
applied, as there were no clinical trials or randomised control trials available.  The 
majority of the papers were diagnostic test studies. 
 




Adults (aged >18 years) with upper limb lymphoedema 
secondary to breast cancer 
Assessment Upper Limb Lymphoedema Measurements 
Types of 
Measurement 
At least one of the measures were required: 
 Circumferential Tape Measure (CTM) 
 Perometry 
 Three-Dimensional Camera Imaging (3DCI) 
Limits 
 English language only 
 Date limit of 2008 
Types of evidence 
included 
No filters applied to this topic as there were no clinical 




 Risk factors of lymphoedema 
 Early diagnosis criteria 
 Treatment outcomes 
 Subjective reporting 
 Incidences of lymphoedema 
 Measures truncal or lower limb oedema 
Types of 
Measurement 
 Use of advanced medical imaging  
 Other methods of measurements (Water 
Displacement, TDC, BIS)  
 Anatomical imaging  
 Simulation modelling 
Type of literature 
 Letters or editorials 
 Conference abstracts 
 Systematic, Literature or Methodological reviews 
Irrelevant 
 Head & neck, or genital oedema 
 Animal trials   
Other  Non-English language 
 
3.2.3 Study Selection 
One person, the researcher, for appropriateness, reviewed retrieved article titles and 
abstracts with duplicates removed.  Studies excluded during analysis of the full text were 





3.2.4 Data Extraction and Synthesis 
Data from each of the critiqued papers were extracted into an evidence table       
(Appendix 3) to document the analysis performed for each article.  The subject headings 
used included the purpose of the study, research design, sample, validity of the study, 
the study results and the clinical benefit of the study.  The findings of the evidence are 
summarised in a concise narrative below. 
 
3.2.5 Critical Appraisal 
Each paper was critiqued using the Critical Appraisal Skills Programme (CASP) 
(Critical Appraisal Skills Programme, 2017).  As each study reported was related to 
diagnostics, the CASP for Diagnostic Test Studies was used.  This 12-item checklist 
evaluates the validity, results and impact of each study.  Table 8 provides an overview 
of the CASP Diagnostic Test Study criteria used for the lymphoedema methods of 
measurement studies.  Papers scored '2' if answered yes, '1' if unsure, and '0' if no.  Scores 
were totalled at the end of each row to a maximum value of 24. 
 
3.3 Results 
3.3.1 Included Studies 
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
flowchart (Shamseer et al., 2015; PRISMA, 2018) was used as a guide for the collation 
of the data (Figure 10).  Articles identified from Ovid MEDLINE and Embase totalled 
756.  A further 68 abstracts were identified from the other search engines utilised (refer 
to Table 6).  The total number of articles identified for the full search was 824.  This was 
reduced to 650 abstracts on removal of duplicates (n=174).  By implementing the 
exclusion criteria, the number of papers identified for full review was 44.  Of the 44 
papers for the full review, one was excluded as irrelevant as the 3D data was extrapolated 

















































 n = 756 
Excluded for duplication 
n = 174 
Abstracts eligible for review  
n = 650 
 
Abstracts excluded (n = 606): 
  11  non-English language 
 65  risk factors of lymphoedema 
  24  early diagnosis criteria 
177  treatment outcomes 
  10  focused on subjective reporting 
  38  incidence of lymphoedema 
    9  truncal or lower limb oedema 
  29  medical imaging 
  33  other methods of measurement  
  21  letters / editorials 
179  conference abstracts 
    2  irrelevant – head & neck; animal trials 




Articles identified for review 




PubMed, ProQuest Dialog, 
Cochrane, Google Scholar 
n= 68 
Total number of records 
n = 824 
Articles identified for critique 




Articles excluded (n = 1): 



































Table 8: Items of Critical Appraisal Skills Programme (CASP) (Critical Appraisal Skills 
Programme, 2017): Diagnostic Test Study specific for lymphoedema measurements 





Clearly identifies the 
population, test, setting and 
outcomes 
Lacks clarity about 
population, test, setting and 
outcomes 
Fails to identify population, 





standard used, both sides 
measured 
Incomplete reference 
standard described, one or 
both sides measured 
Inappropriate reference 





All patients were measured 
with all measurement 
instruments on both sides 
One measurement 
instrument was used on a 
proportion of patients on 
one or both sides 
All patients were measured 
with one or more 
measurement but only on 
one side 
4 Blinding 
Results blinded, tester 
unaware of outcome of 
other test 
Unclear or <30 min between 
measurements 




Diagnosis of upper limb 
lymphoedema, or at risk 
clearly described 
Lymphoedema not clearly 
defined, other oedema; age 
unclear, inappropriate 
exclusions 
No match on sexes/age 






described for research  
question, both sides 
measured 
Incomplete protocol 
described for research 
question, one or both sides 
measured 
Protocol not appropriate for 




Sensitivity and specificity 
and/or likelihood ratios 
clearly presented 
Sensitivity and specificity 
and/or likelihood ratios 
unclear 
Sensitivity and specificity 





Results intentional; clear 
confidence limits identified 
Results intention clear; 
confidence limits vague 
Results occurred by chance; 







Results can be applied to 
own population 
Some aspects of the results 
can be applied to own 
population such as age, sex, 
ethnicity 






Resources in terms of both 
expertise and services 
available to apply the test to 
own patients 
Some resources in terms of 
expertise and/or services 
available to apply the test to 
own patients 
Resources in terms of 
expertise and services 
unavailable to apply the test 
to own patients 
11 
All  outcomes 
considered 
Outcomes will result in 
improved patient well-being 
and management 
Outcomes will result in 
improved patient well-being 
or management 
Outcomes will not result in 
improved patient well-being 
and management 
12 
Impact of using 
test on 
population 
Positive change to current 
practice 
Modification to current 
practice 






3.3.2 Quality of the Studies 
The pivot table created from the database of articles analysed (Table 9) identified that 
‘diagnostic test study’ (n=36) was the most commonly used research method.  The lack 
of standardisation in the measurement procedures, and the variations in thresholds used 
to diagnose lymphoedema, created confusion.   
 
Table 9: Types of research methods from the systematic literature review 
Research Design Count 
Blinded Repeat Measures Observational Study 1 
Case-control study 1 
Cross-sectional Study 4 
Diagnostic Test Study 36 
Prospective Cohort Study 1 
Grand Total 43 
 
All studies were critiqued against the CASP criteria with the results shown in Table 10.  
Following a critique of the articles, 19 (44.2%) studies scored 22 or more out of 24, with 
only two papers scoring the maximum of 24; these were De Vrieze et al. (2019) and 
Spinelli et al. (2019).  The lowest scored papers at 17 out of 24, were Verhulst et al. 
(2017) and Yamamoto, Yamamoto, & Yoshimatsu (2017).   
 
3.3.3 Limitations 
There are several limitations with the systematic literature review, most of which are 
attributed to the quality of the studies comparing or validating methods of measurement 
for lymphoedema.  The limitations are identified in Table 11.  Twenty-four of the 
reviewed studies did not identify any limitations, yet 19 of these were found to have 
limitations identified by the researcher.  Blinding could not be identified in 25 papers, 
and blinding was unclear in eleven studies, bringing the quality and validity of these 
studies into question where tools that are prone to user error could be manipulated for 
favourable outcomes. 
 
3.3.3.1 Single Reviewer 
The researcher (Cheryl Pike) produced this systematic literature review.  It has not been 
piloted in clinical practice, and it does not include perspectives of patients, peers or other 
health professionals in its inception and conduct.  This limitation has been addressed 
through the review of two supervisors overseeing the construct of this thesis. 
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Table 10: CASP outcomes of each research study paper 
Study Year 


































































































































































































Chen, Tsai, Hung, & Tsauo 2008 2 2 1 2 2 2 2 2 2 2 2 2 23 
Tewari, Gill, Bochner, & Kollias 2008 2 2 2 1 2 2 2 2 2 2 2 2 23 
Czerniec et al. 2010 2 2 2 0 2 2 2 1 2 2 2 2 21 
Devoogdt et al. 2010 1 2 2 2 2 2 2 2 2 2 2 2 23 
Ancukiewicz et al. 2011 2 2 2 0 2 2 1 1 2 2 2 2 20 
Foroughi et al. 2011 2 2 2 0 2 2 2 2 2 2 2 2 22 
Lee, Boland, Czerniec, & Kilbreath 2011 2 2 2 0 2 2 2 2 2 1 2 2 21 
Ancukiewicz et al. 2012 2 2 2 0 2 2 2 2 2 2 1 0 19 
Asim et al. 2012 2 2 2 0 2 2 2 2 2 2 2 2 22 
Brorson & Höijer 2012 2 2 2 0 2 2 2 2 2 2 2 2 22 
Dylke, Yee, Ward, Foroughi, & 
Kilbreath 
2012 2 2 2 0 2 1 2 2 2 2 2 2 21 
Katz-Leurer & Bracha 2012 2 2 2 2 2 2 2 2 2 2 1 0 21 
Adriaenssens, Buyl, Lievens, Fontaine, 
& Lamote 
2013 2 2 2 0 2 2 2 2 2 2 2 2 22 
Bulley, Coutts, & Tan 2013 2 2 2 2 2 2 2 2 2 2 1 1 22 
Lu, DeSouza, Armer, Anderson, & Shyu 2013 1 2 2 0 2 2 1 0 2 2 2 2 18 
Erends, van der Aa, van der Hulst, & de 
Grzymala 
2014 2 1 1 1 2 1 2 2 2 1 2 2 19 
Lu, Han, DeSouza, Armer, & Shyu 2014 2 2 2 0 2 2 1 2 1 1 2 2 19 
Öhberg, Zachrisson, & Holmner-
Rocklöv 
2014 2 2 2 0 2 2 2 2 2 0 2 2 20 
Buffa et al. 2015 2 1 1 1 2 1 2 2 2 2 2 2 20 
Mori, Lustman, & Katz-Leurer 2015 2 2 2 0 2 1 2 2 2 2 2 2 21 
Tidhar et al. 2015 2 2 2 0 2 2 2 2 2 2 0 0 18 






































































































































































































Hameeteman, Verhulst, Vreeken, Maal, 
& Ulrich 
2016 2 2 2 1 2 2 2 2 2 1 2 2 22 
Hoevenaren et al. 2016 2 2 2 0 2 2 2 2 2 1 2 2 21 
Yamamoto et al. 2016 2 2 2 0 2 2 2 2 2 2 2 2 22 
Peleg & Katz-Leurer 2017 2 2 2 0 2 2 2 2 2 2 2 2 22 
Verhulst et al. 2017 2 1 1 1 2 1 0 2 2 1 2 2 17 
Wang et al. 2017 2 2 2 0 2 2 2 2 2 2 0 0 18 
Yamamoto, Yamamoto, & Yoshimatsu 2017 2 2 2 0 2 2 2 1 2 2 0 0 17 
Batista, Baiocchi, Campanholi, 
Bergmann, & Duprat 
2018 2 2 2 1 2 2 2 2 2 2 2 0 21 
Cau et al. 2018 2 2 2 0 2 2 2 2 2 0 2 2 20 
Karakashian, Shaban, Pike, & van Loon 2018 2 1 2 1 2 2 2 2 2 2 2 2 22 
Landau, Kim, Gould, & Patel 2018 2 2 2 1 2 2 2 2 2 1 2 2 22 
Preuβ, Killaars, de Grzymala, 
Binnebösel & Neumann 
2018 2 2 2 1 2 2 2 2 2 1 2 2 22 
Sharkey et al. 2018 1 2 2 0 0 2 2 1 2 2 2 2 18 
Sun et al. 2018 2 2 2 0 2 2 2 2 2 2 2 2 22 
DeSnyder et al. 2019 2 2 2 1 2 2 2 1 2 1 2 2 21 
De Vrieze et al. 2019 2 2 2 2 2 2 2 2 2 2 2 2 24 
Karakashian, Pike, & van Loon 2019 2 1 1 0 2 2 2 2 2 2 2 2 20 
Lu & Dixon 2019 2 2 2 0 2 2 2 2 2 2 2 2 22 
Rafn, McNeely, Camp, Midtgaard, & 
Campbell 
2019 2 2 2 1 2 2 2 2 2 2 2 2 23 
Spinelli et al. 2019 2 2 2 2 2 2 2 2 2 2 2 2 24 
Binkley et al. 2020 2 2 2 2 2 2 2 2 2 1 2 2 23 
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Table 11: Methodology, cohort and limitations of each paper 
Author Year Cohort Methodology Limitations 
Chen et al. 2008 14 BCRL Diagnostic Test Study 
No ethics approval or consent gained reported.  Small cohort may lower variability among 
participants thus affecting the authenticity of the results 
Tewari et al. 2008 87 mixed Diagnostic Test Study No consent reported.  Hand volume not included. Blinding is unclear 
Czerniec et al. 2010 51 mixed Diagnostic Test Study None identified by authors. No blinding identified 
Devoogdt et al. 2010 112 BCRL Diagnostic Test Study 
No consent reported.  Reliability measurements were performed on healthy arms of the BCRL 
cohort. Surgery was performed during the two measurement sessions. 
Ancukiewicz et al. 2011 677 BCRL Diagnostic Test Study None identified by authors. No consent reported.  No blinding identified 
Foroughi et al. 2011 57 healthy Cross-sectional study Only written instructions for self-measurement were provided 
Lee et al. 2011 40 mixed Diagnostic Test Study None identified by authors. No blinding identified 
Ancukiewicz et al. 2012 677 BCRL Diagnostic Test Study None identified by authors. No consent reported.  No blinding identified 
Asim et al. 2012 193 BCRL Diagnostic Test Study No ethics approval reported.  No pre-surgery volume available for comparison over time. 
Brorson & Hoijer 2012 10 BCRL Diagnostic Test Study 
None identified by authors. No ethics approval reported.  Very small cohort and no blinding 
identified 
Dylke et al. 2012 204 healthy Diagnostic Test Study 
Only perometer circumferences were used and not the more commonly used tool of tape measure. 
Hand dominance was determined by asking the participant, using clarification of which hand they 
wrote with if needed.  The validated method of the Edinburgh Handedness Inventory may be more 
accurate; however, in clinics, the self-determined method is usually used.  Equations for frustum 
and cylinder methods provided, but not for perometer 
Katz-Leurer & Bracha 2012 16 BCRL Diagnostic Test Study Lack of blinding for the second evaluation 
Adriaenssens et al. 2013 80 mixed Diagnostic Test Study None identified by authors. No blinding identified 
Bulley et al. 2013 30 healthy Diagnostic Test Study 
Study would benefit from larger and more varied participants. Numbers of participants were not 
consistent for the different pilot studies. 
Lu et al. 2013 6 healthy Diagnostic Test Study 
None identified by authors. No ethics approval or consent gained reported. Cohort small and only 
healthy participants included 
Erends et al. 2014 33 healthy Diagnostic Test Study None identified by authors. No ethics approval or consent gained reported 
Lu et al. 2014 13 healthy Diagnostic Test Study 
None identified by authors. No ethics approval or consent gained reported. Cohort small and only 
healthy participants included 
Öhberg et al. 2014 25 BCRL Diagnostic Test Study None identified by authors. Relatively small cohort and no blinding identified 
Buffa et al. 2015 30 healthy Diagnostic Test Study None identified by authors. Only healthy participants included 
Mori et al. 2015 17 BCRL Diagnostic Test Study None identified by authors. Small cohort and no blinding identified 
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Author Year Cohort Methodology Limitations 
Tidhar et al. 2015 5 BCRL Diagnostic Test Study 
Study design – study conducted as part of a conference day, thus not all therapists could measure 
all the patients.  Results of the inter-rater reliability of the arm measurements raised another 
limitation as only 56% of the therapists measured within the limit of +5% from the true mean. 
Cau et al. 2016 12 healthy Diagnostic Test Study Small cohort. No blinding identified 
Hameeteman et al. 2016 11 BCRL Diagnostic Test Study 
No ethics approval or consent gained reported. Lack of blinding causing potential diagnostic 
review bias 
Hoevenaren et al. 2016 27 mixed Diagnostic Test Study 
None identified by authors. No ethics approval or consent gained reported. Relatively small cohort 
and no blinding identified 
Yamamoto et al. 2016 35 healthy Diagnostic Test Study 
Relatively small cohort. All participants were Japanese females. Tape measure method, as opposed 
to water displacement, was used for volumetry 
Peleg & Katz-Leurer 2017 30 mixed Case-control study 
No ethics approval or consent gained reported. Limitations are related to selection bias, external 
validity, the measurement tool and research manipulation 
Verhulst et al. 2017 10 healthy Diagnostic Test Study None identified by authors. Small cohort and only healthy participants included 
Wang et al. 2017 484 healthy Diagnostic Test Study 
Normative ‘absolute’ thresholds do not identify all patients with lymphoedema in a Chinese 
population. Limitations for absolute diagnostic thresholds for diagnosing lymphoedema was 
recognised in the development of criteria for bio-impedance spectroscopy.  
Yamamoto et al. 2017 54 healthy Diagnostic Test Study 
No consent reported. Volumetry was determined by tape measurement and not the gold standard of 
water volumetry. Only Japanese women were included in the cohort; thus results may differ for 
men and other ethnic populations 
Batista et al. 2018 91 mixed Diagnostic Test Study 
Measurements were taken at 10cm intervals, and measurements made only once on each subject. 
This would justify the large random variability observed between methods. Cohort mainly people 
without lymphoedema, which may result in a higher disagreement between the methods 
Cau et al. 2018 200 BCRL 
Prospective Cohort 
Study 
None identified by authors. No blinding identified 
Karakashian et al. 2018 31 mixed Diagnostic Test Study 
None identified by authors. Relatively small cohort; service evaluation, not a research study. No 
protocol given for CTM as the comparator  
Landau et al. 2018 11 BCRL Diagnostic Test Study None identified by authors. No ethics approval reported.  Very small cohort 
Preuβ et al. 2018 37 BCRL Diagnostic Test Study None identified by authors 
Sharkey et al. 2018 35 healthy Diagnostic Test Study 
None identified by authors. No consent reported. No standardised protocol for measurements for 
experts and students.  Researchers did not time the methods of measurements but instead estimated 
the time taken to perform the tests 
Sun et al. 2018 287 BCRL Diagnostic Test Study 
Simulated circumferential measurements do not account for test-retest reliability and human error 
of tape measurement. Exclusion of the hand is a fundamental limitation of current perometry 
methods 
DeSnyder et al. 2019 30 BCRL Diagnostic Test Study 
None identified by authors. No consent reported. Reporting of repeatability and reproducibility in 
terms of percentage makes it difficult for comparison to other papers 
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Author Year Cohort Methodology Limitations 
De Vrieze et al. 2019 30 BCRL Cross-sectional Study 
Relatively small cohort. A lower limb optoelectric device was utilised; this was remedied through 
a strict positioning protocol 
Karakashian et al. 2019 23 BCRL Diagnostic Test Study Garment properties and geometries not included in this work 
Lu & Dixon 2019 73 mixed Diagnostic Test Study None identified by authors. No ethics approval reported. No blinding identified 
Rafn et al. 2019 41 mixed Cross-sectional Study 
No ethics approval reported. Disproportion of educational accomplishments compared to general 
population; thus, there is a suspected higher engagement in research by the cohort.  Study was 
performed in a metropolitan area of high socioeconomic status. All participants had access to 
internet thus performance of the written instructions alone was not tested 




Expert therapists performed the measurements. Intra-rater estimates were based on one rater.  
Unable to recruit 24 patients in each stage category. Single scores to capture reduction of 
lymphoedema severity raises concerns as to its value for clinical or research purposes 




Sample size not based on a formal sample size calculation. LymphaTech included both inter- and 
intra-rater variance; perometer only measured intra-rater variance. 
 
Key: 




Large-scale studies are a challenge where the epidemiology of upper limb lymphoedema 
is dependent upon one condition, i.e. the consequences of breast cancer treatment.  Based 
on the Central Limit Theorem, at least 30 participants should be recruited for a study 
(Field, 2013).  The cohort or sample size for the studies varied immensely from six to 
677, some with healthy participants only, and others with a good mix of healthy 
participants and BCRL.  The majority of studies had good-sized cohorts of 30 or more 
participants, while 14 studies recruited less than the recommended 30.  Most studies 
focused on BCRL participants (n=19), while 13 studies utilised healthy participants 
only, and 12 studies had a mixture of BCRL and healthy participants. 
 
3.3.5 Robustness of Papers 
Nineteen studies did not state whether consent or ethical approval was gained before 
embarking on the research (Table 11).  Seven papers reported their results in a scientific 
format, but the abstract was a narrative (Dylke et al., 2012; Lu et al., 2013; Lu et al., 
2014; Cau et al., 2016; Hoevenaren et al., 2016; Wang et al., 2017;  Cau et al., 2018). 
 
The following three sections will describe the procedure and analyse the outcomes of 
the three chosen methods of measurement, namely CTM, perometry and 3DCI.   
 
3.3.6 Circumferential Tape Measurement (CTM) 
Of the 43 papers reviewed, 23 studies were identified for CTM.  Of the papers critiqued 
using CASP, five papers scored 23 or 24 (out of 24), these were De Vrieze et al. (2019), 
Rafn, McNeely, Camp, Midtgaard, & Campbell (2019), Devoogdt et al. (2010), Chen, 
Tsai, Hung, & Tsauo (2008) and Tewari, Gill, Bochner, & Kollias (2008).  Table 12 
provides a summary of the findings from each of the critiqued papers relating to CTM.   
 
Within the clinical setting, the most common technique for determining limb volume is 
CTM.  CTM is a method of limb volume measurement whereby the circumference of 
the limb is measured at set intervals along the arm from the wrist to the axilla (armpit).  
The two more commonly used methods are 4cm-CTM and 5-point CTM (Table 13) 
where 4cm-CTM measures the arm at 4 cm intervals from the wrist to the axilla.  The 5-
point CTM method measures five set points up the arm, i.e. the wrist, widest part of the 
forearm, the elbow, widest part of the upper arm and the point nearest the axilla. 
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Method Primary Results 








Compared WD to 5-point CTM and perometry 
to establish which was the more reliable, time-
efficient and clinically feasible method of 
measurement to use 
5-point CTM was the best measurement method in terms of reliability (intra- and 
inter-rater reliability was 0.987 and 0.984 respectively), low error rate, low cost, 
few limitations and time spent (264.13 seconds) 
Rafn et al. 
(23) 
2019 






Self-measurement using a tape measure by a 
participant at home and in a laboratory is 
compared to 10cm-CTM by a therapist and 
perometry 
High to excellent intra-rater reliability between non-BCRL group and therapist 
10cm-CTM (ICC>0.88), and excellent for BCRL group (ICC>0.91).  A near-
perfect correlation between BCRL group and perometry (r=0.98, p<0.001), and 
those without BCRL (r=0.95, p<0.001) 
Batista et al. 
(21) 
2018 




10cm-CTM was compared to perometry to 
determine the LOA 
Pearson’s correlation coefficient for volume, VD and %VD were 0.99, 0.88 and 
0.86, respectively.  The LOA for volume ranged from -202 to 181ml, for VD it 
ranged from -101 to 141ml and %VD ranged from -5 to 6.8% 







Circumferential and volume parameters were 
defined to compare CTM to 3DCI. 
Camera = Laser Scanner 3D system (LS3D) 
Good correlation between CTM and 3DCI on affected (R2=0.738; p<0.05) and 
unaffected side (R2=0.762; p<0.05). Statistical difference between CTM and 3DCI 
for circumference and volume on the affected side, and for circumference on the 
unaffected side; interestingly, total volumes were identical on the unaffected side. 







Arm 3D image captured with volumes analysed 
by Mirror software.  4cm-CTM measured from 
ulnar styloid to upper arm mark, and WD 
measured to upper arm mark. All methods were 
timed. Camera = Vectra 3D imaging system 
3DCI correlated well with 4cm-CTM (R2=0.991) and had good agreement with 
mean %VD of 2.8% (SD 2.0). 3DCI and WD correlated well (R2=0.987) with good 
agreement of %VD at 2.0% (SD 2.1).   
Time efficiency indicated 3DCI needed 9.8 min less than 4cm-CTM to perform, 
and 19.0 min less than WD. 







Assessing intra-and inter-rater reliability of 
4cm-CTM and perometry to determine the 
accuracy of CTM compared to perometry when 
measured by experts versus students 
Experts had lower SEM than students (25 ml vs 29.55 ml) for 4cm-CTM. Moderate 
intra-rater reliability with students (Cronbach’s alpha=0.6755) but excellent for 









CTM measurements are compared with the arm 
in horizontal versus vertical position 
Intra-rater reliability for both groups was excellent (ICC>0.997). A non-significant 
interaction effect of arm size, position (horizontal vs vertical) and group was noted 
(F1,28=3.30, p=0.08). A significant interaction was noted for arm volume between 
positions and groups (F1,28=4.42, p=0.04) 







To determine whether the normative-based 
thresholds by 10cm-CTM for the detection of 
lymphoedema differed for a Chinese population 
Dominant arm circumferences were significantly larger than the non-dominant 
arm (F1,4796=9.2, p=0.002).  Dominant limb volume larger than non-dominant 
(F1,3840=6.6, p=0.01) and increased along length of limb (F3,3820=2598.2, p<0.001); 
no interaction identified.  Age, body weight and BMI did not affect circumference 










Development of a new mathematical model for 
determining Localised Arm Volume Index by 
using segmental CTM volumes 
Intra- and inter-rater reliability were all very high for all segments (r>0.98).  
Differences were observed for different BMI groups with higher BMI having 








Method Primary Results 







Comparison of reliability and correlation 
between CTM and 3DCI. One arm was 
measured twice by each of the two raters for 
both 4cm-CTM and 3DCI. 
CTM has no significant difference in terms of intra-reliability with no significant 
differences for calculated volume. Note no ICC values given. Pearson's correlation 
coefficient between CTM and 3DCI was very high (R2=0.923, p<0.05); however, 
circumference and volume differences were statistically significant between 









Comparing arm volumetry by CTM with four 
truncated cone volumes to a new Upper 
Extremity LO (UEL) index according to BMI 
groups 
There was a statistically significant difference in arm volume between BMI groups 
(p<0.001); however there was no statistically significant difference in UEL index 
between BMI groups (P>0.667) 







Self-administered CTM was compared to WD 
and 5-point CTM to determine its reliability 
and validity 
Self-measure had excellent reliability with ICC of affected side ranging 0.97 to 
0.99, and for the unaffected side ranging 0.96 to 0.99.  Validity: Pearson's 
correlation coefficient between self-measure and WD was 0.59-0.68 (p<0.01), and 
with 5-point CTM was 0.88-0.95 (p<0.01). 








Experienced physiotherapists measured both 
arms of one patient three times using 5-point 
CTM to determine the SEM and the reliability 
of measurements between therapists 
SEM was 27.5 ml (CI 20.5-34.4 ml) with scaled SEM at 0.82%. 83% of therapists 
achieved SEM of <1% (p=0.847). No statistically significant difference seen 
between affected and unaffected side measurements (p=0.945) 







Circumference and volume of both arms was 
measured by WD, 4cm-CTM and 3DCI by one 
of two physiotherapists to evaluate the 
performance of 3DCI against commonly used 
4cm-CTM 
4cm-CTM underestimates volume compared to WD but was not statistically 
significant (CI=-99.78-51.22, p=0.512). No statistically significant difference was 











Both arms were measured three times by 
perometer and compared to the commonly used 
methods of WD and CTM 
CTM produced highest volume and WD lowest volume, with perometer volumes 
in between. Volume of dominant arm was 2.2% > non-dominant arm 







Used CTM to determine the prevalence of LO 
in the cohort. Different methods of CTM were 
used (3-point vs 10cm), and different thresholds 
were considered 
LO was defined as >7.5% increase in any circumference in at-risk arm – produced 
23.3% prevalence, with sensitivity of 83% and specificity of 81%. For >10 cm 
increases, prevalence was 12.9%, with sensitivity of 66% and specificity of 89%. 











Compared 4cm- and 5-point CTM to WD to 
determine their correlation 
Coefficient of variance for 4 cm CTM = 0.628%, 5-point CTM = 0.632% and WD 
= 0.609%.  Difference between 4 cm and 5-point CTM volumes was not 
significant. All methods had high correlation coefficients (r=0.813-0.915) and high 
regression coefficients (β=0.863-1.089). Excess volume had no statistical 



















5-point CTM was measured twice, one week 
apart. Compared test-retest reliability of 
segmental volume to total limb volume 
Total VD of LO arm was 7% > unaffected arm (p<0.01); and for segmented VD 
this was 7-8% > unaffected (p<0.01). Circumferential test-retest values were 
ICC=0.96-0.99 in LO arm and ICC=0.98-1.00 for unaffected arm.  Test-retest 
reliability for volume was excellent for both unaffected (ICC=0.99) and LO arms 
(ICC>0.98). SEM increased in unaffected arm when using segmental limb volume 












Inter-rater reliability testing of a home-CTM 
protocol versus therapist CTM and perometry 
within two weeks 
Moderate to high concordance between home-CTM and therapist-CTM (rc=0.68-
0.93), and high concordance between therapist-CTM and perometry (rc=0.83-
0.94). LOA varied dependent on the measurement location with a bias range of -











Participants were assessed twice over four 
weeks in which both arms were measured by 
10cm-CTM, perometer and BIS to determine 
the relationship between each method and the 
SEM 
Strongest relationship was for limb VD between 10cm-CTM and perometer 
(rc=0.99), and weakest between BIS and 10cm-CTM (rc=0.89).  LOA showed 10 
cm-CTM to underestimate limb volume compared to perometer. All 3 methods 
had excellent intra-rater reliability (ICC CTM=0.96; perometer=0.99; BIS=0.96). 









The unaffected arm of patients was measured 
twice over nine days by 3 therapists who were 
blinded to each other's results. A new 4cm-
CTM device was compared to WD to determine 
its reliability and validity 
Circumference measurements demonstrated intra-rater reliability ICC ranging 
from 0.977-0.996 and inter-rater reliability ICC ranging from 0.942-0.994. Arm 
volume intra-rater ICC was 0.997, and inter-rater ICC was 0.994. Circumference 
measurement and calculated volume intra-and inter-rater SEMs were low (range 
0.8%-2.0%). High correlation between CTM and WD (r=0.973). SRD noted at an 
increase of >1 cm in circumference, and >55 ml of arm volume was clinically 
significant 







Investigated and compared the reliability of 
WD and 3-point CTM by two blinded therapists 
by taking two measurements 10 min apart 
Excellent intra-and inter-rater reliability observed between methods (ICCs for both 
were >0.99, p<0.05). SEMs for WD was 27.3, and SEMs for CTM was low, 
ranging from 0.13-0.37. SRD for WD was 75.6, and for CTM it ranged from 0.37 
to 1.02 
Tewari et al. 
(23) 
2008 87 women 
Diagnostic Test 
Study 
Compared 10cm-CTM, using a narrow and 
broad tape measure, to WD to assess for 
accuracy 
Significant correlation in volume estimations between narrow and wide tape CTM 
(r=0.95, p<0.0001). Narrow tape CTM vs WD had Pearson’s correlation 
coefficient of 0.92 (p<0.0001); and wide tape CTM vs WD was 0.88 (p<0.0001) 
 
Key: 
3DCI = Three-Dimensional Camera Imaging %VD = Percentage Volume Difference    AUC = Area Under Curve   BC = Breast Cancer       
BCRL = Breast Cancer-Related LO  BIS = Bio-impedance Spectroscopy   BMI = Body Mass Index   CI = Confidence Interval  
CTM = Circumferential Tape Measurement ICC = Intra-class Correlation Coefficient  LO = Lymphoedema       LOA = Limits of Agreement   
SD = Standard Deviation   SDC = Smallest Detectable Change  SEM = Standard Error of Measurement   SRD = Smallest Real Difference   
UEL = Upper Extremity Lymphoedema TDC = Tissue Dielectric Constant   VD = Volume Difference   WD = Water Displacement   
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CTM is poorly standardised in both research and clinical practice, with taught methods, 
access to volumetric calculation programmes, and personal choice influencing this 
continued practice (Chen et al., 2008; Peleg & Katz-Leurer, 2017).  The lack of 
standardisation presents challenges in comparing findings and reduces the repeatability 
of the outcomes for continued monitoring of a patient if different methods of CTM are 
used between appointments.  Variables upon which CTM should be performed and 
interpreted include 1) patient position [the position of the patient's arm in relation to their 
body];    2) measurement points [first mark and points along the arm being measured]; 
3) tape measure [type and method of application]; and 4) the mathematical formula used 
for volume calculation. 
 
Patient positioning was mentioned in eight studies, with six of them using a seated 
position (Table 13).  Eleven studies report positioning the arm in a horizontal position, 
with one study (Peleg & Katz-Leurer, 2017) comparing the vertical (arm down by the 
side) position to the horizontal.  This study concluded that the vertical position in healthy 
participants significantly increased limb volume compared to the horizontal position in 
the healthy cohort; however, this was not replicated in the lymphoedema cohort (Peleg 
& Katz-Leurer, 2017).  The positioning of the forearm was documented in seven of these 
studies with five pronating (palm down) the forearm (Czerniec et al., 2010; Katz-Leurer 
& Bracha, 2012; Peleg & Katz-Leurer, 2017; Wang et al., 2017; Batista et al., 2018), 
while the other two studies had the participants supinating (palm up) their forearm (Cau 
et al., 2016; Cau et al., 2018).  Incidentally, these last two studies were performed by the 
same researchers; hence there is insufficient evidence to recommend supination of the 
forearm.  Thus, based on the evidence from the eight studies, the most commonly used 
posture for standardisation would be for both arms held in the horizontal position and 
forearms pronated. 
 
The 'first mark' on the limb determines the reference point from which arm volume 
measurements commence.  The first mark was identified in 16 studies with the majority 
opting for the 'wrist' as their identifying landmark from which the arm measurements 
were made to ensure repeatability on the opposite arm and between sessions (Table 13).  
The wrist was defined as the crease created when the hand is extended (lifted off the 
table), thus reducing variation between users.  The second most common first mark used 
was the Ulnar Styloid process, mentioned in five studies (Table 13). Research  
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Table 13: Variables for consideration when using CTM 






Tool Used for 
Marking 























































































































































































De Vrieze et al.  2019                                         
Rafn et al.  2019                                      
Batista et al.  2018                                       
Cau et al.  2018                                    
Landau et al.  2018                                        
Sharkey et al. 2018                                        
Peleg & Katz-
Leurer  
2017                                     
Wang et al.  2017                                    
Yamamoto et al.  2017                                        
Cau et al. 2016                                    
Yamamoto et al.  2016                                         
Mori et al.  2015                                          
Tidhar et al.  2015                                        
Öhberg et al.  2014                                   
Adriaenssens et al.  2013                                    
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Tool Used for 
Marking 























































































































































































Asim et al.  2012                                        
Brorson & Höijer 2012                                         
Katz-Leurer & 
Bracha 
2012                                      
Foroughi et al. 2011                                       
Czerniec et al. 2010                                      
Chen et al.  2008                                       





demonstrates that all first marks are highly valid and reliable (Tewari et al., 2008) and 
that they should be used for the repeatability of CTM measures between sessions. 
 
Brorson & Hoijer’s (2012) study comparing 4cm-CTM versus the 5-point method found 
that there was no statistically significant difference between these two methods of CTM.  
The advantage of the 4cm-CTM method is that it is more sensitive in detecting limb 
volume change and distortion in limb shape as it measures between 10 and 12 points 
along the arm compared to the 5-point method.  Table 13 identifies six different points 




Figure 11: 4cm-CTM Guidance (LNW, 2017).  Participant rests hands palm down on a 
table, arms straight at shoulder height (A). The ‘first mark’ is measured from the base of 
the little finger to above the ulnar styloid process (B). Measurements are taken every 4 
cm along the outer arm to about 2 cm below the axilla crease (C). The tape measure is 
placed snugly around the limb to overlap the mark in the 'middle' (D). 
 
Five studies mention the tool used to mark the participant’s arms for taking 
circumferential measurements (Table 13).  Öhberg, Zachrisson, & Holmner-Rocklöv 
(2014) used a ruler to mark their participant’s arms as they suggested that a tape measure 
would adhere to the irregular shape of the lymphoedematous arm thus distorting the 
actual distances between points (Figure 11).  All other studies utilised a tape measure at 
tension to negate the distortion along the arm.  When performing CTM, the type of tape 
measure used does not influence the reliability and validity of CTM (Tewari et al., 2008).  
Placement of the tape measure needs care to reduce errors such as applying the tape too 
tight, too loose, or by compressing tissue (Chen et al., 2008; Tewari et al., 2008; Asim 
et al., 2012).  Research recommends placing the tape perpendicular to the limb with 
56 
 
consistent tautness at each fixed point (Öhberg et al., 2014), or by placing the tape snugly 
around the arm without tightening the tape (Brorson & Hoijer, 2012; Öhberg et al., 
2014).  
 
A further identifier of the lack of standardisation existent in CTM is that there are two 
types of calculation for limb volume, each based on the concept of the limb being defined 
as either a cylinder or truncated cone.  As such, there are different methods for 
calculating limb volumes from the multiple circumferential measurements of the limb.  
'Frustum' (also referred to as truncated cone) and 'Cylinder' (also referred to as disc 
method) volume methods are the more conventional geometric formulae used to 
calculate limb volume from circumferential measurements.  From Table 13, it is evident 
that the most commonly used calculation in the literature is the frustum method, with 18 
studies utilising this equation.  Essentially, the total volume of geometry is subdivided 
into 𝑛 segments, and calculated by adding the volumes of each segment 𝑖, as shown in 
Figure 12.  A benefit of this method of measurement is that the limb can be calculated 
in segments or as a whole (Katz-Leurer & Bracha, 2012). 
 














Figure 12: Geometric and mathematical representations of limb volume formulae:  
Frustum segment (left) and Cylinder segment (right).  C1 and C2 are the lower and upper 
circumferences of each segment, while L is the length of each segment. 
 
Influential work from Sitzia (1995), and later studies by Devoogdt et al. (2010), 
Foroughi et al. (2011) and Adriaenssens et al. (2013), demonstrates that the Cylinder 
method is inaccurate as it can overestimate limb volume by up to 5%.  Thus the frustum 
method is recommended as it assumes that the limb resembles a cone shape as opposed 




Arm dominance needs to be considered as the dominant limb generally measures 1.6% 
to 4.7% bigger than the non-dominant limb (Smoot et al., 2011; Wang et al., 2017).  For 
this reason, it is ideal that pre-operative measurements are taken for those people having 
axillary node excision, as they will be at risk of developing lymphoedema.  With this 
pre-operative measurement, the limb volume difference will be the baseline, and normal 
arm dominance will be accounted for (Smoot et al., 2014).  However, as discussed in  
section 2.4.3 (page 21), pre-operative measurements are rarely achieved in practice due 
to resource limitations on lymphoedema services. 
 
Formative work by Casley-Smith (1994) demonstrated that patients (and therapists) are 
more likely to understand limb volume differences in terms of ‘percentage of oedema’ 
as opposed to ‘altered percentage of normal’ or ‘altered percentage of the initial volume’.  
Within this paper, the recommended equation for presenting volume difference in 
unilateral limb lymphoedema is ‘Difference in Oedema/Normal’; and for bilateral limb 
oedema, the equation is ‘Difference in Volume/Initial Volume.  The former method of 
calculation has been used in many research studies (Czerniec et al., 2010; Adriaenssens 
et al., 2013; Tidhar et al., 2015; Peleg & Katz-Leurer, 2017; Wang et al., 2017) as it 
presents the least errors in calculation and appears to be the most meaningful way of 
expressing an alteration in the amount of lymphoedema (Casley-Smith, 1994).  Absolute 
volume difference has also been used in research.  It is calculated by subtracting the 
initial limb volume from the current limb volume of the same arm where a negative 
value indicates a reduction in limb volume  (Casley-Smith, 1994).  In clinical practice, 
patients have a better understanding of limb volume difference expressed as both a 
volume (cups or pints) and percentage of the lymphoedema arm compared to their 
‘normal’ (unaffected) arm, thus supporting Casley-Smith’s (1994) findings. 
 
Newer models for determining the extent of lymphoedema and treatment outcomes are 
the ‘Upper Extremity Lymphoedema Index’ [UEL] and the ‘Localised Arm Volume 
Index’ [LAVI] (Wang et al., 2017; Sharkey et al., 2018).  UEL is calculated by dividing 
the person’s body mass index (BMI) into the summated squared circumferences, while 
LAVI is the percentage proportion of one localised UEL compared to the standard 
localised UEL.  Both methods were found to be highly reproducible and were less 
affected by body physique compared with the frustum method, however, both studies 
were performed on healthy participants with no history of arm lymphoedema or breast 
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cancer.  The authors express that these methods would be transferable to a pathological 
cohort, i.e. BCRL, but to date, no study exists to confirm this. The calculations are not 
complex, but the points of measurement used are questionable as they measure the hand, 
wrist, elbow and 5cm above and below the elbow.  Therefore, a potential for error exists 
in the presentation of lymphoedema where localised swelling may be distal, or proximal, 
to the points measured. 
 
De Vrieze et al. (2019) developed a list of 12 limitations regarding clinical feasibility 
which were scored for each method.  Water displacement and CTM showed statistically 
significant differences in means against perometry (p<0.05).  For time efficiency, 
perometry was the fastest in terms of set up time and execution of bilateral limb 
measurements with a mean time of 1:43 min.  However, for clinical feasibility, 
perometry was rated second to CTM, resulting in an overall ranking of CTM as the 
highest, indicating that CTM is the most appropriate method of measurement for use in 
clinical practice. 
 
3.3.6.1 Thresholds for Diagnosing Lymphoedema Using CTM 
There exists a lack of consensus over diagnostic thresholds for the diagnosis of 
lymphoedema.  Ten different thresholds were identified from the five studies that 
utilised volume measurement differences between arms in diagnosing lymphoedema 
(Table 14).  The most commonly referenced methods were >10% volume difference in 
total upper limb volume, >200 ml difference between arms, with the third commonly 
used threshold being >2 cm circumference difference at any point along the arm.   
 
Asim et al. (2012) used CTM to determine the prevalence of lymphoedema in their 
breast cancer cohort (n=193).  Different methods of CTM were used (3-point vs 10cm-
CTM), and different thresholds were considered.  Interestingly, for 10cm-CTM, 
thresholds chosen were 20%, 15% and 10%, whilst for 3-point CTM the thresholds were 
7.5%, 10% and 2 cm difference.  The only discernible reason is that these thresholds 
were chosen to compare their study outcomes with the Sentinel Node Biopsy versus 
Axillary Clearance (SNAC) trial.  Their results for 3-point CTM thresholds had the 
highest sensitivity for >7.5% increase in any circumference in the 'at-risk' arm at 83% 
(specificity was 81%), and the highest specificity was 89% when using an increase of 
>10% threshold (sensitivity was 66%).  No sensitivity or specificity data was provided 
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for the 10cm-CTM thresholds.  No conclusion was given as to which method of CTM 
was more accurate, as they state that the protocol chose 3-point CTM from the 
International Breast Cancer Study Group Trial (IBCSG 10-93).  They do however 
conclude that CTM is a simple 'office method' of screening for lymphoedema and that 
patient history and >10% increase in any circumference is optimal for determining 
lymphoedema as it has the highest specificity of the thresholds tested.  However, with 
moderate sensitivity, this conclusion is debatable, as several false negatives will be 
missed, causing delays in treatment and risking complications such as fibrosis and the 
risk of cellulitis. 
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         
Czerniec 




         
 
Wang et al. (2017) used the 10cm-CTM method and calculated cut-off thresholds at two 
standard deviations (2SD) ranging from 0.6 to 0.7cm at the wrist, and 1.6 to 2.3cm at 
40cm up the arm for the non-dominant and dominant sides respectively.  This is a more 
labour intensive method to use in clinical practice in terms of needing to remember the 
differences in circumference required for diagnosing lymphoedema at each point up the 
arm. 
 
In clinical practice, it is best to consider sensitivity testing for lymphoedema, especially 
for those at risk of lymphoedema, as early detection and treatment are known to 
minimise complications (Blaney et al., 2015). Thus, when considering Asim et al.’s 
(2012) results, the threshold of >7.5% is the more sensitive for detecting lymphoedema 
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and should be considered for standardisation of diagnosing lymphoedema going 
forward. 
 
3.3.6.2 Validity and Reliability of CTM 
Concurrent Validity: 
This looks at the similarity between a new measure against existing or comparable 
measures (Glen, 2015a).  Eight papers report on concurrent validity, with correlations 
between CTM and water displacement, perometry or 3DCI of 0.91 (range 0.80-0.99) 
(Tewari et al., 2008; Czerniec et al., 2010; Foroughi et al., 2011; Brorson & Hoijer, 
2012; Mori et al., 2015; Cau et al., 2016; Batista et al., 2018; Rafn, McNeely, Camp, 
Midtgaard, & Campbell, 2019). 
 
Convergent Validity: 
Determines the extent to which measures that are related, correlate (Trochim, 2020).  
Three studies reported on this subcategory of construct validity.  The correlation 
between different CTM intervals, 4cm-CTM to 5-point CTM, was 0.87 (range 0.81-
0.92) (Brorson & Hoijer, 2012).  Tewari et al. (2008) report that the correlation between 
different widths of tape measure, 8 mm and 15 mm, was 0.95, whilst Mori, Lustman, & 




To help distinguish between the various reported reliability tests, an explanation of each 
follows.  Intra-class Correlation Coefficient (ICC) is a reliability index in test-retest, 
intra-rater (ICCintra) and inter-rater (ICCinter) reliability analysis (Koo & Li, 2016), with 
values closer to 1.00 indicating excellence.  Standard Error of Measurement (SEM) 
quantifies the amount of variability in a test and is measured in the same units as the 
original measurement with values closer to 0 indicating stronger reliability (Huang & 
Leong, 2016).  For purposes of comparison, the SEM for each study was converted to 
percentages.  Furthermore, the Smallest Detectable Change (SDC) has been calculated 
which can be defined as the smallest change that can be detected by a device beyond 
measurement error (de Vet & Terwee, 2010).  The SEM was used to calculate the SDC 




Eight papers reported excellent ICC values for CTM.  Pooled ICC data showed an 
ICCintra value of 0.97 (95% CI=0.88, 1.00) (Chen et al., 2008; Czerniec et al., 2010; 
Devoogdt et al., 2010; Katz-Leurer & Bracha, 2012; Mori et al., 2015; De Vrieze et al., 
2019; Rafn et al., 2019) and an ICCinter value 0f 0.95 (95% CI=0.88, 0.99) (Devoogdt et 
al., 2010; De Vrieze et al., 2019; Rafn et al., 2019).  The weighted mean SEM was 2.0% 
(=2.8%) and the weighted mean SDC was 5.5% (=8.3%)  (Czerniec et al., 2010; 
Devoogdt et al., 2010; Foroughi et al., 2011; Brorson & Hoijer, 2012; Adriaenssens et 
al., 2013; Tidhar et al., 2015; Cau et al., 2016; Batista et al., 2018; Sharkey et al., 2018).   
 
Three studies looked at self-measurement using CTM.  Intra-rater reliability varied 
from 0.88 to 0.99, with the lower values attributed to non-BCRL groups (Mori et al., 
2015; Rafn et al., 2019). Foroughi et al. (2011) performed an inter-rater reliability test 
of a home-CTM protocol versus therapist-CTM and perometry within two weeks.  
Moderate to high concordance was observed between home-CTM and therapist-CTM 
(rc=0.68-0.93).  From these three studies, self-administered CTM appears to be highly 
reliable with the use of a protocol. 
 
3.3.6.3 Benefits and Considerations of CTM 
The advantages of CTM are that it is easy to perform (Chen et al., 2008; Asim et al., 
2012; Rafn et al., 2019), allows for analysis of segments individually or the total limb 
(Devoogdt et al., 2010; Brorson & Hoijer, 2012), and is not reliant on physique (Blaney 
et al., 2015).  It is portable to most environments and is low cost (Asim et al., 2012; 
Tidhar et al., 2015; Cau et al., 2016; Cau et al., 2018; Rafn et al., 2019).  The added 
benefit of CTM to the therapist is that it aids clinical decisions such as choosing a 
garment size suitable for the person, deciding on the more appropriate material of the 
compression garment and determining when a change in treatment may be required 
(Tidhar et al., 2015).  These latter decisions also take into account the person’s subjective 
feedback about their lymphoedema management. 
 
Conversely, CTM is user-dependent and can be prone to technical errors such as 
inconsistent pressure in tape application, inaccurately marked points on the limb, and 
deviation of the angle of the tape relative to the long axis of the limb (Chen et al., 2008; 
Tewari et al., 2008; Batista et al., 2018).   It can be a time-consuming procedure 
(Devoogdt et al., 2010; Landau et al., 2018) with Landau, Kim, Gould, & Patel (2018) 
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reporting an average time of 15:42 min to perform the setup, execution and calculation 
of the results.  It is also worth remembering that CTM is a single measure and is thus 
unable to differentiate between changes in muscle, bone, fat and fluid of the limb 
(Tewari et al., 2008; Czerniec et al., 2010; Peleg & Katz-Leurer, 2017).  
 
3.3.7 Perometer 
Seventeen studies were identified and reviewed for perometry.  Two of the papers 
analysed using CASP scored 24 (out of 24); these were De Vrieze et al. (2019) and 
Spinelli et al. (2019).  Table 15 provides a summary of these critiqued papers. 
 
 
Figure 13: Perometer 1000 NT (portable model). The hand rests on the support while a 
frame is moved along the stand, capturing the circumference of the limb. 
 
The perometer (Figure 13) is a technology-based circumferential measure.  Specifically, 
it is an infrared optoelectric imaging system used for the indirect measurement of arm 
or leg volumes. It offers information on circumferences, contours and provides 
schematic representations of the cross-sectional area of the limb (Lee et al., 2011; 
Adriaenssens et al., 2013; Bulley, Coutts, & Tan, 2013).  The estimated time taken to 
perform the perometer measurement is on average 2 min per limb, as opposed to CTM 
which takes more than 10 min for both limbs (Sharkey et al., 2018); and is reportedly 
faster to perform than water displacement (Lee et al., 2011).    
 
Pero-System Messgeraete GmbH, Wuppertal, Germany (Pero-System Messgeraete 
GmbH, 2017), are the only manufacturers of the perometer.  There are currently four 
perometer models, each comprising a square measuring frame that is moved manually 
back and forth at 90 to the base plate (Czerniec et al., 2010; Foroughi et al., 2011).  The 
frame contains parallel-acting light curtains made of photosensors and infrared light-
emitting diodes (LEDs) which illuminate and scan the limb (Czerniec et al., 2010; 
Ancukiewicz et al., 2011; Foroughi et al., 2011; Dylke et al., 2012).    The measurements  
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Method Primary Results 








Compared new 3DCI device (LymphaTech) 
to perometry to determine its reliability and 
validity 
Both methods displayed ICCs of >0.99. SEM for both methods nearly identical, 
ranging from 28.3 to 32.8ml. The convergent validity analysis demonstrated no 
systematic difference between methods.  The Bland Altman plot identifies a mean 
volume difference between methods for the affected side of -7.8ml, and -4.8ml for 











Both arms were measured by each therapist 
three times, by one or two raters, or in groups 
of 5 to 6 raters, using a perometer in two 
positions to determine repeatability, 
reproducibility and precision/tolerance (P/T) 
ratios 
Baseline P/T ratio was 19.9%, repeatability was 65.0% and reproducibility 19.0%. 
BMI, height and weight were all significant (p<0.003). Difference from old to new 
patient position reduced variations in limb volume by 28% (p=0.02). P/T ratio for 
the new position was 6.5%, repeatability 2.4% and reproducibility 6.1%. Over-
diagnosis and under-diagnosis both reduced to 0% from 3.5% and 2.3% 
respectively for threshold of 10% volume difference 








Compared 3 types of WD to CTM and 
perometry to establish which was the more 
reliable, time-efficient and clinically feasible 
method of measurement to use 
Intra- and inter-rater reliability for volume ranged from 0.897 to 0.975 with an 
SEM of 92.01ml (95% CI). Perometry was fastest in terms of set up time and 
execution of bilateral limb measurements with a mean time of 1min 43sec. All 
other measures showed statistically significant differences in the means against 
perometry (p<0.05). For clinical feasibility, perometry was rated second to CTM 









Compared new assessment tool (Cancer-
related LO of the Upper Extremity [CLUE]) 
to perometry by measuring twice by two 
therapists over 7-21 days  
ICC for intra-rater reliability was 0.93 (95% CI), and for inter-rater reliability it 
was 0.98 (95%CI). Pearson’s correlation between the measurement tools was 0.79 




46 at risk 




CTM was compared to perometry to 
determine the LOA 
Very strong correlation for volume, VD and %VD were observed with Pearson's 
correlation coefficients of r=0.99, 0.88 and 0.86, respectively.  The LOA for 
volume ranged from -202 to 181ml, for VD it ranged from -101 to 141ml and 
%VD ranged from -5 to 6.8% 









Assessing intra-and inter-rater reliability of 
CTM and perometry to determine the 
accuracy of CTM compared to perometry 
when measured by experts versus students 
Perometer had lower SEMs for students compared to CTM (24.88 vs 114.1); 
however, SEM experts perometer was higher than CTM (38.99 vs 25).  There was 
moderate intra-rater reliability with students (Cronbach's alpha=0.764) but 
excellent ICC for the expert groups (Cronbach's alpha=0.99) 







Women with BC were screened for LO using 
perometry and compared total limb VD to 
simulated VD at 4cm intervals, landmark (3-
point), and landmark-midpoint (5-point) 
methods 
Correlation coefficient was consistently >0.98 for all simulated methods compared 
to total limb perometry.  Both landmark methods significantly underestimated 
upper arm volume but overestimated forearm volume. Volume change for LO was 
detected most commonly in the upper arm (63.4%), forearm (11.1%) and equally 
in both segments (25%).  Both landmark methods had greater sensitivity compared 
to 4cm and total limb (93.1 and 90.3% vs 81.9 and 77.8%) and greater specificity 


















Both arms were measured three times by 
perometer and compared to one measurement 
of commonly used methods of WD and CTM  
Intra-class correlation for perometer was excellent (ICC > 0.997 for healthy group, 
and >0.998 for BC group). CTM produced highest volume and WD lowest volume, 
with perometer volumes in between. Volume of dominant arm was 2.2% > non-
dominant arm. 







Develop a standardised protocol for the 
upright perometer and test its reliability on 
two separate occasions 24-48hrs apart by two 
raters 
A series of pilot studies were undertaken to develop the final standardised protocol.  
High intra-and inter-rater reliability observed (ICC=0.953-0.989); however, the 
LOA results were less positive, ranging from -941 to 915ml. 








Compared 3DCI to perometer in first 
experiment; then determined accuracy and 
ability of 3DCI to detect localised swells 
To note: authors state that ‘perometer cannot be considered as ground truth, since 
its application in LO is predicted upon its ability to provide repeatability, but not 
necessarily accuracy in the readings’. Perometry underestimates volume compared 









Both arms were measured pre-and post-
operatively over 3 years together with BMI. 
The purpose was to compare absolute change 
in arm size (2cm) to relative arm volume 
change (200ml) to quantify BCRL 
Paper reports 'strong' correlation of unaffected arm volume with bodyweight 
(Kendall's τ=0.65, p<0.0001), and BMI (Kendall's τ=0.55, p<0.0001), but values 
are moderate. The median relative arm volume change was 7.7% resulting from a 
200ml change in arm volume.  For subset group (n=45), local change of 2cm in 
circumference corresponded to a relative arm volume change of 7.5%.  For subset 
group (n=124), relative arm volume change in affected arm did not correlate to 
weight or BMI (P>0.05) 







A single assessment was performed to 
determine the normative values for inter-arm 
differences by obtaining both circumferential 
(10cm method) and volume measurements by 
perometer. Volume calculations compared 
included perometer, truncated cone and 
cylinder (calculated) methods 
Volumes versus simulations had high correlation coefficients ranging from 0.851 
to 0.988. Concordance between calculated methods was very high (0.999-1.000). 
Mean bias for total arm volume was 2.9% with bias largest in dominant arm. The 
LOA (2SD) between methods was largest between perometry and truncated cone 
method for dominant arm (LOA=-1-10%). Paired t-tests between dominant and 
non-dominant arm revealed significant differences at all but 30cm point (95%CI). 
All perometer segments were significantly different between sides (p<0.03-0.001). 
Diagnostic cut-offs for LO were determined at 3SD above the mean. Regression 









Both arms were measured pre-and post-
operatively up to three times at a session.  
The measurement protocol was revised 
throughout the study to increase accuracy of 
the measurements, and a formula for the 
quantitative assessment of developing LO 
was constructed 
At baseline measure, there was no statistically significant difference between sides 
(p=0.42). Statistical analysis identified volume ratios as most appropriate for 
quantification of both asymmetry and temporal changes. Formula for RVC was 
developed = (A2U1)/(U2A1)-1, where A1, A2 are arm volumes on affected side at 
different time points, and U1, U2 are volumes on the unaffected side.  RVC is not 
significantly associated with hand dominance, age or time since diagnosis of BC.  
Baseline weight correlates (p=0.0074) with higher RVC; however, BMI or weight 




















Inter-rater reliability testing of a home-CTM 
protocol versus therapist CTM and perometry 
within two weeks 
Moderate to high concordance between home-CTM and therapist CTM (rc=0.68-
0.93), and high concordance between therapist-CTM and perometry (rc=0.83-0.94). 
LOA varied dependent on the measurement location with a bias range of -5.5% to 
1.5% therapist-CTM vs perometer, and -2.4% to 4.0% therapist-CTM vs home-
CTM 








Only the LO side or dominant side (for non-
LO group) were measured in a single session. 
Perometer measurement was done twice by 
one rater, and once by a second rater, and one 
measurement done by WD 
Perometer demonstrated excellent inter- (ICC2,1=0.993) and intra-rater reliability 
(ICC2,1=0.989). Paired t-test showed no significant difference in hand volume 
between raters. Strong concordance between perometry and WD (rc=0.88). LOA 










Participants were assessed twice over a 4-
week period in which both arms were 
measured by 10cm-CTM, perometer and BIS 
to determine the relationship between each 
method and the SEM 
Strongest relationship was for limb VD between 10cm-CTM and perometer 
(rc=0.99), and weakest between BIS and 10cm-CTM (rc=0.89).  LOA showed 
10cm-CTM to underestimate limb volume compared to perometer. All 3 methods 
had excellent intra-rater reliability (ICC CTM=0.96; perometer=0.99; BIS=0.96). 
SEM for 10cm-CTM was 85ml; perometer 43mll and BIS ratio 0.05. 
 
Key: 
2SD = Two Standard Deviation  3DCI = Three-Dimensional Camera Imaging 3SD = Three Standard Deviation  %VD = Percentage Volume Difference    
BC = Breast Cancer        BCRL = Breast Cancer-Related Lymphoedema BIS = Bio-impedance Spectroscopy   BMI = Body Mass Index   
CI = Confidence Interval   CTM = Circumferential Tape Measurement ICC = Intra-class Correlation Coefficient  LO = Lymphoedema      
LOA = Limits of Agreement   P/T = Precision/Tolerance ratio  RVC = Relative Volume Change  SD = Standard Deviation  




taken by the perometer are calculated to produce an overall limb volume for each arm, 
which are then compared to one another to provide the volume difference. 
 
According to Lu, DeSouza, Armer, Anderson, & Shyu (2013) and Sun et al. (2018), 
perometry is sensitive to limb volume change and is a specific method for assessing 
lymphoedema.  The first paper published about perometry by Stanton, Northfield, 
Holroyd, Mortimer, & Levick (1997) validated the perometer by comparing it to 4cm-
CTM.  They found the perometer to be highly reproducible, accurate and reliable. 
 
From the literature, two studies recommended protocols for positioning when using the 
perometer.  Ancukiewicz et al. (2011) designed a ‘Perometer Measurement Protocol’ 
(Figure 14) recommended for clinical and research use, and two years later Bulley, 
Coutts, & Tan (2013) also developed a protocol using a different model of perometer.  
In essence, the limb is in the centre of the frame that is moved along the length of the 
arm from the wrist towards the top of the arm, and then back to the starting point.  One 
study compared two positions for their perometer (DeSnyder et al., 2019).  They 
determined that a baseline perometer measurement had repeatability of 65.0% and 
reproducibility of 19.0%, and when re-measured using a new patient positioning, the 
repeatability reduced to 2.4%, and reproducibility to 6.1%.  This change saw both over-
and under-diagnosis rates reducing to 0% from 3.5% and 2.3% respectively for a 
threshold of 10% volume difference between arms.  There are, however, six studies that 
recommend a protocol on patient positioning for the type of perometer used to ensure 
standardisation, allowing for less error between sessions and different therapists 
(Ancukiewicz et al., 2011; Foroughi et al., 2011; Lee et al., 2011; Dylke et al., 2012; 
Bulley et al., 2013; Sun et al., 2018).  
 
The LED lights of the perometer frame cast limb shadows in two planes, capturing limb 
diameters every 3.1 mm (Czerniec et al., 2010) or 4.7 mm (Foroughi et al., 2011; Bulley 
et al., 2013; Lu, DeSouza, Armer, Anderson, & Shyu, 2013; Sharkey et al., 2018), 
dependent on the model and software of the device used.  The perometer software uses 
these captured diameters to build an image of the limb and calculate its volume (Czerniec 
et al., 2010; Dylke et al., 2012).  Stanton et al.'s (1997) work explain that volume 
calculations are based on the assumption of a circular or elliptical cross-section; 




Figure 14: Perometer Measurement Protocol (Ancukiewicz et al., 2011)2 
 
or ellipse shapes.  Foroughi et al. (2011) measured each limb by perometer once, as their 
literature review showed it to have excellent reliability and reproducibility with repeated 
measures.  Concurrently, Ancukiewicz et al. (2011) warn that caution should be taken 
when interpreting perometer results when a single measurement of a limb is made due 
                                                 
2 Reprinted from International Journal of Radiation Oncology Biology Physics, volume 79, issue 5, 
Ancukiewicz et al., Standardised Method for Quantification of Developing Lymphedema in Patients 
Treated for Breast Cancer, pages 1436-1443., Copyright (2011), with permission from Elsevier  
68 
 
to potential discrepancies in limb volumes of 3% for 17% of patients and more than 5% 
for 5.8% of patients. 
 
The unaffected limb is used as the control for comparison in unilateral lymphoedema, 
using either a limb volume ratio (affected/unaffected), or limb volume difference 
(affected-unaffected) to gauge the severity of lymphoedema or treatment outcomes 
(Czerniec et al., 2010; Ancukiewicz et al., 2011; Dylke et al., 2012; Adriaenssens et al., 
2013; Lu et al., 2013; Sun et al., 2018).  Interestingly, Dylke, Yee, Ward, Foroughi, & 
Kilbreath (2012) found that the frustum and cylinder formulae calculated from the 
perometer circumferences could be used interchangeably.  However, these were not 
interchangeable with the perometer calculation even though the computer software sums 
the numerous elliptical discs to calculate limb volume (Bulley et al., 2013).  This was 
due to significant differences in total volume differences between the equations used.  
For this reason, perometry cannot be used interchangeably with CTM or water 
displacement (Czerniec et al., 2010; Lee et al., 2011; Dylke et al., 2012; Adriaenssens 
et al., 2013; Sun et al., 2018) as these measurement techniques are inequivalent, 
producing different and incompatible total limb volumes. 
 
3.3.7.1 Thresholds for Diagnosing Lymphoedema Using Perometry 
As with CTM, there exists a lack of consensus over diagnostic thresholds in 
lymphoedema measurement using perometry.  From the papers reviewed for perometry, 
five studies report a threshold used to diagnose lymphoedema, identifying four different 
thresholds, as summarised in Table 16.  The most commonly used threshold methods 
reported were ‘10% relative percentage difference’ (Czerniec et al., 2010; Dylke et al., 
2012; Adriaenssens et al., 2013; Bundred et al., 2020) and ‘absolute interlimb volume 
difference of 200ml’ (Czerniec et al., 2010; Ancukiewicz et al., 2012; Dylke et al., 2012; 
Bundred et al., 2020). The third commonly mentioned threshold was ‘1.5cm to 2cm 
interlimb circumference difference’ (Ancukiewicz et al., 2012; Dylke et al., 2012; 
Bundred et al., 2020).  To note, none of these studies take into account arm dominance.  
 
Ancukiewicz et al. (2012) measured breast cancer patients' arms pre-and post-
operatively over 3 years together with BMI.  The purpose was to compare absolute 
change in arm size (2cm) to relative arm volume change (200ml) to quantify BCRL.  
The median relative arm volume change was 7.7% resulting from a 200ml change in 
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arm volume.  A subset group of 45 participants had a localised change of 2cm in 
circumference, which corresponded to a relative arm volume change of 7.5%.  For 
another subset group of 124 participants, the relative arm volume change in the affected 
arm did not correlate to weight or BMI (p>0.05).  Thus the 2cm and 200ml thresholds 
correlate at 7.5%-7.7% in diagnosing lymphoedema. 
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Dylke et al. (2012) found small, but significant differences where the mean bias for total 
arm volume was 2.9%, and the largest bias in the dominant arm.  They proposed a 
diagnostic cut-off of 3SD and determined cut-offs of 1.3cm at the wrist to 3.1cm at the 
axilla on the dominant side, and 1.2cm to 2.7cm for the non-dominant arm at the same 
landmarks.  For volume cut-offs, they found that the perometer had higher thresholds 
than CTM for both the dominant and non-dominant arms, with all values above the 
recommended 200ml threshold.  The higher volume thresholds are accounted for by the 
proposed 3SD as opposed to the more commonly used 2SD due to 8% of their cohort 
that would be incorrectly diagnosed with lymphoedema. 
 
3.3.7.2 Validity and Reliability of Perometry 
Concurrent Validity: 
Four studies report on this, with correlations between perometry and CTM or water 
displacement of 0.92 (range 0.84-0.99) (Czerniec et al., 2010; Foroughi et al., 2011; Lee 




Two studies reported on this subcategory of construct validity using simulated models 
from the perometry data.  The correlation between total limb perometry and various 
simulated CTM methods was 0.99 (range 0.98-1.00) (Dylke et al., 2012; Sun et al., 
2018).   
 
Reliability: 
Nine papers reported good to excellent ICC values for perometry.  Pooled ICC data 
showed an ICCintra value of 0.97 (95% CI=0.85, 1.00) (Czerniec et al., 2010; Lee et al., 
2011; Dylke et al., 2012; Adriaenssens et al., 2013; Bulley et al., 2013; Sharkey et al., 
2018; De Vrieze et al., 2019; Spinelli et al., 2019; Binkley et al., 2020) and an ICCinter 
value of 0.98 (95% CI=0.90, 1.00) (Lee et al., 2011; Bulley et al., 2013; De Vrieze et 
al., 2019; Spinelli et al., 2019).  The weighted mean SEM was 3.4% (=4.6%) and the 
weighted mean SDC was 9.4% (=12.8%) (Czerniec et al., 2010; Foroughi et al., 2011; 
Dylke et al., 2012; Adriaenssens et al., 2013; Bulley et al., 2013; Lu et al., 2013; Batista 
et al., 2018; Sharkey et al., 2018; Binkley et al., 2020). 
 
3.3.7.3 Benefits and Considerations of Perometry 
The benefits of the perometer are that it requires little time to operate (Ancukiewicz et 
al., 2011; Lee et al., 2011; Adriaenssens et al., 2013; Lu et al., 2013), is safe to use in 
the presence of open wounds or infection as it does not require direct contact with the 
limb, and requires minimal technical training for staff (Lee et al., 2011).  There is only 
one type of portable perometer available which offers more flexibility in terms of cost 
and use (Adriaenssens et al., 2013).  The perometer software can build an image of the 
limb from the captured data (Czerniec et al., 2010; Dylke et al., 2012), which gives the 
therapist a 2-D view of the difference in shape between the limbs. 
 
Disadvantages of perometry are that it is cost-prohibitive (Adriaenssens et al., 2013; Lu 
et al., 2013; Sharkey et al., 2018; Binkley et al., 2020), bulky in size requiring space for 
setting up (Binkley et al., 2020), calculates total limb volume thus is unable to 
discriminate between fat, fluid, muscle and bone (Czerniec et al., 2010), does not easily 
capture the extremity and root of the limb (Czerniec et al., 2010; Sun et al., 2018), and 
most devices are not portable (Lu et al., 2013).  The images built from the data are not 
quantifiable and other than confirming the observed visual differences in shape, the 
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images provide no further information to the therapist.  Lastly, there are reports of 
software failure when using the perometer (Dylke et al., 2016). 
 
3.3.8 Three-Dimensional Camera Imaging (3DCI) 
3DCI has not been used in a lymphoedema clinical setting to date, but studies show its 
potential as a fast, accurate, and cost-effective method of measuring for lymphoedema.  
This newer method of determining limb volume using 3D modelling is derived from a 
variety of methods.  From the 16 studies for 3DCI, seven types of 3D devices were 
identified, including Asus Xtion Pro 3D, Kinect KinectTM, LymphaTech system, Laser 
Scanner 3D system (LS3D), Vectra 3D imaging system, 5-pod stereophotogrammetry 
system and static 3D Microsoft KinectTM system.  The maximum score the papers in this 
group achieved on the CASP table was 23 by Binkley et al. (2020), while five papers 
scored 22, namely Hameeteman, Verhulst, Vreeken, Maal, & Ulrich (2016), 
Karakashian et al. (2018), Landau et al. (2018), Preuβ, Killaars, de Grzymala, 
Binnebösel, & Neumann (2018) and Lu & Dixon (2019).  Table 17 provides a summary 
of the findings from each of the critiqued papers relating to 3DCI.   
 
3DCI has been used in various clinical settings including respiratory monitoring, falls 
risk assessment, assessment of spatiotemporal gait variables (Öhberg et al., 2014), 
dermatology, rehabilitation, assisted living (Dylke et al., 2016), and for determining 
patient size for radiation dose monitoring during CT scanning (Cook, Couch, Couch, 
Kim, & Boonn, 2013).  
 
Initial studies utilising 3D technology focused on facial oedema (Aldridge, Boyadjiev, 
Capone, DeLeon, & Richtsmeier, 2005; Plooij et al., 2009; Maal et al., 2010; van der 
Meer, Dijkstra, Visser, Vissinl, & Ren, 2014).  These studies have been expanded to 
include breast assessment (Henseler et al., 2012; Henseler, Kuznetsova, Vogt, & 
Rosenhahn, 2014) and hand oedema (Vicini et al., 2012; Hoevenaren et al., 2015). 
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3DCI System Method Primary Results 









Compared new 3DCI device (LymphaTech) 
to perometry to determine its reliability and 
validity 
ICCs of >0.99. SEM ranged from 28.3 ml to 32.8 ml. The 
convergent validity analysis demonstrated no systematic 
difference between methods.  The Bland Altman plot identifies 
a mean volume difference between methods for the affected side 
of -7.8 ml and -4.8 ml for the unaffected side.  It shows volumes 









Asus Xtion Pro 
3D 
The framework was built generating 
computational models from 3DCI in which 
Finite Element Analysis was performed to 
determine the sub-garment pressures based 
on the local curvature of each subject’s arms. 
Images were post-processed using 
MATLAB.  
Average maximum sub-garment pressure was 5100 Pa 
(38.25mmHg) as opposed to the intended 2500 Pa 
(18.75mmHg).  Subcutaneous results show that pressure exerted 
by garments exist more on adipose tissue than intended firmer 
LO skin and tissues. A novel finding was that a negative sub-
garment gradient pressure exists from the wrist to the elbow 
Lu & Dixon 
(22) 
2019 








Both arms measured in single session once 
by 3DCI and twice by Perometer 
(consecutively). 3DCI scanned front and 
back of patient for 30 seconds each side and 
then post-processed using MATLAB.  
Validity had correlation of 0.88.  Absolute volume agreement 
analysis resulted in a difference of -117.6 ml (SD 228.6).  Bland-
Altman analysis resulted in a %VD of -0.47% (SD 6.01) with a 
bias of 6.02 ml. Comparing BCRL to non-BCRL, there is no 
significant difference in %VD (p=0.28), but significantly greater 
VD (p=0.03) between arms in BCRL women. 









Circumferential and volume parameters 
were defined to compare CTM to 3DCI. 
Good correlation between CTM and 3DCI on the affected 
(R2=0.74; p<0.05) and unaffected side (R2=0.76; p<0.05). There 
was a statistical difference between CTM and 3DCI for 
circumference and volume on the affected side and 
circumference on the unaffected side. Interestingly, total 











Asus Xtion Pro 
3D 
Healthy group: one arm measured with 
3DCI to determine repeatability and 
reliability 
BCRL group: Both arms were measured 
once by 3DCI and 4cm-CTM.  Volume and 
shape were analysed. Meshlab was used for 
analysing 3DCI data.  
Healthy group: Repeatability mean volume was 2.52 litres (SD 
0.03) with a coefficient of variation 0.99%. Speed of camera did 
not influence the outcome. Reliability had ICC(3,1) of 0.95. 3DCI 
integral formula underestimated volume compared to CTM. 
Shape related metrics such as circumference and circularity were 
used to distinguish between LO and unaffected arms (p<0.05). 
Radial and oedema maps were developed using colour coding to 
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Full arm 3D image captured with volumes 
analysed by Mirror software.  4cm-CTM 
measured from ulnar styloid to upper arm 
mark, and WD measured to upper arm mark. 
All methods were timed. 
3DCI correlated well with CTM (R2=0.99) and had good 
agreement with mean %VD of 2.8% (SD 2.0). 3DCI and WD 
correlated well (R2=0.99) with good agreement of %VD at 2.0% 
(SD 2.1).  Time efficiency indicated 3DCI needed 9.8 min less 
than CTM to perform, and 19.0 min less than WD. 








Both arms were measured twice using 3DCI 
and WD over two sessions. Volumes were 
analysed using Mirror software 
Validity: both healthy and LO arm correlations were 1.00. WD 
measured larger volumes than 3DCI. Paired-samples t-test 
shows VD not significant for healthy arms (p=0.06), but 
significant for LO arms (p<0.001).   
Reliability: Intra-rater ICC was 1.00 for both arms. Paired-












Landmarks placed using 3D-printed device 
to identify the wrist. The hand and forearm 
of each subject were measured twice by first 
rater and once by a second rater. Images 
were analysed using 3ds Max 2015 software. 
Reproducibility mean difference was 0.6 ml (SD 7.6) and paired-
samples t-test had no significant difference between 
measurements (p=0.75). Hand volume difference for intra-rater 
was 1 ml (SD 10.2), and between raters was 1.4 ml (SD 9.2). 
Paired-samples t-test showed no significance for intra-rater 
(p=0.50) measurements. ICC for both intra- and inter-rater 
reliability was excellent (ICC=0.99).  









Comparison of reliability and correlation 
between 4cm-CTM and 3DCI. One arm 
measured twice by each of two raters for 
both 4cm-CTM and 3DCI.  Data were 
processed using Rodin4D software. 
Poor statistical data.  Reliability (intra and inter) reported as 
excellent, but no ICC given. Reproducibility very high with a 
difference of 0.02 dm3 between raters.  Validity: correlation was 
0.92 (p<0.05). Bland-Altman plot demonstrates consistency 









Both arms measured twice by WD and 3DCI 
to determine use of 3DCI in volume 
measurements for arms.  Volume 
determined using Autodesk 3ds Max 2012 
software. 
Mean VD was 13 ml (SD 15.6). Paired-sample t-test showed no 
significant difference (p=0.33). Pearson’s correlation coefficient 
was 0.99 (p=0.01). Bland-Altman plot indicates strong 
correlation between methods but shows higher LOA between 
3DCI than WD measurements. 3DCI overestimates volume by 















3DCI of both hands were captured using 
study protocol to investigate the use of 3DCI 
as a reproducible and useful tool for 
measuring LO of the hand.  Data were 
analysed using 3ds Max 2015 software.  
Mean VD between hands was 73 ml (SD 64). Healthy control 
group had mean difference of 8ml with dominant hand bigger. 
Reproducibility showed average difference of 5.2ml (SD 5.2) 
with statistically significant difference in hand volume between 
groups (chi-square = 18.9; p<0.00). 










Two raters measured one arm twice with 
both WD and 3DCI. Plastic cylinders were 
also measured.  Study done to determine 
Both raters had similar results with bias range of 21.7 ml and 
22.2 ml. 3DCI slightly underestimates volume compared to WD. 








3DCI System Method Primary Results 
accuracy and reliability of 3DCI for both 
human arms and inanimate objects. All 
measurements were timed.  Data were 
analysed using MeshLab software. 
volume and accuracy; however, highly significant relationship 
between BMI and accuracy was found (p=0.004). Intra- and 
inter-rater reliability of 1.00.  SEM between methods was 
similar. Duration of tests was higher for WD (2min 3sec) than 
3DCI (42sec) (p<0.00). 










Two raters measured the right arm of each 
subject twice with both WD and 3DCI. The 
3DCI images were viewed and analysed 
using Mirror software allowed for merging 
of the anterior and posterior views taken 
with 3DCI. The study was done to determine 
the validity and reliability of 3DCI volume 
measurements compared to WD.  
Validity: Correlation was 0.98. 3DCI volumes were higher than 
WD with mean VD of -13.8 ml (SD 59.3). Paired-sample t-test 
showed no significant difference between methods (p=0.19).  
Reliability: Intra-rater reliability was 0.99. Paired-sample t-test 
showed no significant difference between two 3DCI 
measurements (0.67), with a mean volume difference of -1.39ml 
(SD 18.8). Strong agreement between measures on Bland-
Altman plot: differences ranging from -30.0 to 30.0ml.   












System validated using a PVC pipe. Both 
arms measured twice by perometer and 
3DCI. Localised swelling determined by 
taping a pen to the forearm of one subject. 
Both arms measured by 3DCI and WD twice 
in sets of three with a 2-hour time-lapse.  
3DCI overestimated volume compared to perometry with a bias 
error ranging from -0.4 to 7.8%. 3DCI is sensitive to pick up 
small change in volume of less than 1%.  3DCI overestimates 
volume compared to WD with a bias error ranging from -7.51 to 
8.83%; however, the mean volume difference between the two 
methods was 8.35ml.  Correlation was 0.98. 











Circumference and volume of both arm 
measured by WD, CTM and 3DCI by one of 
two physiotherapists to evaluate the 
performance of 3DCI against commonly 
used CTM.  MATLAB was used to analyse 
the image data.  
No statistically significant difference between the methods 
(p>0.05). A systematic bias between therapists was observed 
(p=0.02). For circumference, 3DCI systematically differed to 
CTM (p=0.002) with increased disagreement the higher up the 
limb measurements were taken. Inter- (0.98, p<0.001) and intra-
rater (0.99, p<0.001) reliability was excellent  










Compared 3DCI to perometer in first 
experiment; then determined accuracy and 
ability of 3DCI to detect localised swells. 
Localised swelling was tested by taping a 
pen to the inner forearm of a subject 
3DCI overestimates volume compared to perometry with a 
percentage discrepancy ranging from 4.7 to 12.8%.  3DCI was 




3D = Three Dimensional   3DCI = Three-Dimensional Camera Imaging %VD = Percentage Volume Difference  BC = Breast Cancer        
BCRL = Breast Cancer-Related Lymphoedema CI = Confidence Interval   CTM = Circumferential Tape Measurement ICC = Intra-class Correlation Coefficient 
LO = Lymphoedema       LOA = Limits of Agreement   SD = Standard Deviation   SEM = Standard Error of Measurement   
VD = Volume Difference   WD = Water Displacement 
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Öhberg et al. (2014) compared a 3DCI system to water displacement and CTM to 
calculate upper limb volume.  The 3DCI set up involved three fixed cameras within a 
predefined frame with a positional laser mounted to mark the distal end of the 
measurement space (Figure 15).  They found that 3DCI volumes were overestimated 
compared to water displacement and that CTM volumes were underestimated compared 
to water displacement.  Öhberg et al. (2014) confirmed recommendations of measures 
not being interchangeable, even though they correlated well.  They concluded that 3DCI 
offered a modern alternative to CTM.   
 
 
Figure 15: Öhberg et al.'s 3D camera system (2014). Utilises three Microsoft KinectTM 
cameras ( ) with the ‘box’ indicating the measurement subspace aligned by a laser3 
 
Öhberg et al. (2014) acknowledged that using 3DCI  within a clinical setting was 
uncertain but that it could be an invaluable educative tool for patients as it would provide 
a graphical representation of how the shape of the limb changes over time.  These visual 
changes could potentially motivate patients to be more concordant with their 
lymphoedema self-management, as they would be able to understand visually where the 
lymphoedema was improving or changing.  They noted that at the time of their paper 
going to print that a newer model of 3D camera was to be launched later that year with 
a system using only a single handheld camera to perform volumetric measurements as 
opposed to their static three camera set up. 
 
The Microsoft KinectTM is a single unit combination device consisting of an RGB 
camera (a camera that delivers red, green and blue components) with an infrared depth 
sensor.  This camera is used in the computer gaming industry, most notably XBox.  
                                                 
3 Reprinted from Lymphatic Research and Biology, volume 12, issue 4, Öhberg et al., Three-Dimensional 
Camera System for Measuring Arm Volume in Women with Lymphoedema Following Breast Cancer 
Treatment, pages 267-274., Copyright (2014), with permission from LiebertPub 
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Cook, Couch, Couch, Kim, & Boonn (2013) did a proof of concept and initial validation 
of the Kinect camera to determine radiation dose monitoring by more accurately 
estimating patient volume thus enabling better dose prescription for CT scanning. 
Henseler, Kuznetsova, Vogt, & Rosenhahn (2014) validated the Microsoft KinectTM 
device for 3D breast assessment with the potential for better surgical outcomes for breast 
reconstruction surgery. 
 
Lu et al. (2014) compared water displacement and perometry to a new algorithm for 
their 3DCI utilising the Microsoft KinectTM.  Their algorithm, the Iterative Clustered 
Closest Points, required the 3DCI to be held 80 cm from the target limb to capture the 
image most accurately.  They mobilised the 3DCI around the limb by attaching a 
gyroscope and accelerometer to the camera.  The optimal position of the model’s arm 
was at 90 abduction.  They report that the Kinect device is ‘biased’ by 5.16% and thus 
they ‘corrected’ their outputs accordingly. 
 
Concurrently, Erends, van der Aa, van der Hulst, & de Grzymala (2014), did a validity 
and reliability study for measuring upper limb volume on healthy participants.  They 
compared their Vectra XT 3D imaging system (Canfield Imaging Systems, Fairfield, 
NJ) to water displacement.  The Vectra XT 3D imaging system comprised of six digital 
single-lens reflex cameras divided over three stations with four flashes mounted within 
the Vectra unit (Figure 16).  This system captures images in 180; thus, the anterior and 
posterior sides have to be captured separately and then 'stitched' together.  Within a 
clinical setting, this would be a time-consuming procedure marking up the person's arm 
on both sides and then ensuring the images align when they are amalgamated and 
analysed. 
   
 





Figure 17: SkanLab system: Microsoft KinectTM camera attached to a rotating frame 
(Buffa et al., 2015) 
 
Buffa et al. (2015) developed a SkanLab system utilising the Microsoft KinectTM camera 
on a rotating stand (Figure 17) and using Skanect (Occipital, San Francisco, USA) 
software together with MeshLab (Visual Computing Lab, Pisa, Italy) to interpret the 
images.  Time taken to perform each measure showed that 3DCI was slightly faster than 
water displacement (p0.00) at about 2.5 min.  They conclude that 3DCI may be useful 
for monitoring latent lymphoedema and early intervention due to its high accuracy in 
terms of bias (0.6%) and limits of agreement (-2.6% to 1.4%). 
 
 
Figure 18: Laser Scanner 3D method (Cau et al., 2016). The system consists of a laser 
scanner (wand probe), a transmitter and a signal processing unit4 
 
Cau et al. (2016) compared CTM to the laser scanner 3D method (O&P Scan Rodin4D, 
Pessac, France).  This particular device (Figure 18) is cited as being used in 
orthopaedics, on the design of orthoses, and other health and well-being applications as 
it has demonstrated accuracy and reproducibility compared to water displacement.  The 
wand is kept at a fixed distance of one meter on a stand where the hand is supported and 
                                                 
4 Reprinted from Journal of Vascular Surgery: Venous and Lymphatic Disorders, volume 4, issue 1, Cau 
et al., Comparative study between circumferential method and laser scanner 3D method for the evaluation 
of arm volume in healthy subjects, pages 64-72., Copyright (2016), with permission from Elsevier 
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moved back and forth along a single scanning plane.  Cau et al. (2016) report that 3DCI 
has the potential to measure geometric parameters and shape information of scanned 
limbs. 
 
A 3D stereophotogrammetry system (3dMD Cranial, Atlanta, USA – Figure 19) was 
studied by Hoevenaren et al. (2016) initially looking at hand volume between healthy 
and lymphoedema hands.  They found a statistically significant difference in hand 
volume between the groups (p<0.00), with an average volume difference of 73ml 
(22.5%).  Hand dominance may need to be accounted for as there was an 8 ml (2.7%) 
difference in hand volumes in the healthy group.  They concluded that 3DCI could be 
used for quantifying hand volumes as it is accurate and reproducible.  Hameeteman et 
al. (2016) compared the 3D stereophotogrammetry (3dMD Cranial, Atlanta, USA – 
Figure 20) to water displacement.  They performed two landmark-based cut-off images 
of the forearm and upper arm from which volumes were calculated and added together 
for total arm volume.  They conclude that 3DCI is an accurate and reliable method for 
measuring upper limb volume and can be used for early detection of a change in limb 
volume, and for monitoring conservative and surgical treatment outcomes. 
 
 
Figure 19: 3D Stereophotogrammetry setup: 3dMD® cranial system is a 5-pod system 
with 15 cameras to capture 3D images (Schaaf, 2009) 
 
Karakashian et al. (2018) used a commercially available ASUS Xtion Pro 3D (A.X.Pro3-
D-ASUS, Taiwan) depth-sensing camera in conjunction with software from RecFusion 
(ImFusion, Munich, Germany).  This camera is a single unit that is mounted on a camera 
tripod stand with a ball joint and an attached selfie stick with a 3D printed mount, and 
with the participant seated with their arm abducted, palm down, to shoulder height 
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(Figure 20).  Volume measurements were compared to 4cm-CTM as used in a clinical 
setting.   
 
 
Figure 20: ASUS Xtion Pro 3D camera system (Karakashian et al., 2018).  The 3D 
camera is attached to a selfie stick via a 3D printed mount and rotated using a tripod 
stand with a ball joint. The subject sits with the arm abducted, palm down, to shoulder 
height, with fingers in line with the ball joint of the tripod stand. 
 
Data from the 3D images were selected, ‘cleaned’ from the surrounding clinical 
environment and cropped at the wrist and upper arm to isolate the area to be measured 
(Figure 21) (Karakashian et al., 2018).  Volume calculations for this 3DCI method 
utilised the ‘integral’ formulae where triangle j is one of the triangles describing the 
triangulated arm surface as 
 
where Nf is the number of vertices and Nd is the number of dimensions (Karakashian et 
al., 2018).  F is a vector field, n is the surface normal and Aj is the area of triangulation.  
The integral equation is considered more accurate than both the frustum and cylinder 
methods in the calculation of limb volume as the latter make simplified assumptions on 
the geometry, whilst the former takes into consideration the true limb shape 
(Karakashian et al., 2018). 
 
The data was further extrapolated to produce radial maps where the affected and 
unaffected maps were subtracted (after mirroring one of the two) to produce an ‘oedema 
distribution’ map, i.e. swelling map (Figure 22).  These maps are colour coded so that 
red demonstrates areas of greater deviance from the ‘normal’ thus indicating the location 
of the lymphoedema, cyan represents the correlation of size between the affected and 
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unaffected limbs, and dark blue indicates areas smaller than the unaffected side.  The 
maps clearly show that the lymphoedema is not homogeneously distributed along the 
arm, which is verified by the circumferential measurement data and cross-sectional area 
distributions from the 3D images.   This study is the first of its kind and can be linked to 
the suggestions made by Öhberg et al. (2014) and Cau et al. (2016) to investigate limb 
shape as a tool for determining lymphoedema distribution.  It has the potential to create 





Figure 21: Preparation of 3D image to convert into limb volume data and radial maps 
(Karakashian et al., 2018). (A) Area selected (green) for analysis using an STL file to 
triangulate the surface. (B) The cropped arm mapped on a regular grid after being 
‘cleaned’ from the surrounding clinical environment and unwanted body parts. 
 
 
Figure 22: Swelling map in lymphoedema (Karakashian et al., 2018).  The relative radial 
changes between the two arms are projected as a ‘new arm’ (left) and mapped as a  - z 
graph (right).  The colour scale changes from red (positive for swelling) to blue (negative 
difference) enabling the identification of localised oedema.  
 
Karakashian, Pike, & van Loon (2019) consequently utilised the 3D images and 
computational modelling to elucidate the effect that limb shape may have on sub-
bandage /sub-garment and subcutaneous pressures, stresses and strains.  This study 





garment, with a maximum sub-garment pressure of 5,100 Pascal (Pa), exceeding the 
intended sub-garment pressure of 2,500 Pa.  Furthermore, a positive pressure gradient 
was found in the forearm, which is counterproductive to the required negative pressure 
gradient for lymph drainage.  This study demonstrated how technology could be utilised 
in garment design and treatment strategies.  
 
Of interest, Gonzalez-Jorgea, Riveirob, Vazquez-Fernandezc, Martinez-Sáncheza, & 
Ariasa (2013) confirmed that the Microsoft KinectTM and ASUS Xtion Pro 3D are very 
similar camera systems suitable for close-range imaging.  However, an article published 
by Good on 25th October 2017 has alerted the public to the demise of the Kinect camera. 
According to Good (2017), Microsoft has confirmed that they are no longer 
manufacturing the Kinect camera due to the evolution of the Xbox consoles and the 
rumoured ability of the camera to spy on individuals.  Thus researchers who had hoped 
to expand the use of this camera system into a clinical setting will have to source a new 
3D camera system and validate its use. 
 
 
Figure 23: LymphaTech system: compatible depth sensor camera is attached to an iPad 
tablet via a custom bracket and integrates with the built-in camera of the device via the 
custom bracket to overlay the depth and colour imaging (Binkley et al., 2020)5 
 
The newest method of 3DCI technology is the LymphaTech system (Binkley et al., 
2020) which consists of a commercially available depth camera (Structure Sensor; 
Occipital, Inc, Boulder, CO, USA) interfaced with a smartphone or tablet computer 
(Figure 24).  Currently, compatibility is limited to iOS devices, but there are plans to 
expand it to Android and Windows devices.  Two software programmes were developed 
supporting the implementation of the hardware, to provide application and visual cues 
                                                 
5 Binkley et al., Assessing Arm Volume in People During an After Treatment for Breast Cancer: 
Reliability and Convergent Validity of the LymphaTech System, Physical Therapy, 2020, volume 100, 
issue 3, pages 1-11, by permission of Oxford University Press 
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to capture the image initially, and secondly to carry out the image processing and 
analysis to quantify and track patient metrics.  The area can be scanned at a distance of 
0.5 to 1.5m.  This device was compared to perometry by comparing limb volume and 
limb volume differences.  Binkley et al. (2020) concluded that their 3DCI provided 
similar limb volumes to perometry and found that the results supported the reliability 
and validity of their LymphaTech system.  
 
3.3.8.1 Thresholds for Diagnosing Lymphoedema Using 3DCI 
Threshold testing was not considered in any of the studies, with only one study 
referencing a 10% volume difference or a 200ml difference between arms as diagnostic 
criteria for lymphoedema through water displacement as their comparator 
(Hammeteman et al. 2017). 
 
3.3.8.2 Validity and Reliability of 3DCI 
Concurrent Validity: 
Eight studies report on concurrent validity with correlations between 3DCI and CTM, 
perometer, or water displacement of 0.94 (range 0.74-0.99) (Erends et al., 2014; Lu et 
al., 2014; Cau et al., 2016; Hameeteman et al., 2016; Cau et al., 2018; Landau et al., 
2018; Preuβ, Killaars, de Grzymala, Binnebösel, & Neumann, 2018; Lu & Dixon, 2019).  
 
Reliability: 
Eight papers reported excellent ICC values for 3DCI.  Pooled ICC data showed an 
ICCintra value of 0.99 (95% CI=0.95, 1.00) (Erends et al., 2014; Öhberg et al., 2014; 
Buffa et al., 2015; Hameeteman et al., 2016; Verhulst et al., 2017; Karakashian et al., 
2018; Preuβ et al., 2018; Binkley et al., 2020) and an ICCinter value of 1.00 (95% 
CI=0.98, 0.99) (Buffa et al., 2015; Verhulst et al., 2017).  The weighted mean SEM was 
1.7% (=2.5%) and the weighted mean SDC was 4.7% (=6.9%) (Lu et al., 2013; Buffa 
et al., 2015; Landau et al., 2018; Preuβ et al., 2018; Lu & Dixon, 2019; Binkley et al., 
2020). 
 
3.3.8.3 Benefits and Considerations of 3DCI 
Advantages of using 3DCI are that it is a simple, fast, accurate, easy to use and safe 
means of providing limb volumetric measurements (Öhberg et al., 2014; Buffa et al., 
2015; Hoevenaren et al., 2015; Cau et al., 2016; Cau et al., 2018; Landau et al., 2018; 
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Binkley et al., 2020).  It requires minimal training to operate (Lu et al., 2014; Öhberg et 
al., 2014; Verhulst et al., 2017), and the single-camera 3DCI devices are portable and 
relatively inexpensive, especially compared to the perometer (Lu et al., 2014; Buffa et 
al., 2015; Cau et al., 2016; Verhulst et al., 2017; Cau et al., 2018; Binkley et al., 2020).  
As 3DCI is a non-invasive, contactless technique, there are no known contra-indications 
for its use; thus, it can be safely used in the presence of lesions, wounds and cellulitis 
(Erends et al., 2014; Cau et al., 2016; Hameeteman et al., 2016; Cau et al., 2018; Landau 
et al., 2018).  3DCI could also be used in clinical practice to inform garment design 
(Karakashian, Pike, & van Loon, 2019).   
 
3DCI measures less than 1 ml variations in volume (Lu et al., 2013; Lu et al., 2014; Cau 
et al., 2016; Karakashian et al., 2018) and is recommended for use in the early detection 
of lymphoedema as it is an accurate measure which can also be used for self-monitoring 
of limb volume (Lu et al., 2014).  3DCI can capture the shape of the limb and quantify 
the differences in shape between the arms (Karakashian et al., 2018).  Thus a further 
benefit of 3DCI is that it can be used as an educative tool for patients and therapists as 
they can visualise the effects of treatment and may become a motivational tool for 
treatment concordance (Öhberg et al., 2014; Karakashian et al., 2018). 
 
A disadvantage of 3DCI is that not every clinic has the availability to a 3DCI system 
and trained staff to perform the measurement using the more complex 3DCI systems 
such as  Vectra 3D Camera systems and 3D stereophotogrammetry (Hameeteman et al., 
2016; Hoevenaren et al., 2016; Verhulst et al., 2017).  Furthermore, people with limited 
shoulder range of movement may not be able to position their arm to accommodate this 
measurement. 
 
As 3DCI is a form of photography, a therapist would need to gain written consent from 
the patient before their limbs are measured.  This is not considered a disadvantage but a 
safeguard, to ensure the patient would be willing for their photographic data to be stored 
electronically. All NHS Health Boards have photographic consent form templates 







Table 18 provides a summary of the measurement properties analysed for this systematic 
review.  The findings show clear evidence for excellent validity and reliability of CTM, 
perometry and 3DCI in measuring upper limb volume.  Pooled results for the reliability 
of the measurements are summarised in Table 19.  3DCI had the lowest variance, SEM 
and SDC in the measurement of the upper limb, but these differences were small. 
 
Table 18: Summary of the measurement properties of included studies 
Study 
Reliability Validity 








De Vrieze et al. 
(2019) 
0.99 0.98     
Rafn et al. (2019) 0.86 0.88 2.2% 6.1% 0.95 (P)  
Batista et al. (2018)   -5%-6.8% 
-13.9%-
18.8% 
0.86-0.99 (P)  
Sharkey et al. (2018) 0.96  1.2% 3.3%   
Tewari et al. (2018)     0.92 (WD) 
Compare narrow 
to  wide tape: 0.95 
Cau et al. (2016)   2.8% 7.8% 0.92 (3DCI)  
Mori et al. (2015) 0.98    0.80 (WD) 
Compare plastic 
with paper tape: 
0.98 
Tidhar et al. (2015)   0.8% 2.2%   
Adriaenssens et al. 
(2013) 
1.00  2.2% 6.1%   
Brorson & Hoijer 
(2012) 
  2%-3% 5.5%-8.3% 0.87 (WD) 










Foroughi et al. (2011)   0.8%-2% 2.2%-5.5% 0.84-0.94 (P)  
Czerniec et al. (2010) 0.96  7% 19.4% 0.99 (P)  
Devoogdt et al. 
(2010) 
1.00 0.99 1.3%-1.5% 3.6%-4.2%   
Chen et al. (2008) 0.99      
 Perometry (P) 
Binkley et al. (2020) 0.99  1.3%-1.5% 3.6%-4.2%   
De Vrieze et al. 
(2019) 
0.99 0.98     
Spinelli et al. (2019) 0.93 0.98     
Sharkey et al. (2018) 0.96  0.8% 2.2%   
Sun et al. (2018)      
Full arm versus  
simulated 4cm and 
5-point: 0.98 
Adriaenssens et al. 
(2013) 
1.00  2.2% 6.1%   



















Lu et al. (2013)   9.8% 27.2%   




Full arm versus 
simulated 10cm: 
0.99 






Lee et al. (2011) 1.00 0.99   0.88 (WD)  
Czerniec et al. (2010) 0.99  7% 19.4% 0.99 (CTM)  
 3DCI 
Binkley et al. (2020) 0.99  1.4%-1.6% 3.9%-4.4%   
Lu & Dixon (2019)   -0.5%-6% 
-1.4%-
16.6% 
0.88 (P)  
Cau et al. (2018)     0.74 (CTM)  
Karakashian et al. 
(2018) 
0.95      
Landau et al. (2018)   0.5%-0.7% 1.4%-1.9% 0.99 (CTM)  
Preuβ et al. (2018) 1.00  0.2%-0.3% 0.6%-0.8% 1.00 (WD)  
Verhulst et al. (2017) 0.99 0.99     
Cau et al. (2016)     0.92 (CTM)  
Hameeteman et al. 
(2016) 
1.00    0.99 (WD)  
Buffa et al. (2015) 1.00 1.00 0.6%    
Erends et al. (2014) 0.99    0.98(WD)  
Lu et al. (2014)     0.98 (WD)  
Öhberg et al. (2014) 0.98      













































































































































Key for Tables 16 and 17: 
3DCI = Three-Dimensional Camera Imaging CI = Confidence Interval 
CTM = Circumferential Tape Measurement 
ICCinter = Intra-class Correlation Coefficient for interrater reliability  
ICCintra = Intra-class Correlation Coefficient for intrarater reliability 
SEM = Standard Error of Measurement   SDC = Smallest Detectable Change 
WD = Water Displacement
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Based on the analysis of the studies, CTM, perometry and 3DCI can be recommended 
for clinical practice.  However, none of the measurement methods is interchangeable, 
thus therapists need to keep this in mind (Ward et al., 2009a; Ward et al., 2009b; 
Devoogdt et al., 2010; Lee et al., 2011; Brorson & Hoijer, 2012; Adriaenssens et al., 
2013; Bulley et al., 2013; Öhberg et al., 2014; Landau et al., 2018).  In addition to 
considering validity and reliability, the choice of measurement method will also depend 
on access, feasibility and costs.  The perometer is an expensive device compared to CTM 
(Adriaenssens et al., 2013; Lu et al., 2013; Sharkey et al., 2018; Binkley et al., 2020); 
and dependent on the type of 3DCI utilised, this can also be a costly means of measuring 
limb volume.   
 
Space is premium within any clinic, thus large devices such as the static perometers and 
some of the larger 3DCI devices, e.g. Vectra 3D, 3dD Stereophotogrammetry and static 
3D Microsoft KinectTM system, may not be feasible.  In small clinical areas, CTM, 
mobile perometer and 3D devices would be more practical. As many lymphoedema 
services are community based, rarely having access to dedicated facilities, the portability 
of the device has to be a factor when measuring lymphoedema. Furthermore, to further 
promote self-management, patients could be encouraged to measure themselves at home 
following a protocol, and CTM has demonstrated to be an effective method of self-
measurement (Foroughi et al., 2011; Mori et al., 2015; Rafn et al., 2019), whilst Lu, Han, 
DeSouza, Armer, & Shyu (2014) suggest that 3DCI could also be used as a self-
monitoring tool.  
 
None of the studies reported on the sensitivity and specificity of the methods used.  
Ideally, a measurement method should have a high sensitivity to detect all cases of 
lymphoedema, and high specificity to exclude false-positive outcomes.  Further research 
is needed to analyse the different methods of volume measurement and to preferably 
compare it to a gold standard method of volume measurement, which according to some 
papers is water displacement (Devoogdt et al., 2010; Lee et al., 2011; Adriaenssens et 
al., 2013; Öhberg et al., 2014; Buffa et al., 2015; Mori et al., 2015).   
 
Moreover, there is a general lack of evidence and consensus as to the recommended 
threshold for diagnosing lymphoedema based on volume measurement.  However, two 
studies, one for CTM (Asim et al., 2012) and the other for perometry (Ancukiewicz et 
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al., 2012) indicate that a 7.5% volume difference between arms could be considered as 
a threshold for diagnosing lymphoedema.  Hidding et al. (2016) explain that although 
SEM is the smallest amount of change that can reliably be measured, the SEM values 
are generally smaller than the normal differences between arms.  They argue for the use 
of SDC as a better clinical reference point for commencing treatment for lymphoedema 
as there is no recognised threshold for lymphoedema diagnosis.  This review presented 
the weighted mean SDC values of 4.7% for 3DCI, 5.5% for CTM, and 9.4% for 
perometry (refer to Table 19).  Hidding et al. (2016) suggest that treatment before these 
cut-off points could lead to overtreatment, which should be avoided.  Further research 
into the use of SDC versus threshold should also be investigated, as well as research 
looking at the sensitivity and specificity of the different thresholds for CTM and 
perometry, and to introduce this for 3DCI as well. 
 
The time needed to perform a measurement was reported in three studies.  Buffa et al. 
(2015) measured only the time taken to perform the measurement whilst Landau et al. 
(2018) timed the set-up, execution and calculation of limb volumes in their study.  De 
Vrieze et al. (2019) timed the set-up and execution of the limb volume measurements 
between CTM, perometry and various methods of water displacement.  They were also 
the only study to look at the burden of the different measurement methods and found 
CTM to be the better method of limb volume measurement.  However, there are more 
factors to consider than the timing of the method, and they need to include the cost of 
the device (including depreciation and servicing), the cost of the therapist’s time, 
therapist preference, but also patient choice based on their understanding of the results 
from the method of measurement.  This would make a more economical and Value-
Based argument for choosing one method over the other in clinical practice. 
 
3.4.1 Strengths and Weaknesses 
Through this systematic literature review, a meta-analysis for the reliability of CTM, 
perometry and 3DCI on measuring BCRL was performed.  Based on the analysis, the 
use of CTM, perometry and 3DCI for measuring upper limb lymphoedema can be 
recommended, as many studies were included in the meta-analysis. 
 
Limitations have also been identified.  As there is no validated gold standard that could 
be used as a comparator test, all methods of measurement were reviewed independently.  
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In the research literature, lymphoedema of the upper limb is predominantly described in 
women with breast cancer.  Medical treatment received for breast cancer results in a 
higher risk for developing lymphoedema than other types of upper limb lymphoedema 
causes, except for melanoma (Rockson, 2018); however, melanoma numbers remain 
very low compared to BCRL, making recruitment difficult, hence, no study currently 
exists for this group either.  As BCRL is largely a female condition, research studies 
exist in women more than men.  Other causes of upper limb lymphoedema can include 
vascular insufficiency, for example, deep vein thrombus, dependency, example due to a 
stroke, filariasis and even primary lymphoedema.  These cases are rare, thus poorly 
represented in the literature. 
 
The quality of the studies varied immensely with numerous limitations identified, 
including cohort size, and lack of description of a clear methodology, including ethics 
gained, recruitment selection and measurement protocol.  The risk of bias raised 
concerns, firstly about the diversity of the cohort selection, which was not always 
described, consecutive participants were included in some studies, and random selection 
via advertisement was mentioned.  Secondly, only a few studies reported on the severity 
of the lymphoedema being measured. Thirdly, measurement protocols of the comparator 
test were poorly described, especially in studies on perometry and 3DCI.  Lastly, the 
blinding of the investigators was described clearly in only seven studies.  Therefore, bias 
cannot be excluded in this review. 
 
3.4.2 Implications for Daily Practice and Future Research 
All the methods of measurement have evidence for good reliability and validity.  Based 
on the measurement properties and feasibility, it is recommended CTM be used as best 
practice in measuring lymphoedema in the upper limbs.  Positioning for CTM should be 
standardised with the patient sitting down, hands resting palm down on a flat surface, 
and the starting point to be used is the crease of the wrist.  Both arms must be measured, 
measurements calculated to volume, and the volume then needs to be calculated to 
percentage limb volume difference. 
 
In future research, measurement protocols and results should be reported clearly and in 
a uniform way to facilitate the future synthesis of the literature. It is strongly 
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recommended that attention be paid to sensitivity, specificity and diagnostic thresholds 
for the different types of lymphoedema measurement methods in studies. 
 
3.5 Conclusion 
From this systematic literature review, it is evident at this time that there is no study 
concurrently comparing CTM, perometry and 3DCI to determine validity, reliability and 
differences in the outcomes reported.  CTM is a commonly used method of measuring 
limb volume within clinical practice, the perometer is considered by some to be a gold 
standard method of limb volume measurement and 3DCI, while being able to measure 
for limb volume, also has the potential benefit of interpreting shape as an additional 
diagnostic measure for lymphoedema.  Currently, neither CTM nor perometry can 
identify areas of localised swelling. Thus swelling maps have the potential to identify 
localised oedema that can inform treatment.  
 
3DCI is shown to be both a reliable and valid method of limb volume measurement 
compared to both CTM and perometry; however, the evidence is limited due to the 
varying devices used.  Also, the systematic literature review has revealed that 
lymphoedema could be assessed through limb shape by utilisation of swelling maps 
from the data extrapolated from 3DCI.  It has the potential for clinical use if utilising 
one of the more portable devices, i.e. LymphaTech, Microsoft KinectTM, Asus Xtion or 
Laser Scanner 3D systems.  However, no studies to date have looked at this method 
within the clinical setting.  Only one study exists looking at the use of limb shape as a 
means of assessing lymphoedema (Karakashian et al., 2018); thus further studies are 
needed to provide evidence of this new technological benefit.  A longitudinal study 
would determine repeatability and sensitivity to change over time, including limb shape, 
and could be considered as part of a clinical programme of care.   
 
Thus from the systematic literature review, and the research gaps identified, it would be 
worth comparing 3DCI to CTM and perometry concurrently to establish its reliability, 
validity and accuracy.  Further analysis of swelling maps would add to the limited 
evidence to ascertain their value in the diagnosis of lymphoedema, and consideration for 

























The systematic literature review presented in Chapter 3 demonstrated that CTM, 
perometry and 3DCI have excellent validity and reliability, however, no study exists 
comparing these three methods within one study.  Karakashian et al. (2018) to date 
presents the only study where images taken by 3D camera are converted into oedema 
maps, thus offering a different means of assessing lymphoedema through limb shape 
deviation.  However, their study was part of a service evaluation and lacked clear 
protocols for the comparator measurements.  A gap in knowledge proves the need for 
this study. 
 
This chapter describes the research design and research methods used for this study.  The 
data collected from the Asus Xtion Pro 3D camera was converted into limb volume, and 
volume difference was calculated and expressed in terms of millilitres (ml) and as a 
percentage (%), and then compared to both CTM and perometry.  Furthermore, the data 
was used to create oedema maps, which were compared to the volume measurements to 
determine any correlations between these different methods. 
 
4.2 Aims 
The study aimed to determine: 
1) the validity, reliability and accuracy of upper limb volume results obtained from 
3DCI compared to CTM and perometry; and  
2) whether the shape of the limb is a feasible alternative to measure lymphoedema. 
 
As there are two aims for this study, two hypotheses and null hypotheses are required.  
A hypothesis is a statement specifying the relationship between variables, with the null 
hypothesis being presumed to be initially true (Parahoo, 2014).  The first hypothesis is 
that 3DCI is a valid, reliable and accurate method of measurement for lymphoedema; 
thus, the null hypothesis is ‘3DCI is not a valid, reliable nor accurate method of 
measurement for lymphoedema’.  The second hypothesis is that shape entropy derived 
from 3DCI is an alternative method that correlates to arm volume measurement.  The 
resultant null hypothesis is ‘shape entropy derived from 3DCI is not an alternative 





The objectives drawn from the research questions posed in the introduction are: 
1. Determine whether 3DCI volume outcomes are comparable to CTM and 
perometry as a measure of intra-rater reliability 
2. Assess the criterion validity of 3DCI against previously validated measures, i.e. 
CTM and perometry 
3. Establish whether 3DCI is an accurate method of measurement for upper limb 
lymphoedema 
4. Ascertain whether limb shape derived from 3DCI is a potential new method of 
lymphoedema measurement 
 
4.4 Research Methodology and Design  
Antwi & Hamza (2015) explains that research methodology is informed by the paradigm 
(a school of thought with a set of beliefs [Parahoo, 2014]) guiding a chosen research 
project.  Due to the empirical nature of lymphoedema assessment and the research 
questions being asked, the quantitative research paradigm (also referred to as the 
deductive or scientific research paradigm), was the research methodology of choice 
(Atieno, 2009; Parahoo, 2014; Antwi & Hamza, 2015).  Atieno (2009) posits that this 
paradigm ensures validity by the process of rigorous clarification, definition, and use of 
pilot experiments, while Antwi & Hamza (2015) explain that it is an approach to 
thinking about and doing research, thus testing hypotheses. 
 
 
Figure 24: Tree of different types of study design (CEBM, 2014) 
 
The Centre for Evidence-Based Medicine (CEBM) (2014) developed a 'tree of possible 
study designs' (Figure 24) whereby basic study designs are subdivided into descriptive 
or analytic studies, and analytic studies are further divided into experimental or 
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observational studies.  The analytic studies are analogous to the quantitative research 
paradigm as they are all empirical. 
 
To determine whether 3DCI is comparable to CTM and perometry, the optimal 
methodological approach considered was an analytic, observational longitudinal study 
utilising a diagnostic test study framework.  The CEBM (2014) explains that 
observational studies investigate and record exposures (such as interventions or risk 
factors) and observe outcomes (such as disease) as they occur.  Howick (2013) states 
that observational studies dominate the literature and can be subdivided into exploratory, 
descriptive and analytical studies.  Caruana, Roman, Hernández-Sánchez, & Solli (2015) 
explain that longitudinal studies are a form of observational analytic study that employs 
continuous or repeated measures to follow particular individuals over some time. Data 
collected for individuals from a predefined group can be statistically analysed to 
determine change over time for the group, or particular individuals.  A diagnostic test 
study evaluates how well a new test is able to predict or diagnose a disease (Bland, 
2010).  Bland (2010) clarifies that the basic design is to compare test results on people 
with the disease with test results on people without the disease by comparing the new 
test to a gold standard, or reference standard. 
 
Consideration should be given to the experience of the key stakeholders, i.e. the 
participant (patient) and the researcher (clinician) involved in the study, to understand 
their thoughts on the interventions (measurements) received.  Qualitative data utilising 
methods such as semi-structured interviews, focus groups or feedback (verbal or 
written), could determine what the stakeholders thought of the interventions 
(Hammerberg, Kirkman, & de Lacey, 2016). However, qualitative data was not 
collected for this study as the first step was to identify some of the other parameters, 
such as, 'is 3DCI a valid method of measurement', 'is it accurate, reliable and repeatable', 
'does it offer more data for lymphoedema assessment', and 'how else may the data from 
the images be manipulated for clinical use'?  Subsequent qualitative studies may be 
required in the future once the feasibility of 3DCI has been established. 
 
Daya (1996) posits that diagnostic tests are based on the principle that individuals with 
disease are different from those without disease, and that the test can distinguish between 
these two groups.  Di Ruffano, Hyde, McCaffery, Bossuyt, & Deeks (2012) advise that 
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the priority for diagnostic test studies is to establish the benefit of the new test.  Thus 
new tests should only be introduced into clinical practice when the evidence, through 
proper analysis, indicates that they have a better chance of improving patient health care 
than existing tests.  Hence, diagnostic test studies aim to determine whether a test or 
method of measurement is useful in clinical practice. 
 
For a test to be clinically meaningful, determination of how the test results will affect 
clinical decisions is integral, while also taking into consideration the costs, risks, and the 
acceptability of the test (Glasser, 2008).  Ideally, a new test should be tested against a 
'gold standard' or 'reference standard' (Daya, 1996; Rutjes, Reitsma, Coomarasamy, 
Khan, & Bossuyt, 2007).  However, from Chapter 2, it has been determined that there is 
currently dispute over the claimed gold standard of lymphoedema measurement, i.e. 
water displacement, especially as it is not used internationally.    
 
Rutjes, Reitsma, Coomarasamy, Khan, & Bossuyt (2007) identify four situations where 
the lack of a gold standard does not negate the value of a diagnostic test study.  These 
include 1) ascribe or adjust for missing data on reference standard, 2) correct imperfect 
reference standard, 3) construct reference standard, and 4) validate index test results.  
The results are combined to construct a reference standard by 1) deterministic predefined 
rules (composite reference standard), 2) consensus procedure among experts and 3) a 
statistical model based on actual data (Knottnerus & Muris, 2003; Rutjes et al., 2007).  
As previously reported, the most commonly used method of assessing for lymphoedema 
is CTM which can meet all the criteria as a construct reference standard for use in this 
methodology. 
 
Furthermore, diagnostic tests require an evaluation of the reproducibility, accuracy, and 
variation among those with and without disease.  In evaluating and applying the results 
from a diagnostic test study, the validity of the study requires an independent, blind 
comparison with a reference standard, the methodology must be fully explained, and the 
results should show sensitivity and specificity (Daya, 1996).  Parahoo (2014) explains 
that when studying current phenomena by pursuing information from the future, a 




The diagnostic test study employed 3D scanning technology to determine its accuracy 
and speed of application compared to CTM and perometry, with the data collected fitting 
the remit of an observational analytic study.  It was a prospective, longitudinal study 
taking place over six months, utilising sequential sampling with a diagnostic test study 
framework.  Two phases were designed for the analysis of the results based on the 
distinct objectives focusing on limb volume and limb shape.  Phase One analysed the 
validity, reliability and accuracy of limb volume between the three methods of 
measurements identified.  Phase Two explored utilising 3DCI data as a new innovative 
method of assessing lymphoedema through limb shape.   
 
The next sections will elucidate the study design, criteria, ethical considerations, and the 
data collection process.  After that, the two phases will identify which of the research 
questions and objectives they will be analysing, along with the methods employed to do 
this. 
 
4.5 Research Study 
The title of the study submitted for ethical approval was 'exploiting 3D scanning 
technology in lymphoedema for accurate and fast measurements of volume and shape' 
(Appendix 4).   The aims and objectives identified in sections 4.2 and 4.3, were utilised 
in the construct of this study.  However, as the thesis developed, this title was changed 
to be more reflective of the gaps identified in the systematic literature review, together 
with the more focused aims and objectives of this thesis.  Demographic and 
anthropometric data of the participants were collected and analysed.  Due to the two 
distinct aims for the study, two phases of analysis were undertaken.  Phase One focused 
on limb volume measurements from 3DCI, CTM and perometry, and Phase Two 
concentrated on limb shape derived from the 3DCI data as a measurement tool for 







Figure 25: Diagram illustrating the two phases of the study 
 
4.5.1 Study Design 
The number of participants for recruitment was based on clinic referrals to the local NHS 
lymphoedema service within one year.  A post-hoc sample size calculation was 
completed (see section 4.5.4) as result.  Twenty participants referred to the local NHS 
lymphoedema service were recruited based on them meeting the eligibility criteria as 
described in section 4.5.2.  After gaining consent, participants were assessed every two 
months for six months, comparing 3DCI to CTM and Perometry.  The 'study scheme 
diagram' (Figure 26) clarifies and breaks down the study design 
 
Study Title: Can 3D Camera Imaging Provide Improved Information to 
Assess and Manage Lymphoedema in Clinical Practice?
Measurements taken (repeated four times over six months):
CTM, Perometry, 3DCI
Recruit 20 people with BCRL
PHASE ONE
Compare limb volume data of the three methods of 
measurement
PHASE TWO
Extrapolate data from 3DCI to create 
oedema maps







































Figure 26: Study Design Scheme giving an overview of the study protocol 
Upon receipt of referral (Appendix 7) for person with unilateral upper limb lymphoedema, 
a trained therapist identified potential participants against study criteria 
 
Service receptionist posted out the ‘Participant Information Sheet’ (Appendix 5) 
and 'Patient Letter' (Appendix 6) with the initial appointment letter 
 
Patient confirmed they had received in the post, and then read the 'Patient 
Information Leaflet'.   
• Patient given the opportunity to ask questions.   
• Patient given the option to participate 
 
Agreed Declined (n=4) 
Patient Consent gained at Initial Appointment 
• CTM 
• Perometer measurement  
• 3DCI  
2-, 4- and 6-month follow 
up appointments issued 
by lymphoedema service 
receptionist 
Review appointments performed 
by Researcher 
• Check anthropometric data 
• CTM  
• Perometer measurement  
• 3DCI  
Data collected by researcher   
and entered onto 3D Study 
Assessment Form (Appendix 10) 







Oedema maps created from extrapolated 
data from Phase One 3DCI 
Phase Two Analysis: 
Limb Shape 
Participant Data collected by Researcher 
Demographic, anthropometric, lymphoedema 
and medical history 
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Table 20 lists the methods of data collection for each objective which is discussed in 
more detail in sections 4.6.2 and 4.7.2 for each of the study phases.  Objectives one to 
three were measured through the calculation of limb volume and used as a comparator 
amongst the three methods of lymphoedema measurement.  Objective four explored 
limb shape, utilising the 3D data, compared to the results from objectives one to three.   
 
Table 20: Research Objectives and Data Collection 
Objective Method of Data Collection 
1. Determine whether 3DCI volume 
outcomes are comparable to CTM and 
perometry (intra-rater reliability) 
 Researcher captured measurements 
manually and written on 3D Study 
Assessment Form (Appendix 10).  
 Data transferred by researcher onto 
electronic databases (Excel & SPSS)  
2. Assess the criterion validity of 3DCI 
against previously validated measures, 
i.e. CTM and perometry 
 Data captured by researcher on 3D Study 
Assessment Form  
3. Establish whether 3DCI is an accurate 
method of measurement for 
lymphoedema 
 Data captured by researcher on 3D Study 
Assessment Form  
4. Ascertain whether limb shape derived 
from 3DCI is a potential new method of 
lymphoedema measurement 
 Data from oedema maps and calculated 
limb volumes as entered on 3D Study 
Assessment Form by researcher 
 
4.5.2 Participants and Setting 
Twenty participants referred to their local NHS lymphoedema service in one NHS Wales 
Health Board were recruited into this study.  Referrals to the service were done either 
by the General Practitioner, the Breast Care Nurse, or as a self-referral if the patient had 
attended a Lymphoedema Risk Reduction session.  The lymphoedema service 
receptionist and a lymphoedema therapist were trained and familiarised with the study 
protocol.  This enabled the lymphoedema therapist to identify potential participants from 
the referrals based on the study inclusion and exclusion criteria.   
 
The lymphoedema receptionist sent the patient their initial assessment appointment, 
together with the 'Participant Information Sheet' (Appendix 5) and 'Patient Letter’ 
(Appendix 6).  It ensured that the potential participant had more than 24 hours to read 




4.5.2.1 Inclusion Criteria  
Participants selected had unilateral (one-sided) lymphoedema of their upper limb 
secondary to breast cancer.  Participants had to be adults (aged 18 or over), and both 
male and female genders were included. 
 
4.5.2.2 Exclusion Criteria  
Participants were excluded if they: 
 were unable to consent due to poor mental health or dementia 
 were unable to lift their arm to shoulder height 
 were unable to commit to the scheduled appointments 
 had active disease (cancer) or were under palliative care 
 presented with a chronic or non-chronic disease, other than lymphoedema that 
may affect the swelling of their arm   
 were women who were pregnant. 
 
4.5.2.3 Criteria for Premature Withdrawal 
Participants could withdraw from the study if they withdrew their consent, no longer 
wanted to partake in the study, or were unable to attend the scheduled appointments.  
Once recruited, the data was retained unless the participant requested that their data be 
excluded from the study. 
 
4.5.3 Ethical Approval and Considerations 
This study was conducted with adherence to the Health & Care Professions Council 
Standards of Conduct, Performance and Ethics (2016), the Chartered Society of 
Physiotherapy’s Code of Member’s Professional Values and Behaviour (2011),  and the 
guidance as set out by the Good Clinical Practice Reference Guide (National Institute 
for Health Research Clinical Research Network [NIHR CRN], 2016).  The ethical 
principles as advocated by Beauchamp & Childress (2012) and Parahoo (2014) 
including non-maleficence, beneficence, fidelity, veracity, confidentiality and justice 
were considered throughout the study to protect participants from harm.  Thus, the rights, 




Ethical approval was granted for the study in March 2016 from the College of Human 
Health Sciences and College of Medicine Research Ethics Committee, Swansea 
University.  Subsequent application via the Integrated Research Application System 
(known as IRAS) received approval in June 2016 from the West of Scotland Research 
Ethics Service (REC Reference 16/WS/0127).  The local NHS Research and 
Development (R&D) approval was later granted in August 2016.  Appendix 4 provides 
evidence of the ethics and R&D approvals for this study.  
 
The study protocol together with the aims and objectives were discussed in a meeting 
with the local lymphoedema service based in an NHS Wales Health Board.  The benefits 
of the study to the service, and to the lymphoedema community were conveyed.  The 
benefits included a comprehensive assessment of the patient's reported lymphoedema 
and the opportunity for a nurse or physiotherapist to partake in research (which meets 
one of their governance criteria for registration).  Furthermore, the 3DCI equipment 
utilised would be handed over to the service for ongoing use, and the study would offer 
an exciting opportunity for the service to be part of a new and original lymphoedema 
assessment whereby the shape of the limb could be measured. 
 
The lymphoedema receptionist and a lymphoedema therapist were trained for one hour 
to assist with the research recruitment and protocols.  The inclusion and exclusion 
criteria were explained in detail to them, to ensure new referrals received to the service 
were scrutinised against these criteria to identify potential participants.  The tasks given 
were for the lymphoedema therapist to triage the referrals against the criteria, and for 
the lymphoedema receptionist to send out the appointment letter together with the study 
literature described in section 4.5.2.  
 
4.5.3.1 Informed Consent 
Lymphoedema referral forms (Appendix 7) are standardised across Wales and require 
details on the site and severity of the lymphoedema, as well as the potential cause.  All 
(n=68) referrals for upper limb lymphoedema to the local NHS lymphoedema service 
from September 2016 to April 2018 were screened against the study inclusion and 
exclusion criteria.  Information as described in section 4.5.2 was posted out to those 
meeting the criteria.  As per standard operating procedures, this was within 48 hours of 
receipt of the referral.  Both the researcher and lymphoedema therapist’s details were 
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included should a patient wish to contact them to gain more information about the study.  
Appointments were made for between two and four weeks from the date the referral was 
received on the allocated research days provided by the researcher.  At the patient’s 
initial appointment at the lymphoedema clinic, they were asked if they had received the 
research information, and whether they had read the information posted to them.  They 
were given time to ask questions regarding the research and were then asked if they 
would like to participate in the study.   
 
Efforts were made to ensure that patients were not coerced into partaking in the study 
by ensuring the patient information leaflet was provided to them before their 
appointment so that they had the opportunity to read it before their appointment.  It was 
explained that their participation would be voluntary and that their decision would not 
affect how they were assessed and treated at the lymphoedema clinic.  It was also 
explained that they could withdraw from the study at any time without giving a reason 
and that it would not impact their lymphoedema care from their lymphoedema clinic 
(Parahoo, 2014).  Once a patient confirmed that they were willing to participate in the 
research study, they were asked to sign a Consent Form (Appendix 8) of which they 
received a copy, a copy was retained for the research portfolio, and the original was 
placed within the patient's clinic notes. 
 
4.5.3.2 Participant Impact 
The risks to harm for this study were considered to be low for the participants due to the 
study procedures being non-invasive (Appendix 9).  At the initial assessment, some 
participants could experience mild discomfort when elevating their arm to shoulder 
height for the measurements to be taken.  This was addressed by providing stretching 
exercises and physiotherapy to relieve the discomfort for future measurements. 
 
Both Swansea University and the R&D department at the NHS Wales Health Board 
considered the appointments to be part of a participant's usual lymphoedema reviews, 
thus no reimbursement for travel or out of pocket expenses could be offered.  This was 






Participants were allocated unique research numbers to anonymise their acquired data.  
This unique number was allocated in sequential order of recruited participants on the 
screening log.  No identifiable patient information was collected.  Only the 
lymphoedema service held the participant's details; the researcher accessed specified 
demographic, medical information and the required clinical assessments with non-
patient identifiable data on the 3D Study Assessment Form (Appendix 10), thus only 
allocated anonymous research numbers were visible.  Participants were issued an 
appointment date before leaving the session for their review appointment.  
 
For those participants who failed to attend their review appointment, the lymphoedema 
service tried to make contact via telephone and mail to enquire the reason for not 
attending.  If the participant requested to withdraw from the study, their telephone 
number was provided to the researcher to enquire the reason for withdrawing to 
understand whether the information provide could be improved for future projects.  
Furthermore, the enquiry could determine what the participant’s views and tolerance for 
the study were, and to ensure that the data collected previously could be used for the 
study (n=0).  Where participants failed to respond to contact attempts (n=3), it was 
assumed that they wished to withdraw from the study and that their data could be used 
for statistical analysis.  These were documented accordingly. 
 
All data collected for the study were kept in a research file that was locked in a filing 
cabinet in the researcher's office.  Only the researcher had access to the research files.  
Participants were assured of their anonymity throughout the thesis and in any 
publications by use of their allocated research numbers.  This is in keeping with Good 
Clinical Practice guidelines (NIHR CRN, 2016). 
 
4.5.3.4 Confidentiality 
The study protocols followed Data Protection regulations (Data Protection Act, 2018) 
and Research Ethics guidance (NIHR CRN, 2016) ensuring participant confidentiality, 
safe record keeping, and qualified research staff with up to date Good Clinical Practice 
certification.  Allocation of a unique research number to each participant ensured the 
anonymity of the database being analysed.  Individuals were able to be tracked via the 
screening log which was kept in a file and locked in a cabinet in the researcher's office 
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to which only the researcher had access.   Data were entered into a password-protected 
spreadsheet, and the hard data copies were filed and locked in a filing cabinet in the 
researcher’s office as per the Health Board Policy and Data Protection Act (2018).    
 
Participant clinical and research notes are to be retained for seven years on completion 
of the study as per guidance from R&D.  Disposal of these notes will be performed per 
this guidance, which is currently via the secure data disposal services within the Health 
Board.  The researcher is the data custodian.  
 
4.5.4 Location of the Research 
The study took place in one of the seven Health Boards in Wales.  The population for 
this health board is more than 500,000, and they employ over 13,000 staff.  Patients 
diagnosed with breast cancer attend a central hospital for their surgery, and since 2004, 
these patients have routinely been invited by the lymphoedema service to attend a 
lymphoedema risk reduction programme.  Once patients have attended this programme, 
they can self-refer to the lymphoedema service at any point in the future. 
 
The service currently has a caseload in excess of 3,000 patients, of which 30% have 
lymphoedema, or are at risk of lymphoedema, due to breast cancer treatment.  There are 
currently 16 members of staff, both registered and unregistered professionals, who are 
strategically managed by Lymphoedema Network Wales.  Potential and recruited 
participants were seen at one of two hospital sites within the Health Board.  Participants 
could choose which location they preferred to be seen for the duration of the study, as is 
usual practice.  The participant was seen by the researcher at each point of contact 
regardless of the venue they chose to be seen.  Allocated treatment rooms at each site 
were utilised for the study. 
 
4.5.5 Sampling  
Twenty eligible people newly referred to the lymphoedema service were recruited for 
the study in the time available.  Post-hoc calculations were performed to determine 
whether this sample size would be sufficient.  When discussing statistical power, there 
are four interrelated concepts to consider, namely power, effect size, sample size and 
alpha (UCLA Institute for Digital Research and Education, 2019). For this study, post 
hoc analysis using the Analysis of Variance (ANOVA) repeated measures, within 
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factors f-test, was used to determine the power of the sample size with an effect size of 
0.25.  This small effect size was to ensure that any variance would be too small to detect 
other than statistically and is the lower limit of what is clinically relevant, which will 
help reduce the effect of a Type I error (UCLA Institute for Digital Research and 
Education, 2019).   
 
In this study, the number of measurements was four (participants measured at their initial 
assessment, 2-, 4- and 6-month reviews), with the dependent variable being limb 
measurement (Laerd Statistics, 2018a).   The Power of Analysis, using a software 
programme called G*Power (version 3.1.9.4), produced an Output Power of 0.73, with 
a standard margin of error of 0.05 (see Figure 27).  It means the study sample will give 









Figure 27: Power of Analysis Results (UCLA Institute for Digital Research and 
Education, 2019) 
 
Missing data due to failure to attend sessions, equipment failure, or data processing, is 
considered as ‘missing completely at random’, and although Power may be lost in the 
study design, the analysis will remain unbiased (Kang, 2013).  Statistics Solutions 
(2021) advise the use of a t-test following either pair-wise or list-wise deletion of missing 
data to check whether any difference in the samples between the data sets exists.      
 
4.5.6 Recruitment 
Recruitment commenced October 1, 2016, and finished April 30, 2018.  Potential 
participants received the relevant letters and documents as described in section 4.5.2, 
and at their first appointment, the Participant Information Sheet (Appendix 5) was 
discussed, and any queries answered.  At this stage, the patient could decide whether 
they would like to participate in the study.  The patient was checked against the criteria, 
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including ensuring they could elevate their arm to the required shoulder height level.  If 
the patient was eligible, consent was gained and data collected.  If the patient was 
ineligible, the reason for exclusion was documented on the screening log, and they were 
assessed under the standard lymphoedema service protocol.  Figure 28 provides a 
diagrammatic representation of the recruitment process.  
 
4.5.7 Methods 
A means of controlling bias was done in the form of blinding, where the data collection 
sheets for each session were independent of all previous sessions.  However, continuity 
in CTM was assured by transferring the value for the first mark, as well as the required 
number of marks to be measured, between sessions.  The participant's height was 
transferred between sessions, as this was unlikely to change over six months; however, 
weight was re-measured at each point of contact, and BMI calculated using Lymcalc 
software. 
 
4.5.7.1 Demographic and Anthropometric Data 
Previous studies (Hidding et al., 2016; Levenhagen et al., 2017) indicate that certain 
patient demographics and anthropometric data may influence lymphoedema 
measurements.  The participant’s age, gender, handedness and affected side were 
documented.  Some papers report (Wang et al., 2017) that ethnicity may influence 
measurements; thus, this was also collected.   
 
The impact of a person's medical history and cancer treatment cannot be dismissed; 
consequently, a full medical history and the most commonly reported medications were 
collated, together with the type of cancer treatment the participant had had such as 
surgery, type of lymph node excision, chemotherapy, radiotherapy and hormone 






Figure 28: Schedule of Recruitment and Assessment – diagrammatic format of events 
from the time of receipt of referral to the first appointment 
 
Cellulitis adversely affects lymphoedema (Lam et al., 2006), and this data was gathered 
to determine its effect on lymphoedema through the measurement methods.  Time since 
surgery and time from surgery to onset of lymphoedema was collected to understand 
whether this would have an impact on the severity of the lymphoedema as measured by 
CTM, perometry and 3DCI.  The staging of the participant’s lymphoedema was 
determined following the measurements using both the ISL staging and BLS grouping, 
Referral received and triaged by lymphoedema trained therapist against 
criteria
Lymphoedema receptionist sent the patient:
 Appointment letter
 Participant Information Sheet (Appendix 5)
 Patient Letter (Appendix 6)
At initial appointment:
 Discussed the Patient Information Sheet
 Patient given opportunity to ask questions
 Patient assessed against study criteria
Ineligible






















as discussed in section 2.3 and defined in Appendix 1.  It helped classify the severity of 
the participant's lymphoedema. 
 
Employment status was captured to determine how many of the participants were 
employed, and to explore if this had any relevance on the lymphoedema measurements.  
Obesity adversely affects lymphoedema (Mehrara & Greene, 2014).  Each participant 
had their height measured at the initial assessment, and their weight measured at each 
session to determine their BMI.  The BMI range was determined using the World Health 
Organization’s (2021) Nutritional Status for adults (Table 21). 
 
Table 21: Nutritional status for adults (World Health Organization, 2021) 
BMI Nutritional status 
Below 18.5 Underweight 
18.5–24.9 Normal weight 
25.0–29.9 Pre-obesity 
30.0–34.9 Obesity class I 
35.0–39.9 Obesity class II 
Above 40 Obesity class III 
 
Smoking is known to cause cardiovascular disease, including thickening and narrowing 
of the blood vessels and blood clots (Yanbaeva, Dentener, Creutzberg, Wesseling, & 
Wouters, 2007), which will have a direct impact on the lymphatic system.  However, no 
study exists to determine whether smoking has a direct impact on the lymphatics and 
resultant lymphoedema.  Excessive alcohol consumption is known to cause liver disease 
and weakening of the immune system (Centers for Disease Control and Prevention, 
2019), both of which will impact the lymphatic system.  Therefore, exploring whether 
smoking and excessive alcohol consumption affect lymphoedema measurement could 
offer new information for clinical practice.  
 
4.5.7.2 Methods of Lymphoedema Measurements Used 
Chapter 3 provided a detailed description of the methods of measurement used in this 
study, including positioning and execution of each test.  For clarity, CTM was performed 
per the 'All Wales Lymphoedema Guidance: Measuring Volumes to Determine 
Lymphoedema Outcome’ (LNW, 2017).  The protocol devised by Ancukiewicz et al. 
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(2011) was used when executing the perometer measurements, and the protocol 
described by Karakashian et al. (2018) was used when performing 3DCI measurements. 
 
CTM, perometry and 3DCI were executed at each session by the researcher.  As 
discussed in section 4.5.7, bias was controlled as all data from previous sessions were 
blinded for both the researcher and the participant.  Timing of each method was executed 
at the initial assessment only and included set up and execution of the test.  Results were 
calculated using the various formulas for each method of measurement which was the 
cylinder method (Equation 1) for CTM, disc method (same as for cylinder) for 









The percentage volume difference (%VD) between the arms of a given participant was 
calculated by dividing the volume difference (VD) by the unaffected arm volume (LVu) 





) ∗ 100 
 
Absolute volume difference (AVD) was calculated whereby the volumes of the same arm 
were compared over time to the initial assessment volume (VIA) (Equation 4).  
Percentage AVD (%AVD) was calculated by dividing AVD by VIA and multiplying by 
100 (Equation 5). 
 
𝐴𝑉𝐷 = 𝑉 − 𝑉𝐼𝐴 
 











%VD and %AVD were calculated for each method of measurement and compared in the 
statistical analysis (Appendix 11). 
 
Extrapolation of the 3DCI data produced lymphoedema maps as described by 
Karakashian et al. (2018).  Furthermore, a new metric was introduced by Watson, 
Karakashian, Pike, & van Loon (Submitted), which is a single value that describes the 
shape of the arm (the concept finds its origins in computer graphics) whereby the swollen 
arm is considered to be more ‘round’ and ‘stretched’, thus lacking in definition.  This 
new metric is proposed to capture this change in shape without considering the actual 
volume of the arm (which is normalised to 1 for each participant).  This metric is 
calculated for each arm, used for further analysis, and is known as redundancy (R), with 
values closer to 1.00 indicating no shape distortion.   
 
4.5.8 Baseline Visit and Data Collection 
As described in section 4.5.3.1, consent was gained before the commencement of the 
study assessment.  A study log was kept of all persons screened and indicated those that 
met the criteria, and the reasons others were ineligible for the study.  Participants’ 
demographic and anthropometric data were collected, followed by the three 
investigative measures, i.e. CTM, perometry and 3DCI.   
 
4.5.9 Treatment of Participants 
Following the assessment, a treatment plan together with advice and compression 
garments was formulated and documented by the lymphoedema therapist.  These 
outcomes were captured on the 3D Study Assessment Form (Appendix 10) for future 
research to explore how active treatment may affect limb volume and shape.  Participants 
were reviewed at two, four and six months, where the researcher took repeat CTM, 
perometry and 3DCI measurements.  The participant’s lymphoedema treatment plan was 
reviewed and amended according to the measurement outcomes by the lymphoedema 






4.6 Phase One: Diagnostic Test Study of Limb Volume 
4.6.1 Phase One: Research Questions, Aim, and Objectives 
The aim of Phase One was to determine the validity, reliability and accuracy of limb 
volume results obtained from 3DCI compared to CTM and perometry. 
 
The objectives of Phase One were to: 
1.1 Determine whether 3DCI volume outcomes are comparable to CTM and 
perometry (intra-rater reliability) 
1.2 Assess the criterion validity of 3DCI against previously validated measures, i.e. 
CTM and perometry 
1.3 Establish whether 3DCI is an accurate method of measurement for lymphoedema 
 
Table 22 provides a breakdown of Phase One's objectives and the planned methods of 
analysis that were used to measure these objectives.   
 
Table 22: Phase One objectives and methods of analysis 
Objective Data Collection Method Methods of Analysis 
1.1 Determine the intra-rater 
reliability of 3DCI compared 
to CTM and perometry 
 Researcher captured 
measurements manually and 
written on 3D Study Assessment 
Form (Appendix 10).  
 Data transferred by researcher 
onto electronic databases (Excel 
& SPSS) 
 Intra-rater Correlation 
Coefficient (ICC) with a 
confidence interval of 95%  
 Standard error of measurement 
 Minimum detectable change  
1.2 Assess the criterion validity of 
3DCI against previously 
validated measures, i.e. CTM 
and perometry 
 Data captured by researcher on 
3D Study Assessment Form 
 Pearson’s Correlation 
Coefficient  
 Bland-Altman plots   
1.3 Establish whether 3DCI is an 
accurate method of 
measurement for lymphoedema 
 Data captured by researcher on 
3D Study Assessment Form 
 Sensitivity and Specificity 
using 2x2 tables  
 
4.6.2 Data Collection 
To meet the three objectives, data were gathered on the demographic, lymphoedema and 
medical history, and anthropometric details of the participant at the initial assessment.  
Furthermore, data were collected on the timing and outcomes of the methods, which 
measured limb volume and VD in millilitres (ml), and %VD and %AVD in percentile.  
Measures were chosen based on clinical use (CTM), validated imaging comparator 




An assessment form (Appendix 10) was devised for this study to ensure the required 
data was collected and recorded.   
 
4.6.3 Data Analysis 
Guidance was sought from a senior statistician at Swansea University.  Data handling 
and analysis were performed using IBM® SPSS® Statistics, version 26 (IBM 
Corporation).   Bossuyt et al. (2015) explain the development of 'The Standards for the 
Reporting of Diagnostic Accuracy Studies' statement which aims to improve the quality 
of reporting of diagnostic test studies and consists of a list of 30 essential items 
(Appendix 12) to ensure comprehensiveness and transparency in reporting of diagnostic 
test studies.  These were reflected on to ensure concordance with this guidance during 
the reporting of the study.   
 
The validity and reliability of measures are vital indicators of the quality of measuring 
instruments.  Validity is often defined as the extent to which an instrument has measured 
what they purport to measure (Kumar, 2005; Kimberlin & Winterstein, 2008; Salkind, 
2011; Field, 2013).  The concept of validity ensures that answers to a research question 
are gained through the correct procedures and can be applied to any aspect of the 
research process (Kumar, 2005). Thus, it looks at whether the instrument measures what 
it was designed to measure (Field, 2013).   
 
In research, there are three types of validity, namely content validity, criterion validity 
(can be concurrent or predictive) and construct validity (Kumar, 2005; Salkind, 2011; 
Field, 2013).  The first type, content validity, is relatively easy to apply as a logical link 
must exist between the objectives and the research questions (Kumar, 2005; Salkind, 
2011).  Criterion validity is where a new measure is compared to an existing or 
comparable measure to determine the same or similar outcomes.  Concurrent validity,  a 
sub-group of criterion validity, occurs when data are collected simultaneously using the 
new instrument and existing criteria, and predictive validity is when data from the new 
instrument are used to predict observations at a future point in time (Kumar, 2005; 
Salkind, 2011; Field, 2013).  Construct validity, is a more sophisticated technique where 
the underlying construct or idea behind an instrument is validated by statistical 




Reliability is defined as the consistency of measurements (Mehta et al., 2018) and refers 
to the quality of a measurement process that provides accuracy and repeatability, i.e. an 
instrument should be interpreted consistently across different situations (Kumar, 2005; 
Salkind, 2011; Field, 2013).  Different types of reliability exist.  Repeatability, or test-
retest reliability, evaluates the stability of the measure administered over a set amount 
of time.  Parallel forms of reliability are when the similarity between two different forms 
of the same test are examined.  Inter-rater reliability is where different researchers apply 
the same test, and intra-rater reliability is where the same researcher performs the 
repeated tests.  Internal consistency is the correlation of two halves of data from the same 
test construct (Kumar, 2005; Kimberlin & Winterstein, 2008; Leddy, Crowner, & 
Earhart, 2011; Salkind, 2011).   
 
The development and validation of an instrument can be ascertained by reducing error, 
and the reporting of findings in an unbiased and objective way (Kumar, 2005; Kimberlin 
& Winterstein, 2008).  The ability of a measure to detect change over time is expressed 
as responsiveness (Kimberlin & Winterstein, 2008).  Reliability is a crucial component 
of responsiveness and must be appropriate to the people being studied.  Sensitivity and 
specificity look at the probability of correctly identifying a condition and evaluating the 
probability of correctly identifying the absence of a condition, respectively (SAGE, 
2019). 
 
The goal of diagnostic test studies is to determine whether a test is useful in clinical 
practice.  To accomplish this, the test needs to be reproducible, accurate, and be able to 
affect clinical decisions (Daya, 1996; Glasser, 2008).  Kimberlin & Winterstein (2008) 
explain that reliability evaluates the stability of measures administered at different times 
to the same individuals or using the same standard (test-retest or intra-rater reliability).  
Reliability coefficients range from 0.00 to 1.00, with higher coefficients indicating 
higher levels of reliability (Kimberlin & Winterstein, 2008).   
 
Objective 1.1 compared the volumetric data from the three measurement methods to 
ensure that each method was repeatable, reproducible and thus reliable by calculating 
the ICC with a confidence interval of 95%, standard deviation, standard error of 
measurement, and smallest detectable change.  As only one rater was used per session, 
intra-rater reliability was tested. Intervals for test-retest studies should be over short 
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periods of time, however with the sessions allocated as per the clinic standard operating 
procedures, and with known minimal change in clinical presentation over a period of 
four to six months with lymphoedema, only sessions one and two were compared 
(Ochalek, Gradalski, & Szygula, 2015). All data for the six months were utilised to 
determine the mean values of limb volume for the affected and unaffected (control) 
arms, the volume difference (VD) between the affected and control arm, and the 
percentage volume difference (%VD) at each point of assessment.  The SD, SEM, and 
P-Values for each of the data were also analysed.  
 
Leddy, Crowner, & Earhart (2011) explain that a new assessment can be validated by 
comparing it to previously validated measures. For this study, concurrent validity (a 
subset of criterion validity) was assessed as a new method of measurement was being 
compared to existing measures to determine whether they produce the same or similar 
outcomes.  Objective 1.2 required the calculation of correlation between the methods 
that were analysed through the application of Pearson's Correlation Coefficient (r).  
Agreement of the measures is possible through Bland-Altman plots. The Bland-Altman 
analysis determined the bias, or mean difference, between 3DCI and the two reference 
techniques (CTM and perometry), as a measure of validity and accuracy (Montenij, 
Buhre, Jansen, Kruitwagen, & de Waal, 2016).  However, before undertaking this 
analysis, the data requires a test of Normality to determine whether it followed a normal 
distribution (Glen, 2017).  The Shapiro-Wilk and Kolmogorov-Smirnov tests of 
Normality, as well as Q-Q plots, were used as described by Field (2013).  Where data 
deviated from the normal, normalisation of data was done using the Box-Cox power 
transformation (Currell, 2015; Glen, 2015b).  
 
A test result is all that is known in clinical practice; thus confidence is required in 
knowing how good the test is at predicting abnormality, i.e. what proportion of patients 
with abnormal test results are genuinely abnormal?  According to Glasser (2008), there 
are at least six ways to determine a test’s accuracy, and these are all interrelated.  These 
include sensitivity and specificity, 2x2 tables, predictive value, Bayes formula of 
conditional probability, likelihood ratio and Receiver Operator Characteristic curves.  
Determining which test to use is based on the question(s) being asked and personal 
preference.  To note, Glasser (2008) reports that reproducibility does not require a gold 
(reference) standard, while accuracy does.  Altman & Bland (1994) and Daya (1996) 
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describe sensitivity as the proportion of true-positives that are correctly identified by a 
test, and specificity as the proportion of true-negatives that are correctly identified by a 
test.  Akobeng (2007) explains that sensitivity and specificity are inversely related 
according to the choice of cut-off values used, and Receiver Operator Characteristic 
curves can be used to identify these.  The threshold used for diagnosing lymphoedema 
in this study was >5% difference in limb volume, as this threshold is used in clinical 
practice in Wales.  For purposes of this study, calculations of sensitivity and specificity 
utilising 2x2 tables were used to address Objective 1.3. 
 
4.7 Phase Two: Diagnostic Test Study of Limb Shape 
4.7.1 Phase Two Research Questions, Aim, and Objectives 
The aim of Phase Two was to determine whether limb shape is a feasible alternative to 
measure lymphoedema.   
 
The objectives for Phase Two were: 
2.1 Evaluate limb shape derived from 3DCI as a new method of lymphoedema 
measurement 
a) Determine trends between oedema maps and limb volume 
b) Use of oedema maps to monitor treatment outcomes (limb volume change)  
c) Consider limb shape as a tool to diagnose lymphoedema 
2.2 Ascertain 3DCI as a sensitive measure of changes in lymphoedema  
a) Sensitivity to change in limb volume over time 
b) Sensitivity to change in limb shape over time 
 
Table 23: Phase Two objectives and methods of analysis 
Objective Method of Analysis 
2.1 Evaluate limb shape derived from 3DCI as a new 
method of lymphoedema measurement: 
a) Determine trends between oedema maps and 
limb volume  
b) Use of oedema maps to monitor treatment 
outcomes (limb volume change)  
c) Consider limb shape as a tool to diagnose 
lymphoedema 
 Compare shape redundancy (R-value) to 
volumetric data from Phase One 
 Pearson’s Correlation Coefficient 
 Bland-Altman plot  
 Violin plots 
2.2 Ascertain 3DCI as a sensitive measure of changes in 
lymphoedema  
a) Sensitivity to change in limb volume over time  
b) Sensitivity to change in limb shape over time 




Table 23 provides a breakdown of Phase Two’s objectives and the planned methods of 
analysis that were used to measure these objectives.  The chosen methods used and the 
data collected for this phase of the study are discussed in the next section. 
 
4.7.2 Data Collection 
Data collected for the volume outcomes for Phase One were utilised to meet the two 
objectives of Phase Two.  These include data from that used in clinics (CTM), the 
validated imaging comparator (perometry) and the study method (3DCI).  The devised 
assessment form (Appendix 10) collected and recorded the data.  As the 3D conversion 
software was still being refined at the time of the study, the 3DCI images were shared 
with the College of Engineering, Swansea University, who converted the images into 
oedema maps (swelling maps), and corresponding shape redundancy values.  It is 
anticipated that this software will form a package that will automatically convert the 
3DCI image into oedema maps at the point of measurement in the future.  As described 
in section 4.5.7.2, calculation of shape redundancy provides an R-value, which was 
compared to the limb volume differences for analysis of correlation and agreement 
between the various methods of measurements to determine the value of shape as a new 
method of lymphoedema measurement.  In addition, descriptive analysis of each oedema 
map is compared to the %VDs reported for each method from Phase One.  
  
4.7.3 Data Analysis 
Working in collaboration with the Engineering Department of Swansea University, the 
3DCI data were converted into oedema maps and shape redundancy (R-value) calculated 
(refer to section 4.5.7.2).  These were compared to the volumetric data from Phase One, 
which enabled an interpretation of change in shape over time, potentially informing 
treatment outcomes.    
 
Objective 2.1 determined any correlations between volumetric measurements and 
derived oedema maps from the 3DCI data.  This was aided by the mathematical 
calculation of the limb shape through shape redundancy.  The limb Shape Redundancy 
Value (R-value) was compared to the various limb %VD through the use of Boxplots 
and Violin plots.  A boxplot visually shows the distribution of numerical data and 
skewness through displaying data quartiles (or percentiles) and averages, including the 
minimum score, lower quartile, median, upper quartile, and maximum score (McLeod, 
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2019).  Violin plots (Figure 29) are similar to box plots as it shows the peaks in the data 
pertaining to the median and interquartile ranges, but uniquely the bulge of the shape 
demonstrates higher probability, while the thinner sections represent a lower probability 
of the measure (Carron, 2016).  These plots determined the trends between limb shape 
and limb volume outcomes.  As in Phase One, Pearson's Correlation Coefficients and 
Bland-Altman plots were utilised to ascertain the criterion validity of the oedema maps 
compared to limb volume outcomes. 
 
    
Figure 29: Interpreting a Violin Plot (Carron, 2016; Cohen, 2018).  The white dot, thick 
black bar and thin black line represent the median (mid-point of the data), interquartile 
range (middle 50% of scores for the group) and the rest of the distribution akin to a Box 
Plot.  The wider the kernel (purple body) of the Violin Plot, the higher the probability of 
the measure. 
 
As discussed in section 4.6.3, there are several methods to determine the sensitivity of a 
new method of measurement.  For Objective 2.2, 2x2 tables were utilised by comparing 
R-value to limb volume data as calculated by CTM, perometry and 3DCI, to determine 
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5.1  Recruitment 
The recruitment process for this study, together with the number recruited, is illustrated 
in Figure 30.  Although this study was open to men and women, only women were 
recruited as no men had been referred to the lymphoedema service with upper limb 
lymphoedema during the 19-month duration of the study.  Sixty-eight referrals to the 
NHS Wales Lymphoedema Service were screened from September 2016 to March 2018 
against the study inclusion and exclusion criteria as described in sections 4.5.2.1 and 
4.5.2.2.   
 
Twenty women were recruited between October 2016 and April 2018.  At the screening, 
participants were excluded if only hand (n=2) or breast oedema (n=1) was identified, 
presence of bilateral upper limb lymphoedema (n=1), where no lymphoedema was 
observed or palpated (n=29), or if the referral was inappropriate (n=1).  The 
inappropriate referral was for a patient with a musculoskeletal injury.  Those participants 
who were unable to consent (n=1) due to dementia, had active or palliative disease (n=3), 
or insufficient shoulder range of movement (n=6), were excluded.  Thus 35.3% (n=24) 
of screened new referrals were eligible for the study.  Four people who met the eligibility 
criteria declined to partake in the study due to time commitment (n=2), and travelling 
required for the sessions within the study (n=2). 
 
Recruitment was more challenging than initially envisioned possibly due to a successful 
Lymphoedema Risk Reduction programme at the lymphoedema service, which resulted 
in a smaller volume of referrals to the department than anticipated (refer to section 
4.5.2). 
 
5.2 Size of Sample 
From the original 20 participants recruited, there was an attrition rate of 15% (n=3) in 
which one participant did not return following the initial assessment, and two failed to 
attend their final session.  One of the last two participants missed their second session 
due to undergoing minor surgery at the time of their appointment.  Contact could not be 
made with any of the three participants who did not return in an attempt to understand 
their reason for not attending their appointment.   
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Every effort was made to retain participants, but attempts at contacting them were made 
no more than three times on separate days.  None of these participants responded to mail 
correspondence sent by the lymphoedema service either.  As none of these participants 
requested their data be excluded from the study, all measurements taken have been 
included for analysis, as agreed during the consenting process.  
 
Missing data was managed as ‘missing completely at random’. These data were deleted 
list-wise, and a t-test performed to check whether any difference in the sample sets 

























Figure 30: Flow diagram of recruitment study processes 
 
Excluded:   n=44 
Hand oedema only   2 
Breast oedema only  1 
Bilateral upper limb LO  1 
No lymphoedema identified 29 
Inappropriate   1 
Unable to consent  1 
Active/palliative disease 3 
Insufficient shoulder range  
of movement   6  
Sep 2016 - Mar 2018 
Screened new referrals to  
Lymphoedema Service n= 68 
 
Fulfilling Inclusion Criteria n=24 
Declined:   n=4 
Travel    2 
Time commitment  2 
Apr 2018 
Final Recruitment to Study n=20 
Nov 2018  
Completed Study n=17 
Withdrawn:   n=3 
Failed to return after IA           1 
Failed to return for final session 2 
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5.3 Demographic Details 
The anthropometric data were collated with a summary of the descriptive demographic 
details in Table 24.  The mean age was 58.9 years (range 43 to 77 years).  The cohort 
ethnicity was 95% Caucasian (n=19), one of Asian origin.  Most participants were still 
employed (70%, n=14), 85% (n=17) did not smoke, and 35% (n=7) drank occasionally.  
The mean weight was 82.7 kg (SD 17.0), and the mean BMI was 32.2 kg/m2 (SD 7.0).  
From Table 24, it is evident that most of the participants (90%, n=18) were overweight 
or obese, with only two (10%) participants in the normal weight category.  
 
All participants were female with lymphoedema secondary to breast cancer treatment 
with the average time since surgery being three years (SD 3.70).  The time of onset of 
lymphoedema since surgery was 1.89 years (SD 2.66 years); however, one participant 
was receiving neoadjuvant chemotherapy (i.e. chemotherapy before surgery) at the time 
of the assessment.  Handedness was analysed in which 18 (90%) participants were right 
hand dominant, with 50% (n=9) of these being the affected arm.  There was good 
representation between those with affected dominant (55%) versus affected non-
dominant (45%) sides. 
 
5.4 Medical Details 
Table 25 gives a summary of the medical details about the cohort.  Of the 19 participants 
who had had surgery, 12 (60%) had a mastectomy and 16 (80%) had axillary node 
clearance (ANC), with five of the participants having had sentinel lymph node biopsy 
prior to the ANC.  Nine (45%) participants had all four breast cancer treatments available 
i.e. surgery, radiotherapy, chemotherapy and hormone therapy.  Of those who had 
hormone therapy, one had stopped following 10 years of treatment. 
 
Lymphoedema ISL Staging (Appendix 1) shows most participants were in Stage I 
reversible lymphoedema (70%, n=14), with the BLS Grouping (Appendix 1) mostly in 
Group 1 early lymphoedema (65%, n=13).  Three participants (15%) had one or more 
previous episodes of cellulitis, but none were on prophylactic antibiotics.  The most 
common chronic comorbidity was arthritis (n=7), with cardiac/respiratory and skin 




Table 24: Demographic details of study cohort 
Variable Category n (%) 
Age Group 
40-49 3 (15) 
50-59 7 (35) 
60-69 8 (40) 
70+ 2 (10) 
TOTAL 20 (100) 
 
Ethnic Origin 
Caucasian 19 (95) 
Asian 1 (5) 
Other 0 (0) 
TOTAL 20 (100) 
 
Employment 
Employed 14 (70) 
Unemployed 2 (10) 
Retired 4 (20) 
TOTAL 20 (100) 
 
Lifestyle Choices 
Do not Smoke 17 (85) 
Smoke 3 (15) 
TOTAL 20 (100) 
 
Do not drink alcohol 5 (25) 
Drink alcohol occasionally 7 (35) 
1-5 units per week 5 (25) 
6-9 units per week 2 (10) 
10 or more units per week 1 (5) 
TOTAL 20 (100) 
 
BMI Groups 
Normal weight (18.5-24.9) 2 (10) 
Overweight (25-29.9) 7 (35) 
Obese Class 1 (30-34.9) 4 (20) 
Obese Class 2 (35-39.9) 5 (25) 
Obese Class 3 (40 or more) 2 (10) 
TOTAL 20 (100) 
 
Time Since Surgery 
Less than 2 years 8 (40) 
2-5 years 8 (40) 
More than 5 years 3 (15) 
Not had surgery 1 (5) 
TOTAL 20 (100) 
 
Time from Surgery to 
BCRL Onset 
Less than 2 years 10 (50) 
2-5 years 8 (40) 
More than 5 years 1 (5) 
Not had surgery 1 (5) 
TOTAL 20 (100) 
 
Handedness 
Right Dominant 18 (90) 
Left Dominant 2 (10) 
TOTAL 20 (100) 
 
Affected Side 
Right 9 (45) 
Left 11 (55) 






Table 25: Medical details of study cohort 
Variable Category n (%) 
Surgery Type 
Wide Local Excision 7 (35) 
Mastectomy 12 (60) 
No Surgery 1 (5) 
TOTAL 20 (100) 
  
Sentinel Node Biopsy 2 (10) 
Axillary Node Sampling 1 (5) 
Axillary Node Clearance 16 (80) 
No surgery 1 (5) 
TOTAL 20 (100) 
 
Chemotherapy 
Yes 15 (75) 
No 5 (25) 
TOTAL 20 (100) 
 
Radiotherapy 
Yes 15 (75) 
No 5 (15) 




Yes 14 (70) 
- Aromatase Inhibitor 7 (35) 
- Tamoxifen 4 (20) 
- Herceptin 2 (10) 
No 6 (30) 
TOTAL 20 (100) 
 
Multiple Treatments 
Surgery, Radiotherapy, Chemotherapy 13 (65) 
Surgery, Radiotherapy, Hormone Therapy  11 (55) 




ISL Stage I – Reversible 14 (70) 
ISL Stage IIa – Pitting 4 (20) 
ISL Stage IIb – Non-pitting 2 (10) 
TOTAL 20 (100) 
 
BLS Group 1 – Early  13 (65) 
BLS Group 2 – Uncomplicated 3 (15) 
BLS Group 3a – Complex One Limb 4 (20) 
TOTAL 20 (100) 
 
Cellulitis 
Yes 3 (15) 
No 17 (85) 
TOTAL 20 (100) 
 
Medical Conditions 
Arthritis 7 (35) 
Cardiac/Respiratory Condition 5 (25) 
Skin Conditions 5 (25) 
Hypertension 4 (20) 
Stroke / Mini-stroke 3 (15) 
Hypercholesterolaemia 3 (15) 
Diabetes 2 (10) 
Hyperthyroidism 2 (10) 
Vascular Disease 2 (10) 
 
Allergies 
Elastoplast/Micropore 4 (20) 
Penicillin 3 (15) 






5.5 Phase One: Limb Volume Results and Analysis 
5.5.1 Objective 1.1: Determine the Reliability of 3DCI Compared to CTM 
and Perometry  
The two-tailed paired-samples tests between sessions one and two, i.e. assessment and 
first follow up at 2-months, (Table 26) shows all measures to be significant (p<0.00) 
with the intra-rater reliability of CTM being the highest at 0.92 (95% CI=0.89, 0.94).  
Perometer had an ICCintra value of 0.89 (95% CI=0.85, 0.93), and 3DCI ICCintra was 0.87 
(95% CI=0.80, 0.93).  The SEM for CTM, perometry and 3DCI was 0.95%, 1.33% and 
1.72% respectively, with the SDC values at 2.63%, 3.69% and 4.77% respectively. 
 
Table 27 summarises all the data from CTM, perometry and 3DCI over the four sessions 
in terms of mean values of limb volume for the affected and unaffected (control) arms, 
the VD between the affected and control arm, and the %VD at each point of assessment.  
Also presented are the SD, SEM, and P-Values for each of the data analysed.  Overall, 
3DCI showed the lowest mean limb volume for both the affected and unaffected arms, 
the smallest VD between arms, as well as the smallest SD and SEM values with all data 
significant at p=0.00.   Incidentally, the lowest %VD was with CTM, even though the 
limb volume difference was the highest of the three measurements.  When comparing 
limb volumes of the affected and unaffected arms, 3DCI was found to underestimate 
limb volume by 278 ml compared to CTM, and by 354 ml compared to perometry.  
 
3DCI was the fastest measurement to perform with an average time of 1:50 min             
(SD 0:17 min).  To note, even though two participant’s data could not be used due to 
corruption of the images, the measurements were still performed and timed.  CTM took 
the longest at 5:54 min, but this can be explained by the need for repeated measuring of 
a limb, where the marking on the arm may have been incorrect due to either the 
participant's arm position or the researcher's error in the 4cm spacing.  Additionally, 
errors were made due to the patient engaging in conversation during the measuring 
process that distracted the researcher while recording the data.  Perometry and 3DCI are 
automated methods of measuring, thus does not require the same level of concentration 
to perform as CTM.
124 
 
Table 26: Paired-samples correlations for CTM, perometry and 3DCI between sessions 1 and 2 
 ICCintra Sig. Mean (SD) SEM SDC 
95% CI of the Difference 
Lower Upper 
CTM (n=18) 
Affected Arm (ml) 0.92 0.00 225.67 (550.51) 129.76 359.68 -48.09 499.43 
Control Arm (ml) 0.89 0.00 -159.56 (553.07) 125.65 300.31 -424.64 105.53 
Volume Difference (ml) 0.94 0.00 67.67 (137.49) 32.41 89.84 -0.70 136.04 
Percentage Volume Difference (%) 0.92 0.00 2.11 (4.04) 0.95 2.63 0.10 4.12 
Perometer (n=16) 
Affected Arm (ml) 0.90 0.00 28.88 (277.29) 69.32 165.68 -118.88 176.63 
Control Arm (ml) 0.93 0.00 -16.06 (255.77) 63.94 177.23 -152.35 120.23 
Volume Difference (ml) 0.85 0.00 44.94 (148.63) 37.16 103.00 -34.26 124.14 
Percentage Volume Difference (%) 0.86 0.00 2.06 (5.32) 1.33 3.69 -0.77 4.90 
3DCI (n=16) 
Affected Arm (ml) 0.93 0.00 -1.66 (209.03) 52.26 144.86 -113.04 109.73 
Control Arm (ml) 0.89 0.00 32.72 (207.24) 51.81 143.6 -77.71 143.15 
Volume Difference (ml) 0.87 0.00 -34.31 (147.45) 36.86 102.17 -112.87 44.26 
Percentage Volume Difference (%) 0.80 0.00 -1.44 (6.88) 1.72 4.77 -5.10 2.23 
 
Key: 
3DCI = Three-dimesional Camera Imaging CI = Confidence Interval   CTM = Circumferential Tape Measure    
ICCintra = Intraclass Correlation Coefficient for intrarater reliability    SD =  Standard Deviation 










































2980.9 (108.9) 261.4 0.00 2850.4 (753.0) 177.5 0.00 249.0 (374.7) 88.3 0.01 7.8 (10.2) 2.4 0.00 
Session 3 
(n=19) 
2881.4 (1106.2) 253.8 0.00 2781.3 (758.0) 173.9 0.00 206.3 (387.7) 88.9 0.03 6.3 (9.9) 2.3 0.01 
Session 4 
(n=17) 
3058.4 (1128.1) 273.6 0.00 2868.4 (763.7) 185.2 0.00 255.4 (437.3) 106.1 0.03 8.0 (10.7) 2.6 0.01 
TOTAL 
(n=74) 









3043.4 (565.4) 141.4 0.00 2883.3 (498.9) 124.7 0.00 160.1 (276.3) 69.1 0.04 5.8 (9.7) 2.4 0.03 
Session 3 
(n=19) 
3129.2 (861.5) 197.6 0.00 2879.7 (614.1) 140.9 0.00 260.5 (462.9) 106.2 0.02 8.4 (12.0) 2.8 0.01 
Session 4 
(n=17) 
3152.0 (1004.0) 243.5 0.00 2866.4 (703.6) 170.6 0.00 274.8 (494.5) 119.9 0.04 8.8 (14.0) 3.4 0.02 
TOTAL 
(n=72) 









2726.6 (566.5) 141.6 0.00 2498.1 (436.4) 109.1 0.00 228.4 (297.7)  74.4 0.01 9.2 (11.4) 2.9 0.01 
Session 3 
(n=17) 
2743.4 (541.9) 131.4 0.00 2566.2 (398.9) 96.7 0.00 177.2 (259.8) 63.0 0.01 6.6 (9.4) 2.3 0.01 
Session 4 
(n=15) 
2745.4 (527.8) 136.3 0.00 2516.3 (497.8) 128.5 0.00 229.1 (284.3) 73.4 0.01 9.9 (13.5) 3.5 0.01 
TOTAL 
(n=66) 




5.5.2 Objective 1.2: Assess the Validity of 3DCI Against Previously 
Validated Measures, i.e. CTM and Perometry 
5.5.2.1 Relationship Between the Three Methods of Measurement Using 
Pearson's Correlation Coefficient 
The criterion validity of 3DCI at all time points through the application of Pearson's 
Correlation Coefficient demonstrated high correlations between methods, with 
marginally higher correlation with CTM (r=0.86) than perometry (r=0.82) (refer to Table 
28).  The highest correlation was between CTM and perometry (r=0.96).  All 
correlations were significant with p<0.01. 
 
Table 28: Pearson's correlation coefficient between CTM, perometry and 3DCI’s 
calculations of total volume difference 
 
CTM Total VD Perometer Total VD 
3DCI Total VD Pearson Correlation .86** .82** 
Sig. (2-tailed) .00 .00 




**. Correlation is significant at the 0.01 level (2-tailed). 
 
5.5.2.2 Agreement Between the Three Methods of Measurement Utilising 
Bland-Altman Plots 
Prior to normalisation of the total VD data for each method of measurement, Table 29 
illustrates that there was some agreement between the tests as all p-values were >0.05.   
 
Table 29: Agreement between the methods of measurement through comparison of their 
volume differences 
 t df Sig. (2-tailed) 
Difference 3DCI-CTM 1.100 65 .275 
Difference 3DCI-Pero 1.819 64 .074 
Difference CTM-Pero .432 71 .667 
 
3DCI initially had a statistically non-significant Kolmogorov-Smirnov test (p=0.68) that 
could be used to indicate a normal distribution.  However, for CTM total VD, data were 
normalised using the logarithm of the data.  Furthermore, due to an extreme deviation 
caused by data entry number 68 for perometry, this data was removed to allow for the 
normalisation of the data through the application of the logarithm to the adjusted total 
VD data for perometry (Currell, 2015) (Appendix 13). 
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For the Bland-Altman plot between 3DCI and CTM (Figure 31), the raw VD data for 
each method was used as it showed a strong distribution within the upper and lower 
limits of agreement (calculated at 1.96 x SD), with two outliers above the upper limit of 
agreement.  Using the raw VD data for 3DCI and CTM, the mean calculated difference 
was 19.09 ml (SD 140.95 ml).  This large SD is due to the existent SD noted for both 
3DCI and CTM as indicated in Table 27 which were higher than each of the VDs for 
each of the methods.  The upper limit of agreement was 295.35 ml, and the lower limit 
of agreement -257.17 ml.  The associated coefficient chart (Appendix 13), had a B-value 
for the mean of 0.09 (close to zero), with a non-significant p-value of 0.21, indicating 
no proportional bias; therefore, there was a level of agreement between 3DCI and CTM. 
 
 
Figure 31: Bland-Altman Plot: a scatterplot of the mean of 3DCI and CTM methods 
plotted against the difference between the two methods 
 
For the Bland-Altman plot between 3DCI and perometry (Figure 32), the raw VD data 
for each method was used as it showed a strong distribution within the upper and lower 
limits of agreement, with two outliers above the upper limit of agreement.  Using the 
raw VD data for 3DCI and perometry, the mean calculated difference was 36.72 ml (SD 
162.77 ml).  Again, the large SD was due to the existent SD noted for both 3DCI and 
perometry as indicated in Table 27.  The upper limit of agreement was 355.75 ml, and 
the lower limit of agreement -282.32 ml.  The associated coefficient chart (Appendix 
13), had a B-value for the mean of 0.05, with a non-significant p-value of 0.21, indicating 





Figure 32: Bland-Altman Plot: a scatterplot of the mean of 3DCI and perometry methods 
plotted against the difference between the two methods 
 
The Bland-Altman plot between CTM and perometry (Figure 33), required the 
normalised data for both methods using the logarithm of the VD data (Appendix 13) as 
the raw data showed no proportional bias between the methods.  Using this data, there 
was one outlier above the upper limit of agreement, and two below the lower limit of 
agreement.  Using the normalised data for CTM and perometry, the mean calculated 
difference was -0.08 ml (SD 0.78 ml).  The upper limit of agreement was 1.45 ml, and 
the lower limit of agreement -1.61 ml.  The associated coefficient chart (Appendix 13), 
had a B-value for the mean of 0.10, with a non-significant p-value of 0.75, indicating no 
proportional bias; therefore, there was a level of agreement between CTM and perometry 
using normalised data. 
 
 
Figure 33: Bland-Altman Plot: a scatterplot of the mean of the logarithm of CTM and 
perometry methods plotted against the difference between the two methods 
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5.5.3 Objective 1.3: Establish the Accuracy of 3DCI Compared to CTM 
and Perometry   
As in clinical practice, lymphoedema was diagnosed at a >5% volume difference 
between the affected and unaffected arms.  The results from the 2x2 crosstabulations 
(Table 30) indicate excellent sensitivity between 3DCI and CTM (91.7%), and 
perometry (100%), meaning that 3DCI has a very high probability of detecting 
lymphoedema compared to CTM and perometry.  It also had a very low false-negative 
rate ranging from 0% to 8.3% compared to perometry and CTM respectively. 
 
The specificity (the ability to detect no lymphoedema) of 3DCI was moderate compared 
to CTM (66.7%) and perometry (50.0%), with false positives ranging from 33.3% to 
50% compared to CTM and perometry respectively. 
 
Of note, the values between 3DCI and perometry are very similar to that between CTM 
and perometry, where the sensitivity was 100%, and specificity slightly higher at 60%. 
 




Negative Positive Negative Positive 
3DCI 
Negative 66.7% 8.3% 50.0% 0.0% 





Positive 40.0% 100.0% 
Key: 




5.6 Phase Two: Limb Shape Results and Analysis 
5.6.1 Objective 2.1: Evaluate Limb Shape Derived from 3DCI as a New 
Method of Lymphoedema Measurement 
There are three sub-objectives from this primary objective, which is to evaluate limb 
shape as a new method of lymphoedema measurement.   
 
Figure 34 provides an example of the oedema maps created, with all oedema maps 
available for each participant for each session attended in Appendix 14.  Each map has 
the relevant %VD for CTM, perometry and 3DCI, as well as the percentage difference 
between the calculated R-value.  These will be referred to for the duration of phase two 
of the results.   
 
5.6.1.1 Objective 2.1a) Determine Trends Between Oedema Maps and 
Limb Volume 
Similar expressions of analysis were used to determine trends between oedema maps 
and limb volume.  As for limb volume analysis in Phase 1, the intra-rater reliability and 
criterion validity of limb shape using the R-value were compared to the limb volume 
data from Phase One. 
 
5.6.1.2 Reliability 
The paired-samples tests between sessions one and two (Table 31) show the R-value for 
the lymphoedema arm to have a moderate correlation as the ICCintra was 0.71 and 
statistically significant (p=0.01).  The correlation for the control arm was moderate with 
an ICCintra value of 0.50 but was not statistically significant as p>0.05.  The correlation 
for both the redundancy difference and redundancy percentage difference between the 
arms have negative poor ICCintra of 0.24 and 0.22 respectively with no statistical 
significance (p>0.05).   
 
Table 32 summarises all the data from R-value over the four sessions in terms of mean 
R-value of the affected and unaffected (control) arms, the difference between the 
affected and control arm, and the percentage difference at each session.  Also presented 





Initial Assessment     Follow up 1 
CTM = 13%      CTM = 9% 
Perometer = 9.5%      Perometer = 8.8% 
3DCI = 7%      3DCI = 15% 
R-value = -1%      R-value = 4% 
 
  
Follow up 2      Follow up 3 
CTM = 11%      CTM = 13% 
Perometer = 7.5%      Perometer = 10.7% 
3DCI = 12.8%      3DCI = 15.1% 
R-value = -1%      R-value = 0% 
 
Figure 34: Oedema maps derived from 3DCI: cyan = no difference between arms; yellow 
to red = larger than unaffected side; blue = smaller than unaffected side 
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Table 31: Paired-samples correlations for Shape Redundancy (R-value) 
 ICCintra Sig. Mean (SD) SEM SDC 
95% CI of the Difference 
Lower Upper 
Shape Redundancy Value (R-value) (n=14) 
Affected Arm 0.71 0.01 0.00 (0) 0.00 0.00 0.00 0.00 
Control Arm  0.50 0.06 0.00 (0.01) 0.00 0.00 0.00 0.01 
Difference -0.24 0.46 0.00 (0.01) 0.00 0.00 -0.01 0.00 
Percentage Difference  -0.22 0.49 -2.92 (15.21) 4.39 12.17 -12.58 6.75 
 
Table 32: Summary of the data from R-value over the four sessions 

























0.07 (0.01) 0.00 0.00 0.07 (0.01) 0.00 0.00 0.00 (0.01) 0.00 0.53 2.00 (8.67) 2.17 0.37 
Session 2 
(n=13) 
0.07 (0.01) 0.00 0.00 0.07 (0.00) 0.00 0.00 0.00 (0.01) 0.00 0.25 3.54 (10.23) 2.84 0.24 
Session 3 
(n=14) 
0.07 (0.00) 0.00 0.00 0.07 (0.01) 0.00 0.00 0.00 (0.01) 0.00 0.12 3.79 (8.03) 2.15 0.10 
Session 4 
(n=14) 
0.07 (0.01) 0.00 0.00 0.07 (0.01) 0.00 0.00  0.00 (0.01) 0.00 0.05 4.50 (8.17) 2.18 0.06 
TOTAL 
(n=57) 





5.6.1.3 Validity  
Three methods of testing the criterion validity of limb shape through R-values were 
used, namely Pearson's Correlation, Bland-Altman plots and Box- and Violin Plots.   
 
Relationship Between Methods Using Pearson's Correlation Coefficient 
From Table 33 it can be seen that the percentage difference calculated for limb shape, 
i.e. R-value, has a poor Pearson's correlation with the %VD from all three methods of 
measurements (3DCI r=0.39; CTM r=0.23; perometer r=0.19).  However, 3DCI volume 
measurements were statistically significant with the R-value (p=0.002), even though 
there was a poor correlation.  Thus, even though there was a poor correlation with the 
volume methods, there was a statistical significance with 3DCI volume measurements, 
indicating some agreement, although poor, between the volume and R-values calculated 
from 3DCI. Furthermore, as the R-value is a different construct to volume and %VD, 
and based on these poor correlations, it is recommended not to compare these two 
constructs to each other. 
 
Table 33: Pearson's correlation coefficient between R-value percentage difference (%Diff) 
and 3DCI, CTM and perometry percentage volume difference (%VD) 
Correlations 
 3DCI %VD CTM %VD Perometer %VD 
R-value % Diff Pearson Correlation .392** .227 .190 
Sig. (2-tailed) .002 .081 .146 
3DCI %VD Pearson Correlation 1 .787** .766** 
Sig. (2-tailed)  .000 .000 
CTM %VD Pearson Correlation  1 .932** 
Sig. (2-tailed)   .000 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
Agreement Between Shape Redundancy and the Three Methods of Measurement 
Utilising Bland-Altman Plots 
Table 34 illustrates that there was no agreement between the R-value and the volume 
measurement methods as all p-values were <0.05.   
 
Tests of normality show that the R-value had significance values of <0.05, with a 
Kolmogorov-Smirnov test p-value of 0.03, and Shapiro-Wilk of 0.00.  The normalisation 
of data was done by transforming the data to the square root of the values (Appendix 
15).  This produced a statistically significant Kolmogorov-Smirnov test p-value of 0.20 
and Shapiro-Wilk of 0.06.  The differences between the normalised R-value data and 
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3DCI, CTM and Perometry %VD were calculated to determine agreement, however, all 
tests remained statistically significant (p<0.05), thus no level of agreement exists 
between R-value and the volume-based measurements (Table 35), confirming that these 
data should not be compared to each due to their different constructs. 
 
Table 34: Agreement between R-value percentage difference and 3DCI, CTM and 
perometry %VD 
 t df Sig. (2-tailed) 
Difference R-value-3DCI -3.917 59 .000 
Difference R-value-CTM -2.864 59 .006 
Difference R-value-Perometer -2.683 59 .009 
 
Table 35: Agreement between the square root of R-value percentage difference and 3DCI, 
CTM and perometry %VD 
 t df Sig. (2-tailed) 
Difference square root R-value-3DCI -5.347 36 .000 
Difference square root R-value-CTM -4.005 36 .000 
Difference square root R-value-Perometer -3.561 36 .001 
 
Correlations Between Methods Utilising Box- and Violin Plots 
The Boxplot (Figure 35) shows that the mean values for the R-value are lower than for 
limb volume, with the interquartile range and adjacent values being much lower as well.   
 
Figure 35: Boxplot showing the mean values for the percentage differences of Shape 
Redundancy (R-value), 3DCI, CTM and perometry.  The  and  indicate the case 
numbers as outliers and the overlap of cases respectively. 
The Violin Plots (Figure 36) show a lower probability of correlation with the R-value 
compared to any of the three volumetric methods of measurement.  From the Box Plots 
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and Violin Plots, it is evident that there is a poor correlation between shape redundancy 
and limb volume calculations. 
 
 
Figure 36: Violin Plots showing the probability of correlation between R-Value, 3DCI, 
CTM and perometry  
 
5.6.1.4 Objective 2.1b) Use of Oedema Maps to Monitor Treatment 
Outcomes (Limb Volume Change)  
From the oedema maps in Appendix 14, the range of colours from blue to red portrayed 
in the reconstructed arm highlight the deviation of the lymphoedema arm from the 
'normal'.  Cyan is when the two arms match in shape and girth, however the redder the 
image, the bigger the deviation, indicating the presence of lymphoedema.  The 
concentration of the colours also indicates where the worst of the lymphoedema is, i.e. 
localised lymphoedema.   
 
Shape deviation was primarily detected around the elbow with nine highlighting 
swelling around the back or outer elbow; three had swelling along the inner aspect, and 
two along the anterior (front) of the elbow.  Swelling generally extended down the 





The radial maps proved most useful in nine cases as the reconstructed arm was cyan or 
blue, which could be interpreted as no lymphoedema, however, looking at the radial 
maps highlighted significant shape distortion of the back of the arm. 
 
In two cases (participant 2 and 11) changes in shape distortion were not identified by 
perometer, and in one case (participant 16), the perometer showed a significant increase 
in volume which neither the oedema map nor CTM or 3DCI identified. 
 
Some problems were identified with 3D imaging in that it was not possible to identify 
the arms for participant 6 as they could not be distinguished from the trunk.  The 
participant had a BMI of 49.2kg/m2 resulting in her upper arm resting on her trunk, even 
with her arm held out to her side at shoulder height.  In two case (participant 9 and 10), 
overstretching of one arm to the other caused mismatching of the images, resulting in 
either false positive readings from the oedema map, or no oedema map to be constructed.  
There was also a case (participant 20) where images were taken as per protocol for all 
four sessions, however, the data were corrupted somehow, thus no 3DCI data was 
available for calculation or construction of the oedema maps. 
 
Further analysis of the oedema maps and the %VD results of the three methods are 
presented in Table 36.  This table provides a summary of whether the oedema maps 
match the %VD data from CTM, perometry and 3DCI over time.  From this, 14 (82%) 
of CTM %VD match the oedema maps, 11 (65%) compared to perometry %VD and 16 
(94%) against the 3DCI %VD.  This indicates a good trend of oedema maps 
corresponding with calculated %VD to CTM and 3DCI, and moderate compared to 
perometry.  However, the R-values do not match very well (n=8; 47%), with five 
participant’s R-values either changing drastically over time, missing or was a 50:50 split 
in matching or not; thus, caution is advised when using shape redundancy to diagnose 
lymphoedema. 
 
5.6.1.5 Objective 2.1c) Consider Limb Shape as a Tool to Diagnose 
Lymphoedema 
The current R-value does not seem a valid method of determining the presence of 
lymphoedema based on the results from the three validity tests.  However, visual 
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feedback has the potential to confirm limb volume outcomes.  This will be discussed 
further in Section 6.5.2. 
 
Table 36: Oedema maps matching CTM, perometry and 3DCI %VD over time 
Participant 
Number 
CTM Perometer 3DCI Oedema Map 
Yes No Yes No Yes No Yes Unsure No 
1          
2          
3          
4          
5          
6 No Image No Image No Image No Image 
7          
8          
9          
10 No Image No Image No Image No Image 
11          
12          
13          
14          
15          
16          
17          
18          
19          
20 No Image No Image No Image No Image 
 
5.6.2 Objective 2.2: Ascertain 3DCI as a Sensitive Measure of Change in 
Lymphoedema 
As for Phase One, 2x2 crosstabulations were used to compare the R-values to the %VD 
for the three methods of measurements. 
 
5.6.2.1 Objective 2.2a) Sensitivity to Change in Limb Volume Over Time 
Section 5.5.3 showed VD measured by 3DCI to have good sensitivity when compared 
to CTM (79.4%) and perometry (73.5%).  Thus, 3DCI volume measurements 
demonstrate sensitivity to change in limb volume over time. 
 
5.6.2.2 Objective 2.2b) Sensitivity to Change in Limb Shape Over Time 
The R-value was compared to the %VD for 3DCI, CTM and perometry to determine 
whether limb shape value had similar sensitivity over time (Table 37).  The results from 
the 2x2 crosstabulations indicated poor to moderate sensitivity between R-value and 
perometry (28.6%), CTM (45.5%) and 3DCI (50.0%).  Specificity was moderate to 
excellent compared to perometry (60.0%), CTM (83.3%) and 3DCI (100%). 
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Table 37: 2x2 Crosstabulation of sensitivity and specificity between R-Value, 3DCI, CTM 
and perometry 
 
3DCI CTM Perometer 
Negative Positive Negative Positive Negative Positive 
R-Value 
Negative 100% 50.0% 83.3% 54.5% 60.0% 71.4% 
Positive 0.0% 50.0% 16.7% 45.5% 40.0% 28.6% 
Key: 
Green highlight = Sensitivity (true positive) Purple highlight = Specificity (true negative) 
 
When reflecting on the oedema maps (Appendix 14) and Table 36, oedema maps do 
reflect sensitive change over time that follow the trends of %VD.  Thus, shape 















This study aimed to determine the validity, reliability and accuracy of upper limb 
volume results obtained from 3DCI compared to CTM and perometry.  This was 
achieved by proving the criterion validity and intra-rater reliability of 3DCI against 
CTM and perometry, and was found to be similar to the current literature.  The accuracy 
of 3DCI volumes demonstrated good sensitivity, but moderate specificity. This was the 
first study to report sensitivity and specificity, and more research with a bigger cohort is 
encouraged to add more value to this data.  The study also sought to discover whether 
limb shape is a feasible alternative to measure lymphoedema.  As the use of limb shape 
to assess for lymphoedema is a new concept, not only does it need to be 'a feasible 
alternative' to therapists and patients, it has to prove that it offers more detailed 
information about the lymphoedema.  This proved to be more challenging as comparing 
volume to shape, or a value of shape (R-value), is in itself a fundamentally different 
construct of measurement to volume. Comparing each oedema map to the %VD of each 
measurement showed good similarity, but more research is needed to define the shape 
objectively for comparison purposes.     
 
Based on the results, 3DCI could be used within a clinical setting, as it provides limb 
volume information as well as images in the form of oedema maps.  Through the 
information produced from limb shape, both the patient and therapist could gain 
additional information to the standard limb volume data by clearly visualising and 
highlighting the problem areas of the lymphoedema using colour coding.  This would 
inform the localisation and extent of the problem, thus allowing for improved decision 
making in terms of the type of treatment options that could be made available.  For 
example, adding soft textured foam to the problem area, or introducing alternative 
massage techniques to the localised swelling, thus providing specific, individualised 
treatment for each patient’s symptoms. Patients may be more receptive to this method 
of measurement where their lymphoedema can be visualised, thus potentially improving 
their compliance with the treatment. 
 
 Cohort Demographics 
The calculated average age of breast cancer cases from 2015-2017 was 63.5 years (range 
17 to 90+), and the most prevalent age group for breast cancer for this period was 65-70 
years (Cancer Research UK, 2020).   As about 21% of women who have breast cancer 
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treatment develop lymphoedema (DiSipio et al., 2013), it would be logical for a BCRL 
cohort to be of a similar age group.  Unfortunately, no data exists to report on the average 
age of BCRL cohorts.  For this study, the mean age was slightly lower than the national 
breast cancer average at 58.9 years.   
 
The literature reports that BMI affects limb volume (Ancukiewicz et al., 2012; Buffa et 
al., 2015); conversely, Wang et al.'s (2017) study contradicted this; however, their cohort 
was all in the healthy BMI range (20-24.9 kg/m2), whereas all other papers reported on 
a range of healthy to obese (BMI>30 kg/m2) participants.  This study’s participants had 
an average BMI of 32.2 kg/m2 which is equivalent to the obese class I category (World 
Health Organization, 2021).  As in the literature, this study’s BMI ranged from the 
healthy to obese class III (23.2 – 49.2 kg/m2). 
 
From a recent online report published by McCarthy (2020), 12.2% of the UK population 
are left-handed.  This study, therefore, had a representative sample with 10% of the 
participants being left-handed.  There was a good split between affected dominant, and 
affected non-dominant arm (45:55), thus this sample had a good representation for hand 
dominance as affected or unaffected.  Although Wang et al. (2017) found hand 
dominance influenced CTM and limb volume as the dominant arm measured 
significantly bigger than the non-dominant arm, Ancukiewicz et al. (2011) did not find 
hand dominance to affect relative volume change using the perometer.  To date, no 
research using 3DCI has examined how much hand dominance may affect limb volume 
measurements. 
 
It is recognised that cancer treatment is a cause of secondary lymphoedema 
(Lymphoedema Framework, 2006).  Tsai et al. (2018) report that surgical methods were 
found to contribute to the development of arm lymphoedema, with mastectomy and 
axillary node clearance being a higher risk than a wide local excision and sentinel lymph 
node biopsy.   The main surgery for this study’s cohort was mastectomy (n=12) and 
axillary node clearance (n=16), thus is representative of this higher risk group for 
developing lymphoedema secondary to breast cancer treatment. 
 
Alcohol consumption is considered a causative factor of breast cancer (NHS UK, 2020). 
From this cohort, 75% of the participants drank alcohol ranging from occasionally to 10 
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units per week, and 15% of the participants smoked.  Alcohol consumption has not been 
confirmed to be a cause of lymphoedema, and none of the participants reported alcohol 
consumption as an exacerbating factor.  Smoking is known to be harmful to health, 
including the circulatory system (Babizhayev & Yegorov, 2011); however, no study to 
date has found an effect of smoking on the lymphatic system.  Interestingly, Bedi et al. 
(2015) report that smoking negatively predicted lymphoedema in their study following 
treatment for Sarcoma.  At this time, until there is a definitive causative link between 
lymphoedema and alcohol/smoking, the relevance of collecting this data has to be 
questioned.  A study comparing measurements before and after alcohol consumption or 
smoking could be considered, but it is recognised that there may be ethical concerns due 
to these being identified risk factors to ill health.   
 
 Validity and Reliability of 3DCI 
6.2.1  Concurrent Validity 
This study demonstrated good concurrent (criterion) validity of 3DCI with CTM 
(r=0.86), and perometry (r=0.82).  These data are lower than the average reported in the 
systematic literature review (0.94) but falls within the reported range of 0.74-0.99. 
 
Nevertheless, a high correlation does not necessarily mean that the methods have good 
agreement (Montenij et al., 2016; Doğan, 2018).  Criterion validity was further 
determined through the use of Bland-Altman plots which looked at the agreement of the 
limb volume differences measured by 3DCI, CTM and perometry.  The Bland-Altman 
plots showed a level of agreement between 3DCI and CTM and perometry, with no 
proportional bias.  The low mean volume differences between the methods indicate a 
good agreement between the methods as the mean volume difference between the 
volume differences of 3DCI and CTM was 19 ml (SD 141 ml), and between 3DCI and 
perometry it was 37 ml (SD 163 ml).  Lu & Dixon (2019) also constructed Bland-Altman 
plots comparing 3DCI to perometry that showed a low mean volume difference of 6 ml 
(SD 133 ml), again supporting good agreement between the methods of measurement. 
 
Results from this study show that 3DCI underestimated limb volume compared to CTM 
by 278 ml.  This outcome is similar to Karakashian et al. (2018) who found 3DCI to 
underestimate CTM by  100 ml, however, it is in contrast to both Cau et al.’s (2016; 
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2018) papers who found 3DCI to overestimate limb volume compared to CTM.  The 
large difference between the volumes of this study and Karakashian et al.’s (2018) can 
be explained by not matching limb length (systematic error) between 3DCI and CTM in 
this study, whereas Karakashian et al. (2018) matched arm lengths, but these did not 
extend to the axilla.  The difference in volumes is also thought to be due to the geometric 
approximations used when calculating volume by CTM to be inaccurate, i.e. the 
truncated cone formula postulates that every segment of the limb represents a perfect 
circle and that the walls of the cone are rectilinear (De Vrieze et al., 2019).  Furthermore, 
3DCI accounts for the volume of the actual shape of the arm, as opposed to the measured 
segments used in CTM.  That is, 3DCI measures every millimetre circumferentially, 
whereas CTM uses a range from 4 cm to 10 cm spacing between measured 
circumferential points.  Thus, results from  3DCI could be considered as the more 
accurate method for measuring limb volume.  
 
This study also found 3DCI to underestimate limb volume compared to perometry by an 
average of 364 ml.  Conversely, three papers reported 3DCI to overestimate volume 
compared to perometry (Lu et al., 2013; Lu et al., 2014; Lu & Dixon, 2019), with Lu & 
Dixon (2019) quoting a volume overestimation of 118 ml.  Lu et al. (2014) report that 
the discrepancies between 3DCI and perometry may be due to two factors, namely arm 
length not being identical for both methods (systematic error), and the deformation of 
the arm during the scan (random error), i.e. any slight movement will affect volume 
calculations.  This study and Lu et al.'s (2014) study used similar methodologies in terms 
of capturing images, i.e. the perometer was captured identically (apart from the patient 
position being sitting versus standing) and the 3DCI had arms held to the side 
unsupported at shoulder-height.  Of note, all of Lu’s studies used the Microsoft KinectTM 
camera, and this study utilised a similar infrared camera called Asus Xtion Pro 
(Gonzalez-Jorgea, Riveirob, Vazquez-Fernandezc, Martinez-Sáncheza, & Ariasa, 
2013).  Due to the errors in capturing the images in this study, thought to be due to slight 
movement of the unsupported arm, it is recommended that a platform, similar to that 
used in perometry, be designed for 3DCI to offer more stability to the arm whilst the 
measurement is being taken. 
 
Similarly to CTM, 3DCI is thought to be more accurate than perometry due to volume 
measurements being taken every 1 mm as opposed to 3.1 mm or 4.7 mm.  The perometer 
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also uses cylinder type formulae, and although the gaps between measurements are not 
as significant as for CTM, the irregularity in limb shape cannot be accounted for.  Also, 
3DCI utilises an algorithm based on the actual surface area of the limb as opposed to 
circumferential points; thus, all shape distortion is included in the calculation.  
Furthermore, the engineers at Swansea University question the accuracy of the 
perometer as a rectangular frame is taking the image of an oval or circular object.  Thus, 
the corners of the perometer frame could be distorting the limb image, resulting in a less 
accurate volume measure for the limb.  Therefore, to understand all the discrepancies 
described, further research is required with stricter controls of the participant's 
positioning, identifying the limb length before taking measurements, and testing the 
perometer and 3DCI with a known volume object, such as a tube, for accuracy and 
calibration. 
 
Most of the other studies in the systematic literature review compared 3DCI to water 
displacement, which found it to correlate well (range 0.98 to 0.99) (Landau et al., 2018; 
Preuβ et al., 2018; Hameeteman et al., 2016; Erends et al., 2014; Lu et al., 2014; Öhberg 
et al., 2014).  There was some disagreement as to whether 3DCI over or underestimates 
volume compared to water displacement.  However, from this thesis' systematic 
literature review, most papers report 3DCI to overestimate volume compared to water 
displacement.  This could be due to arm length discrepancies in either measurement or 
motion of the arm during 3DCI measurement. 
 
From the results of this study and the literature review, volumetric methods of 
measurements should not be used interchangeably as they produce different and 
incompatible total limb volumes. 
 
6.2.2  Intra-Rater Reliability 
This study investigated whether 3DCI was a reliable method of measurement compared 
to CTM and perometry.  As the study consisted of one researcher performing the 
measurements at each appointment, only intra-rater data analysis was possible.  The 
intra-rater correlation coefficient of 3DCI was statistically significant (p<0.00) with a 
good ICCintra of 0.87.  This is lower than the 3DCI ICCintra reported in the literature that 
ranged from 0.95 to 1.00.  Mehta et al. (2018) explain that once a cohort threshold of 
n=80 is achieved, larger groups do not seem to influence intra-rater correlation 
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coefficient results. Interestingly, all studies reporting on intra-rater correlation 
coefficient values for 3DCI had cohorts smaller than 40.  This may account for the 
differences in the reported correlations for this study as the participant number was only 
20, lower again than the recommended 30 in the literature, and is explained in the 
limitations of this study. 
 
Furthermore, 3DCI demonstrated good intra-rater reliability, as the results from the test-
retest data are more consistent due to the lower differences in volume between 
measurements and smaller standard deviations when compared to other measurements. 
3DCI had the lowest mean limb volume for both the affected and unaffected arms over 
the study period, as well as the smallest VD (214 ml) between arms, the lowest SD      
(274 ml) and SEM (33.8) values with all data significant at p=0.00.   However, the lowest 
%VD was with CTM (8.1%), and the highest was 3DCI with 8.6%.  3DCI had an SEM 
of 1.4% and SDC of 3.9%; compared to the systematic literature review, these values 
are slightly lower (SEM 1.7%; SDC 4.7%), indicating similarity in results. 
 
Results from this study indicate that 3DCI has good criterion validity for the 
measurement of limb volume as it correlates highly to CTM and perometry, and there is 
an agreement between 3DCI and the other two measurements with no proportional bias 
seen from the Bland-Altman plots.  Furthermore, when determining the reliability of 
3DCI compared to CTM and perometry in upper limb lymphoedema, the good intra-
rater correlation coefficient value, lower standard deviation and the smaller standard 
error of measurement all indicate 3DCI to be a reliable tool for the measurement of 
upper limb volume.  Compared to the literature, this study supports the findings that 
3DCI is a valid tool for the measurement of lymphoedema; however, without a gold 
standard measure against which to compare 3DCI, its validity remains inconclusive.  
 
6.3 Establish the Accuracy of 3DCI Compared to CTM and 
Perometry   
Bossuyt, Irwig, Craig, & Glasziou (2006) posit that where studies are analysing 
comparative accuracies, they could compare the new test with existing tests and verify 
test results against the same reference standard.  A simple estimate of a new test's 
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sensitivity and specificity is required to determine whether it can serve as a replacement, 
alternative or adjunct, i.e. a test's ability to detect true positives and true negatives.   
 
From the results of this study, 3DCI demonstrated good levels of accuracy in that 92% 
of lymphoedema cases compared to CTM (sensitivity) and 100% when compared to 
perometry were positively detected, with low false-negative rates less than 8%.  
However, 3DCI’s accuracy at detecting non-lymphoedema cases was moderate in that 
its specificity compared to CTM was 67% and perometry 50%, with false positives up 
to 50%.  In clinical practice, with the higher rate of over-diagnosing lymphoedema, it is 
even more important to ensure the examination includes visual and palpation assessment 
in conjunction with the patient’s reported symptoms when using 3DCI.  As 
lymphoedema is the second most feared side effect of cancer treatment among breast 
cancer patients (Cornelissen et al., 2018), it stands to reason that over-diagnosing 
lymphoedema will further increase existent distress (Alcorso & Sherman, 2015), 
therefore it is vital that an accurate diagnoses be made when measuring for 
lymphoedema. A larger cohort may present different outcomes, and with no papers (Lu 
et al., 2013; Öhberg et al., 2014; Lu et al., 2014; Erends et al., 2014; Buffa et al., 2015; 
Hoevenaren et al., 2016; Hameeteman et al., 2016; Cau et al., 2016; Levenhagen et al., 
2017; Verhulst et al., 2017; Preuβ et al., 2018; Landau et al., 2018; Karakashian et al., 
2018; Cau et al., 2018; Lu & Dixon, 2019; Karakashian et al., 2019;  Binkley et al., 
2020) reporting on 3DC’s sensitivity or specificity against other methods, further 
research and analysis is needed. 
 
In Wales, a diagnosis of lymphoedema is made when there is >5% limb volume 
difference between the affected and unaffected limbs (LNW, 2020).  The diagnosis must 
be supported by both the clinical report and presentation from the patient as well.  This 
5% threshold was utilised in this study.  Within the systematic literature review, Asim 
et al. (2012) and Ancukiewicz et al. (2012) both report that 7.5% may be the ideal 
thresholds for diagnosing lymphoedema.  However, until the method of diagnosing 
lymphoedema through the application of thresholds for limb volume is resolved, 
research will continue to report the vast discrepancies of lymphoedema incidence, and 
due to the differing thresholds, makes lymphoedema research continually challenging.  
Nevertheless, with 3DCI being an accurate and sensitive method of volume 
measurement, the lower threshold of 5% volume difference between arms would reflect 
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a more sensitive change over time.  Further research to determine the most appropriate 
threshold for diagnosing lymphoedema using 3DCI should therefore, be considered. 
 
6.4 Ascertain Whether Limb Shape Derived from 3DCI is a Potential 
New Method of Lymphoedema Measurement 
The reliability, validity and accuracy of shape versus volumetric measurement were 
determined, and the results highlighted that by using the R-value, there was a statistically 
significant but moderate intra-rater correlation of 0.71 (p=0.01).  This is similar to 
Gillies, Kinahan, & Hricak's (2016) findings, where they found converting image data 
into quantitative results helped with making a diagnosis and then deciding upon 
treatment options.   
 
The criterion validity of shape redundancy showed a poor correlation with limb volume 
measures (Pearson’s correlations coefficient <0.39) that was confirmed visually using 
box- and violin plots.  There was also no agreement between the methods as Bland-
Altman plots were not possible, given that the R-value were statistically significant 
(p<0.05) for the t-test between the methods of measurement. 
 
The accuracy of shape redundancy demonstrated poor to moderate sensitivity (range 
29% to 50%), but moderate to excellent specificity (range 60% to 100%).  Thus using 
shape redundancy has a low ability to detect lymphoedema, but a good probability to 
determine the absence of lymphoedema.  More research is required to build the evidence 
base for this unique concept of lymphoedema measurement by quantifying shape. 
 
Further analysis of shape was done in the form of visual interpretation of the oedema 
maps.  The colours towards red indicate a stronger deviation from the 'norm' (unaffected 
side), whereas cyan indicates a closer relationship with the 'norm'.  From this study, 94% 
of the oedema maps matched the findings from %VD as recorded by 3DCI, 82% 
compared to CTM and 65% to perometry.  A literature review by van de Water et al. 
(2018) concluded that patients prefer to receive positively framed risk information and 
that they prefer to receive graphical over textual information. The current visual 
interpretation of the oedema maps may be subjective for scientific purposes; however, 
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for a patient, it may help confirm where the worst of their lymphoedema problem may 
be and add to the understanding of the need for bespoke treatment.   
 
Thus, the use of oedema maps has the potential to be used as a new and alternative 
measure of lymphoedema.  With the oedema maps being sensitive to small changes in 
volume and shape, this method may be useful as a risk reduction measurement tool; 
however, further research with this specific cohort of patients would be needed.  Also, 
from this study's results, 3DCI has the potential to replace both CTM and perometry as 
not only does this method of measurement provide limb volume data, it also supports 
findings through the use of oedema maps that offer more information in terms of 
localised swelling, which CTM and perometry are not sensitive enough to detect and 
report.  Clinical research regarding the use of oedema maps with different stages of 
lymphoedema is needed.  Also, a study determining the effect of oedema maps on people 
less compliant with their lymphoedema self-management would be of interest to 
understand whether visual feedback of their lymphoedema changes their approach to 
treatment.  Furthermore, utilisation of deep infrared thermograms (heat maps) should be 
considered as according to Belgrado et al. (2010) the use of infrared thermal cameras 
can obtain surface thermograms of high precision and excellent resolution depicting 
dermal backflow.  These thermal images could then be compared to the 3DCI oedema 
maps to determine similarities in the detection of lymphoedema and localised swelling.   
 
Shape redundancy (R-value), however, does not currently seem to add much value to 
limb shape as an assessment tool as, even though it has moderate reliability, it has poor 
validity with limb volume measurements.  Further research into the application of 
oedema maps in clinical practice is needed to explore whether R-value could be used as 
an additional tool measuring upper limb shape changes over time.   
 
6.5 Potential Benefits of 3DCI in Clinical Practice 
6.5.1  Timing of Measurements 
Timing for CTM measurements in this study varied greatly from 3:49 min to 8:49 min.  
In clinical practice, measuring limbs using CTM can fluctuate due to the need to repeat 
measures as a result of errors in marking the limb, positioning the limb, or writing the 
measured values incorrectly on the datasheet.  Furthermore, experienced therapists are 
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likely to perform the measurements more quickly than newly trained staff.  CTM is the 
only hands-on method of measuring limb volume, and as such is a personal procedure 
to perform for patients.  Often patients like to converse while measurements are being 
taken, which lengthens the process even more.  Furthermore, as the therapist's hands are 
in close contact to the skin during measuring, it is easy for the therapist to palpate the 
skin and tissue, enabling them to detect changes in tissue consistency and determine the 
tissue's responsiveness to touch and massage (Johnson, Kennedy, & Henry, 2014).  
However, this also adds contact infection risk as previously discussed. 
 
There was less variation in the timings for perometry (range 1:17 min to 3:08 min) and 
3DCI (range 1:27 min to 2:38 min) compared to CTM.  This would be due to the methods 
utilising technology that requires distancing of the therapist from the patient.  The tests 
are quick to perform, thus thwarting the opportunity for a patient to start a discussion 
during the test as their body position needs changing to measure the opposite limb.  
Perometry still requires close contact between the patient and therapist who has to slide 
the frame back and fore the perometer stand.  The time saved performing these tests 
allows for more discussion time for when the results of the tests are shared with the 
patient during their allocated appointment time.  An unexpected benefit of using this 
study's 3DCI method over perometry is that the limb can be measured supporting the 
COVID-19 social distancing regulations as there is a two-meter gap between the patient 
and the therapist who is standing behind the camera stand.   
 
Three papers report on the timing of the tests in their study, which are summarised in 
Table 38.  Including this study, there is a large discrepancy in times recorded due to 
differences in methods of timing the tests.  This study timed the setup and performance 
of the test, while Landau et al. (2018) included the setup time, performance of the test, 
and the time taken to calculate the results.  Buffa et al. (2015) compared their 3DCI 
system (SkanLab system) to water displacement and timed the duration of the 
measurements.  They found their 3DCI system to be faster than water displacement by 
2:47 min (Buffa et al., 2015).  Landau et al. (2018) timed their three methods of 
measurement which were 3DCI (Vectra 3D system), CTM and water displacement.  
They report that their 3DCI system was on average 9:48 min faster to perform than CTM, 
and 19:00 min faster than water displacement (Landau et al., 2018).  Thus the consensus 
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from the studies reporting on 3DCI in Table 38 is that 3DCI is faster to perform than 
current methods of lymphoedema measurement. 
 
Table 38: Timing of methods of measurement between Buffa et al. (2015), Landau et al. 
(2018), De Vrieze et al. (2019) and Thesis Study 
Method of 
Measurement 
Buffa et al. 
(2015)  
Time (min) 
Landau et al. 
 (2018)  
Time (min) 
De Vrieze et al. (2019) 
Time (min) 
Thesis Study 
(2020)   
Time (min) 
3DCI 0:42 +0:11 5:54 +2:18 - 1:50 +0:17 
CTM  15:42 +3:06 4:24 +0:44 5:54+1:17 
Water 
Displacement 
2:03 +0:29 24:54 +4:06 
Type 1: 10:41 +1:49 
Type 2:   5:35 +0:19 
Type 3: 12:55 +3:54 
 
Perometry   1:43 +0:43 1:56 +0:35 
 
From a Value-Based Healthcare perspective reviewing outcomes, quality and cost 
(Porter, Pabo, & Lee, 2013; Gray, 2017), 3DCI is a time and cost-saving method of 
measurement that has good reliability and validity against CTM and perometry. 
 
6.5.2  Oedema Maps 
The interpretation of shape through oedema maps will provide information that may help 
people who understand visual images better than numbers. Edwards, Elwyn, & Mulley 
(2002) begin by explaining that people interpret words and numbers differently, for 
example, 'likely' might be a 1 in 10 chance for one person, but for another, it may be a 1 
in 2.  Yamagishi's (1997) paper highlighted how people interpreted 1286 out of 10,000 
death rates as riskier than 24.14 out of 100.  It was recognised that standardisation for 
explaining risk was required which resulted in a pictorial explanation of risk ranging 
from 1 in 1, to 1 in 1,000,000,000,000 and comparing it to everyday familiar risks 
(Edwards, Elwyn, & Mulley, 2002).  A study by Garcia-Retamero & Galesic (2010) 
with participants from both America and Germany, revealed that by using visual aids 
that do not require high levels of numeracy, the information given to patients improved 
their medical decision-making based on risk to treatment.   
 
Framing language also has effects such as the persuasive or positive techniques used to 
encourage greater uptake of procedures or examinations such as mammograms. Van de 
Water et al. (2018) established that patient satisfaction was higher when verbal 
information was combined with numerical information.  A more recent study by Kim, 
Trinidad, Mikesell, & Aakhus (2020) found that an appropriate visual format in the 
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delivery of prognosis information can reduce potential negative effects in conveying 
data, as well as helping patients stay positive and motivated.  The use of images has been 
essential during the COVID-19 pandemic in making sure people understand social 
distancing, as opposed to just using numbers, i.e. the 2-meter social distancing has been 
depicted as the length of a door, or the length of two German Shepherds (Figure 37), or 
the length of an SUV car. 
 
 
Figure 37: NHS Wales COVID-19 Social Distancing Guidance 
 
However, Edwards et al. (2002) go on to explain that this does not always allow for a 
fully informed decision to be made as information may be withheld.  They go on to 
explain that the use of images has been explored, and some people may prefer numbers, 
but others may like the use of bar charts, crowd figures, pie charts, thermometer scales, 
or survival curves.  They conclude that a synthesis of current evidence on patients' 
preferences for different information formats is required, together with an assessment of 
the effect of the various formats.  Currently there is no evidence to suggest which method 
of assessment is preferred by patients, however, one could hypothesise that visual 
images could provide more understanding for some. 
 
3DCI, by its very nature, can offer more than just limb volume information due to the 
type of data it collects.  Imaging provides data that circumferential measurements 
cannot, i.e. a visual picture or illustration of the problem area.  Cau et al. (2016) first 
suggested the potential of 3DCI to measure geometric parameters that would enable an 
alternative method of measurement using limb shape.  Karakashian et al. (2018) later 
developed swelling maps (oedema maps) utilising colour codes to visualise the areas of 
deviance between the affected and unaffected arm.  This is something that CTM and 
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perometry cannot offer as these produce volumes over a whole limb resulting in 
localised oedema areas being absorbed into the whole limb volume.  The use of the 3DCI 
camera in this study, the Asus Xtion Pro camera, allowed for images of high quality and 
pixilation to be taken, making it possible to utilise and manipulate the data images into 
the oedema maps.   
 
Given the outcomes of this study, it stands to reason that patients could benefit from a 
visual aid that interprets the severity of their lymphoedema in addition to volumes and 
percentages that are current practice.  The use of colour codes focuses attention on the 
problem areas, and could add value to a lymphoedema consultation in terms of enabling 
better-targeted treatment strategies to manage and reduce the lymphoedema.  
Consequently, for both the patient and therapist, the oedema maps could help identify 
where the lymphoedema is located, and how it changes with the advised treatment, such 
as targeted massage and specific compression therapy.   
 
Gillies et al. (2016) extrapolated data from radiologic examinations and converted the 
images into quantitative data.  This process has been named 'radiomics', and they were 
able to make a diagnosis and decisions regarding treatment options from the interpreted 
radiological images.  They found this method to be highly accurate and anticipate it to 
replace the traditional practice of treating medical images as pictures intended solely for 
visual interpretation.  Thus, there is not only value in images for diagnostic purposes, 
but also the ability to extrapolate quantitative data from image data.  Watson et al. 
(Submitted) attempted to develop a mathematical equation to provide a quantitative 
value for the oedema maps.  This led to the development of ‘shape redundancy’ (R-
value) used in this study.  Given Gillies et al.’s (2016) success in converting images into 
quantitative data, further refinement of the R-value is needed to develop meaningful 
quantification of the oedema maps to aid more accurate recording.  Once refinement is 
made, more qualitative research is required to understand patient perspectives. 
 
6.5.3  Educational Tool 
3DCI could also be used as an educational tool for the patient, their carers or families 
and, the broader professional community to have a greater understanding of the 
lymphoedema severity and locations.  This may have the potential to motivate a patient 
to continue with their treatment, or to consider a change in treatment if required, where 
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the visual oedema maps are not improving, which is suggested by the findings from Kim 
et al.’s (2020) study.  Using the colour spectrum, a patient can visualise how and where 
their lymphoedema is changing, which can help explain some of the sensory alterations 
they may experience such as pain, tightness and heaviness.  They would be able to see 
that if the oedema map has a more extensive and darker area of orange or red, it might 
explain why their arm has been feeling heavier, and make them feel validated in their 
description of their symptoms.  Conversely, if the picture shows an increasing area of 
blue, it would explain why the pain in their arm has been lessening.  Thus, oedema maps 
may help patients understand their lymphoedema and related symptoms better, thus 
educating them on the importance of adhering to their lymphoedema self-management 
plan.  
 
However, no study yet exists to determine whether patients would value this new 
technology or if they would find interpreting images easier than current volumes and 
percentages.  
 
6.5.4  Practicability 
This study was performed within a clinical setting as part of a patient's normal 
lymphoedema care pathway.  This study has therefore demonstrated the practical set up 
and application within the lymphoedema examination rooms without disrupting the 
service.  The device can be collapsed to be stored in the corner of a room or a cupboard.  
The equipment is lightweight and easily portable, thus has the potential to be utilised in 
the community.  3DCI is a non-invasive method of measuring that is not labour 
intensive; thus, there are no health & safety or infection control concerns regarding its 
use within a clinic or community setting.  The work in this study focussed entirely on 
the upper limb.  Studies exist where 3DCI has examined the hand (Hoevenaren et al., 
2015; Vicini et al., 2012), breast (Henseler et al., 2012; Henseler et al., 2014) and facial 
oedema (Aldridge et al., 2005; Plooij et al., 2009; Maal et al., 2010; van der Meer et al., 
2014); however, none have looked at measuring the full lower limb.  If a protocol could 
be developed to measure the lower limb, interest and uptake of 3DCI in a clinical setting 




6.6 Limitations of the Study 
The limitations of the study included key factors in the recruitment protocol, 
unavailability of oedema maps, measuring protocol, the timing of the follow-up 
sessions, and equipment failure. 
 
6.6.1 Recruitment Protocol 
The participants came from only one lymphoedema service in Wales.  Although one 
participant was Asian, there were no other ethnic groups in this study; thus, it was not 
truly representative of the Welsh population.  This cohort was also mainly women of 
middle age; thus, younger (aged less than 40) and older (aged over 70) age groups were 
not adequately represented.  The cohort was small with 20 participants and a 15% 
attrition rate (n=3) resulting in less data collected.  Shrout and Fleiss (1979) advocate at 
least 30 heterogeneous participants are recruited for reliability studies. However, it is 
recognised that before undertaking research, it is prudent to perform a Power of Analysis 
test to determine the required sample size for the study and recruit to that.  This study 
however performed a retrospective Power of Analysis showing a moderate effect (0.73) 
to disprove the null hypothesis of this thesis; however, the sample of 30 as reported by 
Field (2013) would have a high effect (0.99).  The first null hypothesis - 3DCI is not a 
valid and reliable method of measurement for lymphoedema - was disproved as 3DCI 
demonstrated good validity and reliability compared to CTM and perometry, and was 
comparable to the existent literature.  The second null hypothesis - shape entropy derived 
from 3DCI is not an alternative method that correlates to arm volume measurement – 
was found to be true as the R-value demonstrated poor validity and moderate reliability 
compared to volume measurements.  However, this could be due to the R-value and 
volume being completely different concepts of measurements, making them 
incomparable to one another.  Due to the moderate effect of this study’s sample size as 
determined by the Power of Analysis results, more research will be needed to provide a 
stronger effect to prove/disprove these null hypotheses.  Furthermore, research into the 
use of the R-value as an adjunct to limb volume and oedema maps could be investigated 
so that these metrics are not used in isolation, but integrated to build a better 




A further limitation of the study was that the author was the only researcher for the 
duration of the study; thus, no inter-rater correlations were calculable.  It is a strong 
recommendation that future studies include more than one researcher to provide further 
evidence of the inter-rater reliability of 3DCI between users.  Also, there was strong 
reliance on a third party for recruitment into the study, which may have influenced the 
length of time it took to enlist the required number of participants. 
 
6.6.2 Unavailability of Oedema Maps  
A significant limitation was the software being unable to produce the oedema maps at 
the appointment.  This was due to the software not being fully developed at the time of 
the study.  Thus, participants did not get the opportunity to see their oedema maps and 
to visualise the colour coding identifying their lymphoedema along with the localised 
swelling that was present in many of the cases.  This would be important in future studies 
where patient and therapist perceptions could be captured to compare to the quantitative 
data results. 
 
6.6.3 Measuring Protocol 
The positioning of the participant will need stricter control for future studies.  A hand-
rest is recommended to reduce the risk of movement while capturing the image using 
3DCI.  This will also reduce the risk of the arm being flexed when the image is captured.  
Stricter control in terms of arm length across all methods of measurement needs to be 
considered to determine whether there is a change in the validity and accuracy outcomes. 
 
Participants who were in the obese class 3 group (BMI>40kg/m2) and had large limb 
volumes (upper arm >45cm circumference) were not able to be captured with 3DCI as 
the arm could not be isolated from the trunk, i.e. the upper arm was resting on the trunk 
at shoulder height position.  Currently, CTM can measure these limbs as the tape can be 
manipulated between the soft tissues; however, it is recognised that the limb will be 
distorted where it is resting on the trunk thus the readings may be inaccurate.  The frame 
of the perometer was able move some of the truncal tissue exposing most of the upper 
arm, but again the length of the arm captured through perometry differed from that of 




People with reduced shoulder range of movement, i.e. those unable to elevate their arm 
to shoulder height, can currently not be examined using either perometry or 3DCI, as 
both systems require central positioning of the limb to the scanning area.  Thus, further 
research regarding alternative positional considerations is needed in the future. 
 
6.6.4 Follow-up Timescales 
With three participants failing to complete the study, a review of the timescales between 
sessions may be needed.  The usual follow up time for newly assessed patients at the 
lymphoedema service is between two and four months from their initial assessment.  
From this study, two-monthly reviews for six months may be considered onerous to 
patients in terms of travel time required, time off work (for those in employment) and 
the stress of finding parking at a hospital location.  Future longitudinal studies should 
consider longer review timescales between sessions as part of their study protocol; 
alternatively, two sessions within quick succession (two to four weeks) could also be 
considered. 
 
6.6.5 Equipment Failure 
Problems identified with the apparatus were due to software problems for both the 
perometer and 3DCI.  It is unclear why the software systems failed on occasion, but it is 
thought that there was some incompatibility with the organisation's IT systems.  This 
will need to be resolved to allow for seamless capturing of data within the clinical setting 
to ensure data is captured for the assessment of lymphoedema, the implementation of its 
management and the tracking of treatment outcomes.  Improved IT services would also 
allow for more data-rich studies in the future. 
 
6.7 Recommendations for Further Research 
From the limitations and opportunities identified, recommendations for future studies 
can be made.  This next section outlines these recommendations. 
 
6.7.1 Cohort  
It would be ideal for the cohort to be more reflective of a clinical caseload that would 
include both men and women, younger and older age groups, and people of different 
ethnicity.  This would ensure evidence of the outcomes that are translatable to all patients 
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attending a lymphoedema clinic for assessment.  It would also give clinicians more 
confidence in the results applying to their lymphoedema caseloads. 
 
Lymphoedema, due to other causes such as primary, secondary to melanoma treatment 
and vascular insufficiency, needs to be included to capture the different distributions of 
the swelling resulting from the different aetiologies.  This study happened to recruit 
participants who had lymphoedema secondary to breast cancer only.  It is known that 
other causes of lymphoedema respond differently to treatment, and it would be of benefit 
to ascertain whether 3DCI would be more sensitive in detecting the different types of 
changes that people report from other lymphoedema causes compared to current 
methods of measurement and assessment. 
 
Due to the length of time taken to recruit the 20 participants who were new patients to 
the lymphoedema service, it would be worth altering the protocol to allow for more 
recruitment potential by considering existent patients within the lymphoedema service. 
Furthermore, a multi-site study could be considered as it would allow for larger cohorts 
and richer data for the analysis of both intra- and inter-rater reliability.  Posters could be 
put up in clinics and letters to all patients with unilateral limb lymphoedema could be 
sent inviting them to the study. This would ensure an increased chance of recruiting both 
men and women from a larger geographical area, as well as a broader range of 
lymphoedema types.  
 
6.7.2 Extend to Lower Limb and Mid-Line Lymphoedema 
Working jointly with educational and third sector research partners may further expand 
and explore the use of 3D technology to assess lymphoedema for other parts of the body.  
There exists a wealth of research related to upper limb lymphoedema secondary to breast 
cancer; however, the number of patients suffering from lower limb lymphoedema is 
growing, and in Wales, there are more people with lower limb than upper limb 
lymphoedema.  This is due to health professionals becoming more aware of 
lymphoedema from other causes of swelling apart from cancer; thus, a suitable imaging 
system needs to be developed for the lower limbs.   The use of limb shape for lower limb 
lymphoedema would be of particular interest to determine where patterns of localised 




Imaging of the lower limb in obese patients could be challenging as the inner thighs 
resting against each other will distort the shape and potentially preclude the capturing of 
a full 3D image; thus the actual volume of the limb will be difficult to determine.  
Currently, CTM can take some measurements as the tape can be manipulated between 
the thighs, but for some people, even the perometer would not be able to take full leg 
measurements to the groin due to the excess tissues. 
 
Mid-line oedema (head and neck, breast, genital) and extremities (hands and feet) are 
often neglected with new methods of measurement, and there is further research to be 
done with 3DCI to provide a better objective assessment of these lymphoedema sites.  
Head, neck, and genital lymphoedema may need to be incorporated with heat sensor 
technology, as these areas do not have an opposite side to measure as a reference; 
however, longitudinal data would be able to capture change over time to demonstrate 
improvement or deterioration from the first appointment.  There is thus scope for some 
truly innovative technological research for the future. 
 
6.7.3 Patient Perspectives 
The use of oedema maps in clinical practice could be further explored with clinicians 
and patients to determine their interpretations of the images, acceptability of their use in 
assessing lymphoedema, the usefulness of the information they portray, and whether 
they influence adherence to treatment.  Thus there is potential not only for quantitative 
research but also for exploring the qualitative aspect of the use of 3D technology in 
lymphoedema to determine how staff and patients feel about the use of this new 
technology in their service.  Exploring how people interpret the oedema maps, whether 
they are easier to interpret as opposed to limb volumes, and how they would utilise them 
in clinical practice will add further depth to the benefits of this new technological 
assessment.  Further research should investigate whether the use of 3D technology with 
oedema maps could enhance patient compliance due to their improved understanding of 
the measurements taken. 
 
6.7.4 Hardware 
Research into the use of alternative 3D cameras is required as both the Asus Xtion Pro 
3D and Microsoft KinectTM are no longer available on the market.  However, the 
relevance of the 3DCI data from this study is transferable to other systems able to 
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produce high-quality pixelated images.  When reviewing the development of 3D 
imaging from the systematic literature review, it is clear that 3D technology is evolving 
at a rapid pace. From the proof of concept by Lu et al (2013) to the most recent study by 
Binkley et al. (2020), 3D camera technology has changed significantly.  This is evident 
from the use of static cameras of various size and design to the more mobile Microsoft 
KintectTM and Asus Xtion Pro, and more recently to the development of a handheld 
device in the form of a modified iPad – LymphaTech (Binkley et al., 2020).   
 
The evidence of the changing technology is obvious in the everyday use of smartphone 
technology.  People no longer buy a mobile phone for its communication function alone, 
but its camera clarity and function.  Recognising these fast-paced changes in the world 
of technology, the search for a camera that can capture images compatible with the 
conversion software is critical.  Smaller devices may make manipulation of the camera 
even easier, the potential of hands-free systems such as micro-drones, and the possibility 
of blue-tooth technology for the images to be fed directly into the computer software 
should be a possibility with current technological advances. 
 
The challenge lies in finding a camera that provides the same or better quality imaging 
for data extraction and manipulation.  Failing that, the development of a new alternative 
camera that is compact, hands-free, compatible with the software and offers blue-tooth 
options, would be a unique challenge for a technology student looking for a research 
project to advance medical care.  The software systems exist; the algorithms for the 
oedema maps are transferable; the challenge now is finding the hardware to feed into 
the software to produce the oedema maps and build on the current research outcomes, 
pushing its use into clinical practice. 
 
6.8 Summary and Conclusion 
This is the first study to determine whether limb shape could be a feasible measurement 
tool for lymphoedema.  The outcome of this study is that 3DCI does indeed provide new 
information or data in the form of oedema maps and shape redundancy compared to the 
outcomes from CTM and perometry, however, refinement of the R-value is needed. 
3DCI compared to the usual methods of measurements (CTM and perometry) was 
shown to be reliable, valid and accurate as a measure of upper limb volume.  Limb shape 
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demonstrated good similarities to limb volume outcomes and with the use of the oedema 
maps, was able to identify localised lymphoedema and the severity of the focal swelling, 
something that neither CTM nor perometry can do. 
 
Change to practice can be challenging and introducing new methods for the assessment 
of lymphoedema even more so.  Without more robust, large scale, multi-site studies, 
preferably performed within a clinical setting, clinicians are less likely to consider new 
and alternative methods of measurement, especially when current methods seem to be 
functional.  Consideration of cost for devices needs to be outweighed by strong evidence 
supporting the need for change, and the benefits of the new method need to be promoted. 
There was much interest in the production of the oedema maps by the participants.  Thus, 
both patients and therapists could find oedema maps helpful in identifying where the 
lymphoedema is located, how it has changed over time, whether the treatment is 
effective, and highlighting areas where targeted treatment and garments are needed 
through the colour grading system.  However, more robust research is required to prove 
that it is a financially and clinically feasible alternative to current practice. 
 
Newer technologies offer the chance of better options for capturing the 3D data that can 
be further researched on a larger scale to add to the body of evidence of this study.  
Qualitative research must be undertaken to determine the use of limb shape as a teaching 
aid, to determine how patients and staff interpret the results, and whether it is easier to 
interpret results from limb shape as opposed to limb volume and percentages. 
 
Finally, in addressing the thesis title, ‘can 3D camera imaging provide improved 
information to assess and manage lymphoedema in clinical practice’, the answer is 
positive.  Using oedema maps will not only improve the assessment of lymphoedema, 
but the potential for targeted treatment based on the visualised, localised lymphoedema 












It is the difference in the current volume of a limb compared to 
its volume at the initial assessment.  It is calculated by 
subtracting the initial limb volume (VIA) from the current limb 
volume of the same arm where a negative value indicates a 
reduction in limb volume.  Equation:                     
𝐴𝑉𝐷 = 𝑉 − 𝑉𝐼𝐴 
Accuracy The ability of a test to differentiate between healthy and 
pathologic cases.  This should include testing of sensitivity and 
specificity of the test: 
 Sensitivity – the ability of a test to identify true positive 
cases 
 Specificity – the ability of a test to identify healthy cases 




Most common technique for determining limb volume using a 
tape measure. The two more commonly used methods are 4cm 
CTM and 5-point CTM, where 4cm CTM measures the arm at 
4cm intervals from the wrist to the axilla.  The 5-point CTM 
method measures five set points up the arm, i.e. the wrist, 
widest part of the forearm, the elbow, widest part of the upper 
arm and the point nearest the axilla.  Limb volumes are 





ICC is a reliability index in test-retest, intra-rater and inter-rater 
reliability analysis with values closer to 1.00 indicating 
excellence.   
Lymphoedema Lymphoedema is a persistent dysfunction of the lymphatic 
system resulting in swelling that can affect any part of the body, 
but is most commonly seen in the limbs. Lymphoedema can be 





It calculated by dividing the absolute volume difference (AVD) 
by the volume of the limb at initial assessment (VIA) and 






In unilateral limb lymphoedema is the difference in between the 
volumes of the oedema (VO) and Normal (VN) sides, divided by 




) ∗ 100 
In clinical practice, patients have a better understanding of limb 
volume difference expressed as both a volume (cups or pints) 
and percentage of the lymphoedema arm compared to their 
‘normal’ (unaffected) arm 
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Perometer It is a technology-based circumferential measurement.  It is an 
infrared optoelectric imaging system that is used for the 
indirect measurement of arm or leg volume.  It offers 
information on circumferences, contours and provides 
schematic representations of the cross-sectional area of the 
limb (see section 3.5). 
Reliability The ability of a measure or instrument to produce consistent 
outcomes across different situations.  There exists two main 
types of reliability: 
 Repeatability or test-retest reliability - evaluates the stability 
of the measure administered using the same protocol at 
different times to a person 
 Inter-rater reliability - when different researchers apply the 
same test.   
Standard Error of 
Measurement 
(SEM) 
SEM quantifies the amount of variability in a test and is 
measured in the same units as the original measurement with 
values closer to 0 indicating better reliability  
Shape Redundancy 
Value (R-value) 
A single value that describes the shape of the arm (the concept 
finds its origins in computer graphics) whereby the swollen arm 
is considered to be more ‘round’ and ‘stretched’, thus lacking 
in definition (see section 5.5.7.2). 
Sensitivity The proportion of true-positives that are correctly identified by 
a test, i.e. the test identifies the presence of a condition 
Specificity The proportion of true-negatives that are correctly identified by 




A newer method of calculating limb volume using 3D 
modelling and is derived from a variety of methods including 
3D stereophotogrammetry, Microsoft KinectTM, Asus Xtion 
infrared sensors and a modified iPad tablet (see section 3.8 for 
more details on the different types of 3D equipment used in 
research) 
Validity The extent to which an instrument measures what it purports to 
measure.  There are three types of validity: 
 Content Validity – determines the logical link between the 
objectives and the research questions 
 Criterion Validity – where a new measure is compared to an 
existing or comparable measure to determine the same or 
similar outcomes. Two main types: 
 Concurrent validity: the simultaneous accuracy of 
measurment evidenced by comparing with results from a 
previously valudated test 
 Predictive validity: the degree to which a test accurately 
predicts a criterion that will occur in the future 
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 Construct Validity – is a more sophisticated technique 
where the underlying construct or idea behind an instrument 
is validated by statistical procedures. Has two subcategories: 
 Convergent validity: measures that are related should have 
high correlation 
 Discriminant validity: the degree to which two measures 














Adriaenssens, N., Buyl, R., Lievens, P., Fontaine, C., & Lamote, J. (2013). Comparitive 
study between mobile infrared optoelectronic volumetry with a perometer and 
two commonly used methods for the evaluation of arm volume in patients with 
breast cancer related lymphedema of the arm. Lymphology, 46:132-143. 
Akobeng, A. K. (2007). Understanding diagnostic tests 3: receiver operating 
characteristic curves. Acta Paediatrica, 96:664-647. 
Alcorso, J., & Sherman, K. A. (2015). Factors associated with psycohological distress 
in women with breast cancer-related lymphoedema. Psycho-Oncology, 
25(7):749-880. 
Aldridge, K., Boyadjiev, S. A., Capone, G. T., DeLeon, V. B., & Richtsmeier, J. T. 
(2005). Precision and Error of Three-dimensional Phenotypic Measures 
Acquired from 3dMD Photogrammatric Images. American Journal of Medical 
Genetics Part A, 15(3):247-253. 
Allied Health Professions (AHP) Outcome Measures UK Working Group. (2019). Key 
questions to ask when selecting outcomes measures: a checklist for allied health 
professionals. London: Royal College of Speech and Language Therapists. 
Al-Niaimi, F., & Cox, N. (2009). Cellulitis and Lymphoedema: a vicious cycle. Journal 
of Lymphoedema, 4(2):38-42. 
Altman, D. G., & Bland, J. M. (1994). Diagnostic tests 1: senstivity and specificity. BMJ, 
308:1552. 
Ancukiewicz, M., Miller, C. L., Skolny, M., O'Toole, J., Warren, L. E., Jammallo, L. S., 
Michelle, C., & Taghian, A. G. (2012). Comparison of relative versus absolute 
arm size change as criteria for quantifying breast cancer-related lymphedema: 
the flaws in current studies and need for universal methodology. Breast Cancer 
Research and Treatment, 135:145-152. 
Ancukiewicz, M., Russell, T. A., Otoole, J., Specht, M., Singer, M., Kelada, A., Murphy, 
C. D., Pogachar, J., Gioioso, V., Patel, M., Skolny, M., Smith, B. L., & Taghian, 
A. G. (2011). Standardised Method for Quantification of Developing 
Lymphedema in Patients Treated for Breast Cancer. International Journal of 
Radiation Oncology Biology Physics, 79(5):1436-1443. 
Antwi, S. K., & Hamza, K. (2015). Qualitative and Quantitative Research Paradigms in 
Business Research: A Philosophical Reflection. European Journal of Business 
and Management, 7(3):217-225. 
167 
 
Arinaga, Y., Piller, N., & Sato, F. (2016). How can we know the true magnitude of any 
breast cancer-related lymphoedema if we do not know which is the true dominant 
arm? Journal of Lymphoedema, 11(1):27-34. 
Asim, M., Cham, A., Banerjee, S., Nancekivell, R., Dutu, G., McBride, C., Cavanagh, 
S., Lawrenson, R., & Campbell, I. (2012). Difficulties with defining 
lymphoedema after axillary dissection for breast cancer. The New Zealand 
Medical Journal, 125(1351):29-39. 
Åström, K. G., Abdsaleh, S., Brenning, G. C., & Ahlström, K. H. (2001). MR imaging 
of primary, secondary, and mixed forms of lymphedema. SAGE Journals, 
42(4):409-416. 
Atieno, O. P. (2009). An Analysis of the Strengths and Limitation of Qualitative and 
Quantitative Research Paradigms. Problems of Education in the 21st Century, 
13:13-18. 
Babizhayev, M. A., & Yegorov, Y. E. (2011). Smoking and health: association between 
telomere length and factors impacting on human disease, quality of life and life 
span in a large population‐based cohort under the effect of smoking duration. 
Fundamental and Clinical Pharmacology, 25(4):425-442. 
Bakar, Y., Tuğral, A., & Űyetűrk, Ű. (2018). Measurement of Local Tissue Water in 
Patients with Breast Cancer-Related Lymphedema. Lymphatic Research and 
Biology, 16(2):160-164. 
Barrio, A. V., Eaton, A., & Frazier, T. G. (2015). A Prospective Validation Study of 
Bioimpedance with Volume Displacement in Early-Stage Breast Cancer Patients 
at Risk for Lymphoedema. Annals if Surgical Oncology, 22:S370-S375. 
Batista, B. N., Baiocchi, J. M., Campanholi, L. L., Bergmann, A., & Duprat, J. P. (2018). 
Agreement between Perometry and Sequential Arm Circumference 
Meassurements in Objective Determination of Arm Volume. Journal of 
Reconstructive Microsurgery, 34(1):29-34. 
Beauchamp, T. L., & Childress, J. F. (2012). Principles of Biomedical Ethics. 7th 
Edition. New York: Oxford University Press. 
Bedi, M., King, D., Whitfield, R., Hackbarth, D., Neilson, J., Charlson, J., & Wang, D. 
(2015). The Effect of Smoking and Major Vein Resection on Post-therapy 
Lymphedema in Soft Tissue Sarcomas Treated With Neoadjuvant Radiation and 




Belgrado, J. P., Bracale, P., Bates, J., Roh, N., Rosiello, R., Cangiano, A., & Moraine, 
J. J. (2010). Lymphoedema: What can be measured and how... Overview. The 
European Journal of Lymphology, 21(61):3-9. 
Berlit, S., Brade, J., Tuschy, B., Hornemann, A., Leweling, H., Eghardt, V., & Sutterlin, 
M. (2012). Comparing Bioelectrical Impedance Values in Assessing Early Upper 
Limb Lymphedema after Breast Cancer Surgery. in vivo, 26:863-868. 
Berlit, S., Brade, J., Tuschy, B., Hornemann, A., Leweling, H., Eghardt, V., & Sutterlin, 
M. (2013). Whole-body Bioelectrical Impedance Analysis in Assessing Upper-
limb Lymphedema After Breast Cancer Therapy. Anticancer Research, 33:4453-
4556. 
Bilir, S. P., DeKoven, M. P., & Munakata, J. (2012). Economic Benefits of BIS-Aided 
Assessment of Post-BC Lymphedema in the United States. American Journal of 
Managed Care, 18(5):234-241. 
Binkley, J. M., Weiler, M. J., Frank, N., Bober, L., Dixon, J. B., & Stratford, P. W. 
(2020). Assessing Arm Volume in People During an After Treatment for Breast 
Cancer: Reliability and Convergent Validity of the LymphaTech System. 
Physical Therapy, 100(3):1-11. 
Blaney, J. M., McCollum, G., Lorimer, J., Bradley, J., Kennedy, R., & Rankin, J. P. 
(2015). Prospective surveillance of breast cancer-related lymphoedema in the 
first-year post-surgery: feasibility and comparison of screening measures. 
Supportive Care in Cancer, 23:1549-1559. 
BLS & LSN. (2016, December). Consensus Document on the Management of Cellulitis 
in Lymphoedema. London: British Lymphology Society & Lymphoedema 
Support Network. 
Bodystat. (2017). www.bodystat.com/products/. Retrieved from www.bodystat.com: 
https://www.bodystat.com/products/ on 29 June 2017 
Bossuyt, P. M., Irwig, L., Craig, J., & Glasziou, P. (2006). Comparative accuracy: 
assessing new tests against existing diagnostic pathways. British Medical 
Journal, 332(7549):1089–1092. 
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L., 
Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., Kressel, H. Y., Rifai, N., 
Golub, R. M., Altman, D. G., Hooft, L., Korevaar, D. A., & Cohen, J. F. (2015). 
STARD 2015: An Updated List of Essential Items for Reporting Diagnostic 
Accuracy Studies. Radiology, 277(3):826-832. 
169 
 
British Lymphology Society. (2016). Population Needs Assessment. Retrieved from 
British Lymphology Society: https://thebls.com/documents-library on 13 July 
2017 
Brorson, H., & Hoijer, P. (2012). Standardised measurements used to order compression 
garments can be used to calculate arm volumes to evaluate lymphoedema 
treatment. Journal of Plastic and Surgical Hand Surgery, 46:410-415. 
Buendia, R., Essex , T., Kilbreath, S. L., Czerniec, S., Dylke, E., & Ward, L. C. (2018). 
Estiamtion of Arm Adipose Tissue Quotient Using Segmental Bioimpedance 
Spectroscopy. Lymphatic Research and biology, 16(4):377-384. 
Buffa, R., Mereu, E., Lussu, P., Succa, V., Pisanu, T., Buffa, F., & Marini, E. (2015). A 
New, Effective and Low-Cost Three-Dimensional Approach for the Estimation 
of Upper-Limb Volume. Sensors, 15(6):12342-12357. 
Bulley, C., Coutts, F., & Tan, C. W. (2013). Perometry limb volume measurement: 
protocol development and reliability. European Journal of Physiotherapy, 
15:193-200. 
Bundred, N., Foden, P., Todd, C., Morris, J., Watterson, D., Purushotham, A., Bramley, 
M., Riches, K., Hodgkiss, T., Evans, A., Skene, A., Keeley, V., & the 
investigators of BEA/PLACE studies. (2020). Increases in arm volume predict 
lymphoedema and quality of life deficits after axillary surgery: a prospective 
cohort study. Brisith Journal of Cancer, DOI: 10.1038/s41416-020-0844-4. 
Cancer Research UK. (2020). Lymphoedema after breast cancer treatment. Retrieved 
from Cancer Research UK: https://www.cancerresearchuk.org/about-
cancer/breast-cancer/living-with/lymphoedema-after-treatment on 30 May 2020 
Cannon, J., Dyer, J., Carapetis, J., & Manning, L. (2018). Epidemiology and risk factors 
for recurrent severe lower limb cellulitis: a longitudinal cohort study. Clinical 
Microbiology and Infection, 24(10):1084-1088. 
Carron, J. (2016). Violin Plots 101: Visualizing Distribution and Probability Density. 
Retrieved from Mode Blog: https://mode.com/blog/violin-plot-examples on 02 
February 2020 
Caruana, E. J., Roman, M., Hernández-Sánchez, J., & Solli, P. (2015). Longitudianl 
Studies. Journal of Thoracic Disease, 7(11):E537-E540. 
Casley-Smith, J. R. (1994). Measuring and Representing Peripheral Oedema and Its 
Alterations. Lymphology, 27:56-70. 
170 
 
Cau, N., Galli, M., Cimolin, V., Aranci, M., Caraceni, A., & Balzarini, A. (2016). 
Comparative study between circumferential method and laser scanner 3D 
method for the evaluation of arm volume in healthy subjects. Journal of Vascular 
Surgery: Venous and Lymphatic Disorders, 4(1):64-72. 
Cau, N., Galli, M., Cimolin, V., Grossi, A., Battarin, I., Puleo, G., Balzarini, A., & 
Caraceni, A. (2018). Quantitative comparison between the laser scanner three-
dimensional method and the circumferential method for evaluation of arm 
volume in patients with lymphedema. Journal of Vascular Surgery: Venous and 
Lymphatic Disorders, 6(1):96-103. 
Centers for Disease Control and Prevention. (2019). Alcohol Use and Your Health. 
Retrieved from CDC: https://www.cdc.gov/alcohol/fact-sheets/alcohol-use.htm 
on 06 July 2020 
Centre for Evidence-Based Medicine (CEBM). (2014). cebm study designs. Retrieved 
from Centre for Evidence-Based Medicine (CEBM): https://www.cebm.net 
/2014/04/study-designs/ on 24 June 2019 
Chang, D. W., Soami, H., & Skoracki, R. (2013). A Prospective Analysis of 100 
Consecutive Lymphovenous Bypass Cases for Treatment of Extremity 
Lymphedema. Plastic and Reconstructive Surgery, 132:1305-1314. 
Chartered Society of Physiotherapy (CSP). (2011). Code of Member's Professional 
Values and Behaviour. London: Chartered Society of Physiotherapy. 
Chen, Y.-W., Tsai, H.-J., Hung, H.-C., & Tsauo, J.-Y. (2008). Reliability Study of 
Measurements for Lymphedema in Breast Cancer Patients. American Journal of 
Physical Medicine and Rehabilitation, 87(1):33-38. 
Chiewvit, S., & Kumnerdnakta, S. (2017). Lymphosctintigraphic findings that predict 
favorable outcome after lymphaticovenous anastomosis. Lymphology, 50(1):1-
8. 
Cohen, M. X. (2018). How to interpret and create violin plots. Retrieved from 
youtube.com: https://www.youtube.com/watch?v=M6Nu59Fsyyw on 28 
September 2019 
Cook, T. S., Couch, G., Couch, T. J., Kim, W., & Boonn, W. W. (2013). Using the 
Microsoft Kinect for Patient Size Estimation and Radiation Dose Normalization: 




Cornelissen, A. J., Kool, M., Keuter, X. H., Heuts, E. M., Piatkowski de Grzymala, A. 
A., van der Hulst, R. R., & Qui, S. S. (2018). Quality of Life Questionnaires in 
Breast Cancer-Related Lymphedema Patients: Review of the Literature. 
Lymphatic Research and Biology, 16(2):134-139. 
Cornish, B. H., Ward, L. C., Thomas, B. J., & Bunce, I. H. (1998). Quantification of 
Lymphoedema using Multi-frequency Bioimpedance. Applied Radiation and 
Isotopes, 651-652. 
Critical Appraisal Skills Programme. (2017). CASP Checklists. Retrieved from Critical 
Appraisal Skills Programme (CASP): http://www.casp-uk.net/casp-tools-
checklists; accessed 20 January 2018 
Currell, G. (2015). Transforming for Normality. Retrieved from Scientific Data 
Analysis, Oxford University Press: https://www.youtube.com/watch?v= 
alC9rZr1rG8 accesses on 12 April 2021 
Czerniec, S. A., Ward, L. C., & Kilbreath, S. L. (2015). Assessment of Breast Cancer-
Related Lymphedema: A Comparison of Moisture Meter and Spot Bioimpedane 
Measurement. Lymphatic Research and Biology, 13(1):10-19. 
Czerniec, S. A., Ward, L. C., Lee, M.-J., Refshuage, K. M., Beith, J., & Kilbreath, S. L. 
(2011). Segmental measurement of breast cancer-related arm lymphoedema 
using perometry and bioimpedance spectroscopy. Supportive Care in Cancer, 
19:703-710. 
Czerniec, S. A., Ward, L. C., Refshauge, K. M., Beith, J., Lee, M. J., York, S., & 
Kilbreath, S. L. (2010). Assessment of Breast Cancer-Related Arm Lymphedema 
- Comparison of Physical Measurement Methods and Self-Report. Cancer 
Investigation, 28:54-62. 
Data Protection Act. (2018). The National Archives. Retrieved from legislation.gov.uk: 
http://www.legislation.gov.uk/ukpga/2018/12/pdfs/ukpga_ 20180012_en.pdf on 
01 April 2019 
Daya, S. (1996). Study Design for the Evaluation of Diagnostic Tests. Seminars in 
Reproductive Endocrinology, 14(2):101-109. 
de Vet, H. C., & Terwee, C. B. (2010). The minimal detectable change should not 
replace the minimal important difference. Journal fo Clinical Epidemiology, 
63:804-805. 
De Vrieze, T., Gebruers, N., Nevelsteen, I., De Groef, A., Tjalma, W. A., Thomis, S., 
Dams, L., Van der Gucht, E., Penen, F., & Devoogdt, N. (2020). Reliability of 
172 
 
the MoistureMeterD Compact Device and the Pitting Test to Evaluate Local 
Tissue Water in Subjects with Breast Cancer-Related Lymphedema. Lymphatic 
Research and Biology, 18(2):116-128. 
De Vrieze, T., Gebruers, N., Tjalma, W. A., Wiebren, A. A. Nevelsteen, I., Thomis, S., 
De Groef, A., Dams, L., Van der Gucht, E., Belgrado, J. P., Vandermeeren, L., 
& Devoogdt, N. (2019). What is the best method to determine excessive arm 
volume in patients with breast cancer-related lymphoedema in clinical practice? 
Reliability, time efficiency and clinical feasibility of five different methods. 
Clinical Rehabilitation, DOI: 10.1177/0269215519835907. 
Delfin Technologies. (2017). delfintech.com/en/product_information/moisturemeterd_ 
compact/. Retrieved from www.delfintech.com: http://www.delfintech.com/ 
en/product_information/moisturemeterd_compact/ on 29 June 2017 
Delfin Technologies Ltd. (2014). MoistureMeterD Compact User Manual. Kuopio, 
Finland: Delfin Technologies Ltd. 
DeSnyder, S. M., Khietkhah, A., Travis, M. L., Lilly, S. E., Bedrosian, I., Buchholz, T. 
A., Schaverien, M. V., & Shaitelman, S. F. (2019). Optimizing Patient 
Positioning to Reduce Variation in the Measurement of breast Cancer-Related 
Lymphedema. Lymphatic Research and Biology, 17(4):440-446. 
Devoogdt, N., Lemkens, H., Geraerts, I., van Nuland, I., Flour, M., Coremans, T., 
Christiaens, M. R., & van Kampen, M. (2010). A new device to measure upper 
limb circumferences: validity and reliability. International Angiology, 
29(5):401-407. 
Devoogdt, N., Van Kampen, M., Geraerts, I., Coremans, T., & Christiaens, M.-R. 
(2011). Lymphoedema Functioning, Disability and Health Questionnaire 
(Lymph-ICF): Reliability and Validity. Physical Therapy, 91(6):944-957. 
di Ruffano, L. F., Hyde, C. J., McCaffery, K. J., Bossuyt, P. M., & Deeks, J. J. (2012). 
Research Methods & Reportng: Assessing the value of diagnostic tests: a 
framework for designing and evaluating trials. BMJ, 344:e686 doi: 
10.1136/bmj.e686. 
DiSipio, T., Rye, S., Newman, B., & Hayes, S. (2013). Incidence of unilateral 
lymphoedema after breast cancer: a systematic review and meta-analysis. The 
Lancet Oncology, 14(6):500-515. 
Doğan, N. Ö. (2018). Bland-Altman analysis: A paradigm to understand correlation and 
agreement. Turkish Journal of Emergency Medicine, 18:139-141. 
173 
 
Dontje, M. L., Dall, P. M., Skelton, D. A., Gill, J. M., Chastin, S. F., & Team, O. B. 
(2018). Reliability, minimal detectable change and responsiveness to change: 
Indicators to select the best method to measure sedentary behaviour in older 
adults in different study designs. PLoS ONE, 13(4):e0195424 
DOI:10.1371/journal.pome.0195424. 
Dylke, E. S., Schembri, G. P., Bailey, D. L., Bailey, E., Ward, L. C., Refshauge, K., 
Beith, J., Black, D., & Kilbreath, S. L. (2016). Diagnosis of upper limb 
lymphedema: development of an evidence-based approach. Acta Oncologica, 
55(12):1477-1483. 
Dylke, E. S., Yee, J., Ward, L. C., Foroughi, N., & Kilbreath, S. L. (2012). Normative 
Volume Differences Between the Dominant and Nondominant Upper Limbs in 
Healthy Older Women. Lymphatic Research and Biology, 10(4):182-188. 
Edwards, A., Elwyn, G., & Mulley, A. (2002). Explaining risks: turning numerical data 
into meaningful pictures. British Medical Journal, 324:827-830. 
Erends, M., van der Aa, T., van der Hulst, R., & de Grzymala, A. P. (2014). Validity and 
Reliability of Three-Dimensional Imaging for Measuring the Volume of the 
Arm. Lymphatic Research and Biology, 12(4): 275-281. 
EuroQol. (2017). EQ-5D. Retrieved from www.euroqol.org: https://euroqol.org/eq-5d-
instruments/eq-5d-5l-about/on 16 May 2017 
Field, A. (2013). Discovering Statistics Using IBM SPSS Statistics; 4th edition. London: 
SAGE Publication Ltd. 
Fife, C. E., Farrow, W., Hebert, A. A., Armer, N. C., Stewart, B. R., Cormier, J. N., & 
Armer, J. M. (2017). Skin and Wound Care in Lymphedema Patients: A 
Toxonomy, Primer, and Literature Review. Advances in Skin & Wound Care, 
30(7):305-318. 
Finnane, A., Janda, M., & Hayes, S. C. (2015). Does teatment alleviate lympedema 
symptoms? A cross-sectional study evaluating patient perspectives. 
Lymphology, 48: 110-120. 
Foroughi, N., Dylke, E. S., Paterson, R. D., Sparrow, K. A., Fan, J., Warwick, E. B., & 
Kilbreath, S. L. (2011). Inter-Rater Reliability of Arm Circumference 
Measurement. Lymphatic Research and Biology, 9(2):101-107. 
Fu, M. R., Cleland, C. M., Guth, A. A., Kayal, M., Haber, J., Cartwright, F., Kleinman, 
R., Kang, Y., Scaglioa, J., & Axelrod, D. (2013). L-Dex Ratio in Detectng Breast 
174 
 
Cancer-Related Lymphedema: Rliability, Sensitivity, and Specificity. 
Lymphology, 46:85-96. 
Garcia-Retamero, R., & Galesic, M. (2010). Who profits from visual aids: Overcoming 
challenges in people’s understandingof risks. Social Science and Medicine, 
70:1019–1025. 
Gebruers, N., Verbelen, H., De Vrieze, T., Vos, L., Devoogdt, N., Fias, L., & Tjalma, 
W. (2017). Current and future perspectives on the evaluation, prevention and 
conservative management of breast cancer related lymphoedema: A best practice 
guideline. European Journal of Obstetrics & Gynecology and Reproductive 
Bioloy, 216:245-253. 
Gillies, R. J., Kinahan, P. E., & Hricak, H. (2016). Radiomics: Images Are More than 
Pictures, They Are Data. Radiology, 278(2): 563-577. 
Glasser, S. P. (2008). Essentials of Clinical Research. Birmingham: Springer. 
Glen, S. (2015a). Concurrent Validity Definition and Examples. Retrieved from 
StatisticsHowTo.com: Elementary Statistics for the rest of us!: 
https://www.statisticshowto.com/concurrent-validity/ accessed on 07 April 2021 
Glen, S. (2015b). Box Cox Transformation. Retrieved from StatisticsHowTo.com: 
https://www.statisticshowto.com/box-cox-transformation/ accessed on 12 April 
2021 
Glen, S. (2017). Chi-Square Test for Normality. Retrieved from Statistics How To: 
https://www.statisticshowto.datasciencecentral.com/chi-square-test-normality/ 
on 02 February 2020 
Gonzalez-Jorgea, H., Riveirob, B., Vazquez-Fernandezc, E., Martinez-Sáncheza, J., & 
Ariasa, P. (2013). Metrological evaluation of Microsfot Kinect and Asus Xtion 
sensors. Measurement, 46(6):1800-1806. 
Good, O. S. (2017). Kinect is officially dead. Really. Officially. It's dead. Retrieved from 
www.polygon.com: https://www.polygon.com/2017/10/25/16543192/kinect-
discontinued-microsoft-announcement on 28 October 2017 
Grada, A. A., & Phillips, T. J. (2017). Lymphedema: Pathophysiology and clinical 
manifestations. Journal of the American Acadamy of Dermatology, 77(6):1009-
1020. 




Greene, A., Grant, F., Slavin, S., & Maclellan, R. (2015). Obesity-Induced 
Lymphedema: Clinical and Lymphoscintigraphic Features. Plastic and 
Reconstructive Surgery, 135(6):1715-1719. 
Groenlund, J. H., Telinius, N., Skov, S. N., & Hjortdal, V. (2017). A Validation Study 
of Near-Infrared Fluorescence Imaging of Lymphatic Vessels in Humans. 
Lymphatic Research and Biology, 15(3):22-234. 
Guermazi, A., Brice, P., Hennequin, C., & Sarfati, E. (2003). Lymphography: An Old 
Technique Retains Its Usefulness. RadioGraphics, 23:1541-1560. 
Hadamitzky, C., Pabst, R., Gordon, K., & Vogt, P. M. (2014). Surgical procedures in 
lymphedema management. Journal of Vascular Surgery, Venous and Lymphatic 
Disorders, 2(4):461-468. 
Hameeteman, M., Verhulst, A. C., Vreeken, R. D., Maal, T. J., & Ulrich, D. J. (2016). 
3D stereophotogrammetry in upper-extremity lymphedema: An accurate 
diagnostic method. Journal of Plastic, Reconstructive & Aesthetic Surgery, 
69(2):241-247. 
Hammerberg, K., Kirkman, M., & de Lacey, S. (2016). Qualitative research methods: 
when to use them and how to judge them. Human Reproduction, 31(3):498-501. 
Hara, H., Mihara, M., Seki, Y., Todokoro, T., Iida, T., & Koshima, I. (2013). 
Comparison of Indocyanine Green Lymphographic Findings with the Conditions 
of Collecting Lymphatic Vessles of Limbs in Patients with Lymphedema. Plastic 
and Reconstructive Surgery, 132: 1612-1618. 
Harrington, S., Gilchrist, L., & Sander, A. (2014). Breast Cancer Edge Task Force 
Outcomes: Clinical Measures of Pain. Rehabilitation Oncology, 32(1):13-21. 
Health & Care Professions Council (HCPC). (2016). Standards of Conduct, 
Performance and Ethics. Retrieved from hcpc-uk standards of conduct 
performance and ethics: https://www.hcpc-uk.org/standards/standards-of-
conduct-performance-and-ethics/ on 07 July 2019 
Henseler, H., Kuznetsova, A., Vogt, P., & Rosenhahn, B. (2014). Validation of the 
Kinect device as a new portable imaging system for three-dimensional breast 
assessment. Journal of Plastic, Reconstructive & Aesthetic Surgery, 67: 483-488. 
Henseler, H., Smith, J., Bowman, A., Khambay, B. S., Ju, X., Ayoub, A., & Ray, A. K. 
(2012). Investigation into variation and errors of a three-dimensional breast 
imaging system using multiple stereo cameras. Journal of Plastic, 
Reconstructive & Aesthetic Surgery, 65:332-337. 
176 
 
Hidding, J. T., Viehoff, P. B., Beurskens, C. H., van Laarhoven, H. W., Nijhuis-van der 
Sanden, M. W., & van der Wees, P. J. (2016). Measurement Properties of 
Instruments for Measuring of Lymphedema: Systematic Review. Physical 
Therapy, 96(12):1965-1981. 
Hoevenaren, I. A., Maal, T. J., Krikken, E., de Haan, A. F., Berge, S. J., & Ulrich, D. J. 
(2015). Development of a three-dimensional hand model using 3D 
stereophotogrammetry: Evaluation of landmark reproducibility. Journal of 
Plastic, Reconstructive & Aesthetic Surgery , 68:709-716. 
Hoevenaren, I. A., Verhulst, A. C., Hameeteman, M., Vreeken, R. D., Maal, T. J., & 
Ulrich, D. J. (2016). Three-dimensional stereophotogrammetry as an accurate 
tool for analyzing lymphedema of the hand. Journal of Plastic, Reconstructive 
and Aesthetic Surgery, 10:40-46. 
Howick, J. (2013). cebm.net/wp-content/uploads/2014/06/CEBM-study-design-april-
20131.pdf. Retrieved from cebm.net: https://www.cebm.net/wp-
content/uploads/2014/06/CEBM-study-design-april-20131.pdf on 24 June 2019 
Huang, J. L., & Leong, F. T. (2016). Standard Error of Measurement. Retrieved from 
Britannica: https://www.britannica.com/science/standard-error-of-measurement 
/additional-info#contributors on 25 March 2021 
Hvidsten, S., Toyserkani, N. M., Sørensen , J. A., Høilund-Carlsen, P. F., & Simonsen, 
J. A. (2018). A Scintigraphic for Quantitation of Lymphatic Function in Arm 
Lymphedema. Lymphatic Research and Biology, DOI:10.1089/lrb.2017.0054. 
ImpediMed Ltd. (2017). www.impedimed.com/products/l-dex-u400/. Retrieved from 
www.impedimed.com: https://www.impedimed.com/products/l-dex-u400/ on 
29 June 2017 
International Lymphoedema Framework. (2012). Position Document: Best Practice for 
the management of lymphoedema - 2nd edition. Compression Therapy: A 
position document on compression bandaging. Saint-Etienne, France: The 
International Lymphoedema Framework in association with the World Alliance 
for Wound and Lymphoedema Care. 
International Society of Lymphology [ISL]. (2013). The diagnosis and treatment of 
peripheral lymphedema: 2013 consenus document of the International Society of 
Lymphology. Lymphology 46, 1-11. 
177 
 
International Society of Lymphology [ISL]. (2016). The Diagnosis and Treatment of 
Peripheral Lymphedema: 2016 Consensus Document of the International 
Society of Lymphology. Lymphology, 49:170-184. 
Iyigun, Z. E., Selamoglu, D., Alco, G., Pilanci, K. N., Ordu, C., Agacayak, F., Elbuken, 
F., Bozdogan, A., Ilgun, S., Uysal, F. G., & Ozmen, V. (2015). Bioelectrical 
Impedance for Detecting and Monitoring Lymphedema in Patients with Breast 
Cancer. Preliminary Results of the Florence Nightingale Breast Study Group. 
Lymphatic Research and Biology, 13(1):40-45. 
Jain, M. S., Danoff, J. V., & Paul, S. M. (2010). Correlation between bioelectrical 
spectroscopy and perometry in assessment of upper extremity swelling. 
Lymphology, 43:85-94. 
Johnson, K. C., Kennedy, A. G., & Henry, S. M. (2014). Clinical Measurements of 
Lymphedema. Lymphatic Research and Biology, 12(4):216-221. 
Jørgensen, M. G., Toyserkani, N. M., & Sørensen, J. (2017). The effect of prophylactic 
lymphovenous anstomosis and shunts for preventing cancer-related 
lymphedema: a systematic review and meta-analysis. Microsurgery, 1-10. 
Jung, M., Jeon, J. Y., Yun, G. J., Yang, S., Kwon, S., & Seo, Y. S. (2018). Reference 
values of bioelectrical impedance analysis for detecting breast cancer-related 
lymphedema. Medicine, 97(44):e12945 DOI: 10.1097/MD.0000000000012945. 
Kang, H. (2013). The prevention and handling of the missing data. Korean Journal of 
Anesthesiology, 64(5):402-406. 
Karakashian, K., Pike, C., & van Loon, R. (2019). Computational investigation of the 
Laplace law in compression therapy. Journal of Biomechanics, 85:6-17. 
Karakashian, K., Shaban, L., Pike, C., & van Loon, R. (2018). Investigation of Shape 
with Patients Suffering from Unilateral Lymphoedema. Annals of Biomedical 
Engineering, 46(1):108-121. 
Katz-Leurer, M., & Bracha, J. (2012). Test-retest reliability of arm volume measurement 
in women with breast cancer-related lymphoedema. Journal of Lymphoedema, 
7(2):8-13. 
Keeley, V. (2006). The use of lymphoscintigraphy in the management of chronic 
oedema. Journal of Lymphology, 1(1):42-57. 
Keeley, V., Crooks, S., Locke, J., Veigas, D., Riches, K., & Hilliam, R. (2010). A quality 




Kim, S., Trinidad, B., Mikesell, L., & Aakhus , M. (2020). Improving prognosis 
communication for patients facing complex medical treratment: A user-centered 
design approach. International Journal of Medical Informatics, 141, no 
pagination DOI: 10.1016/j.ijmedinf.2020.104147 . 
Kim, L., Jeon, J. Y., Sung, I. Y., Jeong, S. Y., & Do, H. J. (2011). Prediction of 
Treatment Outcome with Bioimpedance Measurements in Breast Cancer Related 
Lymphedema Patients. Annals of Rehabilitation Medicine, 35:687-693. 
Kim, W., Chung, S. G., Kim, T. W., & Seo, K. S. (2008). Measurements of the soft 
tissue compliance with pressure using ultrasonography. Lymphology, 41:167-77. 
Kimberlin, C. L., & Winterstein, A. G. (2008). Validity and reliability of measurement 
instruments used in research. American Journal of Health-System Pharmacy, 
65:2276-2284. 
Klernäs, P., Johnsson, A., Horstmann, V., Kristjanson, L. J., & Johansson, K. (2015). 
Lymphedema Quality of Life Inventory (LyQLI) - Development and 
investigation of validity and reliability. Quality of Life Research, 24(2):427-439. 
Knottnerus, J. A., & Muris, J. W. (2003). Assessment of the accuracy of diagnostic tests: 
the cross-sectional study. Journal of Clinical Epidemiology, 56:1118-1128. 
Koo, T. K., & Li, M. Y. (2016). A Guideline if Selecting and Reporting Intraclass 
Correlation Coefficients for Reliability Research. Journal of Chiropractic 
Medicine, 15:155-163. 
Kumar, R. (2005). Research Methodology second edition. London: SAGE Publications 
Ltd. 
Laerd Statistics. (2018a). Two-way repeated measures ANOVA using SPSS Statistics. 
Retrieved from Laerd Statistics: https://statistics.laerd.com/spss-tutorials/two-
way-repeated-measures-anova-using-spss-statistics.php#targetText=A%20two 
%2Dway%20repeated%20measures,also%20known%20as%20independent%2
0variables) on 02 October 2019 
Laerd Statistics. (2018b). Testing for Normality using SPSS Statistics. Retrieved from 
Laerd Statistics: https://statistics.laerd.com/spss-tutorials/testing-for-normality-
using-spss-statistics.php on 21 October 2019 
Lahtinen, T., Seppala, J., Viren, T., & Johansson, K. (2015). Experimental and 
Alanlytical Comparisons of Tissue Dielectric Constant (TDC) and 
Bioimpedance Spectroscopy (BIS) in Assessment of Early Arm Lymphedema in 
179 
 
Breast Cancer Patients after Axillary Surgery and Radiotherapy. Lymphatic 
Research and Biology, 13(3):176-185. 
Lam, R., Wallace, A., Burbidge, B., Franks, P., & Moffatt, C. J. (2006). Experiences of 
patients with lymphoedema. Journal of Lymphoedema, 1(1):16-21. 
Landau, M. J., Kim, J. S., Gould, D. J., & Patel, K. M. (2018). Vectra 3D Imaging for 
Quantitative Volumetric Analysis of the Upper Limb: A Feasibility Study for 
Tracking Outcomes of Lymphedema Treatment. Plastic and Reconstructive 
Surgery, 141(1):80e-84e. 
Launois, R., Mègnigbêto, A. C., Pocquet, K., & Alliot, F. (2002). A specific quality of 
life scale in upper limb lymphoedema: the ULL-27 questionnaire. Lymphology, 
35(Supplement):1-760:181-187. 
Leddy, A. L., Crowner, B. E., & Earhart, G. M. (2011). Functional Gait Assessment and 
Balance Evaluation System Test: Reliability, Validity, Sensitivity, and 
Specificity for Identifying Individuals With Parkinson Disease Who Fall. 
Physical Therapy, 91(1):102-113. 
Lee, B. B., Andrade, M., Antignani, P. L., Boccardo, F., Bunke, N., Campisi, C., 
Damstra, R., Flour, M., Forner-Cordero, I., Gloviczki, P., Laredo, J., Partsch, H., 
Piller, N., Michelini, S., Mortimer, P., Rabe, E., Rockson, S., Scuderi, A., 
Szolnoky, G., & Villavicencio, J. L. (2013). Diagnosis and Treatment of Primary 
Lymphedema Consensus Document of the International Union of Phlebology 
(IUP)-2013. International Angiology, 32(6):541-574. 
Lee, M.-J., Boland, R. A., Czerniec, S., & Kilbreath, S. L. (2011). Reliability and 
Concurrent Validity of the Perometer for Measuring Hand Volume in Women 
With and Without Lymphedema. Lymphatic Research and Biology, 9(1):13-18. 
Levenhagen, K., Davies, C., Perdomo, M., Ryans, K., & Gilchrist, L. (2017). Diagnosis 
of Upper-Quadrant Lymphedema Secondary to Cancer: Clinical Practice 
Guideline From the Oncology Section of APTA. Rehabilitation Oncology, 
35:E1-E18. 
Lu, G., DeSouza, G. N., Armer, J., Anderson, B., & Shyu, C.-R. (2013). A System for 
Limb-Volume Measurement using 3D Models from an Infrared Depth Sensor. 
IEEE Symposium on Computational Intelligence in Healthcare and e-health 
(CICARE), Singapore, 64-69. 
Lu, G., Han, K., DeSouza, G. N., Armer, J., & Shyu, C.-R. (2014). A new algorithm for 
3D registration and its application in self-monitoring and early detection of 
180 
 
lymphedema. Innovation and Research in BioMedical Engineering (IRBM), 
35:370-384. 
Lu, I. M., & Dixon, J. B. (2019). Assessment of Upper Extremity Swelling Among 
Breast Cancer Survivors wth a Commercial Infrared Sensor. Lymphatic 
Research and Biology, DOI: 10.1089/lrb.2018.0010. 
Lymphoedema Framework. (2006). Best Practice for the Management of 
Lymphoedema. International Consensus. London: MEP Ltd. 
Lymphoedema Network Wales. (2017). All Wales Lymphoedema Guidance: Measuring 
Volumes to Determine Lymphoedema Outcome. Neath: Lymphoedema Network 
Wales. 
Lymphoedema Network Wales. (2020a). LNW End of Year Report 2019-2020. Swansea: 
Lymphoedema Network Wales. 
Lymphoedema Network Wales. (2020b). Lymphoedema Treatment Outcomes. 
Swansea: Lymphoedema Network Wales. 
Maal, T. J., van Loon, B., Plooij, J. M., Rangel, F., Ettema, A. M., Borstlap, W. A., & 
Berge, S. J. (2010). Registration of 3-Dimensional Facial Photographs for 
Clinical Use. American Journal of Oral Maxillofacial Surgery, 68:2391-2401. 
Maclellan, R. A., & Greene, A. K. (2014). Lymphedema. Seminars in Pediatric Surgery 
23, 191-197. 
Makoto, M., Hayashi, Y., Hara, H., Iida, T., Narushima, M., Yamamoto, T., Todokoro, 
T., Murai, N., & Koshima, I. (2014). High-accuracy Diagnosis and Regional 
Classification of Lymphedema Using Indocyanine Green Fluorescent 
Lymphography After Gynecologic Cancer Treatment. Annals of Plastic Surgery, 
72: 204-208. 
Mason, J. M., Thomas, K. S., Crook, A. M., Foster, K. A., Chalmers, J. R., Nunn, A. J., 
& Williams, C. W. (2014). Prophylactic Antibiotics to Prevent Cellulitis of the 
Leg: Economic Analysis of the PATCH I & II Trials. PLoS ONE, 9(2): e82694 
DOI: 10.137/journal.pone.0082694. 
Mayrovitz, H. N. (2010). Local tissue water assessed by measuring forearm skin 
dielectric constant: dependence on measurerment depth, age and body mass 
index. Skin Research and Technology, 16:16-22. 
Mayrovitz, H. N., Arzanova, E., Somarriba, S., & Eisa, S. (2018b). Reference Values 
for Assessing Localized Hand Lymphedema Using Interhand Tissue Dielectric 
Constant Ratios. Lymphatic Research and Biology, 16(5):442-445. 
181 
 
Mayrovitz, H. N., Carson, S., & Luis, M. (2010). Male-female differences in forearm 
skin tisue dielectric constant. Clinical Physiology and Functional Imaging, 
30:328-332. 
Mayrovitz, H. N., Corbitt, K., Grammenos, A., Abello, A., & Mammino, J. (2017a). 
Skin indentation firmness and tissue dielectric constant assessed in face, neck, 
and arm skin of young healthy women. Skin Research and Technology, 23:112-
120. 
Mayrovitz, H. N., Davey, S., & Shapiro, E. (2008). Local tissue water assessed by tissue 
dielectric constant: anatomical site and depth dependence in women prior to 
breast cancer treatment-related surgery. Clinical Physiology and Functional 
Imaging, 28(5):337-342. 
Mayrovitz, H. N., Davey, S., & Shapiro, E. (2009a). Suitability of single tissue dielectric 
constant measurements to assess local tissue water in normal and 
lymphedematous skin. Clinical Physiology and Functional Imaging, 29:123-
127. 
Mayrovitz, H. N., Fasen, M., Spagna, P., & Wong, J. (2018a). Role of handedness on 
forearm skin tissue dielectric constant (TDC) in relation to detection of early-
stage breast cancer-related lymphedema. Clinical Physiology and Functional 
Imaging, 38(4):670-675. 
Mayrovitz, H. N., Grammenos, A., Corbitt, K., & Bartos, S. (2017b). Age-related 
changes in male forearm skin-to-fat tissue dielectric constant at 300 MHz. 
Clinical Physiology and Functional Imaging, 37:198-204. 
Mayrovitz, H. N., Macdonald, J., Davey, S., Olson, K., & Washington, E. (2007). 
Measurement Decisions for Clinical Assessment of Limb Volume Changes in 
Patients With Bilateral and Unilateral Limb Edema. Physical Therapy, 
87(10):1362-1368. 
Mayrovitz, H. N., Weingrad, D. N., & Davey, S. (2009b). Local Tissue Water in At-
Risk and Contralateral Forearms of Women with and without Breast Cancer 
Treatment-Related Lymphedema. Lymphatic Research and Biology, 7(3):153-
158. 
Mayrovitz, H. N., Weingrad, D. N., & Lopez, L. (2015). Patterns of Temporal Changes 
in Tissue Dielectric Constant as Indices of Localized Skin Water Changes in 




Mayrovitz, H. N., Wiengrad, D. N., & Lopez, L. (2016). Tissue Dielectric Contstant 
(TDC) as an index of skin water in women with and without breast cancer: upper 
limb assessment via a self-contained compact measurement device. Lymphology, 
49:27-35. 
McCarthy, N. (2020). The Countries With The Most Left-Handed People. Retrieved 
from Statista: https://www.statista.com/chart/20708/rate-of-left-handedness-in-
selected-countries/ on 30 June 2020 
McLeod, S. (2019). What does a box plot tell you? Retrieved from Simply Psychology: 
https://www.simplypsychology.org/boxplots.html on 10 April 2021 
Mehrara, B. J., & Greene, A. K. (2014). Lymphedema and Obesity: Is There a Link? 
Plastic and Reconstructive Surgery, 134(1): 154e–160e. 
Mehta, S., Bastero‐Caballero, R. F., Sun, Y., Zhu, R., Murphy, D. K., Hardas, B., & 
Koch, G. (2018). Performance of intraclass correlation coefficient (ICC) as a 
reliability index under various distributions in scale reliability studies. Statistics 
in Medicine, 37(18): 2734–2752. 
Mihara, M., Hayashi , Y., Hara, H., Iida, T., Narushima, M., Yamamoto, T., Todokoro, 
T., Murai, N., & Koshimo, I. (2014). High-accuracy Diagnosis and Regional 
Classification of Lymphedema Using Indocyanine Green Fluorescent 
Lymphography After Gynecologic Cancer Treatment. Annals of Plastic Surgery, 
72(2):204-208. 
Moffatt, C. J., Doherty, D. C., Franks, P. J., & Mortimer, P. S. (2018). Community-
Based Treatment for Chronic Edema: An Effective Service Model. Lymphatic 
Research and Biology, 16(1):92-99. 
Moffatt, C. J., Franks, P. J., Doherty, D. C., Williams, A. F., Badger, C., Feffs, E., 
Bosanquet, N., & Mortimer, P. S. (2003). Lymphoedema: an underestimated 
health problem. QJM 96(10), 731-738. 
Moffatt, C. J., Keeley, V., Franks, P. J., Rich, A., & Pinnington, L. L. (2017). Chronic 
oedema: a prevalent health care problem for UK health services. International 
Wound Journal, 14:772-781. 
Monnin-Delhom, E. D., Gallix, B. P., Achard, C., Bruel, J. M., & Janbon, C. (2002). 
High resolution unenhanced computed tomography in patients with swollen legs. 
Lymphology, 35:121-128. 
Montenij, L. J., Buhre, W. F., Jansen, J. R., Kruitwagen, C. L., & de Waal, E. E. (2016). 
Methodology of method comparison studies evaluating the validity of cardiac 
183 
 
output monitors: a stepwise approach and checklist. British Journal of 
Anaesthesia, 116(6):750-758. 
Mori, T., Lustman, A., & Katz-Leurer, M. (2015). Self-measurement of upper extermity 
volume in women post-breast cancer: reliability and validity study. 
Physiotherapy Theory and Practice, 31(4):283-287. 
Mortimer, P. S., & Levick, J. R. (2004). Chronic peripheral oedema: the critical role of 
the lymphatic system. Clinical Medicine, 4: 448-453. 
Narushima, M., Yamamoto, T., Ogata, F., Yoshimatsu, H., Mihara, M., & Koshima , I. 
(2016). Indocyanine Green Lymphography Findings in Limb Lymphoedema. 
Journal of Reconstructive Microsurgery, 32: 72-79. 
National Institute for Clinical Excellence (NICE). (2017). L-Dex U400 for lymphoedema 
after breast cancer treatment (MIB111). Newcastle and York: National Institute 
for Health and Care Excellence. 
National Institute for Health Research Clinical Research Network (NIHR CRN). (2016). 
Good Clinical Practice . Retrieved from nihr.ac.uk: https://www.nihr.ac.uk/our-
research- community/documents/GCP%20Reference%20Guide.pdf on 26 
March 2019 
National Lymphoedema Partnership. (2015). Consensus Statement on the Chronic 
Oedema - Lymphoedema Interface. Retrieved from British Lymphology Society: 
https://www.thebls.com/documents-library on 18 April 2017 
Ng, M., & Munnoch, A. (2010). Clinimetrics of volume measurement in upper limb LE. 
Journal of Lymphoedema, 5(2):62-67. 
Nuutinen, J., Ikäheimo, R., & Lahtinen, T. (2004). Validation of a new dielectric device 
to assess changes of tissue water in skin and subcuaneous fat. Physiological 
Measurement, 25; 447-454. 
Ochalek, K., Gradalski, T., & Szygula, Z. (2015). Physical Therapy in Postmastectomy 
Lymphedema. Lymphatic Research and Biology, 13(1):54-58. 
Öhberg, F., Zachrisson, A., & Holmner-Rocklöv, Å. (2014). Three-Dimensional Camera 
System for Measuring Arm Volume in Women with Lymphedema Following 
Breast Cancer Treatment. Lymphatic Research and Biology, 12(4): 267-274. 
Pappalardo, M., & Cheng, M.-H. (2020). Lymphoscintigraphy for the dagnosis of 
extremity lymphedema: Current controversies regarding protocol, interpretation, 
and clinical application. Journal of Surgical Oncology, 121:37-47. 
184 
 
Parahoo, K. (2014). Nursing Research: Principles, Process and Issues. (3rd ed). 
Basingstoke: Palgrave Macmillan. 
Peleg, R., & Katz-Leurer, M. (2017). Effect of Arm Position on Circumference 
Measurement of Upper Arms in Healthy and in Women With Breast Cancer-
Related Lymphedema. Rehabilitation Oncology, 72-80. 
Perdomo, M., Davies, C., Levenhagen, K., & Ryans, K. (2014). Breast Cancer Edge 
Task Force Outcomes: Assessment Measures of Secondary Lymphedema in 
Breast Cancer Survivors. Rehabilitation Oncology, 32(1):22-35. 
Pero-System Messgeraete GmbH. (2017). How the Perometer works. Retrieved from 
Pero-System: http://pero-system.de/en/funktionsprinzip-von-perometern/ 02 
August 2017 
Pillar, N. (2007). To Measaure or Not to Measure? What and When is the Question. 
Journal of Lymphoedema, 2(2):39-45. 
Plooij, J. M., Swennen, G. R., Rangel, F. A., Maal, T. J., Schutsyer, F. A., Bronkhorst, 
E. M., Kuijpers-Jagtman, A M., & Berge, S. J. (2009). Evaluation of 
reproducibility and reliability of 3D soft tissue analysis using 3D 
stereophotogrammetry. International Journal of Oral Maxillofacial Surgery, 
38:267-273. 
Porter, M. E., Pabo, E. A., & Lee, T. H. (2013). Redesigning Primary Care: A Strategic 
Vision to Improve Value by Organizing Around Patients' Needs. Health Affairs, 
32(3):516-525. 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). 
(2018). Prisma Statement Home Page. Retrieved from www.prisma-
statement.org: http://www.prisma-statement.org/ on 25 February 2018 
Preuβ, M., Killaars, R., de Grzymala, A. P., Binnebösel, M., & Neumann, U. (2018). 
Validity and Reliability of Three-Dimensional Imaging for Measuring Breast 
Cancer-Related Lymphedema in the Upper Limb: A Cross-Sectional Study. 
Lymphatic Research and Biology, 16(6):525-532. 
Pusic, A. L., Cernal, Y., Albornoz, C., Klassen, A., Cano, S., Sulimanoff, I., Hernandez, 
M., Massey, M., Cordeiro, P., Morrow, M., & Mehrara, B. (2013). Quality of 
life among breast cancer patients with lymphedema: a systematic review of 




Rafn, B. S., McNeely, M. L., Camp, P. G., Midtgaard, J., & Campbell, K. L. (2019). 
Self-Measured Arm Circumference in Women With Breast Cancer Is Reliable 
and Valid. Physical Therapy, 99(2):240-253. 
Ridner, S. H., Dietrich, M. S., Deng, J., Bonner, C. M., & Kidd, N. (2009). Bioelectrical 
Impedance for Detecting Upper Limb Lymphedema in Nonlaboratory Settings. 
Lymphatic Research and Biology, 7(1):11-15. 
Ridner, S. H., Shih, Y.-C. T., Doersam, J. K., Rhoten, B. A., Schultze, B. S., & Dietrich, 
M. S. (2014). A Pilot Randomized Trial Evaluating Lymphedema Self-
Measurement with Bioelectrical Impedance, Self-Care Adherence, and Health 
Outcomes. Lymphatic Research and Biology, 12(4):258-266. 
Rincon, K., Shah, P., Ramella-Roman, J., & Bhansali, S. (2016). A Review of 
Engineering Approaches for Lymphedema Detection. IEEE Reviews in 
Biomedical Engineering, 9:79-90. 
Rockson, S. G. (2018). Lymphedema after Breast Cancer Treatment. The New England 
Journal of Medicine, 379:1937-1944. 
Rutjes, A. W., Reitsma, J. B., Coomarasamy, A., Khan, K. S., & Bossuyt, P. M. (2007). 
Evaluation of diagnostic tests when there is no gold standard. A review of 
methods. Health Technology Assessment, 11(50):iii, ix-51. 
Sadeghi, R., Kazemzadeh, G., & Keshtgar, M. (2010). Diagnostic application of 
lymphoscintigraphy in the management of lymphoedema. Hellenic Journal of 
Nuclear Medicine, 13(1):6-10. 
SAGE. (2019). SAGE Research Methods: Sensitivity; Specificity. Retrieved from SAGE 
Research Methods: http://methods.sagepub.com/reference/encyc-of-research-
design/.xml on 29 October 2019 
Sagen, Å., Kårensen, R., Skaane, P., & Risberg, M. A. (2009). Validity for the 
Simplified Water Displacement Instrument to Meassure Arm Lymphedemaas a 
Result of Breast Cancer Surgery. Archives of Physical Medicine and 
Rehabilitation, 90:803-809. 
Salkind, N. J. (2011). Statistics for People Who (Think They) Hate Statistics: 4th edition. 
London: SAGE Publications Ltd. 
Schaaf, H. (2009). Evolution of photography in maxillofacial surgery: from analog to 




Seward, C., Skolny, M., Brunelle, C., Asdourian, M., Salama, L., & Taghian, A. G. 
(2016). A Comprehnsive Review of Bioimpedanc Spectroscopy as a Diagnostic 
Tool for the Detection and Measurement of Breast Cancer-Related 
Lymphedema. Journal of Surgical Oncology, 114:537-542. 
Shah, C., Vicini, F. A., & Arthur, D. (2016). Bioimpedance Spectroscopy for Breast 
Cancer Related Lymphedema Assessment: Clinical Practice Guidelines. The 
Breast Journal, 22(6):645-650. 
Shaitelman, S. F., Cromwell, K. D., Rasmussen, J. C., Stout, N. L., Armer, J. M., 
Lasinski, B. B., & Cormier, J. N. (2014). Recent Progress in the Treatment ad 
Prevention of Cancer-Related Lymphedema. CA: A Cancer Journal for 
Clinicians, 65:55-81. 
Shamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, 
P., & Stewart, L. A. (2015). Preferred reporting items for systematic review and 
meta-analysis protocols (PRISMA-P). British Medical Journal, 349:g7647. 
DOI:10.1136/bmj.g7647. 
Sharkey, A. R., King, S. W., Kuo, R. Y., Bickerton, S. B., Ramsden, A. J., & Furniss, 
D. (2018). Measuring Limb Volume: Accuracy and Reliability of Tape 
Measurement Versus Perometer Measurement. Lymphatic Research and 
Biology, 16(2):182-186. 
Shih, H. B., Shakir, A., & Nguyen, D. H. (2016). Use of indocyanine green-SPY 
angiography for tracking lymphatic recovery after lymphaticovenous 
anastomosis. Annals of Plastic Surgery, 76(3):S232-237 DOI: 
10.1097/SAP.0000000000000766. 
Shinaoka, A., Koshimune, S., Yamada, K., Matsumoto, K., Honda, M., Miyake, M., 
Furuichi, H., Hongo, A., & Kimata, Y. (2017). Accelerated Lymph Flow in 
Early-Stage Secondary Lymphedema Detected by Indocyanine Green 
Fluorescence Lymphography. Journal of Reconstructive Microsurgery, 
33(8):596-602. 
Shrout, P. E., & Fleiss, J. L. (1979). Intraclass correlations: uses in assessing rater 
reliability. Psychological Bulletin Journal, 86(2):420-428. 
Sitzia, J. (1995). Volume measurement in lymphoedema treatment: examination of 
formulae. European Journal of Cancer Care, 4:11-16. 
187 
 
Smoot, B. J., Wong, J. F., & Dodd, M. J. (2011). Comparison of Diagnostic Accuracy 
of Clinical Measures of Breast Cancer-Related Lymphedema: Area Under the 
Curve. Archives of Physical Medicine and Rehabilitation, 92(4):603-610. 
Smoot, B., Paul, S. M., Aouizerat, B. E., Elboim, C., Levine, J. D., Abrams, G., 
Hamolsky, D., Neuhaus, J., Schmidt, B., West, C., Topp, K., & Miaskowski, C. 
(2014). Side of Cancer Does Not Influence Limb Volumes in Women Prior to 
Breast Cancer Surgery. Lymphatic Research and Biology, 12(3):189-193. 
Spinelli, B., Kallan, M. J., Zhang, X., Cheville, A., Troxel, A., Cohn, J., Dean, L., 
Sturgeon, K., Evangelista, M., Zhang, Z., Ebaugh, D., & Schmitz, K. H. (2019). 
Intra- and Interrater Reliability and Concurrent Validity of a New Tool for 
Assessment of Breast Cancer-Related Lymphedema of the Upper Extremity. 
Archives of Physical Medicine and Rehabilitation, 100:315-326. 
Stanton, A. W., Badger, C., & Sitzia, J. (2000). Non-invasive assessment of the 
lymphoedematous limb. Lymphology, 33:122-135. 
Stanton, A. W., Modi, S., Bennet Britton, T. M., Purushotham, A. D., Peters, A. M., 
Levick, J. R., & Mortimer, P. S. (2009). Lymphatic drainage in the muscle and 
subcutis of the arm after breast cancer treatment. Breast Cancer Research & 
Treament, 117(3):549-557. 
Stanton, A. W., Northfield, J. W., Holroyd, B., Mortimer, P., & Levick, J. (1997). 
Validation of an Optoelectronic Limb Volumeter (Perometer). Lymphology, 30; 
77-97. 
Statistics Solutions. (2021). Missing Values in Data. Retrieved from Statistics Solutions: 
https://www.statisticssolutions.com/missing-values-in-data/ on 10 April 2021 
Sun, F., Hall, A., Tighe, M. P., Brunelle, C. L., Sayegh, H. E., Gillespie, T. C., Daniell, 
K. M., & Taghian, A. G. (2018). Perometry versus simulated circumferential 
tape measurement for the detection of breast cancer-related lymphedema. Breast 
Cancer Research and Treatment, 172:83-91. 
Svensson, B. J., Dylke, E. S., Ward, L. C., & Kilbreath, S. L. (2015). Segmental 
Impedance Thresholds for Early Detection of Unilateral Upper Limb Swelling. 
Lymphatic Research and Biology, 13(4):253-259. 
Svensson, B. J., Ward, L. C., Dylke, E. S., & Kilbreath, S. L. (2017). Segmental 
Bioimpedance Informs Diagnosis of Breast Cancer-Related Lymphedema. 
Lymphatic Research and Biology, 15(4):349-355. 
188 
 
Tashiro, K., Yamashita, S., Saito, T., Iida, T., & Koshima, I. (2015). Proximal and distal 
patterns: Different spreading patterns of indocyanine green lymphography in 
secondary lower extremity lymphedema. Journal of Plastic, Reconstructive & 
Aesthetic Surgery, 69:368-375. 
Taylor, R., Jayasinghe, U. W., Koelmeyer, L., Ung, O., & Boyages, J. (2006). Reliability 
and validity of arm volume measurements for assessment of lymphedema. 
Physical Therapy, 86(2):205-214. 
Tewari, N., Gill, P. G., Bochner, M. A., & Kollias, J. (2008). Comparison of volume 
displacement versus circumferential arm measurements for lymphoedema: 
implications for the SNAC trial. ANZ Journal of Surgery, 78:889-893. 
Thomas, R., & Hamilton , R. (2014). Illustrating the (in)visible: understanding the 
impact of loss in adults living with secondary lymphedema after cancer. 
International Journal of Qualitative Studies on Health & Wellbeing, 9. 
doi:http://dx.doi.org/10.3402/qhw.v9.24354. 
Thomas, M., & Morgan, K. (2017). The Chronic Oedema 'Wet Leg' (Lymphorrhoea) 
Pathway. Cimla: Lymphoedema Network Wales. 
Thomas, S. (2017). The use of compressions wraps in the management of lymphoedema. 
Journal of Lymphoedema, 12(1):32-38. 
Tidhar, D., Armer, J. M., Deutscher, D., Shyu, C.-R., Azuri, J., & Madsen, R. (2015). 
Measurement Issues in Anthropometric Measures of Limb Volume Change in 
Persons at Risk for and Living with Lymphedema: A Reliability Study. Journal 
of Personilzed Medicine, 5:341-353. 
Timmer, C. Y., Bosman, J., Geertzen, J. H., & Dijkstra, P. U. (2020). Variation in 
Measurement Results Using Bioimpedance Spectroscopy to Determine 
Extracellular Fluid of Upper Extremity. Lymphatic Research and Biology, 
18(2):110-115. 
Trochim, W. M. (2020). Convergent & Discriminant Validity. Retrieved from 
Conjoint.ly: https://conjointly.com/kb/convergent-and-discriminant-validity/ on 
07 April 2021 
Tsai, R. J., Dennis, L. K., Lynch, C. F., Snetselaar, L. G., Zamba, G., & Scott-Conner, 
C. (2018). Lymphedema following breast cancer: The importance of surgical 
methods and obesity. Frontiers in women's health, 3(2), 
10.15761/FWH.1000144. DOI: 10.15761/FWH.1000144. 
189 
 
UCLA Institute for Digital Research and Education. (2019). Introduction to Power of 
Analysis. Retrieved from UCLA Institute for Digital Research and Education: 
https://stats.idre.ucla.edu/other/mult-pkg/seminars/intro-power/ on 02 October 
2019 
Unno, N., Inuzuka, K., Suzuki, M., Yamamoto, N., Sagara, D., Nishiyama, M., & 
Konno, H. (2007). Preliminary experience with a novel fluorescence 
lymphography using indocyanine green in patients with secondary lymphedema. 
Journal of Vascular Surgery, 45(5):1016-1021. 
Van De Water, L. F., Van Kleef, J. J., Henselman, I., Van Den Boorn, H. G., Vaarzon 
Morel , N. M., Schut, K. F., Daams, J. G., Smets, E. M. A., & Van Laarhoven, 
H. W. (2018). Communicating treatment risks and benefits to cancer patients: A 
systematic review of different verbal and visual communication methods. 
Quality of Life Research, Supplement 1:S56. 
van der Meer, W. J., Dijkstra, P. U., Visser, A., Vissinl, A., & Ren, Y. (2014). Reliability 
and validity of measurement of facial swelling with a stereophotogrammetry 
optical three-dimensional scanner. British journal of Oran and Maxillofacaial 
Surgery, 52:922-927. 
Verhulst, A. C., Wesselius, T. S., Glas, H. H., Vreeken, R. D., Ulrich, D. J., & Maal, T. 
J. (2017). Accuracy and reproducibility of a newly developed tool for volume 
measurements of the arm using 3D stereophotogrammetry. Journal of Plastic, 
Reconstructive & Aesthetic Surgery, 70:1753-1759. 
Vicini, F., Shah, C., Lyden, M., & Whitworth, P. (2012). Bioelectrical Impedance for 
Detecting and Monitoring Patients for the Development of Upper Limb 
Lymphedema in the Clinic. Clinical Breast Cancer, 12(2)133-137. 
Wang, H., Shen, L., Liu, T., Shao, P., Dylke, E. S., Jia, J., & Kilbreath, S. L. (2017). 
Circumference-Based Criteria for Detection of Secondary Arm Lymphedema for 
Chinese Women. Lymphatic Research and Biology, 15(3):262-267. 
Ward, L. (2009). Is BIS ready for prime time as the gold standard measure? Journal of 
Lymphoedema, 4(2):52-56. 
Ward, L. C., Buncet, I. H., Cornish, B. H., Mirolo, B. R., Thomas, B. J., & Jones, L. C. 
(1992). Multi-frequency bioelectrical impedance augments the diagnosis and 
management of lymphoedema in post-mastectomy patients. European Journal 
of Clinical Investigation, 22:751-754. 
190 
 
Ward, L. C., Czerniec, S., & Kilbreath, S. L. (2009b). Operational Equivalence of 
Bioimpedance Indices and Perometry for the Assessment of Unilateral Arm 
Lymphedema. Lymphatic Research and Biology, 7(2):81-85. 
Ward, L. C., Czerniec, S., & Kilbreath, S. L. (2009a). Quantitative bioimpedance 
spectroscopy for the assessment of lymphoedema. Breast Cancer Research and 
Treatment, 117:541-547. 
Ward, L. C., Dylke, E., Czerniec, S., Isenring, E., & Kilbreath, S. L. (2011). 
Confirmation of the Reference Impedance Ratios Used for Assessment of Breast 
Cancer-Related Lymphedema by Bioelectrical Impedance Spectroscopy. 
Lymphatic Research and Biology, 9(1):47-51. 
Watson, D. J., Karakashian, K., Pike, C. E., & van Loon, R. (2019). Limb shape: a novel 
metric for lymphoedema. 
Welsh Assembly Government. (2009). Strategy for Lymphoedema in Wales: Designed 
for Lymphoedema. Retrieved from Welsh Government: http://gov.wales/topics/ 
health/publications/health/strategies/lymphoedema/?lang=en on 18 April 2018 
Williams, A. F., Moffatt, C. J., & Franks, P. J. (2004). A phenomenological study of the 
lived experiences of people with lymphoedema. International Journal of 
Palliative Nursing, 10(6):279-286. 
World Health Organization. (2021). Body mass index - BMI. Retrieved from World 
Health Organization: Regional Office for Europe: https://www.euro.who.int/ 
en/health-topics/disease-prevention/nutrition/a-healthy-lifestyle/body-mass-
index-bmi accessed on 08 April 2021 
Xiong, L., Engel, H., Gazyakan, E., Rahimi, M., Hünerbein, M., Sun, J., Kneser, U., & 
Hirche, C. (2014). Current techniques for lymphatic imaging: State of the art and 
future perspectives. European Journal of Surgical Oncology, 40:270-276. 
Yamagishi, K. (1997). When a 12.86% mortality is more dangerous than 24.14%: 
implications for risk communication. Applied Cognitive Psychology, 11:495-
506. 
Yamamoto, N., Yamamoto, T., Hayashi, N., Hayashi, A., Iida, T., & Koshima, I. (2016). 
Arm Volumetry Versus Upper Extremity Lymphedema Index: Validity of Upper 
Extremity Lymphedema Index for Body-Type Corrected Arm Volume 
Evaluation. Annals of Plastic Surgery, 76(6):697-699. 
Yamamoto, T., Matsuda, N., Doi, K., Oshima, A., Yoshimatsu, H., Todokoro, T., Ogata, 
F., Mihara, M., Narushima, M., Iida, T., & Koshima, I. (2011b). The earliest 
191 
 
finding of indocyanine green lymphography in asymptomatic limbs of lower 
extremity lymphedema patients secondary to cancer treatment: The modified 
dermal backflow stage and concept of subclinical lymphedema. Plastic and 
Recosntructive Surgery, 128:314-321. 
Yamamoto, T., Yamamoto, N., & Yoshimatsu, H. (2017). Localized Arm Volume 
Index: A New Method for Body Typre-Corrected Evaluation of Localized arm 
Lymphedematous Volume Change. Annals of Plastic Surgery, 79(4):390-392. 
Yamamoto, T., Yamamoto, N., Doi, K., Oshima, A., Yoshimatsu, H., Todokoro, T., 
Ogata, F., Mihara, M., Narushima, M., Iida, T., & Koshima, I. (2011a). 
Indocyanine Green–Enhanced Lymphography for Upper Extemity 
Lymphedema: A Novel Severity Staging System Using Dermal Backflow 
Patterns. Plastic & Reconstructive Surgery, 128(4): 941-947. 
Yanbaeva, D., Dentener, M., Creutzberg, E., Wesseling, G., & Wouters, E. (2007). 
Systemic Effects of Smoking. CHEST, 131(5):1557-1566. 
Yoo, J. S., Chung, S. H., Lim, M. C., Kim, Y. J., Kim, K. G., Hwang, J. H., & Kim, Y. 
(2017). Computed tomography-based quantitative assessment of the lower 
extremity lymphedema following treatment for gynecologic cancer. Journal of 
Gynecologic Oncology, 28(2):e18-e28. 
York, S. L., Ward, L. C., Czerniec, S., Lee, M. J., Refshauge, K. M., & Killbreath, S. L. 
(2009). Single frequency versus bioimpedance spectroscopy for the assessment 










APPENDIX 1: Lymphoedema Staging  
Lymphoedema Staging Systems 
Clinical 
Stage 
International Society of 
Lymphology (ISL, 2013) 
British Lymphology Society 
(British Lymphology Society, 2016) 
0 Latent or subclinical state; 
swelling not yet evident 
despite impaired lymph 
transport. May exist months 
or years before oedema 
becomes evident. 
May be primary or secondary. No swelling 
evident despite impaired lymph transport. 
May exist for months or years before 
oedema becomes evident.  
I Early accumulation of fluid 
which subsides with limb 
elevation.  Pitting may occur. 
Swelling present less than 3 months; subtle 
changes in volume; self-reported 
symptoms of heaviness, aching, clothing or 
jewellery feeling tighter; swelling relieved 
by bed rest or elevation. May have 
infection (cellulitis) but no secondary skin 
changes.  
II Limb elevation rarely 
reduces tissue swelling, and 
pitting is manifest. 
Late Stage II the limb may or 
may not pit as excess fat and 
fibrosis appear. 
Swelling affecting a limb(s); present more 
than 3 months; not relieved by bed rest or 
elevation. Subcutaneous tissues are soft 
and normal shape of the limb preserved. 
Swelling does not affect the head and neck, 
trunk or genital regions of the body 
III Encompasses lymphostatis 
elephantiasis where pitting 
can be absent and trophic 
skin changes such as 
thickening, increased skin 
folds, hyperpigmentation, fat 
deposits and papillomatosis 
develop 
3a)  One or more of the following 
secondary skin changes are present - 
fibrosis, hyperkeratosis, papillomatosis, 
recurrent cellulitis/ fungal infections or 
lymphorrhea. Shape of the limb is 
significantly distorted with skin folds; limb 
is heavily impacting on activities of daily 
life; may have psychosocial consequences 
3b)  Swelling is extensive and affects more 
than one site of the body with volume. 
Swelling may affect the limbs, head & 
neck, trunk or genitals. Secondary skin 
changes present. Distorted shape, skin 
folds and heaviness affecting ‘normal’ 
function. Activities of daily life and 
psychosocial health are severely affected  
3c)  Head and neck intervention/ Genital 





Oedema at the end of life and in advanced cancer (British Lymphology Society, 
2016) 
Classification  Description of end of life and advanced cancer oedema/ 
lymphoedema  
At-risk Risk factors: Previous cancer treatment; active or advanced disease 
in the abdomen, groin, chest/breast or head and neck regions; active 
or previous thrombosis; reduced mobility; abnormal liver, renal or 
thyroid function; reduced function or paralysis of a limb(s); 
cellulitis or recurrent infection. No swelling evident but at higher 
risk of developing swelling  
Mild oedema  Swelling may be transient. Affects the limb(s) only and is pitting. 
May reduce with bed rest and elevation. Subcutaneous tissues are 
soft, with no evidence of fibrosis. The skin is intact; however, there 
is a risk of cellulitis and/ or lymphorrhoea through accidental 
trauma. Swelling may be due to thrombosis and should be 
considered as part of examination 
Moderate 
oedema  
May affect the trunk, genitals, head and neck or limb(s) causing 
discomfort. Is not relieved by bed rest, elevation or light 
compression. There is evidence of secondary skin changes such as 
fibrosis, hyperkeratosis and papillomatosis. May have been present 
before exacerbation but is more pronounced with advanced disease 
or deterioration of condition. Function of the affected limb/region 
of the body is affected. Lymphorrhoea may be present, and there is 
a high risk of cellulitis and further maceration of the skin 
Severe oedema  Severe obstruction of the lymphatic and/or vascular pathways 
through advanced cancer rendering limbs heavy and severely 
impacting function (i.e. massive disease in the axillary lymph nodes 
which affects the brachial plexus or a fungating tumour)  
and/or 
Severe obstruction of the lymphatic pathways of the head and neck 
affecting swallow, airway or vision requiring medical intervention 
(pharmacological, surgical, specialist assessment)  
and/or 
Pre-existing lymphoedema considerably worsened. Extensive and 
widespread swelling of the affected areas causing shape distortion 
and secondary skin changes including skin folds, fibrosis and 
pigmentation changes  
and/or 
Extensive generalised oedema affecting more than half of the body, 
which may be due to multiple factors such as immobility, advanced 
disease and hypoproteinaemia. Typically this oedema is present in 





Arm Dermal Backflow Staging (Yamamoto et al., 2011a)6 
 
Stage 0: no oedema or 
dermal backflow detected 
 
Stage I: splash pattern 
observed around the axilla  
 
 
Stage II: stardust pattern is 
limited to proximal to the 
olecranon 
 
Stage III: stardust pattern 
extends distal to the 
olecranon 
 
Stage IV: stardust pattern 
is seen throughout the 
entire limb, including the 
hand 
 
Stage V: diffuse pattern 
evident with the presence 
of stardust pattern 
 
  
                                                 
6 Yamamoto et al., Indocyanine Green–Enhanced Lymphography for Upper Extremity Lymphedema: A 
Novel Severity Staging System Using Dermal Backflow Patterns, Plastic and Reconstructive Surgery, 




Lower Extremity Dermal Backflow (DB) Staging (Mihara et al., 2014)7 
 
No dermal backflow 
 
DB pattern of 
unilateral thigh 
 
DB in unilateral 
thigh and lower 
leg 
 
DB pattern of bilateral 
thighs 
 
DB of bilateral thighs 
and unilateral lower leg 
 
DB of bilateral 






Lower abdominal and 
unilateral thigh DB 
pattern 
 
Lower abdominal and 
unilateral full lower 




thighs DB pattern 
 






Lower abdominal and 
bilateral full lower limb 
DB pattern 
                                                 
7 Mihara et al., High-accuracy Diagnosis and Regional Classification of Lymphedema Using Indocyanine 
Green Fluorescent Lymphography After Gynecologic Cancer Treatment, Annals of Plastic Surgery, 




APPENDIX 2: Types of Lymphoedema Medical Imaging  
1. Lymphangiography and Lymphography  
Lymphangiography is one of the only direct imaging techniques whereby an iodinated 
contrast agent is directly injected into an isolated lymphatic channel.  The dye lasts for 
months to years in the body, enabling long-term follow-up.  This technique is rarely 
performed due to it being invasive, technically challenging to cannulate, and some life-
threatening complications such as contrast-induced nephropathy having been reported 
(Xiong et al., 2014). 
 
Lymphography (Figure 5) refers to a contrast agent or dye that is injected interstitially 
and drains to the lymphatic vessels (Xiong et al., 2014).  It is considered diagnostically 
more accurate than Computed Tomography (CT) scan as it is capable of demonstrating 
the internal architectural anomalies within normal-sized lymph nodes, and due to it 
opacifying the lymphatic channels, it can detect lymphatic fistulas and lymphatic 
leakage (Guermazi, Brice, Hennequin, & Sarfati, 2003).   
 
 
Lymphogram (Guermazi et al., 2003)8 
 
The dye and contrast materials used with these techniques cause the main complications 
as a result of lymphography rather than the technique used (Guermazi et al., 2003).  The 
most common complication is a pulmonary oil embolism which generally remains 
asymptomatic.  Other complications include hypersensitivity to the dye or oil, intra-
alveolar haemorrhage with complete reversibility, hypothyroidism and systemic arterial 
                                                 
8 Guermazi, Brice, Hennequin, & Sarfati, RadioGraphics, 2003, volume 23, pages 1541-1560, with 
permission from the Radiological Society of North America (RSNA®) 
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embolisation to the brain or kidney (rare) (Guermazi et al., 2003).  Due to these 
complications, lymphography is reserved for complex conditions such as chylous reflux 
syndrome and thoracic duct injury, which are difficult to diagnose, and will require 
medical or surgical intervention (International Society of Lymphology [ISL], 2016). 
 
2. Lymphoscintigraphy  
Lymphoscintigraphy (Figure 6) was introduced in the 1950s (Sadeghi, Kazemzadeh, & 
Keshtgar, 2010; Shinaoka et al., 2017) and remains the ‘gold-standard’ for imaging and 
evaluating lymphatic function (Keeley, 2006; Pillar, 2007; Hvidsten, Toyserkani, 
Sørensen, Høilund-Carlsen, & Simonsen, 2018; Pappalardo & Cheng, 2020).  According 
to Sadeghi, Kazemzadeh, & Keshtgar (2010) and Pappalardo & Cheng (2020), it is a 
non-invasive procedure, which is in contradiction to Chiewvit & Kumnerdnakta (2017) 
who correctly acknowledge it is an invasive procedure as a dye is injected into the foot 
or hand.  A radiolabelled colloid is injected into the interstitial space at the first web 
space of each foot or hand using a radiopaque contrast dye.  An external gamma camera 
tracks it as it travels up the lymphatics (Keeley, 2006; Lymphoedema Framework, 2006; 
Maclellan & Greene, 2014; Pappalardo & Cheng, 2020).  It displays the deep pathways 
of lymph flow and lymph nodes in a quantitative and timed manner (Hvidsten et al., 
2018). 
 
Lymphoscintigraphy has mostly replaced the conventional oil contrast lymphography 
for visualising the lymphatic network (Chiewvit & Kumnerdnakta, 2017).  Although 
lymphoscintigraphy has not been strictly standardised, the images are easily repeatable 
and afford a good insight into lymphatic structural abnormalities and (dys)function (ISL, 
2016; Pappalardo & Cheng, 2020).  
 
 
Lymphoscintigraphy of the upper limbs (Chiewvit & Kumnerdnakta, 2017) 
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Lymphoedema is diagnosed by asymmetric visualisation of and/or delayed transit time 
to the regional lymph nodes, dermal backflow, the formation of collateral lymphatic 
channels and a reduced number of regional nodes (Sadeghi et al., 2010; Chiewvit & 
Kumnerdnakta, 2017).  However, Shaitelman et al. (2014) identify limiting factors for 
its use including a relatively poor spatial resolution that limits visualisation of small 
lymphatic vessels, and a long integration time that precludes direct imaging of 
contractile lymphatic pumping.  It is a rarely performed diagnostic procedure due to the 
complexity of the procedure, the potential associated complications and the reliance on 
an experienced radiographer who is practised in reading the images to provide the 
clinician with useful data on which to construct a treatment plan (Maclellan & Greene, 
2014).   
 
3. Indocyanine Green Lymphography  
The newest method for imaging lymphatics is through Indocyanine Green (ICG) 
Lymphography (Narushima et al., 2016) or near-infrared fluorescence imaging 
(Groenlund, Telinius, Skov, & Hjortdal, 2017).  It differs from lymphoscintigraphy in 
that it images the superficial lymphatics up to a depth of approximately two centimetres, 
it visualises the lymphatic activity in real-time, and the results of the scan can be given 
immediately (ISL, 2016; Groenlund et al., 2017).  Makoto et al. (2014) state that the use 
of ICG lymphography provides high-sensitivity detection of lymphoedema and is 
capable of evaluating the pathologic condition over a wide area.  Groenlund, Telinius, 
Skov, & Hjortdal (2017) validated the use of ICG lymphography stating that it has the 
sensitivity to detect changes in lymphatic activity by local hyperthermia and exercise, 
and that pumping pressures demonstrated good repeatability.  Shinaoka et al. (2017) 
found that lymph flow and lymphatic function could be evaluated and that accelerated 
lymph flow in early-stage secondary lymphoedema is detectable.  
 
 
Fluobeam® Near-Infrared Camera 
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ICG was primarily used in angiography until Unno et al. (2007) introduced ICG 
lymphography.  It is a minimally invasive procedure whereby 0.2ml of dilute 
concentration ICG dye (5mg/ml) is injected into, or near to, the webspace of both feet 
or hands (Narushima et al., 2016) and is tracked using a near-infrared camera such as 
the Fluobeam® (Figure 7).  The dye binds to protein molecules in the lymph fluid and 
emits energy in the near-infrared region between 750 and 810 nm (Chang, Soami, & 
Skoracki, 2013).  Once this fluid enters the lymphatic vessels, ICG lymphography can 
detect this near-infrared light and reveals the pathway of the lymphatic vessels, rate of 
flow and function of the superficial lymphatics via software onto a computer screen.  
The advantage of using ICG lymphography over lymphoscintigraphy is that the images 
are of higher resolution, and there is no radiation exposure (Shinaoka et al., 2017). 
 
ICG lymphography can be administered by a medic or qualified Health Care 
Professional within a legal framework known as a Patient Group Directive.  Image 
patterns (Figure 8) are classified as linear, splash, stardust or diffuse (Yamamoto et al., 
2011b; Hara et al., 2013; Makoto et al., 2014) and can be interpreted to inform 
lymphoedema progression, conservative treatment and surgical options.  ICG 
lymphography is also being used to assess the patency of performed lymphaticvenous 
anastomoses (Shih, Shakir, & Nguyen, 2016; Jørgensen, Toyserkani, & Sørensen, 2017) 
and early onset of lymphoedema (Yamamoto et al., 2011a; Jørgensen et al., 2017).   
 
 
Characteristic findings of ICG Green Fluorescent Lymphography (Yamamoto et al., 
2011a)9 
 
                                                 
9 Yamamoto et al., Indocyanine Green–Enhanced Lymphography for Upper Extremity Lymphedema: A 
Novel Severity Staging System Using Dermal Backflow Patterns, Plastic and Reconstructive Surgery, 




The most significant limitation with ICG lymphography is its inability to image the 
deeper lymphatic system due to tracer detection being limited to a few centimetres 
beneath the skin (ISL, 2016; Groenlund et al., 2017).  Where it is clinically indicated, a 
lymphoscintigraphy may be requested in combination with ICG lymphography to 
understand the presenting lymphoedema better, especially where surgery for the 
lymphoedema is being considered. 
 
There are some non-invasive imaging modalities including magnetic resonance imaging, 
computed tomography (CT scan), and ultrasonography; but, these are neither sensitive 
nor specific enough for diagnosing lymphoedema, or they are cost-prohibitive. 
 
4. Magnetic Resonance Imaging (MRI)  
Magnetic Resonance Imaging (MRI) has the advantage of assessing an entire limb 
without exposure to radiation or drug administration; however, it does not allow for 
lymphatic vessel function to be assessed in real-time (Tashiro, Yamashita, Saito, Iida, & 
Koshima, 2015).  It is useful in detecting honeycomb patterns in the subcutaneous tissues 
indicative of fluid or fibrosis, subfascial fluid accumulation and dermal oedema 
(Åström, Abdsaleh, Brenning, & Ahlström, 2001). 
 
5. Computed Tomography (CT-Scan)  
Computed Tomography (CT scan) provides an image (Figure 9) whereby subcutaneous 
tissue structures and volume can be measured.  Classic signs visualised include peculiar 
trabecular areas of honeycombed patterning in the subcutaneous tissue, thickening of 
the skin, epifascial fluid lakes and the absence of oedema within muscular compartments 
(Yoo et al., 2017).   
 
 
Computed Tomography (CT scan) cross-section scan of thighs (Yoo et al., 2017) 
202 
 
Monnin-Delhom, Gallix, Achard, Bruel and Janbon (2002) demonstrated that CT 
imaging has a high sensitivity (93%) and specificity (100%) in confirming the diagnosis 
of lymphoedema; however, due to the high cost of the procedure and the radiation 




Ultrasonography (Figure 10) is the most effective method of measuring the structural 
status of the lymphatic system and of the limb itself.  It is a clinically convenient tool, 
and measurement of soft tissues can be performed within the clinical setting.  It can 
provide information about changes to the thickness of the cutaneous, epifascial and 
subfascial tissue compartments and, identify fluid collection and fibrosis (Kim, Chung, 
Kim, & Seo, 2008).  It is more cost-effective than MRI or CT scans even though these 
provide greater accuracy and certainty (Pillar, 2007). 
 
 













reliability of, and to 
define the limits for 
clinical change 








14 for limb 
volume; 17 for 
tissue tonometry 
Two groups of people with 
lymphoedema: one group 
(n=14) for limb volume by 
water displacement and 3 
site circumference 
measurement; the other 
group (n=17) for tissue 
tonometry only.  The 
protocol described two 
therapists independently and 
alternately performing the 
tests for each method 10 min 
apart.  Mean of each test was 
used to determine interrater 
(ICC[3,1]) reliability.  
Reliability was determined 
for agreement of results 
according to criteria by 
Fleiss between raters 
(ICC[2,1] for intra-rater) or 
trials (Bland-Altman 
analysis), presence of 
systematic changes in mean, 
size of measurement error 
(standard error of 
measurement [SEM]) and 
presence of clinically 
significant changes (smallest 




reliability for volume 
measures (ICC>0.99, 
P<0.05). Interrater reliability 
was high for volume 
measures (ICC>0.99, 
P<0.05). Intra-rater 
reliability for tonometry of 
forearm and hand was high 
(ICC=0.88 and 0.78; 
P<0.05); intra-rater 
tonometry of fingers was fair 
and interrater for all 
tonometry was fair 
(ICCs=0.66-0.71; P<0.05).  
SEM for water displacement 
was 27.2; SEM for 
circumference measurement 
were l ow ranging from 
0.13cm (SEM%=0.5%) to 
0.37cm (SEM%=1.3%). 
SEM tonometry ranged from 
0.11-0.36mm 
(SEM%+4.3%-17.8%).  SRD 
for water displacement was 
75.5; SRD range for 
circumference was 0.37-
0.71cm (SRD%=1.5 to 
3.5%); and SRD tonometry 
was 0.32-1.01mm 
(SRD%=11.9-49.4%). 
Water displacement and 
circumference measure 
are reliable techniques 
for assessment of 
lymphoedema; 
















for the SNAC trial 
Diagnostic Test 
Study 
87 women Ethics was granted. All 
patients had the same tests 
performed: circumferential 
measurement with narrow 
tape, circumferential 
measurement with wide tape 
and water displacement.  A 
clear protocol was followed; 
however, no mention is made 
of blinding or independent 
testing. 
 
A significant correlation 
between wide and narrow 
tape volume estimations was 
found using Pearson's 
correlation coefficient 0.95, 
p<0.0001.  A significant 
correlation between the 
narrow tape and water 
displacement was found with 
a Pearson's correlation 
coefficient of 0.92, (CI 0.89-
0.94, p<0.0001).  Pearson's 
correlation coefficient 
between the wide tape and 
water displacement was 0.88 
(CI 0.84-0.91, p<0.0001). 
Further comparison between 
BMI groups demonstrates 
the highest correlation with 
volume displacement for 
overweight (BMI 25-29.9) 
women using the narrow 
tape.  Lowest correlation was 
for obese women (BMI >30) 
using the wide tape. 
Use of the narrow tape 
measure to estimate limb 
volume is similar to 
water displacement.  
This outcome is useful 
in clinical practice as 
water displacement is a 
time-consuming, messy 
system that is unsuitable 
with some skin problems 
and healing wounds due 
to the risk of cross-
contamination. Use of 
the narrow tape measure, 
which is readily 
available, is subject to 
potential errors, and it is 
recognised that a 
standardised method is 
required.  To reduce 
inter-observer variation, 
it is advised that the 
same therapist review 
the patient to ensure the 
degree of tension 
applied to the measuring 
tape on the limb needs is 
consistent. 














group of 18 
women  
Ethics approval and consent 
was obtained. 
Measurements taken 
included self-report on a 
visual analogue scale (VAS), 
circumferential measures at 
Very strong agreement (0.89 
to 0.99) between measures 
obtained by tape measure, 
perometer and BIS methods 
with the strongest 
relationship between limb 
All physical methods of 
assessment show 
excellent reliability, 
whereas self-report only 






Sample Validity of Study Study Results Clinical Benefit 
swelling, their 
reliability, and their 
standard error of 
measurement 
10cm intervals, perometer 
volume measures and 
bioimpedance spectroscopy.  
The same assessor performed 
all measurements on both 
arms and at two occasions, 
four weeks apart. 
Limits of agreement analysis 
and reliability and SEM were 
considered. 
 
volume difference by the 
truncated cone method (for 
tape measure) and perometer 
(rc=0.99). The weakest 
relationship was between 
BIS and truncated cone 
method (rc=0.89). 
Correlation between VAS 
score and limb volume was 
moderate (tape: rc=0.66; 
perometer: rc=0.65); whereas 
correlation between VAS 
and BIS was higher 
(rc=0.71). 
Truncated cone method 
underestimated limb volume 
compared to perometer. 
All three physical tests 
demonstrated excellent intra-
rater reliability (ICC=0.94 
for volume and ICC=1.00 for 
BIS), with self-reported 
swelling moderately reliable 
(ICC=0.70). 
All physical methods showed 
excellent inter-rater 
reliability with tape 
ICC=0.98; perometer 
ICC=1.00 and BIS 
ICC=0.99. 
Limitations to study 
identified. 
To note, even though 
there was a high level of 
agreement between the 
physical methods, they 











reliability of a new 
self-developed 
measurement device 














Ethical approval gained. 
Measurements taken pre-op 
and between 3 – 9 days post-
op on the unaffected side 
only.  Measurements taken 
by 3 trained physical 
therapists who were blinded 
to each other. 
Measurements included the 
use of the new device: steel 
bar with a tape measure 
every 4cm with weighted 
20g at the end of the tape 
with truncated cone 
(frustrum formula) 
calculation; and water 
displacement. Statistical 
analysis includes Intraclass 
Correlation Coefficients 
(ICCs) using Pearson 
correlation coefficient to 
determine any relationships 
between the new device and 
water displacement; Bland-
Altman analysis was used to 
determine interchangeability 
between methods of 
measure, SEM, and Small 
Real Difference (SRD) 
analysis was also 
undertaken. 
 
ICC for intra-rater reliability 
of the new device ranged 
from 0.977 (95% CI 0.960-
0.986) at the lower arm to 
0.996 (95% CI 0.992-0.998) 
for the upper arm. 
ICC for interrater reliability 
of the new device ranged 
from 0.942 (95% CI 0.828-
0.975) for the lower arm and 
0.994 (95% CI 0.990-0.997) 
for the upper arm. 
SEM for circumference 
measurement was low 
(0.8%), and SEM for 
calculated arm volume was 
low (2.0%). 
SRD for circumferential 
measurements was 3.4%, and 
SRD for calculated arm 
volume was 3.9%. 
Volumes calculated from 
both methods were highly 
correlating (r=0.973). 
However, as there was a 
wide 95% confidence 
interval, it suggests that these 
two methods are not 
interchangeable. 
Study weakness was that 
no measures done on 
lymphoedema side. 
Strengths of the study 
are high sample number, 
age and BMI 
representative of the 
population, 
measurements 
performed in 'the field' 
thus reflective of clinical 
setting (guarantees the 
authenticity of results). 
Measurements were 
taken using bony 
reference point as 
opposed to distance 
from fingertip. 
In follow up of patient, 
always use the same 
method of measure, as 







Sample Validity of Study Study Results Clinical Benefit 
Ancukiewicz et 
al., 2011 
To develop a simple 
and practical formula 
for quantifying upper 
limb lymphoedema, 
accounting for both 
the asymmetry of the 
extremities’ volumes 








Approval gained from the 
Partners Institute Review 
Board. Prospective collection 
of repeated bilateral arm 
volume measurements by 
perometry of breast cancer 
patients was collected 
preoperatively (baseline) and 
post-operatively three to six 
times (time-dependent). 
 
No statistically significant 
difference between baseline 
measurements of the tumour-




(A/U) most closely 
approximates normal 
distribution (skewness 
coefficient of 0.34). Log-
normal distribution of the 
ratio of A/U ratios over time 
proved statistically 
significant (p=0.08). 
Analysis of longitudinal 
variation of Relative Volume 
Change (RVC), weight was 
the only covariate 
significantly associated with 
an expected value of RVC 
(p=0.007); patients with 
higher baseline weight 
tended to develop higher 
RVC in the follow-up. 
Constant arm length during a 
test was used for volume 
calculation even though there 
was a slight variance in 
length between visits.  The 
effect of the arm length on 
RVC was not statistically 
significant (p=0.466). 
The researchers propose 
the use of their protocol 
and formula for 
quantification of RVC 
(= (A2U1)/(U2A1)-1) to 
enable standardised 
reporting of volumetric 
monitoring of 
lymphoedema.   
The researchers have 
devised a 'Perometer 
Measurement Protocol' 
for the positioning of the 







Sample Validity of Study Study Results Clinical Benefit 
Foroughi et al., 
2011 
To assess the inter-
reliability and 










over the age of 
40years 
Ethics and consent gained. 
Inclusion and exclusion 
criteria identified. Measuring 
protocol posted out together 
with a tape measure to 
participants' homes to 
measure 10cm 
circumferences of both arms 
starting at the wrist. 
Participant then seen within 
two weeks at the laboratory 
for 10cm circumferential 
measurement and perometry. 
Anthropometric data 
collected. Reliability at level 
0.8 showed a sufficient 
sample size of 50 people. 
Data expressed as mean and 
standard deviation (SD) or 
median and range once 
tested for normality 
(skewness-1>1). Lin's 
concordance correlation and 
limits of agreement analysis 
used to compare participant's 
measurement to the 
laboratory's two 
measurements. Dominant 
arm used for analysis. 
Medium to high concordance 
between arm circumferences 
by participant and laboratory 
and ranged from rc=0.68 at 
10cm to rc=0.94 at 20cm. 
Measurement concordance 
between laboratory 
circumference measure and 
perometry ranged from 
rc=0.83 for 10cm measure 
and rc=0.94 for 40cm. 
Measure concordance of 
participant circumference, 
and perometer ranged from 
rc=0.76 at 20cm to rc=0.93 at 
10cm. Bias between methods 
minimal, and ranged from -
5.5% at 40cm to 1.5% at 
10cm taken by laboratory 
compared to perometer, and 
from -2.4% at 40cm to 4.0% 
at wrist taken by laboratory 
compared to participants. 
Self-monitoring by tape 
measure using given 
protocol is a cost-
efficient, user-friendly 













20 with breast 
cancer-related 
lymphoedema 
Ethics and consent gained. A 
within-session study 
consisting of a test-retest 
protocol to determine inter- 
and intra-reliability; the 
Measurements using 
perometer demonstrated 
excellent inter- and intra-
rater reliability. Intra-rater 
ICC2,1 was 0.989 (95% CI: 
Perometer offers an 
alternative to water 
displacement for 
measurement of hand 












(BCRL) and 20 
non-LO 
validity of perometer for 
hand volume measurement 
compared to water 
displacement. Inclusion and 
exclusion criteria identified. 
LO arm for BCRL and 
dominant in non-LO 
measured by perometer twice 
by one rater and once by the 
second rater; and then once 
by water displacement.  
Garments removed 2hrs 
before testing.  Tip of the 
third finger to distal palmer 
crease measured. Descriptive 
statistics calculated; ICC2,1 
with 95% confidence 
intervals and Percent Close 
Agreement (PCA) used to 
determine intra- and inter-
rater reliability, paired t-test 
performed to determine the 
difference between means of 
test-retest data. Reliability 
poor when ICC2,1 <0.40; 
moderate 0.40-0.75; 
substantial 0.75-0.90 and 
excellent >0.90.  Limits of 
agreement analysis and Lin's 
concordance correlation used 
to evaluate the relationship 
between measurements taken 
with both methods. 
0.979-0.994); Inter-rater 
ICC2,1 was 0.993 (0.986-
0.996). Paired t-test showed 
no significant differences in 
hand volume taken by 
different raters. PCA showed 
less than 9ml difference in 
hand volume for 80% of 
measurements taken by two 
raters and 73% by a single 
rater. Strong concordance 
between both methods 
(rc=0.88); limits of 
agreement showed perometer 
to overestimate the volume 
of hand obtained from water 




position fingers together 
(including thumb) for 
perometer to reduce 
spaces being interpreted 
as volume. The benefit 
of perometer over water 
displacement: (i) 
convenient and quick 
with reduced set-up time 
and shorter measurement 
time, (ii) excellent inter- 
and intra-rater reliability 
means patient only 







Sample Validity of Study Study Results Clinical Benefit 
Ancukiewicz et 
al., 2012 
To evaluate the 
effect of an absolute 
change in arm size of 
200ml or 2cm 
compared with 
relative arm volume 









Ethics gained. Bilateral 
perometer arm 
measurements taken pre- and 
post-operatively. Using pre-
operative arm measurements, 
the calculated effect of 
200ml arm volume change 
compared with relative arm 
volume change, assuming 
the volume of the opposite 
arm remains unchanged. 
Also calculated the effect of 
circumference increase of 
2cm in the middle of the arm 
in a sample of 45 patients 
compared with relative arm 
volume change. Analysed 
the within-patient variation 
of the unaffected arm 
volumes throughout follow-
up in a subset of 124 patients 
with 6-13 sequential 
measurements. Histograms 
were used; standard 
deviation and range looked 
at within-patient temporal 
variation. Kendall's 
correlation coefficients were 
calculated and Kendall's test 
used as a non-parametric test 
of correlation. 
Pre-op unaffected arm 
volumes ranged from 1,270 
to 6,873 ml (5.4-fold 
variation). Strong correlation 
of unaffected arm volume 
with bodyweight (Kendall's 
Τ = 0.65, p<0.00) and BMI 
(Kendall's Τ = 0.55, p<0.00). 
Absolute volume change of 
200 ml corresponded to 
relative arm volume change 
of 15.7% for pre-op arm 
volume of 1,270 ml and 
2.9% for arm volume of 
6,873 ml. Median relative 
arm volume change for 200 
ml increase was 7.7%. In a 
subset of 45 patients, 
increase of 2 cm 
circumference corresponded 
to relative arm volume 
change of 9.8% for a pre-op 
volume of 1,799 ml and 
6.0% for arm volume of 
4,376 ml. Median relative 
arm volume change for 2 cm 
increase was 7.5%. In subset 
of 124 patients with 6 or 
more sequential 
measurements, range of 
longitudinal variation of 
absolute volume change of 
unaffected arm correlated 
with pre-op arm volume 
Relative arm volume 
change is independent of 
body size and should be 
used as a standard 
criterion for the 
diagnosis of BCRL. 
Changes in the size of 
the contralateral arm 
should be used as a 
control arm to account 
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(Kendall's Τ = 0.34, p<0.00), 
patient weight (Kendall's Τ = 
0.41, p<0.00) and BMI 
(Kendall's Τ = 0.36, p<0.00). 
In contrast, the range of 
variation in relative arm 
volume changes was not 
correlated with pre-op arm 
volume, weight or BMI 
(p>0.05 for all) - even 
though substantial magnitude 
resent (median range 10.5%). 
SD of longitudinal variation: 
for absolute volume changes 
correlate with pre-op arm 
volume, weight and BMI 
(p<0.00), but no correlation 
for relative arm volume 
changes (p>0.05). The 
asymmetry between arms 
pre-op observed as 100 ml in 
30.0% and 200 ml in 8.1% of 
the cohort. 
Asim et al., 
2012 
Primary aims were 












193 women Consent gained (no mention 
of ethics). Inclusion and 
exclusion criteria described. 
Four staff performed 
assessments. The assessment 
consisted of a questionnaire 
and circumferential limb 
measurements at 3 points 
(15cm above and 10cm 
below olecranon, and around 
the hand); 73 patients had 
LO defined as >7.5% 
increase in any 
circumference on the 
operated side (=15.5% 
increase in volume) - 23.3% 
of cohort positive for LO. In 
a subset of 73 patients, LO 
prevalence was 8.2%, 9.6% 
and 19.1% for the forearm, 
upper arm and hand 
respectively.  Prevalence 
Arm circumference 
measure is easy and 
convenient. Threshold 
increase at a single point 
may be more indicative 
of LO than global 
measure. Using ten 
percentage increase 
rather than absolute 






Sample Validity of Study Study Results Clinical Benefit 
Secondary aims were 
to determine local 
risk factors affecting 
rate of LO, measure 
the morbidity 
associated with LO 
using QoL 
questionnaires and to 
establish easy and 
convenient ways to 
detect LO. 
another seven measurements 
taken starting at the base of 
the middle finger, then 10cm 
up to the top of the arm. 
Limb volume calculated 
using the truncated cone 
method. Statistical analysis: 
data entered into the 
Mircosoft Access database. 
A multivariate logistic 
regression method for 
analysis of LO risk factors; a 
binary variable was the 
dependent variable. 
GraphPad Prism analysed the 
Activities of Daily Living 
questionnaire. Continuous 
variables were compared 
using the Mann-Whitney 
test. Arm dominance 
correction applied as 1.4% 
for the forearm, 1.2% for 
hand and 0% for the upper 
arm. 
using >2cm increase at any 
point on the operated side 
was 25.3%. Prevalence using 
subjective method was 
10.8% (3+ score) and 41.9% 
(2+ score).  Sensitivity and 
specificity in arm 
circumference increase of 
>7.5 and >10% was 83% and 
81%, and 66% and 89% 
respectively. Poor 
concordance between 
objective measure and 
subjective symptoms at 
>7.5% threshold; with more 
concordance at >10% 
threshold.  
















10 women with 
unilateral BCRL 
Consent was gained, and 
study followed Good 




taken of both arms as part of 
routine follow-up in 
lymphoedema clinic. 
Calculation of coefficient 
CV% for volume 
calculations was 0.63% for 
4cm CTM, 0.63% for 5 point 
CTM and 0.61% for water 
displacement. Affected arm: 
water displacement had 
larger mean value due to the 
inclusion of hand at 3138 ml, 
4cm was 2972 ml, and 5-
point was 2916 ml. Mean 
Can use 5-point as for 
measuring for made-to-
measure garments to 
gain clinical outcomes 
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variation (CV%) was done 
for each method by 
researcher performing a test 
on colleague ten times. 
Truncated cone method used 
for volume calculation for 
circumferential method, hand 
excluded. Water 
displacement measured hand 
as well. Measurements 
presented as mean, standard 
deviation (SD) and range. 
Student's t-test for paired 
observations used to assess 
significant differences; non-
parametric calculations 
performed finding no 
difference in statistical 
significance; linear 
regression analysis used to 
obtain the coefficient of 
regression ( ) with 95% 
confidence interval, and 
correlation coefficient (r). 
difference between 4cm and 
5-point methods was 56 ml 
(range=179-308 ml) 
indicating fewer segments 
give smaller volume, but not 
statistically significant. A 
high correlation between all 
methods with a coefficient of 
correlation >0.88 and 
coefficient regression close 
to 1. Unaffected arm: water 
displacement mean volume 
was 2498 ml, 4cm was 2390 
ml, and 5-point was 2363 ml. 
Mean difference between 
4cm and 5-point was 26 ml 
(range=224-210 ml). 
Statistical difference 
between water displacement 
and 5-point method 
(p<0.05); a high correlation 
between all methods with a 
coefficient of correlation 
>0.81 and coefficient of 
regression close to 1. Excess 
Volume: water displacement 
mean was 641 ml, 4cm was 
582 ml, and 5-point was 553 
ml. Mean difference between 
4cm and 5-point was 29 ml 
(range=82-164 ml) which 
was not statistically 
significant. Statistical 
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displacement and 4cm 
method was p<0.05 and the 
5-point method was p<0.00.  
A high correlation between 
all methods with a 
correlation coefficient of 
>0.93 and regression 





To describe normal 
inter-limb variance 







a perometer in 






Ethics and consent gained. 
Inclusion and exclusion 
criteria identified. Four age 
groups: 40-49 years, 50-59 
years, 60-69 years and 70+ 
years. Descriptive analysis of 
groups was presented.  A 
single assessment where both 
arms were measured using 
the perometer. 
Circumference 
measurements were gained 
manually from the Peroplus 
software; limb volumes were 
done manually using the 
perometer value and both the 
truncated cone method and 
the cylinder method. All data 
were presented as means + 
standard deviation. Volume 
data for each method was 
compared using concordance 
correlation and limits of 
agreement; paired t-tests 
were used to determine 
whether the circumferences 
Good concordance and high 
correlation between volume 
by perometer truncated cone 
and cylinder methods noted; 
however, small but 
significant differences were 
presented. For total limb 
volumes, the mean bias 
between methods was 2.9% 
with the largest bias between 
perometer and cylinder 
method for dominant limb 
(5.0%).  The limits of 
agreement (2SD) between 
methods were larger when 
perometer compared to 
calculated volume methods 
than calculated methods 
compared to each other. The 
largest limit of agreement 
was -1.0% to 10.0% for 
perometer compared to the 
truncated cone for the 
dominant limb. Paired t-tests 
between dominant and non-
dominant circumference 
Current criteria for 
diagnosing 
lymphoedema is based 
on convenience and not 
normative differences, 
as presented in this 
paper.  It highlights the 
need for pre-operative 
measurements due to 
high inter-limb 
differences. Within 
clinical setting can be 
cumbersome to 
remember values; 
however, it does 
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or volumes of the dominant 
limb were significantly 
different from the non-
dominant limb.  Inter-limb 
differences were used to 
determine diagnostic cut-
offs. Mean and standard 
deviations of the difference 
for each variable were 
determined and cut-offs 
established as means plus 
three times the standard 
deviation.  Regression 
analysis to determine if age, 
side of dominance, weight, 
height, or BMI were related 
to inter-limb differences in 
circumference or volume. 
measurements revealed 
significant differences due to 
dominance esp. for 10cm, 
20cm and 40cm points. No 
significant difference at 
30cm. Paired t-tests for both 
perometer and calculated 
volume methods: all 
perometer determined 
segments were significantly 
different (p<0.03). The cut-
off for diagnosis was based 
on three standard deviations 
above mean difference which 
for the dominant arm was 
1.3cm, 2.4cm, 2.5cm, 2.7cm 
and 3cm, respectively, and 
for the non-dominant arm, it 
was 1.2cm, 1.9cm, 1.9cm, 
2.7cm and 2.7cm. Cut-offs 
for dominant and non-
dominant arm for perometer 
was higher at 370 ml and 
210 ml; and 290 ml and 240 
ml for calculated methods. 
Regression analysis found a 
small but significant 
relationship between inter-
limb volume difference and 
age irrespective of the 
method used.  Hand 
dominance, height, weight 
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Katz-Leurer & 
Bracha, 2012 
To determine the 
test-retest reliability 
of total arm volume 
from circumference 
measurements and 




16 women with 
arm 
lymphoedema 
Ethics and consent gained. 
All subjects had both arms 
measured by the same 
therapist at the same time 
one week apart.  
Measurements were taken 
according to a predefined 
protocol.  The calculation 
used the truncated cone 
formula. 
Paired t-test, intra-class 
correlation coefficient, 
standard of error 
measurements and minimal 
detectable change for total 
and segmental volumes in 
both arms were performed.  
Composite reliability using 
Cronbach and Bland & 
Altman was also done. 
 
Lymphoedema arm 
compared to ‘normal’ was 
statistically significant at 7% 
(p<0.01). 
Test-retest reliability was 
high for the lymphoedema 
arm with ICC=0.96-0.99 and 
the non-lymphoedema arm 
where ICC=0.98-1.00.  
However, the reliability test-
retest for the lymphoedema 
hand was only good with 
ICC=0.60-0.93 compared to 
ICC=0.79-0.91 for the non-
lymphoedema hand. 
The SEM for total volume 
was 47.1ml for non-
lymphoedema arm versus 
78.8ml for the lymphoedema 
arm.  SEM for segmental 
volumes resulted in an 
increase of 66.6ml for the 
non-lymphoedema arm but a 
decrease of 45.0ml for the 
lymphoedema arm. 




reliability in the arm but 
less for the hand.   
Minimal detectable 
change for each segment 
may be used to assess 
real change due to 
treatment effect in these 
segments but may 
overestimate total arm 











the evaluation of arm 
volume in women 







breast cancer  
Ethics and consent gained. 
Description of recruitment 
given.  Measurements taken 
include water displacement, 
4cm circumferential tape 
measure (11 points) using 3 
methods of calculation, and 
perometry was done three 
times for each side (0.47cm 
When comparing dominant 
and non-dominant arms in 
the control group, the 
volume difference was 
significantly higher for the 
dominant arm (ave 2.24%).  
Perometer ICC for control 
group dominant arm was 
0.998; for non-dominant 
Perometer should be 
used due to ease of use 
and reproducibility. 
Limb volume change of 
>10% could be used as 
diagnostic threshold 
criteria for diagnosis of 
BCRL.  Single frustrum 
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circumference intervals) - 
mean calculated as the 
absolute volume of arm.  
Descriptive statistics, 
independent samples t-tests, 
paired-samples t-tests and 
repeated measures analysis 
of variance were performed.  
Intra-class correlation 
coefficient (ICC) for 
absolute agreement was used 
to check intra-rater reliability 
of the three perometer 
measurements. 
0.997. For oedema group, 
ICC of oedema arm was 
0.999 and for non-oedema 
arm 0.998.  Comparing all 
methods: frustrum and disc 
model gave the highest 
volume estimation; water 
displacement gave the lowest 
volume estimation; 
perometer was in-between. 
Control group had a 
significant effect in 
measurement method 
(p<0.001) and in arm 
dominance (p=0.002) for 
volume estimation. No 
significant interaction effect 
(p>0.05) on arm volume 
estimation.  BCRL group had 
a significant effect of 
measurement method 
(p<0.001), side of surgery 
(p<0.001) and interaction 
(p<0.001) between 
measurement method and 
side of surgery on arm 
volume estimation. 
used for volume 
estimation. 
Bulley, Coutts, 
& Tan, 2013 
Develop a protocol 
for the perometer 
and determine the 
inter- and intra-rater 




30 volunteers: 7 
men; 23 women 
Consent and ethics gained. 
Inclusion and exclusion 
criteria identified. Protocol 
development referred to 5 
questions: 1) What are the 
optimal conditions for 
standardising measurements? 
The high ICC for inter- and 
intra-rater reliability in upper 
limbs (0.953-0.989). 
Standard deviation and CoV 
were moderate (SD=281-
309; CoV=18-20). Limits of 
agreement were less positive 
Protocol developed to 
enable greater 
standardisation in the 
measurement of limbs; 
however, further testing 
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2) How can a standard 
proportion of the limb be 
measured in order to allow 
comparisons between and 
within individuals? 3) What 
is the optimal limb position 
within the perometer frame? 
4) Are there any 
considerations relating to the 
speed of the perometer frame 
movement? and 5) Are there 
any considerations relating to 
the generation or 
interpretation of 
measurements? Final 
protocol tested for inter- and 
intra-rater reliability: 2 
researchers took two 
recordings on each volunteer 
on two occasions, 24-48hrs 
apart. Both raters were 
blinded to measurement 
recordings. Landmarks on 
limbs identified and marked. 
Dominant limbs were 
measured. Shapiro-Wilk test 
showed data not normally 
distributed for upper limb 
(p=0.01-0.02). Parametric 
analysis included ICC and 
95% confidence interval 
calculations for both inter- 
and intra-rater reliability. 
Coefficient of variation 
with upper limit range 85 to 
156, and lower limit range -
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(CoV) was calculated, and 








as a method of 
measuring limb 










healthy and one 
lymphoedema 
case reported 
No ethics approval or consent 
gained reported.  Each subject 
was scanned with the 
perometer and the 3D 
camera (Microsoft Kinect) as 
the first experiment; then 
accuracy to detect localised 
swelling was tested as the 
second experiment.  
Volumes and percentage 
volume difference were 
calculated for both 
experiments. 
Perometry shows a 
percentage discrepancy of 
less than 13% to the 3D 
camera – perometer 
underestimates volumes 
compared to 3D camera. 3D 
camera was able to detect a 
small change in volume by 
detecting 80% of a pen taped 
to the forearm of the subject. 
Limitation of the study is the 
very small cohort 
3D camera can 
accurately model the 
human arm and can 
detect small, localised 
differences in limb 
volume. 
Erends, van der 
Aa, van der 
Hulst, & de 
Grzymala, 
2014 
Assess the validity 
and reliability of 3D 
volume 
measurements of the 






33 subjects with 
no 
lymphoedema: 
20 female; 13 
male 
No ethics approval or consent 
gained reported.  Each subject 
was measured by 3D camera 
(Vectra XT) and water 
displacement twice by two 
researchers. Study protocol 
described wherein hand was 
excluded.  Pearson 
correlation coefficient, 
paired sample t-test or 
Wilcoxon signed-rank test 
and Bland and Altman plots 
were used.  
3DCI on average 
overestimated volume by 
13.8cc compared to water 
displacement; however, there 
was a high correlation (0.98) 
between the two tests and no 
significant difference 
between them (p=0.192). 
Intra-rater reliability for both 
measures was 0.99; however, 
no significant difference 
between the two 3DCI was 
noted (p=0.673); but for 
water displacement, there 
was a significant difference 
(p<0.001). There was a high 
inter-rater reliability of the 
3DCI of 0.99 
3DCI has good validity 
and reliability and was 
shown to be more 
reliable than water 
displacement. 
Advantage of 3DCI is 
that it is suitable for 
people with skin lesions, 
and there are no contra-
indications for its use. 
Currently unsuitable for 
measuring the hand due 
to the web spaces. 
Needs training for this 
camera's use due to 
specific landmark 
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equipment is expensive 






questions: 1) how 





surfaces; 2) how 
reliable is the 
method in terms of 
detecting small, 
localised swellings; 
and 3) to what extent 
are the proposed 








perometer test; 7 




No mention of consent or 
ethics. 3D camera calibrated, 
algorithm tested and 
validated on PVC pipes. 
Perometer and 3DCI taken of 
both arms, then 3D repeated 
with a pen taped to anterior 
elbow to detect small 
changes in volume. Both 
arms tested on 7 subjects for 
water displacement and 
repeated after 2 hours. 
Concurrently, six 
consecutive measurements 
by 3D camera taken of both 
arms and averaged for the 
corresponding arm. Pearson 
product-moment correlations 
performed for water 
displacement and 3D image; 
also mean +SD 
Differences in volume 
between perometer and 3D 
are due to differences in arm 
length measured and arm 
movement and/or position 
during the scan (bend at the 
elbow). 3D image was able 
to pick up the volume of pen 
equivalent to less than 1% of 
arm volume. A high 
correlation between water 
displacement and 3D image 
of 0.98317; with mean for 
water displacement at 
1560.06+387.01; and for 3D 
image, it was 
1568.41+374.66 
3D method promising as 
correlates well with 
water displacement and 
picks up the small 
localised change in 
volume. Requires further 
research to address arm 
movement during the 
scan. Proposed research 
to look at breast cancer 
cohort to detect an early 
















25 people with 
lymphoedema 
Ethics and consent gained. 
Power analysis performed 
before the study. 
Volume of affected and 
unaffected arms taken using 
CTM, water displacement 
and 3D-camera by the same 
therapist.  The volume of 
hand was excluded. 
Study protocol described.  
3D camera overestimates 
volume compared to water 
displacement by 45.25 ml 
(CI=-36.31-126.82; p=0.27) 
CTM underestimates volume 
compared to water 
displacement 24.2 8ml     
(CI=-99.78-51.22; p=0.52) 
No statistical significance 
found between the three 
methods. 
Microsoft Kinect camera 
offers an alternative to 
CTM to measure the 
volume of the upper 
limb. 
Could be useful as an 
educational tool for the 
patient: graphical 
representation of shape 
illustrating change over 
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Two separate mixed-design 
ANOVA ‘s were used, and 
Bland-Altman plots. 
motivator to wear a 
compression garment. 











30 adult’s right 
arms (15 men 
and 15 women) 
Ethics and consent gained. 
Subjects recruited by 
convenience sampling; 
exclusion criteria 
incorporated. Study protocol 
described comparing 
SkanLab volumes to water 
displacement volumes by 
two raters and two 
replications. 
The statistical analysis 
looked at bias and limits of 
agreement between 
techniques which was 
determined by Bland-Altman 
method; intra- and inter-rater 
reliability was determined by 
ICC and SEM, and Student's 
t-test assessed duration of 
both tests. 
Bias of SkanLab was -
21.9ml (-5.7%) when 
measuring cylinder; and for 
arm volumes was -9.9 ml     
(-0.6%).  No significant 
relationship between total 
arm volume and accuracy; 
however, the relationship 
between BMI and accuracy 
was highly significant 
(p=0.004); high BMI can 
result in overestimation of 
total arm volume with 
SkanLab.  Intra- and inter-
rater reliabilities were very 
high (ICC >099).  Mean 
duration for water 
displacement was 2min 3sec, 
and for SkanLab 42sec. 
Duration for data cleaning 
using MeshLab was 8min 
35sec. 
SkanLab is a fast, safe 
transportable, hygienic 
and low-cost method for 
assessing total arm 
volume.  It has a high 
level of accuracy and 
reliability; thus has 
potential as a future 
clinical tool. 
Due to high accuracy 
can be used for persons 
at risk of lymphoedema 





To determine if 
people with BCRL 
can perform self-
measurement of arm 
volume reliably and 
validly by using an 
adaptive paper tape 





Ethics and consent gained.  
Inclusion and exclusion 
criteria identified. Limb 
volume measured by water 
displacement and arm 
circumference at six arm 
levels (including hand) using 
a plastic tape measure and 
then paper tape with loop 
Water displacement volume 
difference on day 1 was 
183,2ml (p<0.01) with a 
range of 1.8-40.0% excess 
limb volume. Self-measure 
reliability analysis: ICC 
show excellent values (ICC 
LO side 0.97-0.99; ICC non-
LO side 0.96-0.99).  Self-
Self-measurement by 
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can be tightened 
with one hand. 
form - volume calculated 
using the frustrum method. 
Procedure described. 
Descriptive analysis means 
(+SD) for continued 
variables and percentage for 
category variables. Self-
measurement, plastic tape 
and water displacement had 
test and retest reliability 
assessed within a day (day 1) 
and between days (day 1 and 
day 10) using ICC measure. 
Pearson correlations used to 
assess criterion-related 
concurrent validity between 
methods. 
measure validity analysis: 
Pearson correlation 
coefficient between self-
measure and water 
displacement was 0.59-0.68 
(p<0.01); and between self-
measure and the plastic tape 
was 0.88-0.95 (p<0.01). 





for measuring limb 
volume; determine if 
there is a difference 
between SEM of 
healthy versus 
lymphoedema limbs 









Ethical approval gained; 
participants volunteered – no 
record of consent gained 
from physiotherapists but 
consent gained from patients. 
Each therapist using 6 
points/landmarks on the limb 
measured both limbs three 
times.  Volume calculated 
using the truncated cone 
formula.  The SEM and 
mean scaled SEM were 
calculated, and differences 
were analysed by Kruskal-
Wallis non-parametric test. 
True mean differences of 
each therapist’s 
Average SEM for arm = 
27.5ml; for leg = 83.6ml.  
Mean scaled SEM for arm 
was 0.82% and for leg 
0.64%.  No statistical 
difference in scaled SEM for 
arm found (p=0.847); nor in 
leg (p-0.598). 
No statistical difference 
between healthy and LO 
limb in both arm (p=0.945) 
and legs (p=0.533). 
56% of the first 
measurement of arms was 
within 5% of true mean 
value; 80.5% for legs. 
Importance of using 
measured points as 
opposed to landmarks 
for measuring may result 
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measurements were 
calculated and differences 
calculated using Wilcoxon 
Rank Sum test. 
 
Study limitations identified: 
not all patients were 
measured by each therapist, 
thus reducing external 
validity of study; participants 
not assessed within their 
clinical teams may have 
influenced arm measurement 
results between groups. 
Cau et al., 2016 Develop a protocol 
for limb volume 
assessment using 
laser scanner 3D 
(LS3D), and 





12 healthy adults Ethics and consent gained. 
Circumference 
measurements (CM) 
performed by tape twice by 
both expert LO therapists 
and volume calculated using 
Frustrum method, and LS3D 
(taking 2-3min) by two 
different operators 
identifying same marks used 
during CM. Kolmogorov-
Smirnov test done to verify 
normal parameters; Mean 
and standard deviation (SD) 
or median and interquartile 
range done depending on 
data distribution; Wilcoxon 
test for intra-reliability and 
inter-reliability by Mann-
Whitney test.  Pearson 
correlation coefficient; 
Bland-Altman plots and non-
parametric tests performed. 
CM shows very good intra-
and inter-reliability.  
Excellent intra-and inter-
observer reliability with 
LS3D.  Very high correlation 
between CM and LS3D 
(R2=0.923; P<0.05). Study 
limitations identified. 
LS3D suitable for limb 
assessment as provides a 
quantitative objective 
evaluation of the 
diameters and volume of 
the arm quickly. LS3D 
can quantify treatment 
outcomes based on an 
accurate method. LS3D 
provides a representation 
of the upper limb - 











& Ulrich, 2016 










11 patients (22 
arms including 
hands) 
No mention of ethical 
approval or patient consent. 
Inclusion and exclusion 
criteria identified.  Two 
measurements were taken of 
both arms by 3D stereo-
photogrammetry and water 
displacement.  Study 
protocol described. 
Mean difference, variance 
and standard deviation for 
both methods were 
calculated. Variance 
component analysis was 
performed to determine the 
variance in both methods of 
measurement. 
Pearson's correlation 
coefficient determined the 
correlation between methods, 
and a Bland-Altman plot was 
computed. 
 
Mean volume difference in 
3D measure was 13ml and 
for water displacement 35ml 
Paired sample t-test showed 
no significant difference 
between the two 3D 
measures (p=0.33) and the 
two water displacement 
measures (p=0.84).  
There was a high correlation 
between the means with 
Pearson's correlation of 0.99 
(p=0.01) but does not signify 
the degree of agreement 
between the measurements. 
Delta values indicate that 3D 
measure overestimates the 
volume measured by water 
displacement by 11ml.  
Variances between measures 
had p<0.00.  High ICC for 
both water displacement 
(ICC=0.997; p<0.00) and 3D 
volume (ICC=1.00; p<0.00) 
measurements.   
3D 
stereophotogrammetry is 
an accurate and reliable 
method for determining 
upper limb volume 
measurements.  Results 
show a statistically 
lower variance 





whether 3D imaging 
can be used as a 
reproducible and 
useful tool for 
qualifying and 
quantifying 
lymphoedema of the 
hand 
Diagnostic Test 
Study – pilot 
study 








Ethics not obtained as review 
board had previously 
declared the tool as not 
harmful or invasive, but the 
study was done in 
compliance with 
international medical 
research ethics. Inclusion 
Mean volume difference 
between oedema hand and 
normal hand was 73 ml; 
mean difference between 
hands without oedema was 4 
ml, mean difference in the 
control group was 8 ml. 
Reproducibility showed an 
average difference of 5.2 ml. 
Tool effective and 
sensitive in measuring 
hand oedema; however, 
no comparison made to 
other methods of volume 
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15 healthy 
women 
and exclusion criteria 
identified. 
Both hands captured with 3D 
imaging. 
Study design described. 
Mean difference in hand 
volume calculated.  Kruskal-
Wallis test with post hoc 
analysis performed to 
determine significant 
differences between groups. 
Patient consent gained.   
Kruskal-Wallis analysis 
showed a statistically 
significant difference in hand 
volume between groups (chi-
square=1.89; p<0.00). Post 
hoc analysis showed a 
significant difference 
between people with hand 
oedema and control group 
(p<0.00), and between 
people with and without 
hand oedema (p<0.00).  No 
significant difference 
between non-oedema hand 














with no history 
of lymphoedema 
or breast cancer  
Ethics and consent gained. 
Participants’ height, weight 
and BMI recorded; 
measurements at set points 
on both arms were taken and 
truncated cone volume 
method used. 
The UEL index was 
calculated using 
circumferences and BMI. 
Arm volume and UEL index 
were compared with 
corresponding BMI groups. 
Statistical analysis used an 
analysis of variance. 
 
Mean arm volume was 
1090.9 ml and UEL index 
96.9. Statistically significant 
differences (p<0.001) in arm 
volume between BMI groups 
noted: Low-BMI (<20) vs 
middle-BMI (20-25); low-
BMI vs high-BMI (>25); and 
middle-BMI vs high-BMI. 
Mean UEL indices in low-
BMI= 97.2; middle-BMI= 




Japanese women only in 
study and water 




index allow for better 
body-type corrected arm 
volume evaluation 
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Peleg & Katz-
Leurer, 2017 
To assess the effect 










Sample size was calculated 
to 14 subjects. No ethics 
approval or consent gained 
reported.   
Study protocol described.  5-
point measurements of both 
arms taken and volume 
calculated with the truncated 
cone method.  Calculation 
corrections for handedness 
were taken into account. 
Two arm positions were 
measured: 90 shoulder 
flexion (horizontal) and arm 
dependent (vertical) 
alongside the body.  Three 
measurements were taken in 
each position. 
Kolmogorov-Smirnov test 
for normalcy was performed 
for volume outcome 
measures. Repeated-
measures analysis of 
variance used to assess 
differences in volumes in 
different positions; as well as 
paired t-test to emphasise 
absolute and relative volume 
differences. Intra-class 
correlation coefficient used 
for test-retest reliability. 
SEM used to measure 
absolute reliability. 
ICC values were excellent 
for both groups in both arm 
positions (ICC>0.997). 
BCRL group had a mean 
volume difference of 280ml 
in horizontal position and 
275ml in the vertical 
position; the healthy group 
had 84ml in horizontal and 
108ml in vertical positions. 
Non-significant interaction 
was found between arm size, 
position and group on arm 
volumes (F1,28=3.30, 
p=0.08).  Significant 
interaction noted in arm 
volume between positions 
and between groups 
(F1,28=4.42; p=0.04): volume 
difference with arm position 
change more significant in 
the healthy group than 
BCRL; significant 
interaction effect noted in 
arm volume between arms 
and groups (F1,28=10.45, 
p=0.003) with the difference 
in BCRL group larger. 
In BCRL group, larger arms 
had less volume shift 
(1.37%) in position change 
than small arms (1.61%); 
however, in the normal 
Measurements should be 
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Ethical approval and 
informed consent gained. 
group this was the opposite 
(large=3.36%; small=2.46%) 
Limitations included stage of 
BCRL limited to stage 2, and 
only two arm positions were 
studied. 





measurements of the 
hand and forearm 
with the use of a 
newly developed 
device for landmark 
placement, and the 







(5 male, 5 
female) 
Ethics and consent gained. 
Exclusion criteria identified. 
The study protocol is 
described.  After landmarks 
were placed, the hand was 
measured twice in neutral, 
and then 45 flexion and 45 
extension. 
Paired sample t-test used to 
determine intra- and inter-
rater comparison once mean 
differences were calculated 
for consecutive 
measurements. 
ICC was calculated to 
determine intra- and inter-
rater reliability.  
One-way ANOVA used to 
determine hand position 
during 3D imaging. 
Paired sample t-test showed 
no significant difference 
between measurements 
(p=0.75); no significant 
difference between intra-
rater (p=0.67) and inter-rater 
(p=0.50) measures. 
Both intra- and inter-rater 
reliability was excellent 
(ICC=0.99). 
No significant difference in 
hand volume with position 
neutral compared to 




Landmark allows for 
better reproducibility. 
Although 3D imaging is 
fast and low cost; it 
requires a highly skilled 
3D specialist to process 
the image data. 
Wang et al., 
2017 




volume differences,  
ii) impact of age and 





women of ages: 
20-39 yrs =55; 
40-54 yrs =79; 
54-64 yrs = 203; 
65-74 yrs =125; 
75+ yrs =22  
Ethics and consent gained. 
Inclusion and exclusion 
criteria identified. A single 
session with height, weight 
(for BMI) and arm 
circumference measured at 
10cm intervals and used the 
truncated cone method for 
The extent of dominance and 
location: Dominant limb 
circumference significantly 
larger than non-dominant 
limb and increased 
significantly from wrist to 
40cm location (Limb 
F1,4796=9.2, p=0.002; 
Revised thresholds are 
appropriate for detection 
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iii) population-
specific thresholds 
for Chinese women, 




volume calculation. Segment 
A=ulnar styloid to 10cm; 
Segment B=10-20cm; 
Segment C=20-30cm, and 
Segment D=30-40cm. Data 
presented as mean+SD for 
both arms and segments. 
Inter-limb differences 
expressed as mean (95% 
confidence interval [CI]). 
ANOVA determined 
whether limb and location 
along limb affected 
circumference or volume 
measurements. Duncan's post 
hoc tests identified where 
significant differences 
occurred. Absolute (ml) and 
relative (ratio) inter-limb 
differences calculated for 
volume and circumference. 
Inter-limb differences tested 
for outliers using Tukey "far 
out" test. Univariate 
ANOVA determined 
differences between absolute 
and relative measures; 
Duncan's post hoc analysis 
used to determine where 
differences occurred. 
Regression analysis used to 
determine if age or BMI 
related to inter-limb 
differences in circumference 
Location F4,4796=4820.3, 
p<0.001) with no interaction 
identified. Duncan's post hoc 
analysis showed a significant 
difference between 5 
locations. Limb volumes 
larger along length of limb 
(Limb F1,3840=6.6, p=0.01; 
Location F3,3840=2598.2, 
p<0.001) with no interaction 
identified. Duncan's post hoc 
analysis showed that each 
location volume differed 
significantly to each other. 
Absolute and relative 
differences: 8 cases removed 
in outlier test. Absolute mean 
inter-limb differences in 
circumference were 
significantly different 
ranging from 0.06cm at wrist 
to 0.32cm at 40cm location. 
Post hoc analysis showed no 
significant difference at 
locations. Absolute inter-
limb volume difference 
among segments differed 
with least mean volume 
difference in Seg A (3.1ml; 
95% CI: 1.6-4.7ml) and 
greatest in Seg D (10.2ml; 
95% CI: 7.4-13.0ml). Post 
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or volume. Thresholds for 
classifying women with LO 
determined for 
circumference and volume 
with diagnostic cut off at 
mean plus 2 and 3 times SD. 
between Seg B and C and 
between Seg C and D. Mean 
inter-limb relative 
circumference ratios differed 
significantly ranging from 
1.01 (95% CI: 1.00-1.01) at 
the wrist to 1.01 (95% CI: 
1.01-1.02) at 40cm location. 
Post hoc analysis showed 
wrist significantly different 
to 40cm location but not to 
others. Volume ratios not 
significantly different 
ranging from 1.01 (95% CI: 
1.01-1.02) to 1.02 (95% CI: 
1.02-1.03). Effect of age and 
BMI: Age and BMI did not 
affect any measures. 
Thresholds for detection of 
LO: No significant 
differences between inter-
limb circumference 
differences at 10, 20 and 
30cm; these were collapsed 
for a single cut-off point. 
2SD cut-offs for the 
dominant side were 0.7cm at 
the wrist, 1.8cm for 
collapsed sites and 2.3cm for 
40cm location. 2SD cut-offs 
for the non-dominant side 



























Ethical approval gained. 5 
point limb circumference 
measurements were taken 
(k=1-5) by two researchers. 
LAVI is defined as the 
percentage proportion of 1-
UELIk (upper extremity 
lymphoedema index = arm 
circumference and 
length/BMI) compared with 
s1-UELIk (standard localised 
UELI). 
Intra- and Pearson's 
correlation coefficient tested 
inter-rater reliability. 
Mann-Whitney U test 
analysed variability in body 
physique (high and low BMI 
groups). 
Interrater reliability of 
LAVIk ranged from 0.989 to 
0.997. Intra-rater reliability 
of LAVIk ranged from 0.983-
0.998. 
LAVI is less affected by 
body physique (BMI) 
compared with volumetry. 
Limitations include using 
circumferential tape measure 
as opposed to water 
displacement; women only 
and Japanese population 
only. 
Localised arm volume 
index is calculated only 
with Ck and BMI. It is a 
useful tool to detect 
localised arm volume 
change (even for 
bilateral BCRL). When 
LAVI is higher than 
100%, the region is 














and perometry, relate 
to each other when 





sample of 91 
patients: 52 
men, 39 women 
Ethics and consent gained. 
Sample characteristics 
described. Both arms were 
measured using CM and 
perometry for a length of 
40cm from the wrist. CM 
was measured once by the 
same investigator, had five 
girth measurements taken 
and used the truncated cone 
formula. Perometer was 
taken three times, and the 
mean of the limb volumes 
was utilised. Continuous 
variables are presented by 
A very strong correlation 
between the methods exists 
with Pearson's correlation 
coefficients of rV=0.99, 
rVD=0.88 and rPEV=0.86. 
Bland-Altman plots display a 
visual confirmation of the 
above.  On average, the 
largest arm by perometry 
was 10.6ml smaller than that 
of CM. LOA ranged from-
202ml to 181ml. LOA for 
volume difference of the 
same subject was -101 to 
141ml, with a mean 
Considerable 
measurement bias was 
found between the two 
methods; thus, a direct 
comparison of the two 
method's results should 
be made with caution. 
Limb volume is subject 
to change with time of 
day, temperature, 
hydration status and use 
of compression – 
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their median and 
interquartile ranges, and 
categorical variables by their 
absolute and relative 
distributions. Absolute 
volume (V) of the biggest 
arm, volume difference (VD) 
between arms and relative 
difference (PEV) between 
two arms were estimated for 
each subject.  The agreement 
between CM and perometry 
was compared for these three 
outcomes using Pearson's 
correlation and Bland-
Altman's method. Limits of 
agreement (LOA) were 
calculated to 95%. 
difference of 19.9ml, while 
PEV had a mean difference 
of 0.9%, with LOA ranging 
from -5 to 6.8%. Study 
limitations reported include 
10cm girth measurements as 
opposed to 4cm, CM 
measurement taken once, 
sample mainly non-
lymphoedema subjects, and 
excludes the hand in the 
assessment. 
Cau et al., 2018 Comparison of 
circumferential arm 
measurements (CM) 
by tape to 
measurements 
obtained by laser 
scanner 3D (LS3D). 
Prospective 
Cohort Study 
200 women with 
upper limb 
lymphoedema 
Ethics and consent gained. 
Inclusion and exclusion 
criteria mentioned. Both 
arms measured by 4cm CM 
and volume calculated using 
Frustrum method, and LS3D. 
Kolmogorov-Smirnov test 
done to verify normal 
parameters; Mean and 
standard deviation (SD) or 
median and interquartile 
range done depending on 
data distribution; Spearman 
correlation coefficient; 
Bland-Altman plots and 
Wilcoxon tests performed.  
Spearman correlation 
coefficient between volumes 
determined for LO arm was 
good (R2=0.738; P<0.05); 
for 'normal' arm was good 
(R2=0.762; P<0.05). 
LS3D could be a reliable 
and valid method to 
asses limb 
circumference and 
volume within LO 
clinic.  Has the ability to 
measure geometric and 
shape parameters.  Is 
less time consuming to 
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Karakashian, 
Shaban, Pike, 
& van Loon, 
2018 
Examine the use of 
3D cameras to scan 













Inclusion and exclusion 
criteria identified. R&D 
approval gained for service 




measurements to 3D 
imaging. Study protocol 
described. 
k-means clustering used to 
achieve patient grouping. 
Repeatability, ICC using 
McGraw and Wong 
formulations were analysed, 
and paired-sample t-test was 
used to distinguish healthy 
and affected arms using 
circumference and circularity 
measurements. 
Repeatability of 3D imaging 
demonstrated a 2.52 L 
standard deviation (SD) with 
a coefficient variation of 
0.99%.  A test-retest analysis 
of healthy subjects (ICC) 
was 0.95.  Low-resolution 
scans produced increased 
volumes of 5.76%; thus, 
high-resolution 3D imaging 
is advised.  Shape related 
metric such as circumference 
and circularity were used to 
distinguish between healthy 
and affected arms (p<0.05). 
Swelling maps were created 
to identify the distribution of 
swelling on arms which 
could be used for diagnosis 
and monitoring of 
lymphoedema. 
Shape as a measure of 
lymphoedema provides 
the potential for detailed 




Current methods of 
calculating limb volume 
assume arm is circular; 
as this is untrue, these 
methods could be 
overestimating limb 
volumes by 100ml. 
3D scan takes about 20 
to 30 seconds to 
perform; therefore is 
time-efficient. 
Landau, Kim, 
Gould, & Patel, 
2018 
Determine the 
feasibility of the 
Vectra 3D system to 




11 women with 
BCRL 
Informed consent gained; no 
mention of ethical approval. 
3D imaging of fist, forearm 
and upper arm to 15cm 
proximal to the olecranon. 
Circumferential 
measurements were taken 
every 4cm from ulnar styloid 
process to 15cm above 
olecranon, and water 
displacement (WD) 
performed up to 15cm mark.  
Each technique determined 
All measurements showed 
good agreement. 3D had 
excellent correlation with 
WD (R2=0.987) with an 
average difference of 2%. 3D 
had excellent correlation 
with circumferential volume 
(0.991) with an average 
difference of 2.8%.  Time 
taken to do 3D measure = 
5.9min; circumference = 
15.7min and WD = 24.9min 
3D imaging potential for 
clinical use as is fast, 
accurate, precise and 
reliable for measuring 
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limb volume. Microsoft 
Excel was used to calculate 
the averages, and standard 
deviations and R2 values 
were calculated using 







To investigate the 
reliability of Vectra 
XT for the 
measurement of arm 
volume in BCRL 
patients and to 
compare these 
results to volumes 





37 women with 
unilateral BCRL 
Ethics and consent gained. 
All participants had both 
arms measured twice by both 
WD and Vectra 3D imaging.  
Arm length is taken from 
30% to 80% of total arm 
length (measurement 
excluded hand volume). 
Power of analysis, p<0.05 
determined 33 participants 
required for the study. 
Participant characteristics 
and results were described 
using descriptive statistics.  
Pearson correlation 
coefficient to assess 
associations between WD 
and 3D imaging. Paired t-test 
applied to determine the 
mean volume differences 
between the measurements. 
Bland-Altman plots used to 
analyse agreement between 
the methods. Intra-rater 
reliability of WD and 3D 
imaging determined by ICC.  
Inter-rater reliability not 
assessed as has been 
Mean arm length was 
70.6cm (SD 3.1) for both 
arms. Validity: High 
correlation shown between 
WD and 3D for healthy arms 
(0.996) and BCRL arms 
(0.998). WD measured 
higher limb volumes than 3D 
but was not significant for 
healthy arms (p=0.058), but 
was significant for BCRL 
arms (p<0.001). Bland-
Altman plots show high 
agreement between 
measures. In healthy and 
BCRL arms, 86.5% and 
89.2% of the mean volume 
difference was less than 
50ml. Reliability: Intra-rater 
reliability for WD was high 
for both arms (ICC=0.998); 
for 3D, both arms had ICC of 
0.999. No limitations 
identified.  
3D imaging by Vectra 
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previously determined. A 




Sharkey et al., 
2018 





perometry to  
establish the most 
appropriate method 
for clinical practice 
and research, and to 
compare the 
accuracy and 





35 arm and 26 
leg volunteers:  
Student group 
measured 23 
arms and 22 
legs; Expert 
group measured 
12 arms and 14 
legs 
Ethics gained. Tape measure 
calculation used was the 
summation of 4cm points 
using πr2h. Perometer takes 
measurements at every 
4.7mm.  The student group 
was shown a video 
demonstrating measuring 
techniques and then 
measured the right arm or leg 
of a healthy volunteer twice.  
The expert group performed 
two measurements of each 
method. For inter-observer 
reliability, the mean and 95% 
confidence intervals (CI) 
were calculated.  For intra-
observer reliability, 
Cronbach's alpha was used to 
determine the correlation 
between measures. 
Tape measure: SE was lower 
in the expert group (expert 
SE=25; student SE=29.55); 
expert CI was narrower. 
Perometer: lower SE and CI 
for both groups. SE 
perometer for both groups = 
24.88 vs tape SE average = 
28.04 for arms and SE 
Perometer = 22 vs tape SE = 
114.10 for legs.  However 
expert group arms tape SE = 
25 vs Perometer SE = 38.99.  
Expert data shows excellent 
internal consistency with 
Perometer (Cronbach's 
alpha= 0.90) and tape 
(Cronbach's alpha = 0.94). 
Broadly, Perometer more 
accurate as had smaller SE 
and narrower CIs than tape. 
Major limitation is low 
numbers of participants; 
thus, no conclusive outcome 
made. 
The expertise of value 
for consistency of 
measurements.  
Perometer indicative of 
being more accurate 
than tape. 







selection of 287 
women with 
unilateral breast 
Ethical approval or consent 
not reported. All participants 
have both arms prospectively 
measured with perometry as 
The correlation coefficient 
was consistently >0.98 for all 
measurement methods when 
compared to perometry. 
Landmark measurement 
superior to interval-
based method; however, 
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compare perometry 
to volumetric tape 
measurement for the 






by BMI  
part of a local screening 
programme. Utilising these 
perometer data, simulated 
points were determined for 
4cm intervals, anatomical 
landmarks and 10cm 
proximal and distal to the 
elbow. Calculations of these 
points used the frustrum 
method and were compared 
to the perometer calculated 
volumes. The volume of the 
hand was excluded. 
Perometer measurements 
were treated as the reference 
technique for the analysis. 
The Bland-Altman method 
used to compute the mean 
difference with 95% 
confidence interval. Two-by-
two confusion matrix 
analysis performed for each 
simulated measurement 
against perometry, first for 
full cohort, then stratified by 
BMI. 
There was no significant 
difference in total arm 
volumes between all 
methods used and perometry. 
Anatomical landmark and 
10cm either side of elbow 
significantly underestimated 
upper arm volume compared 
to perometry; and 
overestimation of the 
forearm. For lymphoedema 
screening, the landmark and 
10cm method had greater 
sensitivity (93.1 and 90.3% 
vs. 81.9 and 77.8%), 
specificity (93.5% vs. 68.4 
and 92.6%), positive 
predictive value (82.7 and 
82.3% vs. 46.5 and 77.8%), 
and negative predictive value 
(97.6 and 96.6% vs. 91.9 and 
92.6%) compared to 4cm 
interval method. Methods 
comparable to perometry at 
relative volume change 
(RVC) of >10%; but 
sensitivity reduced to 63.2-
66.7% for RVC 5-10%. BMI 
did not affect confusion 
matrixes. Limitations 
identified include the 
inability to account for test-
retest reliability and human 
error of tape measurement 
upper arm volumes and 
overestimates forearm 







Sample Validity of Study Study Results Clinical Benefit 
due to simulation of the 
circumferences; and the 
exclusion of the hand due to 
limited research in 
perometry. 











30 patients and 5 
healthy 
volunteers 
Board-level approval gained. 
No consent reported. 
Baseline calibration: Two 
operators measured both 
arms of 30 patients three 
times. Lymphoedema 
diagnosed as volume 
difference of >10%. 
Repeatability, reproducibility 
and gage precision/tolerance 
(P/T) ratio were calculated. 
Regression analysis used to 
determine the association 
between BMI, height, or 
weight and variability in 
measurements.  Type I 
(overdiagnosis) and type II 
(underdiagnosis) errors were 
calculated. 
Larger group assessment: 23 
therapists of mixed skill 
level were divided into 
cohorts of 5-6 therapists who 
measured five healthy 
volunteers.  Type I and Type 
II errors were calculated for 
each of the cohorts. 
Optimisation of patient 
positioning: Handlebars and 
Baseline calibration: P/T 
ratio was 19.9%, 
repeatability 65%, 
reproducibility 19%. Type I 
error was 3.5% and type II 
2.3% based on 10% volume 
difference; for 5% volume 
difference, it was 18.2% for 
type I and 17.0% for type II 
error. Univariate analysis 
showed significance for BMI 
(p<0.001), height (p=0.003) 
and weight (p<0.001).  
Multiple regression showed 
height and BMI with the 
highest R-squared values 
(R2=16.27) 
Larger group: Type I error 
was 9.8% and type II 7.8% 
based on 10% volume 
difference, and for 5% 
volume difference it was 
25.9% for type I and 24.9% 
for type II errors. 
Optimisation: Reduced 
variation in limb volume by 
28% (p=0.02). 
Larger group: With 
experienced therapists, the 
Space for and cost of a 
perometer are 
prohibitive to many 
clinics. Standardisation 
of perometry procedure 
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wall bars were installed. One 
operator measured both arms 
of 20 patients three times in 
original and new position. 
Variation calculated by the 
standard deviation of the 
three measurements divided 
by the average of the mean 
of the three arm 
measurements. Student's t-
test used to compare two 
positions. 
New position larger group: 8 
therapists measured eight 
volunteers three times each. 
Type I and type II errors 
were quantified. 
CTM measurement: Four 
therapists measured both 
arms of 3 volunteers at 5 
points. Gag P/T ratio was 
calculated for: 
1) 2cm circumferential 
difference 
2) 10% volume difference 
gage P/T ratio was 6.5%, 
repeatability 2.4% and 
reproducibility 6.1%. Type I 
and type II errors were 0% 
for 10% volume difference, 
and for 5% volume 
difference type I error was 
0.04%, and type II was 
0.02%.  With a mixed skill 
group, the gage P/T ratio was 
18.7%, repeatability 15.0% 
and reproducibility 11.0%. 
CTM: Arm volume gage P/T 
ratio was 9.7% 
De Vrieze et 
al., 2019 
To investigate the 
reliability, time 
efficiency and 
clinical feasibility of 
five commonly used 
methods for 
assessing excessive 
arm volume in 
patients with BCRL 
Cross-Sectional 
Study 
30 women with 
unilateral BCRL 
Ethics and consent gained. 
Inclusion and exclusion 
criteria identified. Five 
methods of excessive arm 
volume determined: M1) 
Traditional volumetry with 
overflow, overflow is 
weighed; M2) Volumetry 
without overflow; upward 
Mean age was 65 years, and 
mean BMI was 28. Intra-
rater reliability showed ICCs 
ranging from 0.777 to 0.987. 
M5 had the highest ICC 
value. Inter-rater reliability 
had ICCs ranging from 0.791 
to 0.984, with M5 at highest 
ICC value.  Set up time: M2 
CTM considered as the 
most appropriate method 
for clinical practice. 
Limitations include a 
relatively small cohort, 
and a lower limb 
optoelectric device being 
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displaced water weighed 
when arm submerged; M3) 
Inverse water volumetry; 
shortness of water is 
measured; M4) Perometry 
(no hand volume); M5) CTM 
using truncated cone method 
(no hand volume).  Both 
arms measured at one visit 
and all measures repeated 
three times by two different 
raters.  VD calculated by 
subtracting non-oedematous 
from oedematous arm 
volumes. Blinding was 
preserved. The timing was 
captured as 1) preparation; 2) 
execution and 3) total time 
taken. Data analysis included 
descriptive statistics with 
mean +SD and median and 
interquartile ranges.  Intra-
class correlation coefficients 
used to examine inter- and 
intra-rater reliability 
(interpretations of outcomes 
described). SEM and paired-
samples t-test were applied. 
One-way ANOVA  assisted 
with post hoc analyses used. 
Data used to compile a 
ranking table to include 
reliability and timing of each 
method 
required the least time (4min 
40sec); with a statistically 
significant difference 
between M1 and M2 
(p<0.01). Execution time: 
M2 had the lowest time (56 
sec), M3 had the highest 
time (5min 34sec) (p<0.01).  
Total time: M4 fastest (1min 
43sec); all others statistically 
significantly different 
(p<0.05). Ranking table: M5 
scored the highest overall 
rank 
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Karakashian, 





elucidating the effect 







23 women with 
unilateral BCRL 
R&D approval and consent 
gained. 3DCI images of 
lymphoedematous arms were 
utilised for the simulation of 
mathematical geometries 
looking at the effects of sub-
garment pressures, 
subcutaneous stresses and 
strains. The forearm segment 
of the lymphoedema arm 
was used. Equations are 
provided for each simulation. 
Delivered pressure and 
Laplace Law: due to non-
circularity of the forearm, 
higher pressures are recorded 
at the mid-forearm – higher 
than the wrist (i.e. negative 
gradient pressure).  Higher 
mean maximum pressures 
were recorded at 5100 Pa, 
even though intended 
pressure from manufacturer 
is 2500 Pa.  Subcutaneous 
stresses and strains: adipose 
tissues follow garment 
pressure patterns more 
closely than stiffer tissues.  
Ironically there was a 
positive gradient pressure in 
the subcutaneous tissues 
under the garment pressures. 
Limitation identified 
was that garment 
properties and 
geometries were not 
included in this work. 
This mathematical 
modelling informs 
clinical effect and use of 
compression garments 
and can inform a 
garment's design, 
leading to optimal 
treatment plans. 
Lu & Dixon, 
2019 
To demonstrate that 
a single stationary 
Kinect for Windows 
v2 IR sensor, in 
conjunction with a 
custom image 
processing 
algorithm, is a tool 
that can be 
implemented in a 
clinical setting to 
calculate arm 
volume in BCRL 
Diagnostic Test 
Study 




Consent gained. Inclusion 
and exclusion criteria 
identified. Protocol for 
Kinect IR system and 
perometer described. Linear 
regression analysis was 
performed to determine the 
level of correlation between 
the perometer and Kinect IR 
system. A Bland-Altman plot 
was used to compare the two 
methods with regards to limb 
volume difference. Cohen's 
kappa agreement for 
Arm volumes in relation to 
limb length had a correlation 
between the perometer and 
Kinect IR system of 0.84. 
With matched arm lengths, 
the correlation value 
increased to 0.88. Percentage 
difference correlation was 
good with R-squared ranged 
at 0.63-0.71.  The Cohen's 
kappa coefficient indicates 
fair agreement with 10% 
volume difference (k=0.27) 
and moderate agreement 
The Kinect IR system is 
a fast, cost-efficient and 








Sample Validity of Study Study Results Clinical Benefit 
with requisite 
clinical accuracy 
categorical data was utilised 
to compare the outcomes of 
both modalities using 
lymphoedema thresholds. 




with 200 ml difference 
(k=0.55). Bland-Altman 
analysis of volume 
differences indicated a bias 
of 6.02 ml; thus, a minor 
correction factor would be 
necessary between the two 
modalities.   Limitations 
identified include the cost of 
the system – cheaper than the 
perometer; inability to 
calculate volume based on an 
elliptical cross-section, and 








To develop and test 
the reliability and 
validity of a written 
and video-supported 
protocol for women 







20 healthy;  
21 BCRL 
Consent gained. Inclusion 
criteria identified.  Methods 
of measurement described: 
1) CTM home self-
measurement, 2) CTM lab 
self-measurement, 3) CTM 
therapist measurement, and 
4) perometer measurement. 
Analysis conducted for each 
group of participants, and the 
affected and unaffected arms 
in BCRL group. Intra- and 
interrater correlations (ICC) 
were calculated using 95% 
confidence intervals. Pearson 
correlation and levels of 
agreement between lab self-
measurement and perometer 
were calculated to determine 
Non-BCRL group: high to 
excellent intrarater reliability 
between 1) and 2) 
(ICC>0.86, 95% CI o.64-
0.94, p<0.001). Interrater 
reliability was high to 
excellent between 2) and 3) 
(ICC>0.88, 95% CI 0.67-
0.96, p<0.001). Correlation 
between 2) and 4) was 0.95 
(p<0.001).   
BCRL group: excellent 
intrarater reliability between 
1) and 2) (ICC>0.93, 95% CI 
0.83-0.97, p<0.001). 
Interrater reliability between 
2) and 3) was excellent 
(ICC>0.91, 95% CI 0.41-
0.98, p<0.001). Correlation 
Self-monitoring of limb 
size may be a cost-
efficient means of early 
identification of BCRL 
to commence earlier 
treatment and better 
prognosis. Those with 
BCRL can detect 
exacerbations and seek 
help more quickly; or 
can be used a means of 
self-monitoring of the 







Sample Validity of Study Study Results Clinical Benefit 
criterion validity. Bland-
Altman plots used for lab 
self-measurement and 
perometer mean differences 
(%). Self-reported ease of 
performing the measurement 
at home versus the lab was 
compared using t-test. 
between 2) and 4) was 0.98 
(p<0.001).  
No limitations were 
identified. 
Spinelli et al., 
2019 
To develop and 
assess intra- and 
interrater reliability 
and validity of a 
clinical evaluation 
tool for BCRL, for 
use in the context of 
outcome evaluation 










Ethics and consent gained. 
Inclusion and exclusion 
criteria defined. The new 
BCRL of the Upper 
Extremity (CLUE) tool is 
validated against perometry 
and the Norman 
lymphoedema survey. CLUE 
consists of 1) obscuration of 
the anatomical architecture 
which was rated as none, 
close inspection, or readily 
apparent; 2) anatomical 
contour which was rated as 
none, readily apparent or 
gross deviation; 3) tissue 
texture assessment which 
was rated as normal, spongy, 
firm or hard; and 4) pitting 
or non-pitting oedema 
present which was rated as 
none, non-pitting or pitting. 
A sophisticated scoring 
system ranges from 0 to 72, 
where 0 indicate no 
lymphoedema. 
CLUE tool excludes 
Stemmers sign and skin folds 
due to low presentation 
within-study sample. The 
intra-rater reliability for 
perometry had an ICC of 
0.93 (95% CI, 0.72-0.99); 
the ICC for CLUE was 0.88 
(95% CI, 0.71-0.96). The 
interrater reliability for 
perometry was 0.98 (95% 
CI, 0.97-0.99), and for 
CLUE the ICC was 0.90 
(95% CI, 0.79-0.95). Pearson 
product-moment correlation 
coefficient between  CLUE 
and perometry was 0.79; 
between CLUE and Norman 
lymphoedema survey ranged 
from 0.40 to 0.53. 
Limitations included 
experienced therapists only 
as raters, inability to recruit 
sufficiently into all 
lymphoedema categories, 
and the use of lymphoedema 
The CLUE tool aims to 
provide an outcomes 
score that can be utilised 
in clinical trials to 
standardise measures of 
improvement.  CLUE 
could be an outcomes 
tool in clinical practice 








Sample Validity of Study Study Results Clinical Benefit 
Descriptive data were 
derived for the three tests 
and reported within a stage 
of lymphoedema. ICCs 
calculated to determine intra- 
and interrater reliability with 
a 95% confidence interval. 
Pearson product-moment 
correlation coefficients to 
determine validity between 
the three tests was performed 
with scatterplots for graphic 
representation. 
severity being reduced to a 
single score being of value 
clinically. 
Binkley et al., 
2020 
To estimate the 
reliability and 
validity of the 
LymphaTech for 
measuring arm 
volume in the 
context of women 








66 women with 
BCRL or at risk 
of BCRL: 
30 with BCRL, 
36 at risk 
Informed consent gained. No 
ethics approval, but study 
approval was granted by the 
LymphaTech Institutional 
Review Board   Protocol for 
each device was given. 
Reliability Design: A 
convenience sample of 30 
participants was measured 
twice by each device: two 
measurements by two raters 
were taken by LymphaTech 
device, and perometer had 
two measurements by one 
rater. 
Validity Design: 66 
participants have at least one 
paired measurement on each 
device. 
Analysis included means and 
SDs for participant 
Participant time of cancer 
treatment was current or 
within 3 years of initial 
diagnosis and treatment. 
Majority had bilateral 
mastectomy with 
reconstruction, average 
number of lymph nodes 
removed was eight, and 
approximately 50% had 
radiotherapy.  
Reliability: LymphaTech and 
Perometer had ICC of >0.99 
for a single measure, and 
0.97 for limb VD.  SEM for 
LymphaTech and perometer 
single measure was 28.3-
35.8ml, and for limb VD it 
was 38.0-40.7ml. 
Mean volume for 66 limbs 
was 2215.9 (SD=637.7)ml 
Arms >3000ml has more 
error associated with 
volume estimations for 
both LymphaTech and 
perometer.  Error is 
reduced by averaging 
two measurements.  
The device is portable, 
thus easy to use in 







Sample Validity of Study Study Results Clinical Benefit 
characteristics as continuous 
measures, and counts or 
percentages for categorical 
data.  Estimates of all 
parameter included 95% CIs.  
Analysis performed using 
STATA v15.1.  Inter-rater 
reliability was tested for 
LymphaTech and intra-rater 
reliability for perometer, and 
validation analyses 
performed included Bland-
Altman plot and ICC. 
for LymphaTech and 2223.7 
(SD=622.2)ml for perometer.  
Thus, LymphaTech 
underestimates volume 
compared to perometry by 
7.8ml. 
Validity: ICC was 0.99 (95% 
CI=0.98-0.99) for affected 
limb; and ICC was 0.98 
(95% CI=0.97-0.99) for 
unaffected limb. Agreement 
showed a mixture of either 
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From: Cheryl Pike (ABM ULHB - Lymphoedema) [mailto:C   
Sent: 11 March 2016 12:54 
To:  
Cc:  
Subject: RE: CHHS and CoM Research Ethics Committee  
 
Dear Dr. Hewitt, 
 
Many thanks for taking the time to talk through the points for clarification. 
 
1)      I am in the process of submitting the research project for NRES approval and am 
working closely with Anne-Claire Owen from ABMUHB Research and Development 
department to ensure all processes are followed. 
2)      As advised by yourself, the debrief summary is no longer required as the queries below 
will answer any concerns raised regarding the normal processes that take place in a 
lymphoedema clinic and lymphoedema assessment. 
3)      I have attached a revised version of the consent form that I hope will be less 
cumbersome to read and will be clearer for a patient to understand what they will be 
agreeing/ consenting to.  I have thus changed the ‘wordy’ paragraph into two points for 
consent. 
4)      Appointments at 2, 4 and 6 months are not part of the normal process.  The ‘normal’ 
lymphoedema pathway for a patient is to be seen 3 months following their initial 
assessment.  At this time the clinician and patient can decide upon a further review 
between 6 and 12 months.  For purposes of the research study we need to gain as much 
data as possible to ensure the data being collected from the new 3D camera is as accurate 
as the ‘research gold standard’ volume measurements utilising the perometer, and is 
comparable to the circumferential measurements that are standard practice within a 
lymphoedema clinic.  We also want to see if the 3D camera is sensitive enough to pick 
up small changes over time. 
5)      The sensitive questions regarding sexuality and anxiety is normal practice and is 
integral to the normal lymphoedema assessment.  As therapists we need to understand 
how the lymphoedema is affecting the patient on an emotional level so that they can be 
referred for emotional / psychological support as needed.  The reason for it being 
repeated in the last session is to determine whether or not the treatment that has been 
agreed between the patient and the lymphoedema therapist is helping them or whether 
it is adversely affecting them emotionally – again to determine whether the patient needs 
more support outside of the lymphoedema clinic. 
 
Should you require further clarification on the above; or if the consent form needs further 





National Macmillan Innovations Lymphoedema Specialist 
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From:   
Sent: 10 March 2016 22:11 
To: '  
Cc:  
Subject: CHHS and CoM Research Ethics Committee  
Dear Cheryl 
 
Reference Number: 10316 
 
The CHHS and CoM Research Ethics Committee has met to consider your proposal and 
asks that you respond to the following queries before approval is granted: 
 
•             NRES approval should be sought. 
•             A debriefing summary is required. 
•             The last paragraph of the consent form is very wordy and should be revised. 
•             Are the appointments of 2, 4 and 6 months part of the normal process? 
•             Is the information collected (questionnaire) part of the normal process? If not, 
why is the applicant asking about sexuality, anxiety etc… and why only on the first and 
last session? If this information is not part of the normal assessment process and is being 
collected for research purposes, then there is a risk of participant distress which should 
be identified in the application and strategies for dealing with potential distress should 
be described.  
 
Approval may now be dealt with by Chair's action. Please respond in an email to me 
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______________________________________________________________________________________________________________ 
Department of Philosophy, History & Law /  Uwch Ddarlithydd, Adran Athroniaeth, Hanes a’r 
Gyfraith 
College of Human and Health Sciences / Coleg y Gwyddorau Dynol ac Iechyd 
Swansea University / Prifysgol Abertawe 
Singleton Park / Parc Singleton 
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APPENDIX 5: Participant Information Sheet for Study 
 
Participant Information Sheet 
Version 3 
16 June 2016 
 
Study Title 
Exploiting 3D scanning technology in lymphoedema for accurate and fast measurements 
of volume and shape 
 
Introduction 
You have been invited to join a research study and this sheet tells you about the piece of 
research and what you would have to do. If you have any other questions please ask any 
of the persons below for more information – their contact details are at the bottom of the 
page. 
 
What is the purpose of this study?  
In an attempt to improve how lymphoedema is measured in a person’s limbs, we would 
like to compare three different ways of measuring your arm at your appointment.  The 
standard measurement is performed by using a ruler and/or tape measure to mark 4cm 
on both your arms, and then taking the circumferential measurements at each of these 
points.  These measurements are then entered into a database that calculates how much 
fluid you have on your affected side compared to your unaffected side.   
 
The two other measurements will include a machine called the perometer and a 3D 
image.  The perometer is a laser scanner that slides up and down your arm which can 
compute the size of your arms to help the therapist determine how much bigger your 
affected side is to your unaffected side.    
 
The final measurement is a new 3D camera which takes images of your arms and will 
then be analysed by a new computer programme.  The data will also tell us how much 
bigger your affected arm is to your unaffected arm, but in addition it will produce images 
that can help the therapist determine where your problem areas are. 
 
The information we get from all the tests will be used to compare how effective this new 
3D image is compared to the standard measurement (tape measure) and the research 




It is hoped that in the future this new 3D imaging can be used in lymphoedema clinics 
to help therapists understand your lymphoedema and provide a more individualised 
treatment programme for you. 
 
Why have I been invited to take part?  
All people who have been referred to the ABMU LHB Lymphoedema Service for 
assessment and management of their arm lymphoedema will be invited to partake in this 
research.  The assessment will form part of your normal assessment and treatment for 
your lymphoedema. 
 
Do I have to take part?  
No, participation is voluntary and you can withdraw at any time without your treatment 
being affected. 
 
Expenses and payments 
No reimbursement of travel or out of pocket expenses will be provided. 
 
What will I have to do?  
If you take part in this study you will be asked to attend for the following visits:  
 
 First/ Initial Assessment.  This will be done at Singleton Hospital and will take 
about 60 to 90 minutes to complete.  The appointment will include a full 
assessment of your lymphoedema, measurements as described above and an 
explanation of what lymphoedema is and how to manage it.  
 
 2 month, 4 month and 6 month follow up to include the above measurements to 
determine how effective the management of your lymphoedema is.  These 
visits are not part of standard care but unfortunately any travel expenses cannot 
be reimbursed. 
 
What is the time commitment? 
It is anticipated that the assessment will take between 60 to 90 minutes to perform the 
consent, the person's medical and lymphoedema history, volumetric measurements and 
commence management of the person’s lymphoedema.  
 
Each follow up (2, 4 and 6 months) will take between 40 to 50 minutes to perform the 
volumetric measurements and ensure that the lymphoedema management is effective for 
the person. 
 
What are the possible disadvantages and risks of taking part?  






What are possible benefits of taking part?  
The aim of this study is to validate a new 3D camera image that would offer more 
accurate measuring of a person’s limbs thus offering the potential for a more 
individualised treatment programme. 
 
What happens when the research stops?  
This study involves the 4 visits described above and afterwards you will continue with 
the national Lymphoedema Pathway for your lymphoedema management.  
 
What if there is a problem?  
If you feel unwell or suffer any unusual discomfort during the study it is important to 
inform your study nurse or therapist as soon as possible. Any complaint about the way 
you have been dealt with during the study or any possible harm you might suffer will be 
addressed. The normal NHS complaints mechanisms will be available to you.  
 
Will your taking part in this study be kept confidential?  
All information that is collected about you will be kept strictly confidential. All data 
collected about you during the study will be made anonymous by allocating you a unique 
number. We will follow ethical and legal practice and all information about you will be 
handled in confidence. The results of this research might eventually be published and 
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APPENDIX 6: Patient Letter for Pilot Study 
Date: xx/xx/xxxx 
 
ABMUHB Lymphoedema Service 
Singleton Hospital, Swansea  
   SA2 8QA 
 Tel:  
 
Patient Letter 
Version 1 - 25 January 2016 
 
Dear Sir / Madam 
 
Study Title: Exploiting 3D scanning technology in lymphoedema for accurate and fast 
measurements of volume and shape 
 
Please find enclosed a ‘Patient Information Sheet’ in which we explain the purpose and the plan 
of this study at the ABMUHB Lymphoedema Clinic based at Singleton Hospital. 
 
The study is to look at new means of assessing people who have swelling of their arm to 
determine if there is a better, more accurate and time saving way of assessing lymphoedema. 
 
Please read the attached information carefully and should you have any queries about the study, 
please contact myself ( ) or Sian Clement, Lymphoedema Service Lead (  
), for clarification. 
 
Please note that there is no pressure on you to accept to be a participant in this study and it will 
not affect your treatment in any way should you choose to join the study and then later withdraw. 
 
Please let us know whether you would like to be a participant or not before your appointment.   
 
At your appointment you will be asked by your therapist whether you have read and understood 
the ‘Patient Information Sheet’ and you will be given an opportunity to ask questions.  You will 
then be asked to sign a consent form before any of the study questions and examinations are 
performed. 
 


















APPENDIX 8: Consent Form 
Patient Identification Number for this trial: _ _ _ 
CONSENT FORM (version 4.1, 16 Jun 2016) 
Title of Project: Exploiting 3D scanning technology in lymphoedema for accurate 
and fast measurements of volume and shape 
Name of Researchers: Cheryl Pike, Dr Raoul van Loon 
Please initial  
all boxes       
1. I confirm that I have read and understand the information sheet 
dated 16 June 2016 (Version 3) for the above study.  I have had 
the opportunity to consider the information, ask questions and 
have had these answered satisfactorily. 
2. I understand that my participation is voluntary and that I am free 
to withdraw at any time without giving any reason, without my 
medical care or legal rights being affected. 
3. I understand that relevant sections of my lymphoedema notes and 
the data collected during the study may be used by designated 
individuals from ABMU Health Board and Swansea University 
for purposes of the research as outlined in the patient information 
sheet.   
4. I give permission for the designated individuals as described in 
point 3 above to have access to my lymphoedema notes and 
research data. 
5. I agree to take part in the above study.    
 
            
Name of Participant   Date    Signature 
            
Name of Person taking consent  Date    Signature  














Cheryl Pike (CI) 
Sian Clement (PI) 
Exploiting 3D scanning technology in lymphoedema for 
accurate and fast measurements of volume and shape 
 
STUDY ReDA NUMBER STUDY SPONSOR RISK ASSESSMENT COMPLETED BY 
IRAS Project ID: 193784 ABMUHB R&D Cheryl Pike 
 
1. SCALE OF RESEARCH:  
Number of Participants to 
be Recruited 







0-50  Minor Risk 
Maximum 20 participants to 
be recruited 
 
2. PATIENT POPULATION: 
Patient Population 
Involved in Study: 







Subjects able to give 
consent - may benefit from 
taking part 
 Minor Risk 
The new 3D scan will provide 
information about the extent 
of lymphoedema and the 
areas most affected 
 
3. INTERVENTION/ LITIGATION: 
Procedures/Interventions 
Involved in the Study: 























Study team have up to date 
training in Good Clinical 
Practice 
 Minor risk 
 
 
5. MONITORING ARRANGEMENT: 
Study type and Monitoring 
Arrangements: 







GCP compliance monitoring 
undertaken Quality Assurance 
Officer/funder/external 
sponsor as part of the protocol 
 Minor risk 
 
 
6. INFORMATION/PERSONAL DATA: 
Nature and Use of Data: 







Data anonymised or 
pseudonymised 
 Minor risk 
 
No data sent outside EU  Minor risk 
 
Clear provision for archiving  Minor risk 
 
Clear processes for result 
dissemination 
 Minor risk 
 
Data stored in secure site  Minor risk 
 
 
7. PROTOCOL:  
Protocol Detail and 
Quality: 







Clear complete rationale 
and scientific justification 
 Minor risk 
 
Clearly defined proposal  Minor risk 
 
Clear guidance for protocol 
violation 





8. FINANCE: Investigator to discuss with R&D Finance Manager 
Financial Details: 







Partially funded research 
with directorate picking up 
the excess 





Quality and Information: 







Clearly defined process for 
informed consent with 
named designation of 
responsibility 
 Minor risk 
 
Clear defined recruitment 
process 
 Minor risk 
 
Patient given at least 48 
hours to consider taking 
part 
 Minor risk 
 
Clearly identified risk and 
benefit 
 Minor risk 
 
Clear and concise consent 
form and patient 
information sheet 
 Minor risk 
 
 
Overall Assessment Score: To be completed by investigator 
To assess overall scores please count amount of ticks under each risk level (ie 1 Scale of Research, 2 Patient 
Population etc.) and enter in the columns below 
 
 No Risk Minor Risk Moderate 
Risk 
High Risk Major Risk 
1. Scale of 
Research 
 1    
2. Patient 
Population 
 1    
3. Intervention 1     
4. Investigator   1    
5. Monitoring 
arrangement 
 1    
6. Personal 
Data/Information 
 5    
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7. Protocol  3    
8. Finance  1    
9. Consent  5    
TOTAL 
(NUMBER)** 
1 18    
 
PROJECT GRADED AS  (highest number) 
(Eg Total (number)** - No risk = 0, Minor risk = 3, Moderate risk = 10, High risk = 9, Major risk 
= 3 then the study is scored as “Moderate Risk”) 
 
 No Risk           Minor Risk           Moderate Risk        High Risk       
 Major Risk 
   
R&D Office use only 












APPENDIX 10: 3D Study Assessment Form 
Lymphoedema History 
Date of lymphoedema diagnosis:       
Type of Lymphoedema:  Primary      Secondary 
Cause of Primary:      Milroy’s Disease     Meige’s Syndrome    Unknown  
 Vascular Malformation   Klippel-Trenaunay-Weber Syndrome  
 Turner’s Syndrome    Lymphoedema Distichiasis  
 Other:           
Cause of Secondary:  Trauma (not surgery)     Infection       Inflammation  
 Cancer (malignant/tumour)    Cancer (treatment)    Venous Disease    
 Obesity       Lipoedema        Factitious      
 Immobility & Dependence      Other:       
Upper Limb:   Upper arm     Forearm     Wrist  Hand 
Affected side:  Left  Right  Dominant side:  Left  Right 
Exacerbating factors:           
Improving factors:           
Family History of Lymphoedema:  Yes   No   N/A 
Medical History 
Cancer History:  Yes    No  Type:       
Surgery (date / type):           
Lymph Node Excision:  Yes    No    No. removed:       No. positive:   
Radiotherapy (date / location):         
Chemotherapy:  Yes    No  Hormone Therapy:  Yes    No  
Other Medical History 
CVA / TIA   Yes    No Detail:        
Cardiac/Respiratory  Yes    No Detail:        
Vascular/Arterial   Yes    No Detail:        
Diabetes   Yes    No Detail:        
Thyroid   Yes    No Detail:        
Skin Condition   Yes    No Detail:        
Weight History   Yes    No Detail:        
Arthritis   Yes    No Detail:        
Mobility Problems  Yes    No Detail:        
Cellulitis Episodes:  Yes    No No. of episodes within last year:    
Prophylactic antibiotics prescribed:  Yes    No   Detail:     
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Other medical conditions:         
           
            
 
Medication:            
           
            
 
Allergies: 
Penicillin:  Yes    No   Latex:  Yes    No 
Elastoplast:  Yes    No    Other:       
 
Social History: 
Occupation:      Hobbies:      
Smoke    Yes    No Detail:          
Alcohol   Yes    No Detail:          
Mobility  Independent      Aids          Wheelchair      Bed bound   
 
Lymphoedema Management - Lymphoedema treatment received (tick all relevant):  
 No treatment   Skin Care Advice         Lymphoedema Exercises 
 Simple Lymph Drainage  Compression Garment  Weight Management  
 Manual Lymph Drainage  MLLB (including 3M)  Lymphassist 
 Deep Oscillation Therapy   Kinesiotape  Laser   Other:    
 
Please indicate type if previously had compression garment:  
 Ready to wear  Made to measure    N/A 
 
Make of compression garment:   Material of garment: 
 Activa       Circular Knit 
 BSN        Flat Knit 
 Haddenham Healthcare 
 Juzo       Compression Class (RAL): 
 MediUK       ccl 1 
 Sigvaris       ccl 2 
 Venosan       ccl 3 
 Other:        ccl 4 
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No. of days per week you wear your garment:   
a. One to two days      
b. Three to four days     
c. Five to six days                                     
d. Every day                                           
e. Not wearing garment 
f. Not applicable 
     
No. of hours you wear your garment: 
a. Nil 
b. 1-5 hours 
c. 6-12 hours 
d. 13 plus hours 
e. Not applicable 
 
Impact of Lymphoedema 
Distress Thermometer 
Using the thermometer, write down the number (0 to 10) 
that best describes how much distress* you have felt in the 
past week, including today: 
 
* Distress is a term used to describe unpleasant feelings 
or emotions that may interfere with your ability to cope with 
lymphoedema, its physical symptoms and its treatment. 
Distress covers a wide range of feelings including anger, 
frustration, sadness, fear, depression, guilt and anxiety. 
 
a. How anxious does your lymphoedema make you feel?    
b. Does your lymphoedema affect your body image?    
c. Does your lymphoedema affect your sexuality?    
d. What effect does lymphoedema have on your hobbies?    
e. What effect does lymphoedema have on your work?    
f. What effect does lymphoedema have on you when shopping for clothes?  
  
g. What effect does wearing a compression garment have on your life?  
   





Visual analogue scale (0-10). Rate your pain and then heaviness of your lymphoedema 
arm using the scale below: 
 
    0 (nothing)       10 (excruciating) 
 




Discolouration:  No  Yes  Detail:        
Temperature:  Normal  Cold   Hot 
Skin:   Normal   Dry        Fragile   Blisters  
 Taut    Shiny   Ulcers   Hyperkeratosis 
   Skin folds   Eczema   Fungal infection     Lymphorrhoea  
   Papillamatosis    Other:       
Tissue:  Pitting  Non-pitting    Fibrosis  Fatty   
 Hard/solid   Firm   Soft 
Shape :  Normal   Distorted   Detail:       
Stemmer’s Sign (affected hand):   Positive     Negative 
 
Range of Movement: 
 RIGHT LEFT 
100% 75% 50% 25% 0% 100% 75% 50% 25% 0% 
Shoulder           
Elbow           
Wrist           








Staging of Lymphoedema 
ISL Staging of Lymphoedema:     
 Stage 0 – Latent       
 Stage I – Reversible     
 Stage II a – Pitting      
 Stage II b – late stage II – Non-pitting   
 Stage III – Elephantatic  
    
BLS Grouping of Lymphoedema: 
 Group 0 – Latent (high risk)  
 Group 1 – Early Lymphoedema (LO) 
 Group 2 – Uncomplicated (established) LO  
 Group 3a – Complex LO: one limb 
 Group 3b – Complex LO: multiple limbs 
 Group 3c – Complex Midline Lymphoedema 
 (Group 4 – Palliative) 
 
Tests: 
3D photo:   Left arm  Right arm  Time taken:     
Perometer:  Left arm  Right arm  Time taken:     
Limb volume measurements:  Measure 1  Time taken:     





Limb Volume 1 
 
 
Limb Volume 2 
Right Left Right Left 
Hand   Hand   
First Mark: 
cm 
1   1   









3   3   
4   4   
5   5   
6   6   
7   7   
8   8   
9   9   
10   10   
Distal Volume mls   Distal   
 
1   1   
2   2   
3   3   
4   4   
5   5   
6   6   
7   7   
8   8   
9   9   
10   10   
Proximal Volume mls   Prox   
Total Volume mls   Total   
Excess mls  Excess ml  
Excess %  Excess %  
Distal Volume Diff ml % Distal ml % 
Proximal Volume Diff ml % Prox ml % 




Problem List       
 Severe complicated swelling        
 Moderate swelling       
 Mild swelling        
 Prevention of LO      
 Dry skin         
 Decreased ROM       
 Scar problems      
 At Risk           
 Excess Body Weight       
 Mobility Problems      
 Psychosocial       
 Other:          
 
Treatment Plan 
 No treatment  Skin Care Advice   Lymphoedema Exercises 
 Simple Lymph Drainage  Compression Garment  Weight Management  
 Manual Lymph Drainage  MLLB (including 3M)  Lymphassist 
 Deep Oscillation Therapy  Kinesiotape    Laser 
 Other:         
 
Type of garment:  Ready to wear  Made to measure   N/A 
 
Garment:  Issued by clinic   Prescription issued 
 
Make of compression garment:   Material of garment: 
 Activa       Circular Knit 
 BSN        Flat Knit 
 Haddenham Healthcare 
 Juzo       Compression Class (RAL): 
 MediUK       ccl 1 
 Sigvaris       ccl 2 
 Venosan       ccl 3 




1st Follow-Up (2 months) 
 
Lymphoedema Management - Lymphoedema treatment received (tick all relevant):  
 No treatment  Skin Care Advice   Lymphoedema Exercises 
 Simple Lymph Drainage  Compression Garment  Weight Management 
 Manual Lymph Drainage  MLLB (including 3M)  Lymphassist 
 Deep Oscillation Therapy  Kinesiotape    Laser 
 Other:         
 
Problem acquiring garment?  Yes  No  N/A Details:     
 
No. of days per week you wear your garment:   
a. One to two days      
b. Three to four days     
c. Five to six days                                     
d. Every day                                           
e. Not wearing garment 
f. Not applicable 
     
No. of hours you wear your garment: 
a. Nil 
b. 1-5 hours 
c. 6-12 hours 
d. 13 plus hours 





Follow-Up Assessment (2, 4, 6 month) 
Subjective Assessment 
Visual analogue scale (0-10). Rate your pain and then heaviness of your lymphoedema 
arm using the scale below: 
 
  0 (nothing)       10 (excruciating) 
 




Discolouration:  No  Yes  Detail:        
Temperature:  Normal  Cold   Hot 
Skin:   Normal   Dry        Fragile   Blisters  
 Taut    Shiny   Ulcers   Hyperkeratosis 
   Skin folds   Eczema   Fungal infection     Lymphorrhoea  
   Papillamatosis    Other:       
Tissue:  Pitting  Non-pitting    Fibrosis  Fatty   
 Hard/solid   Firm   Soft 
Shape :  Normal   Distorted   Detail:       
Stemmer’s Sign (affected hand):   Positive     Negative 
 
Range of Movement: 
 RIGHT LEFT 
100% 75% 50% 25% 0% 100% 75% 50% 25% 0% 
Shoulder           
Elbow           
Wrist           





3D photo:   Left arm  Right arm 
Perometer:  Left arm  Right arm 




Limb Volume 1 
 
 
Limb Volume 2 
Right Left Right Left 
Hand   Hand   
First Mark: 
cm 
1   1   









3   3   
4   4   
5   5   
6   6   
7   7   
8   8   
9   9   
10   10   
Distal Volume mls   Distal   
 
1   1   
2   2   
3   3   
4   4   
5   5   
6   6   
7   7   
8   8   
9   9   
10   10   
Proximal Volume mls   Prox   
Total Volume mls   Total   
Excess mls  Excess ml  
Excess %  Excess %  
Distal Volume Diff ml % Distal ml % 
Proximal Volume Diff ml % Prox ml % 





 No treatment   Skin Care Advice  Lymphoedema Exercises 
 Simple Lymph Drainage  Compression Garment  Weight Management  
 Manual Lymph Drainage  MLLB (including 3M)  Lymphassist 
 Deep Oscillation Therapy  Kinesiotape    Laser 
 Other:         
 
Change in garment needed?:  Yes  No  N/A Detail:      
 
If garment changed please complete: 
Garment:  Issued by clinic   Prescription issued 
 
Make of compression garment:   Material of garment: 
 Activa       Circular Knit 
 BSN        Flat Knit 
 Haddenham Healthcare 
 Juzo       Compression Class (RAL): 
 MediUK       ccl 1 
 Sigvaris       ccl 2 
 Venosan       ccl 3 







APPENDIX 11: Data results from the measurements 
Summary of the Limb Volume, Volume Difference (VD) and Percentage Volume Difference (%VD) for CTM over time 
ID 
# 





















1 2130.5 2044.5 86 4% 07:52 2064 2077.5 -13.5 -1% 2323 2295 28 1% 2265.5 2240.5 25 1% 
2 2884 2657.5 226.5 9% 04:00 3371 2899.5 471.5 16% 3171 2794.5 376.5 14% 3321.5 2873.5 448 16% 
3 2159 2092.5 66.5 3% 07:00 2148.5 2155 -6.5 0% 2162.5 2190 -27 -1% 2191.5 2115.5 76 4% 
4 2552.5 2483 69.5 3% 05:17 2353.5 2415.5 -62 -3% 2493.5 2443.5 50 2% 2388 2445.5 -57.5 -2% 
5 3969 3273.5 695.5 22% 05:59 3998.5 3403 595.5 18% 4015 3679.5 335.5 9% 4191 3805.5 385.5 10% 
6 6715.5 5049 1666.5 33% 07:47 6085 4836.5 1248.5 26% 6264 4753 1511 32% 6449 4758.5 1690.5 36% 
7 4506 4319.5 186.5 5% 04:56 4215 4051.5 163.5 4% 3819.5 3871.5 -52 -1% 4114 4058 56 2% 
8 3135 2850 286 10% 05:08 2994.5 2898 96.5 4% 2824.5 2843.5 -19 -2% 2851.5 2805.5 46 2% 
9 2400 2310 90 4% 05:33 2449 2274.5 174.5 8% 2327.5 2249.5 78 4% 2514 2429 85 4% 
10 2684 2237.5 447 20% 03:49 Failed  to Attend Failed  to Attend Failed  to Attend 
11 2631.5 2516 116 5% 05:39 2610.5 2503 107.5 5% 2466 2438.5 27.5 2% 2494.5 2484 11 1% 
12 3149 3172.5 -23.5 -1% 06:06 3425 3535.5 -110.5 -3% 1825 1742 -83 -3% 3300 3392 -92 -3% 
13 3002 2675 327.5 13% 06:30 2862 2632.5 229.5 9% 2892 2625 267 11% 2934.5 2601 333.5 13% 
14 4077 3093.5 983.5 32% 06:49 4179.5 3105.5 1074 35% 3969 3064 905 30% 3812 2939 873 30% 
15 2256 2108.5 147.5 7% 05:48 2258.5 2101 158 8% 2279 2160 119 6% 2295 2168.5 126.5 6% 
16 2068.5 1817.5 252 14% 06:00 2038.5 1871.5 167.5 9% 1986.5 1818 168.5 9% 1955 1803.5 151.5 9% 
17 2262 2986 276 10% 05:30 3127 3037.5 89.5 3% 3033.5 2910.5 123 4% 3070 2946.5 123.5 5% 
18 3762.5 3564.5 198 6% 08:49 Failed  to Attend 3538.5 3625.5 87.5 3% Failed  to Attend 
19 2502.5 2558 55.5 -2% 04:24 1593.5 2577 27 -1% 1503 2443 11.5 -1% Failed  to Attend 




Summary of the Limb Volume, Volume Difference (VD) and Percentage Volume Difference (%VD) for Perometry over time 
ID  
# 





















1 2716 2851 -135 -5% 01:37 Faulty Equipment 2390 2506 -135 -5% 2355 2447 -92 -4% 
2 3368 3664 296 9% 01:34 3274 3691 417 13% 2951 3306 296 9% 3556 4072 516 15% 
3 2587 2592 -5 0% 02:45 2660 2910 -250 -9% 2436 2441 -5 0% 2192 2232 -40 -2% 
4 2669 2778 109 4% 02:34 2874 2861 -13 0% 2759 2805 109 4% 2555 2575 20 1% 
5 4123 3479 644 19% 01:21 3897 3545 352 10 3946 3589 644 19% 4233 3950 283 7% 
6 4450 6337 1887 42% 02:31 Faulty Equipment 4261 5978 1887 42% 4223 6108 1885 45% 
7 4334 4292 -42 -1% 01:23 3891 3891 0 0% 4202 4066 -136 -3% 3984 3878 -106 -3% 
8 2511 2385 126 5% 01:30 2551 2385 166 7% 2600 2505 95 4% 2551 2548 3 0% 
9 2488 2586 98 4% 01:17 2735 2831 96 4% 2898 2955 57 2% 2853 2919 66 2% 
10 1555 1797 242 16% 02:23 Failed to attend Failed to attend Failed to attend 
11 2637 2556 81 3% 01:31 2832 2754 78 3% 2664 2579 85 3% 2445 2373 72 3% 
12 3459 3647 -188 -5% 01:23 3233 3287 -54 -2% 3289 3289 0 0% 3164 3239 -75 -2% 
13 3840 3506 334 10% 01:40 3523 3238 285 9% 3480 3237 243 8% 3594 3247 347 11% 
14 2343 3241 898 38% 01:31 2801 3771 970 35% 2537 3404 867 34% 2472 3428 956 39% 
15 2337 2390 53 2% 03:00 2548 2796 248 10% 2384 2492 108 5% 2356 2673 317 13% 
16 2193 1867 326 17% 01:30 2090 1929 161 8% 2140 1894 246 14% 2131 1840 291 16% 
17 2979 2793 186 7% 02:25 2755 2580 175 7% 2509 2333 176 8% 2598 2397 201 8% 
18 3103 3229 126 4% 03:08 Failed to attend 2877 3136 259 9% Failed to attend 
19 3192 3079 113 4% 01:59 3022 3112 -90 -3% 2732 2761 -29 -1% Failed to attend 




Summary of the Limb Volume, Volume Difference (VD) and Percentage Volume Difference (%VD) for 3DCI over time 
ID 
# 
First Assessment Follow Up 1 Follow Up 2 Follow Up 3 
Right 
Vol 
Left Vol VD %VD TIME 
Right 
Vol 
Left Vol VD %VD 
Right 
Vol 
Left Vol VD %VD 
Right 
Vol 
Left Vol VD %VD 
1 2316 2352 36 2% 1:57 1883.1 2149.9 266.7 14% 2326.1 2347.2 21.1 1% 2279.7 2401.6 121.9 5% 
2 2104.7 2281.5 176.8 8% 1:43 2094.5 2548.1 453.6 22% 2228.7 2592.6 363.9 16% 2095.9 2632.4 536.5 26% 
3 2409.2 2158.8 250.5 12% 1:55 2318.3 2323.8 -5.5 0% 2318.9 2331.9 -13 -1% 2159.7 2236 -76.3 -3% 
4 2588.4 2713.3 124.9 5% 2:03 2538.3 2519 -19.4 -1% 2333.7 2535.7 202 9% 2362.8 2420.4 57.6 2% 
5 3625 2954.6 670.4 23% 1:41 3461.5 2845.3 616.2 22% 3538.4 3078.3 460.1 15% 3591.3 3183.1 408.2 13% 
6 Arm too big for analysis 1:58 Arm too big for analysis Arm too big for analysis Arm too big for analysis 
7 3710.6 3939.6 229 6% 1:42 3525.9 3861.3 335.3 10% 3630.5 3893 262.5 7% 3631.2 3787.9 156.8 4% 
8 2404.8 2256.1 148.7 7% 1:50 2290 2262.5 27.1 1% 2343.6 2327.5 16.1 1% 2264.3 2299.8 -35.5 -2% 
9 2465.6 2308.8 -156.8 -6% 1:27 2335.9 2314.2 -21.6 -1% 2532.4 2525.1 -7.4 0% 2537.1 2572.5 35.4 1% 
10 2442 3158 716 29% 1:33 Failed to attend Failed to attend Failed to attend 
11 2705.5 2600.6 104.9 4% 1:41 2872.8 2650.6 222.2 8% 2502.2 2624 -121.8 -5% 2780.5 2458.3 322.2 13% 
12 2876.5 3025.2 -148.6 -5% 1:43 2477.2 2702.6 -225.4 -8% 2754.6 2666.5 88.1 3% 2820.1 2936.5 -116.5 -4% 
13 3006.7 2809.7 197 7% 1:30 3008.6 2616.7 391.9 15% 3062.3 2715.9 346.5 13% 2971.3 2582.2 389 15% 
14 2734 3581.8 847.8 31% 2:29 2835.4 3750.2 914.8 32% 2775.4 3753 977.6 35% 2704.1 3523.9 819.8 30% 
15 1878 2142.4 264.4 14% 1:55 1859 2253.4 394.4 21% 2010.5 2140.9 130.4 6% 1596.3 2272.8 676.5 42% 
16 2225.4 2015.4 210 10% 1:34 2191 2004.4 186.3 9% 2111.2 2025.3 85.9 4% 2144.9 2023.1 121.7 6% 
17 2750.4 2470.3 280.1 11% 1:43 3203.3 2914 289.3 10% 2826.6 2676.7 149.9 6% 2837.4 2817.8 19.5 1% 
18 2793.6 2962.3 168.7 6% 2:38 Failed to attend 2891.1 2997 105.8 4% Failed to attend 
19 2275.8 2404.7 -128.9 -5% 1:49 2406.4 2577.2 -170.8 -7% 2394.9 2450.1 -55.1 -2% Failed to attend 




Calculated Absolute Volume Difference (AVD) and Percentage Absolute Volume Difference (%AVD) of the affected upper limb for CTM, Perometry 
and 3DCI over time 
ID 
# 
CTM FU1 CTM FU2 CTM FU3 PERO FU1 PERO FU2 PEROFU3 3DCI FU1 3DCI FU2 3DCI FU3 
AVD %AVD AVD %AVD AVD %AVD AVD %AVD AVD %AVD AVD %AVD AVD %AVD AVD %AVD AVD %AVD 
1 -67 -3.1 193 9.0 135 6.3 Fault -345 -12.1 -404 -14.2 -202 -8.6 -5 -0.2 50 2.1 
2 487 16.9 287 10.0 438 15.2 27 0.7 -358 -9.8 408 267 267 11.7 311 13.6 351 15.4 
3 -11 -0.5 4 0.2 33 1.5 73 2.8 -151 -5.8 -395 -91 -91 -3.8 -90 -3.7 -250 -10.4 
4 -199 -7.8 -59 -2.3 -165 -6.4 83 3.0 27 1.0 -203 -194 -194 -7.2 -178 -6.5 -293 -10.8 
5 66 3.1 258 12.4 336 16.1 -226 -5.5 -177 -4.3 110 -163 -163 -4.5 -87 -2.4 -34 -0.9 
6 -631 -9.4 -423 -6.3 -267 -4.0 Fault -359 -5.7 -229 -3.6 Arm too big for analysis 
7 -291 -6.5 -687 -15.2 -392 -8.7 -401 -9.3 -226 -5.3 -414 -78 -78 -2.0 -47 -1.2 -152 -3.9% 
8 32 1.6 -37 -1.9 -61 -3.2 40 1.6 89 3.5 40 -115 -115 -4.8 -61 -2.5 -141 -5.8% 
9 49 2.0 -73 -3.0 114 4.8 245 9.5 369 14.3 333 5 5 0.2 216 9.4 264 11.4% 
10 Failed to attend Failed to attend Failed to attend 
11 -20 -1.2 -85 -5.3 -53 -3.3 195 7.4 27 1.0 -192 167 167 6.2 -203 -7.5 75 2.8% 
12 50 2.4 -1033 -49.3 -38 -1.8 -226 -6.5 -170 -4.9 -295 -399 -399 -13.9 -122 -4.2 -56 -2.0% 
13 -58 -3.4 -69 -4.1 -72 -4.3 -317 -8.3 -360 -9.4 -246 2 2 0.1 56 1.8 -35 -1.2% 
14 103 2.5 -108 -2.6 -265 -6.5 530 16.4 163 5.0 187 168 168 4.7 171 4.8 -58 -1.6% 
15 3 0.1 23 1.0 39 1.7 406 17.0 102 4.3 283 111 111 5.2 -2 -0.1 130 6.1% 
16 40 3.8 -1 0.0 -10 -0.9 -103 -4.7 -53 -2.4 -62 -35 -35 -1.6 -114 -5.1 -80 -3.6% 
17 25 1.3 -46 -2.3 -29 -1.5 -224 -7.5 -470 -15.8 -381 453 453 16.5 76 2.8 87 3.2% 
18 Failed to attend -137 -3.6 Failed to attend Failed to attend -93 -2.9 Failed to attend Failed to attend 35 1.2 Failed to attend 
19 -7 -0.4 -98 -6.1 Failed to attend -170 -5.3 -460 -14.4 Failed to attend 131 5.7 119 5.2 Failed to attend 




APPENDIX 12: The STARD 2015 List: An Updated List of Essential Items for 




TITLE OR ABSTRACT  
  1 
Identification as a study of diagnostic accuracy using at least one measure of accuracy 
(such as sensitivity, specificity, predictive values, or AUC)  
ABSTRACT  
  2 
Structured summary of study design, methods, results, and conclusions (for specific 





Scientific and clinical background, including the intended use and clinical role of the 
index test  





Whether data collection was planned before the index test and reference standard were 
performed (prospective study) or after (retrospective study)  
Participants 
6 Eligibility criteria  
7 
On what basis potentially eligible participants were identified (such as symptoms, results 
from previous tests, inclusion in registry)  
8 
Where and when potentially eligible participants were identified (setting, location and 
dates)  
9 Whether participants formed a consecutive, random or convenience series  
Test 
methods 
10a Index test, in sufficient detail to allow replication  
10b Reference standard, in sufficient detail to allow replication  
11 Rationale for choosing the reference standard (if alternatives exist)  
12a 
Definition of and rationale for test positivity cut-offs or result categories of the index test, 
distinguishing pre-specified from exploratory  
12b 
Definition of and rationale for test positivity cut-offs or result categories of the reference 
standard, distinguishing pre-specified from exploratory  
13a 
Whether clinical information and reference standard results were available to the 
performers/readers of the index test  
13b 
Whether clinical information and index test results were available to the assessors of the 
reference standard  
Analysis 
14 Methods for estimating or comparing measures of diagnostic accuracy  
15 How indeterminate index test or reference standard results were handled  
16 How missing data on the index test and reference standard were handled  
17 
Any analyses of variability in diagnostic accuracy, distinguishing pre-specified from 
exploratory  
18 Intended sample size and how it was determined  
RESULTS  
Participants 
19 Flow of participants, using a diagram  
20 Baseline demographic and clinical characteristics of participants  
21a Distribution of severity of disease in those with the target condition  
21b Distribution of alternative diagnoses in those without the target condition  
22 Time interval and any clinical interventions between index test and reference standard  
Test results 
23 
Cross tabulation of the index test results (or their distribution) by the results of the 
reference standard  
24 Estimates of diagnostic accuracy and their precision (such as 95% confidence intervals)  





Study limitations, including sources of potential bias, statistical uncertainty, and 
generalisability  
27 Implications for practice, including the intended use and clinical role of the index test  
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28 Registration number and name of registry  
29 Where the full study protocol can be accessed  




APPENDIX 13: Phase 1: Tests of Normality and Bland-Altman Plots 
3DCI 
Tests of normality of the 3DCI data for total volume difference (TVD) had an initial 
skewness more than three times the standard error, with kurtosis only slightly higher 
than the standard error. The Shapiro-Wilk test result for 3DCI had a p-value <0.05, 
indicating that the distribution deviates from normal (Laerd Statistics, 2018b).  
However, the Kolmogorov-Smirnov test had a p-value >0.05, thus normality could be 
assumed.  The Q-Q Plot shows the near normal distribution of kurtosis.  Square root and 
logarithms of the data were perforemd, but these overcorrected the data too much.  Thus 
the original data for 3DCI TVD was used for the construction of the Bland-Altman Plots. 
 
Descriptives of 3DCI Total  Volume Difference Data 
 Statistic Std. Error 
Standardized Residual for 3DCI 
VD 
Mean .0000 .12309 
95% Confidence Interval for 
Mean 
Lower Bound -.2458  
Upper Bound .2458  
5% Trimmed Mean -.0601  
Median -.1853  
Variance 1.000  
Std. Deviation 1.00000  
Minimum -1.60  
Maximum 2.79  
Range 4.39  
Interquartile Range 1.21  
Skewness .944 .295 
Kurtosis .600 .582 
 
Tests of Normality of 3DCI Total Volume Difference Data 
 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
Standardized Residual for 3DCI VD .105 66 .068 .933 66 .002 








Tests of normality of the CTM data for TVD had an initial skewness of nearly 10 times 
the standard error, and the kurtosis was nearly nine times greater than the standard error. 
Both the Shapiro-Wilk and Kolmogorov-Smirnov test results had a p-value <0.05, 
indicating that the distribution deviated from normal.  The Q-Q plot for CTM supports 
this outcome as the data deviates significantly from the diagonal line.  
 
Descriptives of CTM Total Volume Difference Data 
 Statistic Std. Error 
Standardized Residual for 
CTVD 
Mean .0000 .11625 
95% Confidence Interval for 
Mean 
Lower Bound -.2317  
Upper Bound .2317  
5% Trimmed Mean -.1341  
Median -.3489  
Variance 1.000  
Std. Deviation 1.00000  
Minimum -.94  
Maximum 3.65  
Range 4.59  
Interquartile Range .65  
Skewness 2.259 .279 
Kurtosis 4.908 .552 
 
Tests of Normality of CTM Total Volume Difference Data 
 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
Standardized Residual for CTVD .236 74 .000 .707 74 .000 





The square root of the data was performed, but had marginal improvement on the 
distribution of the data. Thus, transforming the data for normalisation was performed 
using the logarithm of the CTM TVD data.  Both the skewness and kurtosis were less 
than the standard error, and both the Kolmogorov-Smirnov and Shapiro-Wilk tests of 
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normality were non-significant (p>0.05), and was confirmed by the improved Q-Q Plot 
of data following the normative line more closely.  Thus, the logarithm of the CTM TVD 
was used for the Bland Altman plots. 
 
Descriptives of the Logarithm of CTM Total Volume Difference Data 
 Statistic Std. Error 
Standardized Residual for 
LNCTVD 
Mean .0000 .12599 
95% Confidence Interval for 
Mean 
Lower Bound -.2518  
Upper Bound .2518  
5% Trimmed Mean .0124  
Median -.0058  
Variance 1.000  
Std. Deviation 1.00000  
Minimum -2.22  
Maximum 1.96  
Range 4.18  
Interquartile Range 1.23  
Skewness -.048 .302 
Kurtosis -.189 .595 
 
Tests of Normality of the Logarithm of CTM Total Volume Difference Data 
 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
Standardized Residual for 
LNCTVD 
.048 63 .200* .983 63 .513 
*. This is a lower bound of the true significance. 















Tests of normality of the perometry data for TVD had an initial skewness of nine times 
the standard error, and the kurtosis was 13 times greater than the standard error. Both 
the Shapiro-Wilk and Kolmogorov-Smirnov test results had a p-value <0.05, indicating 
that the distribution deviated from normal.  The Q-Q plot for perometry confirmes this 
outcome as the data deviates significantly from the diagonal line.  
 
Descriptives of the Logarithm of Perometry Total Volume Difference Data 
 Statistic Std. Error 
Standardized Residual for 
PTVD 
Mean .0000 .11785 
95% Confidence Interval for 
Mean 
Lower Bound -.2350  
Upper Bound .2350  
5% Trimmed Mean -.1382  
Median -.2917  
Variance 1.000  
Std. Deviation 1.00000  
Minimum -1.16  
Maximum 3.84  
Range 5.00  
Interquartile Range .69  
Skewness 2.578 .283 
Kurtosis 7.424 .559 
 
Tests of Normality of the Logarithm of Perometry Total Volume Difference Data 
 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
Standardized Residual for 
PTVD 
.248 72 .000 .705 72 .000 





The square root of the data was performed, but had marginal improvement on the 
distribution of the data. Thus, transforming the data for normalisation was performed 
using the logarithm of the perometry TVD data.  Both the skewness improved 
significantly and was only twice the standard error, but the kurtosis was still three times 
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the standard error.  However, The Kolmogorov-Smirnov test was now non-significant 
with a p-value of 0.20; however the Shapiro-Wilk tests was still significant at p=0.04.  
The Q-Q Plot was improved but had one outlier that caused the significant kurtosis 
value.   
 
Descriptives of the Logarithm of Perometry Total Volume Difference Data 
 Statistic Std. Error 
Standardized Residual for 
LNPTVD 
Mean .0000 .13608 
95% Confidence Interval for 
Mean 
Lower Bound -.2729  
Upper Bound .2729  
5% Trimmed Mean .0323  
Median .1125  
Variance 1.000  
Std. Deviation 1.00000  
Minimum -3.51  
Maximum 1.92  
Range 5.43  
Interquartile Range 1.05  
Skewness -.652 .325 
Kurtosis 2.031 .639 
 
Tests of Normality of the Logarithm of Perometry Total Volume Difference Data 
 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
Standardized Residual for 
LNPTVD 
.103 54 .200* .954 54 .039 
*. This is a lower bound of the true significance. 





Thus, the perometry TVD data entry for number 68 was removed, which resulted in 
significantly improved values for the skewness and kurtosis (both less than the standard 
error), and both the Kolmogorov-Smirnov and Shapiro-Wilk tests of normality were 
non-significant (p>0.05), confirmed by the improved Q-Q Plot of data following the 
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normative line more closely.  Thus, the logarithm of the adjusted perometry TVD was 
used for the Bland Altman plots. 
Descriptives of the Logarithm of Adjusted Perometry Total Volume Difference Data 
 Statistic Std. Error 
Standardized Residual for 
LNCTVD 
Mean .0000 .12599 
95% Confidence Interval for 
Mean 
Lower Bound -.2518  
Upper Bound .2518  
5% Trimmed Mean .0124  
Median -.0058  
Variance 1.000  
Std. Deviation 1.00000  
Minimum -2.22  
Maximum 1.96  
Range 4.18  
Interquartile Range 1.23  
Skewness -.048 .302 
Kurtosis -.189 .595 
 
Tests of Normality of the Logarithm of Adjusted Perometry Total Volume Difference Data 
 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
Standardized Residual for 
LNCTVD 
.048 63 .200* .983 63 .513 
*. This is a lower bound of the true significance. 






















t Sig. B Std. Error Beta 
1 
(Constant) 1.254 22.209  .056 .955 
Mean .087 .068 .158 1.277 .206 
a. Dependent Variable: Difference 3DCI & CTM 
 








t Sig. B Std. Error Beta 
1 
(Constant) 27.624 25.478  1.084 .282 
Mean .047 .079 .074 .590 .557 













t Sig. B Std. Error Beta 
1 (Constant) .094 .552  .170 .866 
Mean -.032 .102 -.045 -.316 .754 





APPENDIX 14: Oedema Maps derived from 3DCI  
Key: cyan = no difference between arms; yellow to red = larger than unaffected side; 
blue = smaller than unaffected side 
Participant 1 
  
Initial Assessment     Follow up 1 
CTM = 4%      CTM = -1% 
Perometer = -4.7%      Perometer = FAULT 
3DCI = 1.6%      3DCI = 14.2% 
Redundancy = -1%     Redundancy = calculation error 
 
  
Follow up 2      Follow up 3 
CTM = 1%      CTM = 1% 
Perometer = -4.7%     Perometer = -3.8% 
3DCI = 0.9%      3DCI = 5.3% 






Initial Assessment     Follow up 1 
CTM = 9%      CTM = 16% 
Perometer = 8.8%      Perometer = 12.7% 
3DCI = 8.4%      3DCI = 21.7% 
Redundancy = 0%     Redundancy = 26% 
 
  
Follow up 2      Follow up 3 
CTM = 14%      CTM = 16% 
Perometer = 8.8%      Perometer = 14.5% 
3DCI = 16.3%      3DCI = 25.6% 









Initial Assessment     Follow up 1 
CTM = 3%      CTM = 0% 
Perometer = -0.2%      Perometer = -8.6% 
3DCI = 11.6%      3DCI = -0.2% 
Redundancy = 14%     Redundancy = -7% 
 
  
Follow up 2      Follow up 3 
CTM = -1%      CTM = 4% 
Perometer = -0.2%      Perometer = -1.8% 
3DCI = -0.6%      3DCI = -3.4% 









Initial Assessment     Follow up 1 
CTM = 3%      CTM = -3% 
Perometer = 4.1%      Perometer = -0.5% 
3DCI = 4.8%      3DCI = -0.8% 
Redundancy = 4%     Redundancy = 19% 
 
  
Follow up 2      Follow up 3 
CTM = 2%      CTM = -2% 
Perometer = 4.1%      Perometer = 0.8% 
3DCI = 8.7%      3DCI = 2.4% 









Initial Assessment     Follow up 1 
CTM = 21%      CTM = 18% 
Perometer = 18.5%      Perometer = 9.9% 
3DCI = 22.7%      3DCI = 21.7% 
Redundancy = 2%     Redundancy = 14% 
 
  
Follow up 2      Follow up 3 
CTM = 9%      CTM = 10% 
Perometer = 18.5%      Perometer = 7.2% 
3DCI = 14.9%      3DCI = 12.8% 
Redundancy = 10%     Redundancy = 3% 
 
Participant 6 







Initial Assessment     Follow up 1 
CTM = 5%      CTM = 4% 
Perometer = -1%      Perometer = 0% 
3DCI = 6.2%      3DCI = 9.5% 
Redundancy = 6%     Redundancy = 8% 
 
  
Follow up 2      Follow up 3 
CTM = -1%      CTM = 2% 
Perometer = -3.2%      Perometer = -2.7% 
3DCI = 7.2%      3DCI = 4.3% 










Initial Assessment     Follow up 1 
CTM = 10%      CTM = 4% 
Perometer = 5.3%      Perometer = 7% 
3DCI = 6.6%      3DCI = 1.2% 
Redundancy = 14%     Redundancy = -3% 
 
  
Follow up 2      Follow up 3 
CTM = 2%      CTM = 2% 
Perometer = 3.8%      Perometer = 0.1% 
3DCI = 0.7%      3DCI = -1.5% 










Initial Assessment     Follow up 1 
CTM = 4%      CTM = 8% 
Perometer = 3.9%      Perometer = 3.5% 
3DCI = -6.4%      3DCI = -0.9% 
Redundancy = -1%     Redundancy = calculation error 
 
  
Follow up 2      Follow up 3 
CTM = 4%      CTM = 4% 
Perometer = 2%      Perometer = 2.3% 
3DCI = -0.3%      3DCI = 1.4% 











Initial Assessment     Follow up 1 
CTM = 5%      CTM = 5% 
Perometer = 3.2%      Perometer = 2.8% 
3DCI = 4.0%      3DCI = 8.4% 
Redundancy = calculation error   Redundancy = -5% 
 
  
Follow up 2      Follow up 3 
CTM = 2%      CTM = 1% 
Perometer = 3.3%      Perometer = 3% 
3DCI = -4.6%      3DCI = 13.1% 







Initial Assessment     Follow up 1 
CTM = -1%      CTM = -3% 
Perometer = -5.2%      Perometer = -1.6% 
3DCI = -4.9%      3DCI = -8.3% 
Redundancy = -6%     Redundancy = 4% 
 
  
Follow up 2      Follow up 3 
CTM = -3%      CTM = -3% 
Perometer = 0%      Perometer = -2.3% 
3DCI = 3.3%      3DCI = -4% 









Initial Assessment     Follow up 1 
CTM = 13%      CTM = 9% 
Perometer = 9.5%      Perometer = 8.8% 
3DCI = 7%      3DCI = 15% 
Redundancy = -1%     Redundancy = 4% 
 
  
Follow up 2      Follow up 3 
CTM = 11%      CTM = 13% 
Perometer = 7.5%      Perometer = 10.7% 
3DCI = 12.8%      3DCI = 15.1% 









Initial Assessment     Follow up 1 
CTM = 32%      CTM = 35% 
Perometer = 38.3%      Perometer = 34.6% 
3DCI = 31%      3DCI = 32.3% 
Redundancy = -15%     Redundancy = 10% 
 
  
Follow up 2      Follow up 3 
CTM = 30%      CTM = 30% 
Perometer = 34.2%      Perometer = 38.7% 
3DCI = 35.2%      3DCI = 30.3% 









Initial Assessment     Follow up 1 
CTM = 7%      CTM = 8% 
Perometer = 2.3%      Perometer = 9.7% 
3DCI = 14.1%      3DCI = 21.2% 
Redundancy = 12%     Redundancy = 0% 
 
  
Follow up 2      Follow up 3 
CTM = 6%      CTM = 6% 
Perometer = 4.5%      Perometer = 13.5% 
3DCI = 6.5%      3DCI = 42.4% 









Initial Assessment     Follow up 1 
CTM = 14%      CTM = 9% 
Perometer = 17.5%      Perometer = 8.3% 
3DCI = 10.4%      3DCI = 9.3% 
Redundancy = -8%     Redundancy = 1% 
  
Follow up 2      Follow up 3 
CTM = 9%      CTM = 9% 
Perometer = 13%      Perometer = 15.8% 
3DCI = 4.2%      3DCI = 6% 










Initial Assessment     Follow up 1 
CTM = 10%      CTM = 3% 
Perometer = 6.7%      Perometer = 6.8% 
3DCI = 11.3%      3DCI = 9.9% 
Redundancy = 0%     Redundancy  = -1% 
 
  
Follow up 2      Follow up 3 
CTM = 4%      CTM = 5% 
Perometer = 7.5%      Perometer = 8.4% 
3DCI = 5.6%      3DCI = 0.7% 









Initial Assessment     Follow up 1 
CTM = 6%      Particiapnt unable to attend  
Perometer = 4.1%       
3DCI = 6%       
Redundancy = 16%      
  
 
Follow up 2      Follow up 3 
CTM = 3%      Did not attend 
Perometer = 9%       
3DCI = 3.7%       










Initial Assessment     Follow up 1 
CTM = -2%      CTM = -1% 
Perometer = 3.7%      Perometer = -2.9% 
3DCI = -5.4%      3DCI = -6.6% 
Redundancy = -4%     Redundancy = -10% 
 
 
Follow up 2      Follow up 3 
CTM = -1%      Did not attend 
Perometer = -1.1%       
3DCI = -2.3%       
Redundancy = 0%       
 




APPENDIX 15: Phase 2: Tests of Normality 
Shape Redundancy 
Tests of normality of the Shape Redundancy (R-value) data for percentage difference 
had an initial skewness more than four times the standard error, with kurtosis sevent 
times greater than the standard error. The Shapiro-Wilk test result for R-value had a p-
value <0.05, indicating that the distribution deviates from normal (Laerd Statistics, 
2018b).  The Q-Q Plot supports this outcome as the data deviates significantly from the 
diagonal line. 
 
Descriptives for Shape Redundancy Percentage Differences 
 Statistic Std. Error 
Standardized Residual for 
RedundancyP 
Mean .0000 .12910 
95% Confidence Interval for 
Mean 
Lower Bound -.2583  
Upper Bound .2583  
5% Trimmed Mean .0627  
Median -.0249  
Variance 1.000  
Std. Deviation 1.00000  
Minimum -3.68  
Maximum 1.97  
Range 5.64  
Interquartile Range 1.14  
Skewness -1.288 .309 
Kurtosis 4.399 .608 
 
Tests of Normality for Shape Redundancy Percentage Differences 
 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
Standardized Residual for 
Shape Redundancy 
.122 60 .026 .888 60 .000 





Transforming the data for normalisation was performed using the square root of the R-
value data.  Both the skewness and kurtosis were significantly less than one times the  
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standard error, and both the Kolmogorov-Smirnov and Shapiro-Wilk tests of normality 
were non-significant (p>0.05), as confirmed by the improved Q-Q Plot of data following 
the normative line more closely.  The logarithm of the data was also calculated, but this 
overcorrected the data.  Thus, the square root of the Shape Redundancy percentage 
differences was used for the Bland Altman plots. 
 
Descriptives 
 Statistic Std. Error 
Standardized Residual for 
SqRtRvalue 
Mean .0000 .16440 
95% Confidence Interval for 
Mean 
Lower Bound -.3334  
Upper Bound .3334  
5% Trimmed Mean .0069  
Median -.0830  
Variance 1.000  
Std. Deviation 1.00000  
Minimum -1.75  
Maximum 1.72  
Range 3.48  
Interquartile Range 1.48  
Skewness -.319 .388 
Kurtosis -.777 .759 
 
Tests of Normality 
 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
Standardized Residual for 
SqRtRvalue 
.116 37 .200* .944 37 .063 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
 
 
 
 
 
 
 
 
